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ABSTRACT 
 
The selective oxidation of organic compounds is one of the most attractive transformations 
for both, industry and academia. Industrial interest stems from the potential application of 
such oxidation methodologies in the economic, greener synthesis of valuable products, 
whereas academic research is challenged by the difficulties in achieving specific, direct 
functionalisation of the “inert” CH bonds in complex molecules. In this Ph. D. thesis, our 
contribution to the selective oxidation of organic substrates using a novel class of iron 
catalysts is presented. 
A general introduction covering the major challenges in the area of iron-catalysed selective 
oxidation of organic compounds is described in Chapter 1. Chapter 2 covers the design, 
synthesis and coordination properties of the novel PyBisulidine type ligands, which we have 
conceived for their potential use in selective oxidation, attempting to overcome some of the 
limitations of current methods. 
The efficiency of such PyBisulidine ligands is demonstrated in Chapter 3, where iron-
PyBisulidine complexes are used for catalysing the aerobic α-oxidation of functionalised 
ethers. High catalytic efficiency, very good mass balance and excellent functional group 
tolerance were achieved with these catalysts under mild conditions. Such advantages stem 
from an unconventional reaction mechanism, involving the dehydrogenative oxygenation of 
the ether substrate to give a peroxobisether, followed by the cleavage of the peroxy bond to 
form two ester molecules. Unlike metalloenzymes and biomimetic iron complexes, H2 is 
released as the sole byproduct during the catalytic cycle. The oxidation mechanism is 
discussed in Chapter 4. 
Like natural dioxygenases, iron-PyBisulidine catalysts were found capable of promoting the 
aerobic cleavage of aliphatic C-C and C-O bonds. Even though biomimetic complexes are 
often seen as simplified models to study enzymatic processes, a more synthetic perspective 
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of the selective aerobic cleavage of ethereal C-C and C-O bonds is described in Chapter 
5.The great potential of such cleavages in organic synthesis is well exemplified in the iron-
PyBisulidine catalysed direct conversion of natural isochromans into biologically active 
isochromanones with excellent selectivity.  
The ability of the iron-PyBisulidine complexes in catalysing aerobic C-C cleavages is 
further expanded in Chapter 6, where the oxidative cleavage of olefinic C=C bonds to 
carbonyl compounds is demonstrated. The catalytic reactions proceeded efficiently, showing 
a broad scope and a mechanism that involves the formation of dioxetane intermediates is 
postulated. Chapter 7 is an extension of Chapter 6, in which iron-PyBisulidine complexes 
were found to catalyse α-methylstyrene linear dimerisation under an inert atmosphere. 
Moreover, control in the regioselectivity of the double bond in the dimers can be achieved 
by modifications in the PyBisulidine ligands. 
Final conclusions and a perspective of the research covered in this Ph.D. thesis are provided 
in Chapter 8. 
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ABBREVIATIONS 
 
α  alpha 
δ  chemical shift 
Å  amstrong 
AcOEt  ethyl acetate 
AcOH  acetic acid 
Ar  aryl 
atm  atmosphere 
°C  Celsius degree 
13C  carbon 13 
CI  chemical ionisation 
circa  approximately 
DCM  dichloromethane 
DCE  1,2-dichloroethane 
FAB  fast atom bombardment 
EI  ionisation potential 
equiv.  equivalent 
ESI   electrospray ionisation 
V 
 
Et2O  diethyl ether 
g  gram(s) 
GC  gas chromatography 
h  hour 
1H  proton 
H2   molecular hydrogen 
HRMS  high resolution mass spectroscopy 
HOMO highest occupied molecular orbital 
Hz   hertz 
i.e.  id est (that is to say) 
IR  infrared spectrometry 
J  coupling constant value 
LUMO lowest occupied molecular orbital 
MeCN  acetonitrile 
MEMCl 2-methoxyethoxymethyl chloride 
mg  milligram(s) 
min  minute(s) 
mL  millilitre 
mmol  milimole(s) 
VI 
 
MS  mass spectrometry 
NEt3  triethylamine 
NMR  nuclear magnetic resonance 
O2  molecular oxygen 
Ph-H  benzene 
Ph-Me  toluene 
ppm  parts per million 
rsm  recovered starting material 
r.t.  room temperature 
S/C  substrate to catalyst ratio 
THF  tetrahydrofuran 
THP  tetrahydropyran 
TMS  tetramethylsilane 
TON  turnover number 
tR   retention time 
vide infra  see below 
vide supra see above 
vs  versus 
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1.1. Iron: metal of the past, metal for the future 
1.1.1. Sustainable chemistry 
Global concern about sustainability is currently leading to a progressive change in 
economics, politics and science. In that regard, the role of chemists has been strongly 
criticised, quoting Terry Collins “chemists have been focused on developing reactions that 
generate only the desired product by using simple process designs and involving almost 
every element of the periodic table instead of using a few more innocuous elements in more 
sophisticated designs”. 1 However, chemists nowadays are well aware of the enormous 
potential and necessity of sustainable chemistry. Indeed, the development of more 
environmentally friendly transformations has become a new great challenge with a growing 
number of publications covering many chemical transformations under greener conditions. 
In addition, the attitude of companies and organizations towards sustainable processes is also 
evolving and nowadays the biggest question that arises is how to accomplish their 
implementation rather than questioning the necessity.
2
 The design of new low-waste 
processes, such as click chemistry transformations
3
 and the incorporation of catalysts to 
reduce the energy consumption have emerged as chief technologies for achieving more 
sustainable chemical processes.  
1.1.2. Sustainable metal catalysis 
Because of their efficiency and lower environmental impact, catalytic transformations are of 
upmost importance in academia and industry. In fact, the industrial synthesis of about 80% 
of all chemicals and pharmaceutical products involves the utilization of catalysts and the 
figure rises up to a 90% in the case of more modern processes.
4
 Catalysis can be generally 
divided in two main areas: 
1. Heterogeneous catalysis in which the catalyst and substrates are in different phases 
2. Homogenous catalysis in which catalyst and substrate are in the same phase 
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Even though heterogeneous catalysis is more applied in industrial transformations, 
homogenous catalysis offers certain advantages, such as higher regio-, chemo- and 
stereoselective control, and because the catalyst and the substrates are present in the same 
phase it is relatively easy to perform mechanistic investigations that allow a better 
understanding of the reaction and the possibility of improving the catalyst. Nevertheless, one 
of the biggest issues of homogeneous catalysis is that the vast majority of homogenous 
catalysts are based on platinum metals of limited abundance, high cost and significant 
toxicity (Figure 1). Therefore, transition metal catalysis is still far from satisfying 
sustainability.
5
 
 
Figure 1. Comparison of market prices of transition metals and iron during the last decade. 
(Values based on  www.platinum.mattey.com data for platinum metals and 
www.metalprices.com data for iron scrap). 
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In order to make catalytic processes more sustainable, three major strategies have merged 
and rapidly expanded during the last years:  
1. Organocatalysis,6 which is based on the utility of small organic molecules for 
accelerating chemical reactions and thus, it eliminates the use of toxic transition 
metals. 
2. Bio-catalysis,7 which aims to apply isolated enzymes or cells as catalysts in order to 
achieve the high efficiency and stereoselectivity of biological processes in 
laboratory and commercial scale transformations.  
3. Sustainable metal catalysis which is focused on the use of highly active catalysts 
based on non expensive, abundant and metabolizable transition metals such as iron, 
copper, zinc and manganese.
4
 
1.1.3. Iron in catalysis 
Among cheap metals, iron is particularly advantageous as it is very accessible due to its 
great abundance on the earth crust and thus, it is relatively cheap compared with precious 
metals (Figure 1). In addition, a large variety of iron salts are commercially available or can 
be easily synthesised and as iron is an essential element, its salts are relatively non-toxic for 
humans.
4
 Furthermore, many oxidation states are accessible; so iron complexes exhibit a 
very ample organometallic chemistry allowing excellent versatility in catalysis.
7
  
Despite all these advantages the impact of iron in the field of catalysis has been surprisingly 
modest compared with that of the other Group VIII metals, the Reppe synthesis and 
subsequent related processes being the most significant contributions in the area.
8
 Only 
relatively recently the potential of iron has started to be explored and very efficient 
transformations that can compete with other platinum metal-catalysed ones have been 
reported
9
. In particular, many iron-based methodologies are being developed in the field of 
oxidation, reduction and coupling chemistry. Thus it can be foreseen that iron has an 
important role to play in future catalysis.
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1.2. Iron catalysed selective oxidation of organic compounds 
1.2.1. Natural metalloenzymes 
Nature has mastered the art of oxidation using metalloenzymes, which are capable of 
selectively oxidizing various substrates with O2 under mild conditions showing excellent 
specificity and chemoselectivity.
10
 Interestingly, most of these enzymes are metalloenzymes 
containing an iron-based active site. Depending on the nature of the prostetic group, 
oxygenases are often classified as heme (or haem) if the metal centre is contained in a 
porphyrin ring, or non-heme when there is no porphyrin core.
11
 
 
 
Scheme 1. Common natural modes of selective oxidation of organic substrates 
 
Depending on the oxygenases used, different modes of O2 activation are possible, leading to 
the insertion of one (monoxygenase activity) or both (dioxygenase activity) oxygen atoms of 
O2 into a C-H bond
10,12
 (Scheme 1). Although the reaction mechanism for different enzymes 
may differ in some aspects, mononuclear iron-metalloenzymes react with O2 to generate a 
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high valent Fe
IV
=O or Fe
V
O(OH) species, which act as the oxidising agent of the reaction
12
 
(Scheme 2). 
 
 
Scheme 2. Mononuclear iron-oxygenase mechanisms 
 
1.2.2. Biomimetic iron catalysts 
Inspired by nature, a great variety of iron-based biomimetic catalysts have been designed to 
replicate and expand naturally occurring oxidations. The groups of Que Jr.
13
, Jacobsen
14
 and 
White
15
 among others
16
 have demonstrated that tetradentate N-donor ligands in combination 
with commercial iron salts are efficient catalysts for the selective oxidation of many organic 
substrates (Scheme 3). However, these biomimetic catalysts generally require the use of 
more active and expensive H2O2 as oxidant and additives (AcOH) to generate the high valent 
iron-oxo species
12
 (Scheme 4). 
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Scheme 3. Examples of biomimetic iron complexes bearing tetradentate N-donor ligands 
 
 
Scheme 4. Formation of iron-oxo species from bioinspired iron catalysts 
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1.3. Major challenges in iron-catalysed selective oxidations 
Even though the iron catalysed selective oxidation of organic substrates has expanded 
broadly with significant advances being reported in the field during the last decade, many 
issues remain unsolved. A summary of the most important challenges in the area is discussed 
herein, mainly covering: type of ligands, O2 activation, oxidation of electron rich substrates 
and selective aerobic C-C cleavage. 
1.3.1. Alternatives to tetradentate ligands 
The application of tetradentate N-donor ligands for biomimetic oxidations has been 
extensively studied either as porphyrin type skeletons or as non-heme designs.
17
 Such 
interest stems from the belief of catalyst decomposition and unselective Fenton-type side 
reactivity under oxidation conditions would be prevented by chelating the iron centre with a 
rigid, tetradentate ligand.
18
 However, iron complexes bearing pentadentate or tridentate N-
donor ligands are much less explored alternatives that might help overcoming some of the 
limitations associated to tetradentate complexes. 
1.3.1.1. Bioinspired pentadentate N-donor ligands 
Inspired by the ability of natural iron
II
-bleomicyne (Fe-BLM) to react with O2 and undergo 
oxidation reactions similar to heme proteins,
19
 the group of Rybak-Akimova developed a 
library of pentadentate N-donor ligands which can complex with Fe
II
 salts in a tetragonal-
pyramidal geometry analogue to natural Fe-BLM. This family of iron complexes were found 
active for the epoxidation of aliphatic olefins with good yields and selectivity using H2O2 as 
oxidant.
20
 The protonation of the pendant amino-arm with non-coordinating triflic acid was 
considered crucial for achieving peroxide activation (Scheme 5).To the best of our 
knowledge, this is the only example in the literature of N-donor pentadentate-iron catalysts 
for oxidation reactions.  
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Scheme 5. Bioinspired N-donor pentadentate-iron catalysts for olefin epoxidation 
 
1.3.1.2. Tridentate N-donor ligands 
Tridentate N-donor ligands have been slightly more investigated for oxidations than 
pentadentate skeletons. However, their application has been surprisingly limited to 
asymmetric olefin epoxidation reactions. Very recently, Niwa and Nakada reported a family 
of Fe
III
 complexes bearing a tridentate 1,8-(bisoxazolyl)carbazole ligand and their 
application for the catalytic asymmetric epoxidation of (E)-alkenes using PhIO as oxidant
21
 
(Scheme 6). Such ligand design possesses the same structural aspects as porphyrines, i.e. a 
conjugated planar structure with donor N atoms, but it can be easily synthesised and 
stereoinductive moieties can be more facilely introduced and modified than in chiral 
porphyrins.
22
 Excellent enantioselectivity was achieved for the epoxidation of stilbenes and 
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cinnamyl alcohol derived alkenes with such iron complexes under mild conditions. 
However, more than stoichiometric amounts of the strong oxidant PhIO as well as additives 
were needed. Indeed, the use of sodium tetrakis[3,5-bis(trifluoromethylphenyl)] borate 
(NaBARF) for abstracting the halogens from the iron pre-catalyst was essential for the 
oxidation to proceed and the addition of a SIPrAgCl (SIPr = N, N’-bis(2,6-
diisopropylphenyl)-4,5-dihydro imidazol-2-ylidene) allowed to improve both the reaction 
yields and enantioselectivity. 
 
 
 
Scheme 6. Asymmetric olefin epoxidation catalysed by tridentate iron
III
-carbazole 
complexes 
 
In addition, extensive research from the group of Beller demonstrated that ruthenium 
complexes with privileged tridentate ligands such as terpyridines (terpy), 
pyridinebisoxazolines (pybox), pyridinebisoxazines (pyboxazines), pyridine bisimidazolines 
(pybims) can be applied to enantioselective olefin epoxidations in the presence of pyridine-
2,6-dicarboxylate using H2O2 as oxidant
23
 (Scheme 7). However, epoxidations attempted 
with analogue iron complexes showed poor results. 
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Scheme 7. Asymmetric olefin epoxidation catalysed by tridentate Ru complexes. 
1.3.2. Use of molecular oxygen as oxidant 
Even though dioxygen is the most desired oxidant in oxidation chemistry
24
 and natural 
enzymes can facilely activate it under very mild conditions, its catalytic activation by 
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synthetic iron complexes or salts has proven a significant challenge, because of two major 
reasons: 
1. The reaction of an organic substrate with O2 is thermodynamically favoured as it is 
linked to high energy release. However, the spin mismatch between ground-state O2 
(triplet) and most organic substrates (singlet) makes the reaction kinetically 
unfavoured.
10
 As a consequence, reactions with O2 tend to proceed slowly. 
2. The O=O bond is relatively strong with a bond dissociation energy (BDE) of 494 
kJ/mol. Having two unpaired electrons on its ground state, O2 can be classified as a 
diradical. Most of its reactions proceed via one-electron steps, with the addition of 
electrons weakening the O-O bond and resulting in more reactive superoxo and 
peroxo species
25
 (Scheme 8). As biomimetic iron catalysts usually rely on the 
formation of an iron-oxo species, the use of H2O2 is widespread, given that the 
cleavage of the O-O bond is easier than in molecular oxygen. 
 
Scheme 8. BDE and length differences between dioxygen, superoxo and peroxo species. 
 
Although most of the synthetic iron complexes rely on the use of hydrogen peroxide as an 
oxidant, a few selected iron catalysts have been proven capable of activating O2. However, 
poor selectivities and a strong need of additives are major drawbacks associated to these 
catalysts.  
1.3.2.1. Oxidations in the presence of a reductant 
1.3.2.1.1. Gif Chemistry 
In 1983, Barton reported a protocol for the mild oxidation of C-H bonds in alkanes using 
metallic iron under aerobic atmosphere. The use of a source of sulfide anions (H2S or Na2S) 
in combination with pyridine and acetic acid as a solvent mixture was found crucial to 
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accomplish the oxidation of adamantane
26
 (Scheme 9). Since this pioneering report, many 
variations of the initial reactive mixture have been reported with a significant contribution 
from the group of Barton himself. As most of their work was developed in Gif-sur-Yvette, 
the name “Gif chemistry” has been coined for such oxidations. The major resemblances and 
limitations
27
 of Gif systems are summarised in Table 1. 
 
 
Scheme 9. Oxidation of adamantine using Na2S as a sulphide source 
 
Table 1. Resemblances and limitations of Gif systems 
 
Despite its limitations some relevant industrial applications of Gif systems have been 
disclosed. For instance, the oxidation of cyclohexane or cyclododecane to their keto/alcohol 
form is used for the industrial production of adipic acid and 1,12-dodecanedioic acid, which 
are important precursors in the manufacture of Nylon.
28
 Due to its high complexity, the 
mechanistic understanding of Gif systems has been quite controversial. Barton hypothesised 
that the predominant formation of the ketone product and the preferential oxidation on 
secondary CH bonds stemmed from the formation of an electrophilic Fe
v
=O species 
undergoing a concerted addition to the CH bond. The preference for oxidising secondary CH 
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bonds was interpreted as a compromise between bond strength (prim > sec > tert) and steric 
hindrance (tert > sec > prim). Such process is known as “non-radical FeIII- FeV manifold” 29 
(Scheme 10). However, formation of hydroperoxide species was also demonstrated, with the 
oxygen content of such peroxide species derived from O2 and suggesting radical side 
reactions.
30
 Moreover, the competitive formation of a Fe
IV
=O species capable of generating 
alkyl radicals was also hypothesised by Barton and co-workers as the “radical FeII – FeIV 
manifold” 30,31 (Scheme 11). Evidence of such manifold is based on the detection of alkyl 
chloride byproducts. 
 
Scheme 10. Non radical Fe
III
 – FeV manifold 
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Scheme 11. Radical Fe
II
 – FeIV manifold 
 
1.3.2.1.2. Greener alternatives to Gif systems: macrocyclic iron catalysts 
Dinuclear Fe
II
 complexes resulting from the combination of iron chlorides with 
poly(azadiphenol) macrocylic ligands were found to catalyse the aerobic oxidation of 
adamantane to its alcohol or keto form
32
 (Scheme 12). Such catalysts are similar to Gif 
systems, requiring the use of hydrogen sulfide as a reductant but affording preferentially a 
mixture of alcohol products. Lower catalysts loadings and much reduced amounts of 
pyridine were used to achieve catalytic activity, resulting in a more environmentally friendly 
protocol. In addition, these macrocyclic complexes are compatible with different solvents, 
with the product distribution being affected by the choice of solvent and reaction time 
(Scheme 12). 
 
Scheme 12. Macrocyclic Fe complexes for the aerobic oxidation of adamantine 
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1.3.2.2. Oxidations in the presence of sacrificial substrates 
1.3.2.2.1. Mukaiyama´s oxidation reactions 
The catalytic aerobic oxidation of an ample variety of organic substrates in the presence of a 
large excess of an aldehyde or an acetal was demonstrated by Mukaiyama and co-workers in 
the early 90´s.
33
 Because many transition metal complexes can serve as active catalysts for 
such transformations and because of its wide scope, the atmospheric aerobic oxidations of 
organic substrates in the presence of a sacrificial aldehyde are known as oxidations under 
Mukaiyama´s conditions. 
In particular, complexes of  deprotonated 2-(acetoxy)ethyl methacrylate (AAEMA
-
) with 
cheap metals such as Fe, Cu or Ni have shown catalytic activity for the oxidation of alkanes, 
alkenes, alcohols, aldehydes, sulfides and cyclic ketones albeit in each case the investigated 
substrate scope is limited to only one or two examples
34
 (scheme 13).  
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Scheme 13. Scope of the oxidation reactions catalysed by the Fe(AAEMA)3 complex using 
iso-butyraldehyde as a sacrificial substrate 
 
Although not much mechanistic evidence has been reported, variations on the reaction 
efficiency with different metals suggest that different mechanisms for oxygen activation and 
different oxygen transfer species may be in operation.
35
 Participation of radical species is 
suggested in all cases as inhibition of different oxidation reactions was detected in the 
presence of radical scavengers. In addition, the isomerisation of the C-C double bond 
observed in cis- and trans-octenes during their Fe(AAEMA)3 catalysed epoxidation 
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reactions is also consistent with the formation of radical intermediates.
35
 The hypothetic 
mechanism for the Fe(AAEMA)3 catalysed oxidation reactions involves the formation of a 
Fe
III
 acyl radical species I by replacement of a AAEMA ligand with a molecule of aldehyde. 
Further reaction of this species with dioxygen would result in the formation of the Fe
V
-oxo 
species II and/or a Fe
III
 peroxoacyl complex III (Scheme 14). Both intermediates could 
serve as the active oxidising agents of the Fe-catalysed Mukaiyama´s reactions.
35
 
 
Scheme 14. Proposed mechanism for the Fe(AAEMA)3 catalysed oxidation reactions 
 
1.3.2.2.2. Biomimetic designs 
Natural α-ketoglutarate-dependent FeII dioxygenases are known to catalyse the aerobic 
oxygenation of organic substrates with additional oxidation and decarboxylation of a 
cofactor, releasing CO2 and succinate.
36
 Inspired by this natural system, Valentine and co-
workers reported a Fe
II
 complex of benzoylformate (BF) and tris-(3,5-dimethyl-1-
pyrazolyl)borohydride (HB(3,5-Me2pz)3) capable of catalysing the aerobic epoxidation of cis 
and trans-stilbenes with additional oxidation of the BF ligand to give benzoate
37
 (Scheme 
15). The reaction proceeded with good yields under mild conditions and it is the first 
reported biomimetic catalyst capable of oxygenating both an organic substrate and a 
cofactor. 
Mechanistic investigations revealed that a free radical autoxidation pathway is not involved 
as no cis/trans isomerisation was detected in stilbene epoxidations and no competitive allylic 
oxidation of cyclohexene was observed. A reaction mechanism involving the formation of a  
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Scheme 15. Fe-catalysed epoxidation of stilbenes catalysed under aerobic conditions and its 
postulated mechanism. 
ferric superoxide that can react with the BF ligand generating a peroxy adduct was 
postulated. This peroxy adduct can react with the stilbene, giving the epoxide product, CO2 
and the benzoate. However, the initial decarboxylation of the peroxy adduct with 
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concomitant formation of other oxo-iron species as oxidizing agents cannot be ruled out 
(Scheme 15). 
 
The iron-catalysed aerobic epoxidation of olefins using a bioinspired sacrifial substrate was 
further expanded by the groups of Costas and Beller, who demonstrated that catalytic 
amounts of iron chloride with an excess of imidazole 1 and ethyl 2-oxocyclohexane 
carboxylate 2 could epoxidise a variety of stilbenes and styrenes with moderate yields and 
selectivity under mild conditions
38
(Scheme 16). 
  
 
Scheme 16. Iron-catalysed aerobic epoxidation of olefins with a bioinspired sacrificial 
substrate 
 
Mechanistic investigations showed consistency with the formation of a dicarboxylate, 
monoimidazole Fe
III
 complex ([Fe
III 
(1-H)(2)2]
+
) as the catalytic active species. Under 
aerobic atmosphere, formation of a superoxide species I was proposed.  The superoxide 
species can be radically added to the olefinic substrate and after O-O cleavage, formation of 
the epoxide product and hydroxylation of the sacrificial keto-ester was postulated (Scheme 
17). However, a competitive four electron oxidation of the sacrificial substrate was also 
observed. Its formation is suspected to stem from the formation of the organic peroxide 
species II, in a similar fashion as the iron-dependent acetylacetone dioxygenase (Dke 1) 
oxygenates 2,4-pentadione.
39
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Scheme 17. Proposed mechanism for the iron-catalysed olefin epoxidation with a 
bioinspired sacrificial substrate  
1.3.2.3. Photoinduced aerobic oxidations 
1.3.2.3.1. Reactions catalysed by simple iron salts 
In the early 90´s the group of Shul´pin developed a novel methodology for the photocatalytic 
(h  > 300 nm) aerobic oxygenation of alkanes and arylalkanes into hydroperoxides using 
FeCl3 as catalyst.
40
 The catalyst is compatible with different solvents such as acetic acid, 
acetonitrile or alcohols; however, the scope of the method is limited to simple alkanes such 
as cyclohexane and toluene. FeBr3 was also found catalytically active for the oxidation of 
the more activated arylalkanes.
41
 The proposed mechanism involves the photoinduced 
homolitic cleavage of the Fe-Cl bond releasing a chloride radical. The chlorine radical 
initiates the formation of carbon-centred radicals that undergo subsequent oxygenation to 
form the final peroxoalkyl species
42
 (Scheme 18). The reduced catalytic efficiency of the 
FeBr3 can be understood on the basis of the lower reactivity of the bromine radical. 
Chapter 1 
 
22 
 
 
Scheme 18. Photoinduced oxygenation of alkanes into alkylhydroxides catalysed by FeCl3 
 
1.3.2.3.2. Bioinspired catalysts 
Inspired by the capability of iron-porphyrines in oxidising organic substrates under aerobic 
conditions via the formation of an electrophilic Fe
IV
=O species, the group of Nocera 
investigated the use of iron bisporphyrine skeletons for undergoing similar aerobic 
oxidations. Extensive studies showed that bis-Fe
III
-µ-oxo-Pacman porphyrin complexes were 
effective for the oxidation of olefins
43
 and activated unfunctionalised aryl hydrocarbon CH 
bonds
44
 under aerobic atmosphere and visible light irradiation (Scheme 19). Even though the 
scope of the CH oxidation is very limited, good TONs were achieved for substrates 
displaying lower CH ionisation energies (EI). The catalytic cycle for such transformation is 
under current investigation; however, the formation of a Fe
IV
=O species capable of 
undergoing hydrogen atom abstraction from the substrate is postulated. In addition, a small 
kinetic isotopic effect (kH/kD) of 1.55 at 25 ºC obtained by comparing the oxidation of 
toluene with deuterated toluene suggests that the oxidation reaction occurs via an 
asynchronous proton coupled electron transfer (PCET) mechanism,
45  
according to which
 
the 
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abstraction of a hydrogen radical from the organic substrate takes place. Subsequent 
oxidation of the carbon-based radical species would afford the reaction product.  
 
Scheme 19. Photoinduced oxidation of hydrocarbons catalysed by bis-iron
III
-µ-oxo-Pacman 
porphyrin complexes 
 
More recently, the groups of Mahy and Auckauloo reported the sophisticated generation of a 
diron
III
 peroxo species via photoactivation of the bioinspired diiron
II
 complex I under 
aerobic atmosphere. The resulting oxygenated diiron
III
 peroxide was found capable of 
oxidising PPh3 to Ph3P=O via oxygen atom transfer.
46
 In addition, triethylamine was used as 
a sacrificial electron donor in the presence of a Ru-pyridine photosensitizer that ultimately 
reduces the initial diiron
III
 species to its diiron
II 
form (Scheme 20). 
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Scheme 20. Photoinduced oxygen activation at a diiron
III
 complex followed by oxygen 
transfer to PPh3. 
1.3.3. Electron-rich substrates: aerobic oxidation of ethers 
The selective catalytic oxidation of C-H bonds has evolved rapidly in the last decade, with 
many iron-based catalysts being now available for the oxidation of complex substrates. 
However, the development of chemoselective catalysts capable of undergoing CH oxidations 
in the presence of electron rich functionalities is a remaining challenge. For such substrates, 
poor selectivity, limited substrate scope and undesired substrate decomposition are often 
encountered limitations, partly because of the harsh reaction conditions required.
47
 
The selective α-oxidation of ethers under aerobic conditions is a long time pursued 
transformation of industrial interest. Efficient methods for the aerobic oxidation of 
functionalised ethers would in principle, facilitate the synthesis of natural products and 
biologically active molecules in an industrial scale.
48
 Because of the aforementioned issues, 
a green and efficient catalytic version of this reaction remains to be developed.  
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1.3.3.1. Stoichiometric metal oxides as oxidising agents 
Early attempts on the selective α-oxidation of ethereal substrates to esters were based on the 
use of transition metal oxides as oxidising agents. In this regard, ruthenium tetroxide (RuO4) 
was found to selectively oxidise tetrahydrofuran (THF) to γ-butyrolactone with quantitative 
yields
49
 (Scheme 21(a)).  More than stoichiometric amounts of oxidising agent were needed 
and the scope of the reaction was not explored further, probably because the oxidation of 
tetrahydrofurfuryl alcohol afforded the aldehyde lactone, suggesting poor functional group 
tolerance. In addition, aryl ethers cannot be oxidised as RuO4 is known to degrade aryl 
groups.
50
 
The reaction scope was slightly improved by the group of Schaeffer, who demonstrated that 
benzyl(triethylammonium) permanganate in stoichiometric amounts could undergo the 
chemoselective oxidation of unfunctionalised alkyl and phenyl ethers to esters
51 
(Scheme 
21(b)). However, the reactions were slow (circa 6 days), low temperatures were needed and 
the scope was mainly limited to few benzyl ethers.  
The selective oxidation of methyl ethers to formates was demonstrated using an excess of 
toxic chromium trioxide (CrO3) in acetic acid.
52
 Non-functionalised aliphatic methyl ethers 
were oxidised with moderate yields under mild conditions. However, the high reactivity of 
such strong oxidant limited the reaction scope, and additional synthetic steps for group 
protection and deprotection were required (Scheme 21(c)). 
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Scheme 21. Selective α-oxidation of ethers to ester using stoichiometric transition metal 
oxides 
1.3.3.2. Catalytic methods using strong oxidants 
Since its introduction in 1958, classical ether oxidation with RuO4 has been exhaustively 
improved. More modern methods allow the in situ preparation of the oxidant from 
commercial Ru salts such as RuCl3 or RuO2 and a strong inorganic oxidant such as NaIO4.
53
 
In addition, Sharpless and co-workers demonstrated that such oxidations could proceed 
using catalytic amounts of Ru by incorporating MeCN in the biphasic CCl4/H2O solvent 
mixture.
54
 Under such conditions, deactivation of the Ru catalysts via insoluble species 
generation is prevented due to the coordinating properties of MeCN. In addition, Sheldon 
and co-workers demonstrated that the efficiency of the ether oxidation can be significantly 
improved by controlling the reaction pH values.
55
 Under basic conditions, aliphatic and 
some benzyl ethers were oxidised to esters at r.t. using small loadings of RuCl2 complexes 
(typically 0.5 mol%). Because the method still requires an excess of NaClO4 as an oxidant, 
undesired side-reactivity such as chlorination in some benzylic positions was observed, 
limiting the reaction scope (Scheme 22).  
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Scheme 22. Ru-catalysed α-oxidation using NaOCl under controlled pH 
 
Less toxic gold-based catalysts have also been explored for oxidation reactions. The 
combination of catalytic amounts of KAuCl4 with an excess of pyridine was found to be an 
active catalyst for oxidising benzylic CH bonds, including ethereal examples such as 
phthalan and isochroman
56
 (Scheme 23). The reactions proceeded with moderate yields; 
however, the structure of the in situ generated catalyst was not elucidated and high catalyst 
loading (5 mol%), harsh reaction conditions (90 ºC) and an excess of terbutylhydroperoxide 
(TBHP) as the oxidising reagent were required. Moreover, the scope of the reaction is 
limited to two substrates, as oxidative cleavage of open chain benzylic ethers to form 
benzoic acid occurred under optimal reaction conditions.  
 
Scheme 23. Gold-catalysed α-oxidation of esthers to esters 
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1.3.3.3. Catalytic aerobic oxidations 
Vaska-type complexes of Ir and Rh were found active for the aerobic oxygenation of THF to 
γ-butyrolactone at r.t57 (Scheme 24 (a)). Undesired byproduct formation occurred, with 
lactol and 4-hydroxybutyraldehyde detected with low yields. Although the reaction required 
low catalysts loading, THF was used in solvent amounts affording the lactone product with a 
maximum TON of 150. Further reaction scope and the reaction mechanism were not 
investigated. 
The use of Rh-based catalysts for the oxygenation of ethers to esters was further explored by 
the group of Nicholas, who coupled the oxidation of ethers to esters with the reduction of 
CO2 to formic acid using catalytic amounts of [Rh(NBD)(PMe2Ph)3][BF4], (NBD= 2,5-
norbornadiene), in a pressurised O2-CO2 atmosphere.
58
 Cyclic ethers and benzyl ethyl ether 
were oxidised with TONs of 100-250 after 6 days at 60 ºC (Scheme 24 (b)). Mechanistic 
investigations using isotopically labelled gas mixtures revealed that the oxygen of the 
lactone products was derived from O2 whereas the formic acid was generated from the CO2 
reduction and ether degradation. Even though the reaction mechanism has not been 
investigated in detail, exposure of THF to the Rh catalyst under O2 atmosphere resulted in 
the formation of tetrahydrofuran hydroperoxide. Addition of CO2 to the reaction mixture 
allowed the formation of γ-butyrolactone and formic acid, probably via Rh-mediated hydride 
transfer from the hydroperoxide to the CO2, as Rh-H species have been detected in solution 
by 
1
H NMR. 
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Scheme 24. Aerobic oxidation of ethers catalysed by Ir and Rh-based complexes 
 
Metallic Pt was also investigated as catalyst for the aerobic oxidation of THF and diethyl 
ether to esters in water at high temperature
59
 (Scheme 25 (a)). The catalyst showed high 
efficiency in the oxidation of THF affording the lactone product with very good yields and 
small amounts of 4-hydroxybutanoic acid that resulted from the ring opening oxidation. 
However, acetic acid was obtained exclusively in the oxidation of diethyl ether due to the 
ester hydrolysis easily occurring in the aqueous phase. The proposed mechanism involves 
the activation of the C-H bond α to the oxygen atom via oxidative addition on the metallic Pt 
surface followed by the aerobic oxidation of the hydrocarbonyl moieties. 
Because the replacement of precious metals with cheap metal catalysts is highly desirable, 
the group of Reetz reported the use of a simple Co(acac)3 complexes as potential catalysts 
for the α-oxygenation of cyclic ethers to lactones under aerobic atmosphere60 (Scheme 25 
(b)). Moderate to very good yields were achieved with minor formation of lactol byproducts; 
however, the scope of the reaction was surprisingly limited to three substrates.  In situ 
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formation of an ether hydroperoxide as the real oxidant has been postulated; but the reaction 
mechanism is unclear. 
In addition, the bioinspired binuclear Cu
II
 -1H-pyrrolo[2,3-b]pyridine (7-azaindole) complex 
was found catalytically active for the aerobic oxidation of benzylic ethers at 80 ºC 
61
 
(Scheme 25 (c)). The reaction proceeded with high TON but low yields for benzylic ethers, 
with benzaldehyde being formed as a byproduct. However, the catalyst was found inactive 
for the oxidation of alkyl ethers. The efficiency of the reaction was improved upon 
increasing the steric bulkiness of the alkyl chain. Thus, the coordination of the catalyst to the 
substrate seemed not essential during the oxidation reaction. However, a good correlation 
between the TON and the calculated ionization potentials was observed. Although further 
mechanistic evidence was not provided, an outer sphere electron transfer was suggested to 
explain the influence of the EI. 
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Scheme 25. Aerobic oxidation of ethereal substrates using Pt and cheap metal-based 
complexes 
1.3.3.4. Iron-catalysed oxidations 
The use of environmentally friendly iron catalysts for the oxidation of ethers is surprisingly 
limited to the example of a FeCl2 catalyzed oxidation of THF under CO2/O2 pressure, which 
yields a variety of species mostly derived from THF ring openings
62
 (Scheme 26 (a)). The 
substrate scope is limited to THF and different product distributions were obtained under 
CO2/O2 atmosphere and pure O2. Both metal assisted and radical processes were proposed 
under the explored reaction conditions. 
Chen and White demonstrated that the biomimetic Fe(PDP) catalyst can oxidise THF and 
tetrahydropyrane (THP) with H2O2/AcOH, yielding a turnover number (TON) of 1-2
63
 
(Scheme 26 (b)).  Byproducts resulting from the ring opening were also detected due to 
undesired Fenton chemistry and/or side reactivity of the highly electrophilic iron-oxo 
species. Further investigations of the substrate scope were not reported probably because the 
catalyst decomposed substrates containing aromatic rings. 
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Scheme 26. Iron-catalysed aerobic oxidations of ethers to lactones 
1.3.4. Aerobic C-C cleavage in organic substrates 
Non-heme iron enzymes capable of activating dioxygen can serve as versatile catalysts for 
an ample spectrum of reactions. Apart from selective oxidation of complex molecules, such 
enzymes are capable of selectively cleaving C-C bonds of organic substrates with 
incorporation of two oxygen atoms into the final product.
64
 Aromatic
65
 and aliphatic
66
 C-C 
bonds can be oxidatively cleaved by different types of dioxygenases with excellent 
specificity and thus, high complexity can be introduced and/or significant structure 
modifications can be effected in the starting substrate (Scheme 27). As a consequence, these 
types of enzymatic transformations are often encountered in bacteria or metabolic processes. 
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Scheme 27. Modes of enzymatic aerobic C-C cleavages 
 
1.3.4.1. Bioinspired iron complexes for the aerobic cleavage of aromatic C-C bonds 
2-Aminophenol-1,6-dioxygenase
67
 (APD) and 3-hydroxyantranilate-3,4-dioxygenase
68
 
(HAD) are iron-containing metalloenzymes found in bacteria that catalyse the degradation of 
aminoaryl compounds into pyridines via aerobic C-C cleavage. The non heme Fe
II
 complex 
[(6-Me3-TPA)Fe
II
(4-tBu-HAP)](ClO4), where 6-Me3-TPA = tris(6-methyl-2-pyridylmethyl) 
amine and 4-tBu-HAP = monoanionic 2-amino-4-tert-butylphenolate, reported by the group 
of Paine, was conceived as a mimic of the active site of HAD enzymes and it was found 
capable of oxidising the C-C bond of  2-amino-4-tert-butylphenolate under mild conditions
69
 
(Scheme 28 (a)). 
The proposed reaction mechanism is similar to the natural metalloenzyme, with the initial 
Fe
II
 complex reacting with O2 to generate the Fe
III
 intermediate I via one electron oxidation. 
Further reaction of this radical Fe
III
 intermediate with O2 results in the formation of a peroxo 
species II that undergoes the C-C cleavage of the 2-aminophenol, generating the 
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semialdehyde intermediate. By dehydration, the semialdehyde is facilely converted into the 
final 4-tert-butyl-2-picolinic acid (Scheme 28 (b)). 
Independently, the group of Fiedler reported the reaction of the Fe
II
 2-aminophenolate 
complex [(Tp
Ph2
) Fe
II
 (
tBu
APH)], where Tp
Ph2 
= tris(pyrazolyl) borate ligand and 
tBu
APH = 2-
amino-4,6-ditertbutylphenol, which upon exposure to aerobic atmosphere resulted in the 
formation of the proposed Fe
III
 radical intermediate
70
 (Scheme 28 (c)). Such findings are 
consistent with the formation of radical Fe
III
 intermediates during natural and bioinspired 
aerobic C-C cleavages. 
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Scheme 28. Biomimetic iron complexes capable of undergoing aromatic C-C cleavage 
1.3.4.2. Bioinspired iron complexes for the aerobic cleavage of aliphatic C-C bonds 
1.3.4.2.1. Iron complexes that mimic acetylacetone-2,3-dioxygenase (Dke 1) 
Dke 1 enzymes catalyse the decomposition of several β-diketones,71 including toxic 
acetylacetone,
72
 into acetate and methyl glyoxal under aerobic conditions. Current interest in 
understanding the mechanism of this transformation stems from the potential application of 
biomimetic complexes in bioremediation processes. Tripodal chelating ligands incorporating 
heterocyclic N-donors have been exploited for the development of iron biomimetics due to 
the resemblance of such structure with the 2-histidine-carboxylate moieties present in the 
active site of the natural enzyme.
71a , 73
 
In 2008, Siewert et al. reported that the Fe(Xanthmal)2 complex was capable of  undergoing 
aerobic C-C cleavage of the malonate part of the ligand, affording an α-ketoester product. 
Additional hydroxylated and perooxoalkyl species were also generated.
74
 Interestingly, the 
Tp
Me2
Fe(Phmal) complex  with Phmal = 3-phenylmalonate, exhibited similar reactivity as it 
decomposed the initial malonate into ethyl benzoylformate and ethylcarbonate in a catalytic 
fashion (Scheme 29). Iron-centered activation of O2 with concomitant formation of a Fe
III
 
superoxo species was proposed as the initial step of the reaction (Scheme 30). 
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Scheme 29. Biomimetic iron complexes for aerobic C-C cleavage of malonates 
 
Scheme 30. Proposed reaction mechanism 
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A series of Tp
R2
Fe(acac
x
) complexes
75
 reported by the group of Fiedler exhibited activity 
comparable to the Siewert system. The nature of the substituents was found to affect the rate 
with which the complexes react with O2 to form the proposed Fe
III
 peroxo intermediate, with 
bulkier substituents such as Ph resulting in much slower reactions. Moreover, among all the 
series of acetylacetonates investigated, only activated electron rich malonates could be 
cleaved (Scheme 31). 
 
Scheme 31. Different reactivity of Fiedler`s iron biomimetic complexes 
 
1.3.4.2.2. Iron complexes that mimic acireductone dioxygenases (ARD) 
ARD enzymes are found in the methionine salvage pathway, an omnipresent pathway in 
biological systems for the regeneration of methionine from 5´-methylthioadenosine.
76
 
Interestingly, two pathways for the degradation of the 1,2-hydroxy-3-oxo-(S)-methyl 
thiopentene  intermediate,which are catalysed by different dioxygenases, have been 
discovered in aerobic systems.
77
 In the on-pathway, the iron-containing dioxygenase (Fe-
ARD´) catalyses the regioselective aerobic C(1)-C(2) cleavage of the intermediate releasing 
formic acid and an α-ketoacid, which is further reacted to generate methionine. In the off-
pathway, the nickel-containing dioxygenase (Ni-ARD) cleaves both the C(1)-C(2) and C(2)-
C(3) bonds, generating formic acid, CO and a carboxylic acid (Scheme 32).  
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Scheme 32. Methionine salvage On and Off pathways  
 
In order to understand the origins behind the different regioselectivity exhibited by such Fe 
and Ni dioxygenases, the group of Berreau reported the mononuclear ([(6-
Ph2TPA)Fe(PhC(O)C(R)C(O)Ph]X complexes, where 6-Ph2TPA = N,N-bis((6-phenyl-2-
pyridyl)methyl)-N-(2-pyridylmethyl)amine), R= H, OH and X= OTf, ClO4, bound to a β-
diketonate ligand, and explored their reactivity under dry and wet aerobic conditions
78
 
(Scheme 33). Surprisingly, the oxidation of a triketone intermediate species facilely occurred 
in the presence of the Fe complex, followed by its C-C cleavage that afforded the ketoacid 
product. However, such oxidative dehydration was not efficient with an analogue Ni-based 
complex. Thus, the dehydration of an intermediate appears to be the major reason behind the 
different regioselectivity between the Fe and Ni-based ARDs. 
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Scheme 33. Biomimetic Fe and Ni TPA complexes showing different reactivity towards the 
oxidation of a triketone intermediate 
1.3.4.3. Aerobic cleavage of olefins 
The selective C=C cleavage of alkenes using biocatalysts has become a growing area of 
research due to the excellent chemo- and regioselectivity with which heme and nonheme 
enzymes can cleave olefins under very mild conditions (r.t., atmospheric O2, aqueous 
media).
79
 As biocatalysts do not suffer from the harsh conditions and safety issues associated 
with chemical C-C cleavages, they have gained popularity for the production of costly 
natural flavour compounds.
80
 
1.3.4.3.1. Olefin cleavage with heme peroxidases 
Conjugated dienoic esters were cleaved to α,β-insaturated aldehydes using natural 
chloroperoxidase (CPO) as catalysts and TBHP as oxidant.
81
 The aldehyde product was 
formed mainly from the trans-dienes under aerobic atmosphere. However, cis-dienes mainly 
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afforded the allylic oxidation product. The postulated reaction mechanism invokes the 
formation of an intermediate radical cation via electron transfer from the olefin to a 
Fe
V
=O(OH) species. Reaction of the radical cation with O2 results in the formation of a 
dioxetane intermediate that is cleaved to generate the aldehyde product (scheme 34).  
 
Scheme 34. Oxidative cleavage of methyl-(2Z, 4Z)-hexadecanoate catalysed by CPO 
Horseradish peroxidise (HRP) is a very versatile peroxidase enzyme that has shown catalytic 
activity for the oxidative cleavage of 3-alkylindoles to acylformanilides in the presence of 
catalytic amounts of H2O2 under aerobic atmosphere.
82
 Additionally, conjugated C=C bonds 
of substrates such as indene and trans-anethole were also cleaved with good yields under 
pressurised aerobic atmosphere (2 atm O2) and acidic aqueous conditions
83
 (Scheme 35). 
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Scheme 35. Aerobic cleavages of allylic olefins catalysed by HRP 
 
1.3.4.3.2. Olefin cleavage with heme and nonheme oxygenases 
Carotenoid Cleavage Oxygenases (CCOs) were found to catalayse the selective C=C bond 
cleavage of carotenoids, affording valuable apocarotenoids as products.
84
 The cleavage 
occurs with exquisite specificity, with different enzymes of this family being capable of 
oxidatively cleaving C=C bonds at different positions
85
 (Scheme 36). Even though the 
reaction mechanism are still unclear, some of this enzymes are been investigated as 
biocatalysts for industrial and academic purposes due to the importance of apocarotenoids in 
the aroma industry.
86
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Scheme 36. Selective C=C cleavage of carotenoids catalysed by different CCO enzymes 
Stilbene-α-oxygenases constitute a family of enzymes capable of cleaving stilbene type 
substrates into carbonyl compounds. Such enzymes specifically react with stilbenes in a 
trans-configuration and incorporating a hydroxyl or a methoxy group in para-position to the 
C=C bond
87
 (Scheme 37).  
 
Scheme 37. C=C cleavage of stilbene substrates catalysed by various stilbene oxygenases 
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Finally, a purified protein isolated from Xanthomonas sp. was found capable of cleaving 
C=C bonds of natural rubbers, such as poly-(cis-1,4-isoprene).
88
 Such protein, known as 
rubber oxygenase (RoxA), exhibited high specificity, cleaving C=C bonds at regular 
intervals of three isoprene units (Scheme 38). Mechanistic investigations are consistent with 
a dioxygenase mode of reactivity. 
 
Scheme 38. C=C cleavage of poly-(cis-1,4-isoprene) catalysed by RoxA 
 
1.4. Aims of the thesis 
Catalytic selective oxidation of organic chemicals is identified as the most important area to 
impact the future chemical industry.
89
 Biomimetic iron-based complexes with tetradentate 
N-donor ligands have been extensively studied and applied for the oxidation of complex 
organic substrates using H2O2 as the oxygen source. Despite the advances achieved in the 
area during the last decade, significant limitations are still unresolved. For instance, the 
development of catalyst capable of dioxygen activation and compatible with electron rich 
functionalities are highly desirable.  
This thesis covers our efforts and possible solutions for many of the limitations that affect 
iron-catalysed selective oxidations, with the main objectives being: 
1) To investigate new ligand designs aiming for more efficient iron-catalysed aerobic 
oxidations. 
2) To gain some mechanism understanding of the oxidation processes developed with 
such catalysts. 
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This thesis is mainly concerned with the application of a novel class of iron complexes for 
the oxidation of two major classes of substrates: oxidation of ethers and olefins. While ether 
oxidation has been studied for a long time, catalysts capable of activating O2 for such 
reactions are few. It was hoped that with a novel class of catalysts such oxidations could be 
performed in a greener, more selective manner and applied for organic syntheses. 
 
Even though the selective oxidation of organic substrates using biologically-inspired Fe 
catalysts has become an extensive area of research, the development of iron-based catalysts 
for the selective aerobic cleavage of organic compounds has received much less attention. In 
fact, such catalysts are often seen either as tools to investigate enzymatic processes or as 
alternatives for the usage of biomass in fuel production or bioremediation processes
66
. 
However, we envisioned that catalysts capable of undergoing selective aerobic cleavage of 
C-C bonds in organic substrates would facilely become an attractive new tool for 
synthesising valuable organic compounds. Thus, this thesis also includes our investigations 
in the area of selective aerobic cleavage of aliphatic and olefinic C-C bonds and aliphatic C-
O bonds, with the major goals being:  
1) To provide an alternative for the synthesis of complex oxygenated products, which 
cannot be obtained by current oxidation methodologies but can be accessed by 
selective oxidative cleavage. 
2)  To replace less environmentally benign oxidative protocols employed in organic 
synthesis with greener aerobic cleavages. 
3) To ultimately develop novel synthetic methodologies. 
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2.1. Introduction 
2.1.1. Ligand design in homogeneous iron catalysis 
Very sophisticated catalytic reactions are being developed nowadays in the area of iron 
catalysis by introducing new ligand designs. For instance, Bullock and co-workers have 
reported the novel Cp
C6F5
Fe(P
tBu
2N
Bn
2)H complex as an electrocatalyst for the oxidation of 
H2.
1
 A rational ligand design introducing pendant amino groups and bulky phosphines 
favours the coordination and splitting of the H2 molecule. The presence of the C6F5 group in 
the Cp moiety increases the acidity of the iron-dihydrogen complex, allowing a faster proton 
transfer during the catalytic cycle (Scheme 1). In addition, iron-dipyrrinato complexes 
developed by the group of Betley can serve as catalysts for the direct amination of aliphatic 
C-H bonds.
2
 These dipyrrinato ligands provide the perfect electronic environment for the 
formation of an iron-imido radical intermediate in which both Fe and N- atoms have radical 
character which facilitates H-abstraction from the substrate and a radical recombination 
process that enables the formation of the amine product (Scheme 2). Therefore, state-of-the-
art ligand design is crucial to achieve catalytic activity in such iron-catalysed 
transformations. 
 
Scheme 1. Iron electrocatalyst for H2 oxidation  
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Scheme 2. Iron-dipyrrinato catalyst for CH amination 
 
From these examples it can already be intuited that the design of a new good catalyst is a 
difficult art that pursues a perfect balance between activity and selectivity: the catalyst must 
achieve good activity in a specific transformation without generating an undesired myriad of 
byproducts. Additionally, the catalyst must be relatively stable under the reaction conditions 
so the efficiency of the transformation is not compromised.
3
 The tremendous difficulty 
behind new catalyst design is well represented in the Ir-Xyliphos catalyst for the industrial 
production of (S)-metolachlor, with fourteen years of intense research invested on its design 
and implementation
4
 (Scheme 3). A careful ligand design, capable of modulating the 
electronic and steric properties of the metal centre, is often viewed as the best strategy to 
create a good homogeneous catalyst.
5
 A cost effective synthetic route and the stability of the 
pre-catalyst and active catalytic species are other important aspects that influence ligand 
design, especially for industrial applications.
4 
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Scheme 3. Industrial synthesis of (S)-metolachlor using an Ir-Xyliphos catalyst 
 
2.1.2. PyBox ligands: successes and challenges 
Since the late 1990’s, pincer ligands have been widely explored in homogeneous catalysis 
due to the high activity, stability and variability of the resulting metal complexes.
6
 These 
tridentate ligands are based on an aromatic backbone tethered by two electron donor groups 
(E) with different spacers such that they can be easily modified at different sites allowing 
control of the steric and electronic properties of the metal centre
7
 (Scheme 4).
 
For these 
reasons, an ample variety of applications have emerged for pincer type complexes in the 
areas of catalysis, molecular recognition and supramolecular chemistry.
6
 
 
Scheme 4. Potential sites for pincer type ligand modifications  
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Among pincer ligands, N-donor based pyridine bis(oxazolinyl) (PyBox) ligands have 
become popular in catalysis since their introduction by the group of Nishiyama in 1989 for 
the asymmetric hydrosilylation of ketones
8
 (Scheme 5). The facile and cost effective 
preparation of this type of ligands
9
 in conjunction with their exceptional stereoinductive 
effects derived from their C2-symmetry
10
 have turned them into widely applied ligands in 
catalysis. Nonetheless, PyBox ligands in combination with commercially available iron salts 
have shown limitations in terms of both activity and stereoinduction. For instance, the 
enantioselective Nazarov cyclization of divinyl ketones using Fe(OTf)2-PyBox complexes 
has been achieved with low yields (43%) due to the limited solubility and activity of the iron 
complex in the reaction solvent
11
 (Scheme 6). Additionally, Nishiyama and co-workers 
reported a Fe-Phebox complex for the enantioselective hydrosilylation of ketones with good 
activity (99%) but only moderate enantioselectivity (63% ee) (Scheme 7), whereas excellent 
enantioselectivity (99%) was achieved with a similar Rh complex
12
 (Scheme 5). 
 
Scheme 5. Asymmetric hydrosilylation of ketones using Rh-PyBox complexes 
 
 
Scheme 6. Iron-PyBox complexes as catalyst in Nazarov cyclizations 
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Scheme 7. Iron-PheBox complex for asymmetric hydrosilylation of ketones 
2.2. Aims of this chapter 
The application of tetradentate N-donor ligands for biomimetic oxidations has been 
extensively studied as phorphirine type skeletons or as non-heme designs
13
 (Chapter 1). 
However, tridentate or pentadentate skeletons are much less explored alternatives. PyBox 
derived ligands have showed good activity for olefin epoxidation in combination with Ru 
salts, whereas poorer results were achieved with their iron counterparts.
14
 Because a careful 
ligand design is a key factor in activating iron for catalytic transformations (vide supra), the 
development of a new family of ligands for its application in iron catalysed oxidation 
reactions is attempted in this chapter. Two main strategies will be described in order to 
overcome the limitations of iron-PyBox complexes: 
 The design of pentadentate N-donor skeletons by combining PyBox type and 
bidentate ligands 
 The design of new tridentate N-donor skeletons capable of overcoming the limited 
solubility and activity of Fe-PyBox complexes. 
2.3. Results and discussion 
2.3.1. Pentacoordinated designs 
Pentacoordinated Fe
II 
complexes are rare in iron-catalysed oxidation reactions. However, the 
bioinspired ligand 7 was applied in the Fe-catalysed olefin epoxidation reactions with good 
efficiency
15
 (Scheme 8).
  
This seminal work prompted us to further investigate pentadentate 
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N-donor skeletons for their application in iron catalysed selective oxidation reactions. 
Initially, we hypothesised that a pentadentate N-donor ligand core could also be achieved by 
combining two independent N-donor ligands: a tridentate PyBox type one and an additional 
bidentate ligand. With this modular design, we expected to gain more versatility and fine 
tuning of the electronic and steric properties of the final iron complexes (Scheme 9).  For 
instance, the NH functionalities would be capable of assisting the O-O cleavage via H-
bonding.  
 
Scheme 8. Pentadentate N-donor ligands for iron catalysed epoxidation of olefins 
 
Scheme 9. Modular N-donor pentacoordinated iron complex design 
 
Preformed iron complexes 8 and 9 were initially tested for their further derivatisation with 
diamine type ligands 11, 12, 13 and 14.  However, the related iron complex 10 was 
discarded due to its poor solubility in common organic solvents.  
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Discouragingly, no coordination of the diamine ligands to the preformed iron complexes was 
achieved after screening different organic solvents,
16
 temperatures and additives (Table 1). 
Nonetheless, the addition of ligand 12 and AgPF6 to the initial dark blue solution of complex 
8 showed color evolution to bright dark pink, suggesting reactivity (Table 1, entry 6). 
Isolation and crystallisation of the resulting species in DCM/hexane allowed the formation 
of crystals suitable for X-ray diffraction analysis. Surprisingly, X-ray diffraction analysis 
revealed a complex cluster formation with a P21 asymmetric unit cell composed of four 
[FeL2]
2+
 (L: PyBox ligand in 8) complexes, eight PF6
-
 counterions and eight DCM molecules 
(Fig. 1).  
Even though the formation of 15 was not expected under the explored conditions, Fe
II
 salts 
have a strong tendency to form octahedral (Oh) complexes with a coordination number of 
six.
17
 Indeed, distorted Oh complexes of the formula [Fe(NNN)2]
2+
 are well studied and can 
be easily synthesised with conjugated (and rigid) tridentate ligands such as terpyridine 
(terpy) and even with PyBox type ligands.
18
 Because these ligands are good σ and π donors 
and π acceptors they can chelate easily to metal ions and the resulting [M(N,N,N)2]
n+
 
complexes tend to be very stable.
19
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Table 1. Screening of the conditions for the coordination of different diamine ligands to 
preformed iron complexes 
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Figure 1. Dicationic Fe-(PyBox)2 formation: reaction conditions and X-ray diffraction 
structure of the half unit cell. 
2.3.2. Tridentate ligands: design, synthesis and properties of PyBisulidines 
2.3.2.1. Design and synthesis of PyBisulidines 
Inspired by the limitations found in the pentacoordination strategy, the design of a new 
pincer type skeleton was attempted to ultimately overcome the double chelate formation, 
limited solubility and poor stereospecificity associated to the previous iron-PyBox 
complexes. To enhance the solubility and gain more flexibility in the final iron pincer 
complex, a bulky and non-conjugated tridentate N-donor skeleton analogous to the recently 
reported pyridine bisimidazolidine (PyBidine) ligand 16 was initially selected
20
 (Scheme 
10). In particular, we envisioned that replacement of the initial imidazolidine moieties with 
the more electron withdrawing sulfonamides could give rise to a new family of ligands with 
interesting coordinating properties, which might confer tunable Lewis acidity on the iron 
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centre and enhance the ability of iron for O2 activation, allowing for better catalytic activity 
and selectivity. Additionally, an ample variety of sulfonamides can be facilely synthesised 
and amended at different positions so that the steric hindrance around the iron centre could 
be tuned by simple modification of the sulfonamide moiety (Scheme 11). 
 
Scheme 10. Structure of the PyBidine ligand and its application for asymmetric endo-
selective [3+2] cycloadditions 
 
Scheme 11. General Pyridine bis(sulfonylimidazolidine) skeleton. 
 Initially, the optimal synthetic conditions for this class of pyridine 
bis(sulfonylimidazolidine) (PyBidine) ligands were investigated. The compound 19 was 
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synthesised by condensation of (R, R)-N-(2-amino-1,2-diphenylethyl)-4-methylbenzene 
sulfonamide 17 with pyridine-2,6-dicarboxaldehyde 18 (Scheme 12). The reaction 
proceeded with excellent yields under acidic catalytic conditions (AcOH) and very mild 
temperatures under inert atmosphere. Additionally, the synthesis was easily scaled up to the 
gram level (circa. 10 g) with excellent efficiency (isolated yields of 90%). 
 
Scheme 12. General procedure for the synthesis of PyBisulidine ligands. 
 
2.3.2.2. Coordination properties of PyBisulidines 
When ligand 19 was combined with equimolecular amounts of Fe(H2O)6(BF4)2 in MeCN,  
the initial colorless solution rapidly evolved to pale orange, indicating some type of 
reactivity (Scheme 13). In an attempt to identify whether the iron metal had successfully 
coordinated to ligand 19, large quality crystals suitable for X ray diffraction were grown in 
MeCN/Et2O. The X ray diffraction analysis revealed a well-defined molecular complex in 
which the iron centre is coordinated to a single PyBisulidine ligand (Scheme 13). The 
complex exhibits a distorted Oh geometry, with the ligand coordinated to the iron centre in a 
tridentate mode with a N
2
-Fe-N
4
 angle of 148.92
o
. The initial stereochemistry of the ligand 
was retained in the final structure of the complex and the absence of conjugation provides 
more flexibility with two new stereocentres of opposite configuration being created in C2 
and C28 in a similar fashion as in the reported Cu-PyBidines complex. Moreover, the spatial 
orientation of the sulfonamide groups in the crystalline complex is also pre-established by 
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the stereochemistry of the dpen moiety as it can be appreciated by comparing the x-ray 
structures of the (R, R) and the (S, S)-isomers of complex 20 (Scheme 14). Remarkably, the 
monocationic complex [Fe(BF4)(NNN)(CH3CN)2](BF4) 20 was formed exclusively under 
these reaction conditions with two molecules of acetonitrile and one of the  BF4
-
 counter ions 
directly coordinating to the iron metal. Because of its innate flexibility, the complex formed 
almost a bowl shaped cavity in which these acetonitrile molecules reside (Scheme 15).   
 
 
Scheme 13. Complexation of the PyBisulidine ligand to a commercially available iron salt. 
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Scheme 14. X-ray structures of the (R, R) and (S, S)- isomers of complex 20. Note that the 
spatial orientation of the sulfonamide is determined in the crystalline structure of the 
complex. 
 
Nonetheless, the coordination of the BF4
-
 counterion was particularly surprising with a short 
Fe-F(BF3) distance of 2.163 Å, indicating a strong bonding between the two atoms. This 
coordinated BF4
-
 ion exhibited nearly tetrahedral geometry [F-B-F 107.5(1)-110.4(2), mean 
109.4°] with the F-B distance [1.445(2) Å] of the coordinated fluorine being longer than the 
other B-F distances [1.377(2)-1.386(2), mean 1.381 Å]. The uncoordinated BF4
-
 ion also 
presented angles close to tetrahedral [F-B-F 108.4(2)-110.0(2), mean 109.4°] but longer B-F 
distances [1.383(3)- 1.391(3), mean 1.387 Å]. The Fe-N bond of the acetonitrile molecule 
trans to the coordinated BF4
-
 was longer than that in the cis (2.114(2) and 2.099(3) Å 
respectively) possibly due to the trans effect of the electronegative fluorine atom. Thus, a 
stretching difference of 0.015 Å between the two Fe-NCMe bonds in the Oh complex 
suggests that the coordination of the BF4
-
 counterion to the iron centre labilises (i.e. 
destabilises) the bond between the iron centre and the MeCN in trans position to the BF4
-
.  
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Scheme 15. A sphere type model of the complex showing the almost bowl shaped cavity in 
which the acetonitrile molecules reside. 
 
Coordination of “weakly coordinating” BF4
-
 ions to other metal complexes have also been 
reported. However, such coordination often occurs in solvents of low dielectric constant.
21
 
To the best of our knowledge, complex 20 is the only example in the literature in which 
coordination of the BF4
-
 to an iron centre is achieved in the presence of strong donor 
solvents (MeCN) and H2O coordination molecules. Unfortunately, 20 is a high spin complex 
and thus a study of the coordination of the BF4
-
 counterion in solution by NMR techniques 
could not be performed. 
The protons of the sulfonylimidazolidine moiety were retained in the structure of the 
complex and characteristic IR absorptions for γNH were detected at 3625 and 3727 cm
-1
, 
whereas the NH stretching bands in the uncoordinated ligand 19 were detected at 3125-3390 
cm
-1
. This bathochromic shift reflects that the acidity of the amine protons is increased upon 
complexation of the amine to the iron centre and upon hydrogen bonding to the BF4
-
 counter 
ions (Scheme 13). These significantly high γNH values and the unusual Fe-FBF3 coordination 
indicate that the iron centre in 20 has a remarkable Lewis acid character. 
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2.3.2.3. Ligand library 
2.3.2.3.1. Sulfonamide substitution 
An ample variety of PyBisulidines incorporating aryl sulfonyl groups of different electronic 
and steric properties were synthesised with excellent yields by simple replacement of the 
initial sulfonamide (Scheme 16). In addition, ligand 27 possessing C2 symmetry was also 
synthesised with excellent yields by replacement of the initial (R,R)-17 sulfonamide with its 
meso form ( Scheme 17). 
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Scheme 16. Library of PyBisulidines synthesised by modification of the sulfonylgroup of 
the initial sulfonamide. 
 
Scheme 17. Procedure for the synthesis of the C2 symmetric PyBisulidine 27. 
 
However, replacement of the aryl sulfonyl moiety with a less bulky N-acetyl group in 
(1R,2R)-N-acetyl-1,2-diphenyl-1,2-ethylenediamine 28, gave no reaction under optimal 
conditions or at reflux in several organic solvents (Scheme 18). This lack of reactivity was 
attributed to the electrophilicity of the carbonyl group in 28, which reduces the 
nucleophilicity of the partial sp
2
-hydridised N of the amide, hampering the cyclization of the 
iminium salt 30 to forward the imidazolidine product (Scheme 19).  
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Scheme 18. Replacement of the sulfonamide with a β-amino amide gave no reactivity. 
 
 
Scheme 19. Proposed mechanism of the acid catalysed synthesis of Pyridine 
sulfonylimidazolidines. 
 
2.3.2.3.2. Amino substitution 
The effect of substitution in the sp
3
-N of the PyBisulidine skeleton was investigated in order 
to evaluate the impact of steric bulkiness and to explore additional tunability of the ligand. 
When compound 31, was subjected to standard cyclisation conditions, the bulkier 
PyBisulidine 32 was obtained with excellent yield (Scheme 20).  
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Scheme 20. General procedure for the synthesis of sp
3
-N substituted PyBidine ligands. 
 
A variety of sp
3
-N-substituted PyBisulidines were obtained with excellent yields by simple 
modification of the arylsulfonyl group or the N-benzyl substituents of the initial N-
(benzylamino-1,2-diphenylethyl) arylsulfonamide (Scheme 21). In an attempt to visualise 
these sp
3
-N-substituted PyBisulidines of increased molecular complexity, beautiful 
gemstone-type crystals of 33 were grown in MeCN/hexane and subjected to X-ray 
diffraction analyses. Ligand 33 showed a bowl shaped geometry with the sp
2
 N of the 
pyridine being in the centre of the bowl (Scheme 22). In addition, the steric crowding pre-
determines the spatial orientation of the N-benzyl substituents in the crystalline compound 
too. 
 
Scheme 21. Library of sp
3
-N-substituted PyBisulidines including modifications in the 
sulfonamide moiety and the N-benzyl substituent. 
Chapter 2 
 
72 
 
 
 
 
 
Chapter 2 
 
73 
 
 
Scheme 22. A zoomed image of the crystal shape and two perspectives of the X-ray 
diffraction analysis of sp
3
-N-substituted PyBisulidine 33 
This bowl shape structure is generated by the interaction among the four phenyl groups 
surrounding the central N atom of the pyridine as shown in the Hirshfeld surface (Scheme 
23). Additionally, the 2D fingerprint of the Hirshfeld surface showed that there is a short 
contact between hydrogen atoms in positions 4 and 4’, consequence of this bowl shape 
structure (Scheme 24).  
 
Scheme 23. Hirshfeld surface of 33 showing a bowl shape structure. The red surfaces 
represent short interatomic distances whereas the blue ones represent long distances. 
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Scheme 24.  2D-Fingerprint of the Hirshfeld surface of PiBisulidine 33. The plot is a 
representation of de ( distance from the surface to external atom) vs di (distance from the 
surface to internal atom) summarising the interactions in the Hirshfeld surface. The features 
along the diagonal (de =  di) are indicative of a short H-H distance between H4 and H4’. 
2.3.2.3.3. Pyridine substitution 
Even thought N-(benzylamino-1,2-diphenylethyl) arylsulfonamides can be easily modified 
and synthesised in one pot, derivatisation of the pyriridine moiety turned out to be more 
complicated. A multistep synthethic pathway was followed to generate the 4-
methoxypyridine-2,6-dicarbaldehyde 39 from  commercially available chelidamic acid 
monohydrate 35 (Scheme 25). 
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Scheme 25. Reaction conditions for the synthesis of substituted pyridine 38: (i) H2SO4 
(98%) in MeOH, reflux 2 h, then NaHCO3 (aq.) up to pH= 8.00  (80% yield). (ii) 
(CH3O)2SO2 , K2CO3 in DMF at r.t. for 24 h (90% yield). (iii) NaBH4 in THF reflux, 1 h, 
then anhydrous MeOH, reflux 3 h (80% yield). (iv) SeO2 in xylene, reflux 24 h (96% yield). 
Condensation of 39 with the standard sulfonamide 17 under optimal conditions afforded 
PyBisulidine 40 with excellent yields, indicating that further functionalisation of the central 
pyridine moiety of the PyBisulidine skeleton can also be achieved (Scheme 26). 
Nonetheless, the longer and more complex synthetic routes needed to perform such 
functionalisation stopped us from making more analogues of 40 unless future catalytic 
performance revealed strong necessity to introduce functionalisation at this specific position. 
 
Scheme 26. Procedure for the synthesis of PyBidines bearing a functionalised pyridine 
linker. 
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2.3.2.3.4. Bidentate designs 
Inspired by the many successful applications of Box ligands as bidentate versions of PyBox 
skeletons, bidentate versions of the PyBisulidine ligands were next attempted. The 
Bis(sulfonylimidazolidine) (Bisulidine) 42 was obtained in good yields upon catalytic acidic 
condensation of phthaladehyde 41 and the initial sulfonamide 17 (Scheme 27).  
 
Scheme 27. Procedure for the synthesis of Bisulidine type ligands. 
A small library of Bisulidine ligands incorporating aryl sulfonyl groups of different 
electronic and steric properties was created by facile replacement of the initial sulfonamide 
17 (Scheme 28). In comparison with the tridentate PyBisulidines, the yields of the bidentate 
Bisulidines were slightly lower probably due to the steric hindrance resulting from 
positioning the two flexible sulfonylimidazolidine rings in close spatial proximity. Indeed, 
phthaldehyde 40 was chosen as a linker because of the longer distance separating the two 
terminal aldehydes in comparison with malonaldehyde type linkers 47-49 that are commonly 
used in Box ligands. Moreover, Box ligands are compatible with different type of linkers, 
with modifications of the bite angle on the resulting Box-metal complex being the main 
reason to select a specific linker
22
 (Scheme 29). However, the innate flexibility of the 
Bisulidine ligands limited the type of linkers that can be used to those resulting in larger bite 
angles, as no Bisulidine formation occurs when smaller malonaldehydes 47 and 48 were 
used as linkers. 
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Scheme 28. Bisulidine type ligands incorporating different aryl sulfonyl substituents. 
 
Scheme 29. Common linkers used in the synthesis of bidentate ligands. 
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2.3.2.3.5. Asymmetric versions 
Asymmetric tridentate NNN ligands have recently drawn some attention for catalytic 
applications as they can potentially provide an on and off chelating effect during the catalytic 
cycle.
23
 Indeed, the asymmetric Ru
II
-Pyrazolyl-imidazolyl-pyridine complex 50 was found 
exceptionally active in the transfer hydrogenation (TH) of ketones
24 
(Scheme 30).  
 
Scheme 30. Asymmetric Ru
II
-NNN complex as an active catalyst for TH. 
As pyrazoles have been used as ligands in oxidation processes and as they are present in the 
active centre of oxidases, an asymmetric pyrazolyl-pyridine-sulfonylimidazolidine ligand 
was constructed in order to investigate the potentially beneficial effects of asymmetry in 
PyBisulidine ligands. The asymmetric Pyrazolyl-pyridine-sulfonylimidazoline ligands 52 
and 53 were prepared in very good yields according to a facile two step synthesis (Scheme 
31).  
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Scheme 31. Two step synthesis of asymmetric PyBisulidine ligands: (i) 50 (1 equiv), 
pyrazole (1.3 equiv), phenanthroline (0.25 equiv), CuI (0.12 equiv), K2CO3 (1 equiv), 
toluene, 120 °C, 24 h. (ii) 51 (1.0 mmol), (R, R)-sulfonamide (1.0 mmol), acetic acid (1.0 
mmol), DCM, 30 °C, 24 h (98% yield).  (iii) 51 (1.0 mmol), N-(2-(arylamino)-1,2-
diphenylethyl) aryl sulfonamide (1.0 mmol), acetic acid (1.0 mmol), DCM, 30 °C, 24 h 
(97% yield). 
2.4. Conclusions 
A new library of tridentate N-donor ligands based on a pyridine bis(sulfonylimidazolidine) 
skeleton was developed. The initial ligand design allowed modifications of the sulfonamide, 
amino moiety, pyridine linker and denticity, giving rise to an ample variety of ligands. 
Comercially available iron salts can facilely coordinate the PyBisulidine skeleton, forming a 
well-defined molecular complex of high flexibility and unusual Lewis acidity.  
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2.5. Experimental section 
2.5.1. General techniques 
Experiments involving air or moisture sensitive reagents were performed under an 
atmosphere of purified N2 using standard Schlenck techniques. Solvents used in these 
experiments were reagent grade or better. MeCN, DCM and CHCl3 were refluxed over CaH2 
and THF and Et2O were refluxed over Na/benzophenone and distilled under purified N2 
atmosphere. Commercial grade solvents used in the synthesis of non air or moisture 
sensitive components were used without further purification. Chemicals employed in the 
synthesis of ligands were purchased from commercial suppliers and used without further 
purification. PyBox and terpyridine ligands and iron salts were purchased from commercials 
suppliers and used without further purification. Analytical thin-layer chromatography (TLC) 
was conducted with TLC Silica gel 60 F254 (Merck) and plates were revealed under UV 
irradiation, iodine, potassium permanganate or vanillin staining. Flash column 
chromatography was performed using Aldrich Silica Gel 60 and columns were packed 
according to the dry method and equilibrated with the appropriate eluent prior to use. HPLC 
grade solvents were used and the solvent mixtures used as eluent are understood as 
volume/volume. 
1
HNMR spectra were recorded on a Bruker Advance 400 (400 MHz) NMR 
spectrometer and reported in units of parts per million (ppm) relative to tetramethyl silane (δ 
= 0 ppm) or CDCl3 (δ = 7.26 ppm). Multiplicities are given as: bs (broad singlet), s (singlet), 
d (doublet), t (triplet), q (quartet), dd (doublets of doublet), dt (doublets of triplet) or m 
(multiplet). 
13
C NMR spectra were recorded on a Bruker Advance 400 (100 MHz) NMR 
spectrometer and reported in ppm relative to CDCl3 (δ = 77.0 ppm). Coupling constants 
were reported as a J value in Hz. Mass spectra were obtained by electrospray ionisation (EI) 
or fast atom bombardment (FAB) at the Analytical Services of the Chemistry Department, 
University of Liverpool and EPSRC National Mass Spectrometry Service Centre, College of 
Medicine, Swansea University. IR spectra were recorded on a Jacso FT/IR-4200 type A 
spectrometer.  
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2.5.2. Synthesis of the iron complexes with previously reported tridentate N,N,N-donor 
ligands 
2.5.2.1. FeCl2(PyBox) complex
25
 (8)
 
In a 100 mL two-necked round bottom flask, FeCl2 x 4H2O (2.0 mmol, 395.8 mg) and 2,6-
bis((R)-4-isopropyl-4,5-dihydrooxazol-2-yl)pyridine (2.0 mmol, 600.0 mg) were added. The 
flask was degassed and placed under a N2 atmosphere. Freshly distilled THF (20 mL) was 
added by syringe and the reaction immediately turned dark blue. The reaction was stirred for 
2h at 25 
°
C and then, the solvent was removed slowly under vacuo. The dark blue precipitate 
was washed with cold, freshly distilled Et2O to afford the complex almost quantitatively 
(97% yield, 830.2 mg). Anal Calc’d for C17H23Cl2FeN3O2 : C, 47.69, H, 5.41, N, 9.81; 
found: C, 47.53, H, 5.32, N, 9.76.  
2.5.2.2. FeCl2(Pyridineimidazolidine)(H2O) complex
25
 (9)
 
This complex was synthesised in a similar fashion as for 8 from FeCl2 x 4H2O (1.15 mmol, 
227.50 mg) and 2,6-bis((4R,5R)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine (1.15 
mmol, 600.00 mg). Anal Calc’d for C35H31Cl2FeN5O : C, 63.27, H, 4.70, N, 10.54; found: 
C, 63.36, H, 4.81, N, 10.46. 
2.5.2.3. FeCl2(terpy) complex
26
 (10) 
In a two-necked round bottom flask equipped with a reflux condenser, terpyridine (0.45 
mmol, 100.00 mg) was added, degassed and placed under a N2 atmosphere. Freshly distilled 
CHCl3 (18 mL) was added by syringe and the mixture was heated to 40 
°
C. In a separated 
two necked round bottom flask, anhydrous FeCl2 (0.58 mmol, 73.80 mg) was added, 
degassed and placed under a N2 atmosphere. Freshly distilled MeOH (6.0 mL) was added by 
syringe and the mixture was heated to 50 
°
C until a clean yellow solution was observed. The 
hot solution of terpyridine was added by syringe to the metal solution resulting in the almost 
immediate formation of the dark purple crystalline metal complex. The crystals were filtered 
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off and washed with hot CHCl3, then with methanol and finally with ether. The crystals were 
dried in vacuo and characterised as the mono-ligand metal complex by microanalysis (65% 
yield). Anal Calc’d for C15H11Cl2FeN3 : C, 50.04, H, 3.08, N, 11.67; found: C, 50.34, H, 
3.11, N, 11.78. 
2.5.3 General procedure for the attempted functionalisation of the preformed iron-
PyBox type complexes. 
In a 50 ml two-necked round bottom flask, 8 (0.11 mmol, 1.0 equiv., 50.00 mg), a bidentate 
ligand (0.16 mmol, 1.0 equiv.) and AgPF6 (0.11 mmol, 1.0 equiv., 29.50 mg) were added. 
The mixture was degassed and placed under a N2 atmosphere. The flask was kept in 
darkness by using kitchen foil and then, 12.0 mL of freshly distilled DCM (or the 
corresponding solvent) were added by syringe. The reaction mixture was stirred overnight. 
2.5.4. Procedure for the synthesis of the dicationic bis(PyBox)Fe
II
 complex (15) 
In a 50 mL two-necked round bottom flask, 8 (0.11 mmol, 1.0 equiv., 50.00 mg), 12 (0.16 
mmol, 1.0 equiv., 60.80 mg) and AgPF6 (0.11 mmol, 1.0 equiv., 29.50 mg) were added, 
degassed and placed under a N2 atmosphere. The flask was kept in darkness by using kitchen 
foil and then, 12 mL of freshly distilled DCM (or the corresponding solvent) were added by 
syringe. Next morning, the pink coloured solution was filtered over Celite under inert 
atmosphere to remove the white precipitate. The clear solution was concentrated to a small 
volume (0.75 mL approx) and crystals of the complex were grown by slow addition of 
distilled hexane (1.0 ml approx) to the concentrated DCM solution. 
2.5.5. General procedure for the synthesis of sulfonyl DPEN derivatives 
Sulfonyl DPEN derivatives were obtained by reaction between DPEN and the corresponding 
sulfonyl chloride as previously reported in the literature.
27
 A representative synthetic 
procedure is described below. 
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(R,R)- N-(2-Amino-1,2-diphenylethyl)-4-methylbenzenesulfonamide ((R,R)-17) 
(R,R)-DPEN (2.8 mmol, 600.0 mg) was dissolved in freshly distilled DCM (20 mL) and 
cooled to 0 °C. NEt3 (4.2 mmol, 585 μL) was added followed by a solution of 4-
methylbenzenesulfonyl chloride (2.8 mmol, 538 mg) in DCM (8 mL) and the reaction 
mixture was stirred overnight at rt.  The system was washed with distilled water (20 mL) and 
the organic phase was extracted, dried over MgSO4, filtered and evaporated under vacuum to 
give a crude product that was purified by column (1/1 hexane/AcOEt) affording the product 
as a white solid (85% yield, 880 mg).  
Analytical data for the sulfonamides used in these syntheses has been reported in the 
literature and thus it is not included in this thesis. 
2.5.6. General Procedure for the synthesis of PyBisulidine ligands 
Pyridine-2,6-dicarbaldehyde (1.0 mmol, 135.0 mg) and (R,R)-N-(2-amino-1,2-
diphenylethyl)-4-t-butylbenzenesulfonamide (2.1 mmol, 860.0 mg) were added to a double 
necked round bottom flask, degassed and placed under a N2 atmosphere. Freshly distilled 
DCM (30 mL) and acetic acid (1.0 mmol, 60 μL) were added and the reaction mixture was 
stirred at 30 °C for c.a. 48 h. The reaction mixture was washed with NaHCO3 (aq) solution 
and the organic layer extracted with DCM, dried over MgSO4, filtered and evaporated in 
vacuo. The residue was purified by silica gel column chromatography or crystallisation to 
afford the product. 
Analytical data 
2-((2R,4R,5R)-4,5-Diphenyl-1-tosylimidazolidin-2-yl)-6-((2S,4R,5R)-4,5-diphenyl-1-
tosylimidazolidin-2-yl)pyridine (19) 
White solid (92% yield, 761.8 mg). Purification by flash 
chromatography (Hexane/EtOAc, 3/2). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.01-7.96 (m,3H), 7.53 (d, J= 8.3 Hz, 
4H), 7.18-7.20 (m, 20H), 7.00-6.96 (d, J= 7.0 Hz, 4H), 4.71 
(d, J= 5.3 Hz, 2H), 4.25 (d, J= 5.3 Hz, 2H), 2.39 (s, 6H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) =158.3, 144.1, 140.0, 
139.5, 138.5, 134.5, 129.9, 128.9, 128.6, 128.1, 127.8, 
127.7, 127.3, 127.1, 124.5, 78.7, 71.8, 69.6, 31.4. IR (neat) 
ν = 3307, 2933, 2888, 1596, 1578, 1496, 1474, 1445, 1348, 1307, 1163, 1093, 1033, 982, 
922, 886, 811, 729, 700, 667, 600, 586 cm
-1
. HRMS (FAB, [M+H]
+) calc’d for 
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[C49H47N5O4S2]
+
: 832.2986, found: 832.2980. Anal Calc’d for C49H46N5O4S2: C, 70.73, H, 
5.45, N, 8.42, found: C, 70.97, H, 5.36, N, 8.24. mp: 157-158 °C. 
 
2-((2R,4R,5R)-4,5-Diphenyl-1-((2,4,6-triisopropylphenyl)sulfonyl)imidazolidin-2-yl)-6-
((2S,4R,5R)-4,5-diphenyl-1-((2,4,6-triisopropylphenyl)sulfonyl)imidazolidin-2-yl) 
pyridine (21) 
White solid (98% yield, 1031.1 mg). Purification by flash 
chromatography (Hexane/EtOAc, 3/1). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.61 (t, J= 7.6 Hz, 1H), 7.26-7.14 (m, 6H), 
7.06-7.04 (m, 5H), 6.90-6.85 (m, 15H),  6.30 (s, 2H), 4.84 (t, 
J= 7.2 Hz, 4H), 3.81 (septet, J= 6.8 Hz, 4H), 3.52 (s, 2H), 
2.75 (septet, J= 6.8 Hz, 2H), 1.14 (d, J= 6.8 Hz, 12H), 0.96 
(d, J= 6.8 Hz, 24H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
159.9, 154.0, 151.8, 139.0, 137.3, 131.3, 128.8, 128.2, 128.1, 
127.7, 127.6, 127.5, 123.8, 123.5, 78.3, 72.1, 71.0, 34.5, 29.7, 25.2, 25.1, 23.9. IR (neat) ν = 
3333, 2959, 2904, 1604, 1566, 1455, 1429, 1385, 1363, 1311, 1289, 1148, 930, 886, 848, 
815, 755, 697, 685, 674 cm
-1
. HRMS (FAB, [M+H]
+) calc’d for 1056.5490, found: 
1056.5487. Anal Calc’d for C65H77N5O4S2: C, 73.90, H, 7.35, N, 6.63, S, 6.07; found: C, 
73.81, H, 7.35, N, 6.66, S, 5.86. mp: 181-184 °C. 
 
 
2-((2R,4R,5R)-1-((4-(tert-Butyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)-6-
((2S,4R,5R)-1-((4-(tert-butyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)pyridine 
(22) 
White solid (95% yield, 866.5 mg). Purification by flash 
chromatography (Hexane/EtOAc, 3/1). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.94 (m, 3H), 7.53 (d, J= 8.5 Hz, 4H), 7.30 
(d, J= 8.5 Hz, 4H), 7.12-7.00 (m, 16H), 6.88 (d, J=6.8 Hz, 2H), 
5.84 (s, 2H), 4.58 (d, J= 6.0 Hz, 2H), 4.17 (d, J= 5.9 Hz, 2H), 
3.48 (bs, 2H), 1.27 (s, 18H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 158.5, 157.1, 139.8, 139.5, 134.4, 128.8, 128.6, 128.2, 
128.1, 127.8, 127.3, 127.2, 126.3, 124.1, 78.5, 72.0, 69.8, 35.5, 
31.5. IR (neat): ν =3296, 2963, 2907, 2866, 1596, 1574, 1496, 1448, 1400, 1348, 1167, 
1111, 1085, 1029, 834, 808, 755, 700, 630 cm
-1
. HRMS (FAB, [M+H]
+) calc’d for 
[C56H59N5O4S2]
+
: 916.3925, found: 916.3923. Anal Calc’d for C56H58N4O4S2: C, 72.10, H, 
6.27, N, 7.64, found: C, 71.69, H, 6.45, N, 7.42. mp: 185-187 °C. 
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2-((2R,4R,5R)-1-((4-Methoxyphenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)-6-
((2S,4R,5R)-1-((4-methoxyphenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)pyridine (23) 
White solid (89% yield, 765.3 mg). Purification by 
crystallization in DCM/MeOH. 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.01-7.95 (m, 3H), 7.56 (dt, J= 8.8, 2.8 
Hz, 4H), 7.19-7.02 (m, 20H), 6.80 (dt, J= 8.8, 2.9 Hz, 4H), 
5.81 (s, 2H), 4.70 (d, J= 5.2 Hz, 2H), 4.25 (d, J=5.3 Hz, 2H), 
3.85 (s, 6H), 3.56 (s, 2H).  
13
C NMR (100 MHz, CDCl3): δ 
(ppm) =163.4, 158.4,140.1, 139.5, 138.4,130.2, 129.3, 128.8, 
128.6, 127.9, 127.8, 127.3, 127.1, 124.4, 114.4, 78.6, 71.8, 
69.6, 55.9.  IR (neat) ν = 3300, 2926, 2888, 1592, 1574, 1496, 1467, 1448, 1345, 1304, 
1260, 1152, 1093, 1023, 985, 892, 837, 804, 749, 729, 700, 630, 608, 564 cm
-1
. HRMS 
(FAB, [M+H]
+) calc’d for : 864.2884; found: 864.2887. Anal Calc’d for C49H45N5O6S2: C, 
68.11, H, 5.25, N, 8.11, S, 7.42; found: C, 67.85, H, 5.27, N, 8.08, S, 7.20. mp: 194-197 °C. 
 
2-((2R,4R,5R)-4,5-Diphenyl-1-((4-trifluoromethyl)phenyl)sulfonyl)imidazolidin-2-yl)-6-
((2S,4R,5R)-4,5-diphenyl-1-((4-(trifluoromethyl)phenyl)sulfonyl)imidazolidin-2-yl) 
pyridine (24) 
 Colourless crystals (79% yield, 739.2 mg). Purification by 
crystallization in DCM/MeOH. 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.99 (d, J= 7.8 Hz, 1H), 7.86 (d, J=7.6  
Hz, 2H), 7.55 (d, J= 8.4 Hz, 4H), 7.45 (d, J= 8.4 Hz, 4H), 
7.17-7.09 (m, 20H), 5.79 (s, 2H), 4.91 (d, J= 3.1 Hz, 2H), 
4.42 (d, J= 3.0 Hz, 2H), 3.58 (s, 2H).
 13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 157.1, 141.4, 140.0, 139.5, 138.5, 134.7 
(d, 
2
JC-F = 32.7 Hz), 129.1, 128.7, 128.2, 128.1, 127.9, 127.6, 
127.1, 126.5, 126.3, 126.2, 125.7, 124.9 (t, 
1
JC-F = 271.2 Hz), 79.4, 71.1, 69.3. IR (neat) ν = 
3289, 1604, 1579, 1457, 1403, 1353, 1321, 1162, 1135, 1095, 1058, 1012, 983, 887, 840, 
811, 736, 711, 620. HRMS (FAB, [M+H]
+) calc’d for [C49H40F6N5O4S2]
+
: 940.2420, found: 
940.2419. mp: 154-155 °C. 
 
2-((2R,4R,5R)-4,5-Diphenyl-1-(naphthalene-1-ylsulfonyl)-4,5-diphenylimidazolidin-2-
yl)-6-((2S, 4R,5R)-4,5-diphenyl-1-(naphthalene-1-ylsulfonyl)-4,5-diphenylimidazolidin-
2-yl)pyridine (25) 
 
White solid (84% yield, 759.4 mg). Purification by flash 
chromatography (Hexane/EtOAc, 3/1). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 8.58 (d, J= 8.6 Hz, 2H), 7.97 ( d, 
J = 8.2 Hz, 2H), 7.91 (d, J= 7.6 Hz, 2H), 7.82 (dd, J= 7.3, 
1.2 Hz, 4H), 7.64-7.61 (m, 2H), 7.59-7.57 (m, 2H), 7.34 (t, 
J= 8.0 Hz, 2H), 7.00-6.94 (m, 10H), 6.77-6.71 (m, 12H), 
5.81 (s, 2H), 4.76 (d, J= 6.8 Hz, 2H), 4.60 (d, J= 6.8 Hz, 
2H), 3.21 (bs, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) 
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= 158.3, 142.2, 138.4, 136.2, 134.1, 131.6, 130.8, 128.5, 127.8, 127.0, 126.6, 126.4, 124.5, 
121.2, 79.8, 70.9, 66.7. Anal Calc’d for C55H45N5O4S2: C, 73.07, H, 5.02, N, 7.75, found: C, 
72.94, H, 5.09, N, 7.89. 
 
2-((2R,4R,5R)-4,5-Diphenyl-1-((4-nitrophenyl)sulfonyl)imidazolidin-2-yl)-6-((2S, 
4R,5R)-4,5-diphenyl-1-((4-nitrophenyl)sulfonyl)imidazolidin-2-yl)pyridine (26) 
 
Colourless crystals (81% yield, 724.1 mg). Purification by 
crystallisation in DCM/MeOH. 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 8.01 (t, J= 7.6 Hz, 1H), 7.97 (d, J= 7.1 Hz, 4H), 
7.82 (d, J= 8.0 Hz, 2H), 7.56 (m, 4H), 7.09-7.28 (m, 20H), 
5.72 (d, J= 5.2 Hz, 2H), 4.91 (s, 2H), 4.46 (m, 2H), 3.54 (t, J= 
3.1 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 156.6, 
150.2, 139.9, 139.6, 129.2, 129.0, 128.8, 128.6, 128.2, 128.1, 
128.0, 127.9, 127.2, 127.1, 126.6, 126.4, 126.2, 124.2, 124.1, 
79.6, 70.9, 69.2. HRMS (FAB, [M+H]
+) calc’d for [C47H36N7O8S2]
+
: 889.1989, found: 
889.1987. 
 
Meso-2-(4,5-diphenyl-1-tosylimidazolidin-2-yl)-6-(4,5-diphenyl-1-tosylimidazolidin-2-
yl)pyridine (27) 
White solid (90% yield, 748.6 mg). Purification by flash 
chromatography (Hexane/EtOAc, 3/2). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.12 (d, J= 7.5 Hz, 2H), 8.08 (t, J= 7.0 Hz, 
1H), 7.52 (d, J=8.2 Hz, 4H), 7.17 (d, J= 8.2 Hz, 4H), 7.05 (t, 
J= 7.5 Hz, 2H), 6.72-6.84 (m, 25H), 6.51 (d, J= 7.4 Hz, 2H), 
6.08 (d, J= 10.6 Hz, 2H), 5.19 (d, J= 6.8 Hz, 2H), 4.51 (q, J= 
6.8 Hz, 2H), 4.30 (t, J= 11.5 Hz, 2H), 2.35 (s, 6H). 
13
C NMR 
(100 MHz, CDCl3): δ (ppm) = 154.2, 144.1, 136.9, 136.3, 
134.9, 129.9, 128.3, 128.2, 128.0, 127.8, 127.7, 127.5, 127.2, 78.9, 67.6, 67.5, 31.3. IR 
(neat): ν = 3289, 3032, 1597, 1495, 1452, 1430, 1334, 1306, 1289, 1187, 1161, 1088, 1048, 
1029, 1003, 967, 941, 887, 858, 800, 762, 707, 691, 662, 623, 580, 565 cm
-1
. HRMS (FAB, 
[M+H]
+) calc’d for [C49H47N5O4S2]
+
: 832.2986, found: 832.2982. Anal Calc’d for 
C49H46N5O4S2: C, 70.73, H, 5.45, N, 8.42, found: C, 70.84, H, 5.48, N, 8.36. mp: 156-157 
°C. 
2.5.7. General Procedure for the synthesis of N-(2-(arylamino)-1,2-
diphenylethyl)arylsulfonamides
28 
(R,R)-N-(2-amino-1,2-diphenylethyl)-4-methylbenzenesulfonamide (4.9 mmol, 1.8 g) was 
added in a two necked flask, degassed and placed under a N2 atmosphere. Freshly distilled 
THF (12 mL) and p-tolylbenzaldehyde (5.4 mmol, 649.0 mg) were subsequently added and 
the reaction mixture was stirred at r.t. for 2 h under inert atmosphere. Then, anhydrous EtOH 
(18 mL) was added to the solution and NaBH4 (7.8 mmol, 297.0 mg) was added portionwise. 
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The reaction system was stirred overnight at r.t. Water was added dropwise until no gas 
evolution was observed and then DCM (20 mL) was added. The solution was filtered and 
the organic phase was washed with water, extracted, dried over MgSO4, filtered and 
evaporated under vacuum to give a crude product that was purified by column (hexane/ethyl 
acetate) affording the pure product. 
Analytical data 
N-((1R,2R)-2-(benzylamino)-1,2-diphenylethyl)-4-methylbenzenesulfonamide
28
 (31) 
White solid, (93% yield, 1.146 g). Purification by flash column 
chromatography (Hexane/EtOAc,  3/1). 
1
H NMR (400 MHz, CDCl3) δ 
(ppm) =  7.4 (d, J = 8.3 Hz, 2H), 7.3 (m, 3H), 7.2 (m, 3H), 7 (m, 9H), 6.9 
(d, J = 6.7 Hz, 2H), 6.1 (bs, 1H), 4.3 (d, J = 7.8 Hz, 1H), 3.7 (d, J = 7.8Hz, 
1H), 3.6 (d, J = 13.0 Hz, 1H), 3.4 (d, J = 13.1 Hz, 1H), 2.2 (s, 3H), 1.7 (bs, 
1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 143.1, 138.6, 137.3, 129.5, 
128.9, 128.8, 128.5, 128.3, 128.0, 127.9(8), 127.9(0), 127.7, 127.6, 127.5, 
67.1, 63.4, 51.2, 21.8. HRMS (CI, [M+H]
+
) calc’d for C28H28N2O2S: 457.1950, found 
457.1949. Anal Calc’d for C28H28N2O2S: C, 73.65, H, 6.18, N, 6.14, found: C, 73.81, H, 
6.15, N, 6.05. 
 
4-Methyl-N-((1R,2R)-2-((4-methylbenzyl)amino)-1,2-diphenylethyl)benzene 
sulfonamide 
White solid, (96% isol. yield, 2.218 g). Purification by flash column 
chromatography (Hexane/EtOAc, 3/1). 
1
H NMR (400 MHz, CDCl3) δ 
(ppm) = 7.3-6.8 (m, 18H), 6.0 (bs, 1H), 4.3 (d, J = 7.4 Hz, 1H), 3.6 (d, J 
= 7.6 Hz, 1H), 3.5 (d, J = 13.0 Hz, 1H), 3.3 (d, J = 13.0 Hz, 1H), 2.2 (s, 
3H), 2.1 (s, 3H), 1.7 (bs, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
143.1, 138.7, 137.5, 137.3, 136.8, 130.8, 129.5, 128.8, 128.4, 128.2, 
128.0, 127.9, 127.8, 127.7(4), 127.7(1), 127.5, 126.5, 126.3, 67.6, 63.5, 
49.3, 21.8, 19.2. HRMS (CI, [M+H]
+
) calc’d for C29H30N2O2S: 471.2106, found: 471.2104. 
Anal Calc’d for C29H30N2O2S: C, 74.01, H, 6.43, N, 5.95, found: C, 73.72, H, 6.55, N, 5.57. 
 
2.5.8. General procedure for the synthesis of sp
3
-N-benzyl substituted PyBisulidine 
ligands. 
Prepared according to the general procedure, using pyridine-2,6-dicarbaldehyde (0.6 mmol, 
81.0 mg), (R,R)- N-(2-amino-1,2-diphenylethyl)-4-methylbenzenesulfonamide (1.3 mmol, 
483.8 mg), acetic acid (1.2 mmol, 60 μL) and DCM (24 mL). 
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Analytical data 
2-((2R,4S,5S)-1-Benzyl-4,5-diphenyl-3-tosylimidazolidin-2-yl)-6-((2S,4S,5S)-1-benzyl-
4,5-diphenyl-3-tosylimidazolidin-2-yl)pyridine (32) 
 
Colourless crystals (93% isol. yield, 607.0 mg). Purification 
by crystallization in DCM/MeOH. 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.67 (t, J= 7.7 Hz, 1H), 7.58 (d, J= 8.1 Hz, 
4H), 7.31-7.10 (m, 22H), 6.96 (d, J= 2.4 Hz, 6H), 6.78 (d, J= 
6.3 Hz, 4H), 6.61 (d, J= 7.3 Hz, 4H), 5.78 (s, 2H), 4.86 (d, J= 
7.9 Hz, 2H), 4.63 (d, J= 8.6 Hz, 2H), 3.35 (m, 4H), 2.51 (s, 
6H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 159.1, 144.2, 
138.5, 138.0, 137.8, 134.2, 129.9, 129.2, 128.8, 128.7, 128.6, 
128.5, 128.4, 127.9, 127.6, 127.5, 125.3, 79.6, 73.7, 72.4, 49.7, 22.1. IR (neat) ν = 1594, 
1494, 1454, 1346, 1160, 1091, 1070, 998, 811, 757, 736, 703, 661, 636. HRMS (FAB, 
[M+H]
+) calc’d for [C63H57N5O4S2]
+
: 1012.3925, found: 1012.3923. Anal Calc’d for 
C63H56N5O4S2: C, 74.75, H, 5.68, N, 6.92, found, C, 74.53, H, 5.68, N, 6.86. mp: 202-203 
°C. 
2-((2R,4S,5S)-1-Benzyl-4,5-diphenyl-3-(methoxyphenyl)imidazolidin-2-yl)-6-
((2S,4S,5S)-1-benzyl-4,5-diphenyl-3-(methoxyphenyl)imidazolidin-2-yl)pyridine (33) 
 
White solid (89%  isol. yield, 607.0 mg). Purification by 
crystallisation in DCM/MeOH. 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.71 (t, J= 7.7 Hz, 1H), 7.62 (d, J= 7.1 
Hz, 4H), 7.26-7.13 (m, 7H), 6.98-6.93 (m, 6H), 6.82 (d, J 
=7.2 Hz, 4H), 6.67 (d, J= 7.1 Hz, 4H), 5.79 (s, 2H), 4.87 
(d, J= 7.8 Hz, 2H), 4.65 (d, J= 7.8 Hz, 2H), 3.91 (s, 6H), 
3.39 (d, J = 13.9 Hz, 2H), 3.32 (d, J= 13.9 Hz, 2H), 2.13 (s, 
6H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 163.4, 
158.9, 138.4, 137.3, 137.1, 136.5, 135.2, 130.5, 130.0, 
128.8, 128.4, 128.2, 128.1, 127.5, 127.1, 126.8, 125.5, 124.7, 114.1, 79.5, 73.3, 71.9, 55.8, 
46.8, 29.7.  IR (neat) ν = 2923, 2852, 1593, 1575, 1495, 1453, 1382, 1311, 1266, 1246, 
1179, 1158, 1091, 1074, 1011, 970, 895, 833, 747, 699, 673, 653, 628, 569, 551 cm
-1
. Anal 
Calc’d for C65H57N5O6S2: C, 73.08, H, 5.38, N, 6.56, found: C, 73.18, H, 5.32, N, 6.44. mp: 
232-233 °C. X-ray diffraction of this compound is provided in pages 72-73. 
2-((2R,4S,5S)-1-Benzyl-4,5-diphenyl-3-(methoxyphenyl)imidazolidin-2-yl)-6-
((2S,4S,5S)-1-benzyl-4,5-diphenyl-3-(methoxyphenyl)imidazolidin-2-yl)pyridine (34) 
 
White solid (92% isol. yield, 576.4 mg). Purification by 
crystallisation in DCM/MeOH.  
1
H NMR (400 MHz, CDCl3) δ 
(ppm) =  7.68-7.66 (m, 1H), 7.64-7.59 (m, 4H), 7.22-7.14 (m, 
20H), 6.98-6.93 (m, 4H), 6.66 (d, J = 7.4 Hz, 4H), 5.79 (s, 2H), 
4.86 (d, J = 7.8 Hz, 2H), 4.63 (d, J = 7.7 Hz, 2H), 3.91 (s, 6H), 
3.40 (d, J = 13.9 Hz, 1H), 3.32 (d, J = 13.9 Hz, 2H). 
13
C NMR 
(100 MHz, CDCl3) δ (ppm) = 163.2, 158.8, 138.1, 137.7, 
137.3, 130.4, 128.7, 128.6, 128.5, 128.3, 128.2, 128.1, 128.0, 
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127.5, 127.2, 124.8, 114.0, 79.2, 73.3, 72.0, 55.7, 49.3. Anal Calc’d for C63H57N5O6S2: C, 
72.46, H, 5.50, N, 6.71, found: C, 72.23, H, 5.47, N, 6.61. IR (neat) ν = 3102, 1592, 1576, 
1493, 1454, 1346, 1313, 1264, 1241, 1157, 1090, 1075, 1055, 1018, 837, 820, 762, 743, 696, 
674, 628, 589, 569, 541 cm
-1
. mp: 209-210 °C. 
 
2.5.9. General multistep procedure for the synthesis of 4-methoxypyridine-2,6-
dicarboxaldehyde 
2.5.9.1. Synthesis of dimethyl-4-hydroxypyridine-2,6-dicarboxylate
28
 (36) 
Chelidamic acid monohydrate (8.00 mmol, 1.46 g) was suspended in MeOH (35 mL) and 
sulphuric acid (97%) was added slowly under vigorous stirring until complete solution of the 
starting acid. The resulting yellow solution was refluxed for 2 h and then solvents were 
removed in vacuo. Water was added (20 mL) and the solution was neutralised with saturated 
NaHCO3 to pH 8 and the aqueous solution was extracted with DCM (4 x 20 mL). The 
organic phase was dried over MgSO4, filtered and evaporated under vacuo to afford the 
product as a white solid (80% yield, 1.41 g).  
1
H NMR (400 MHz, CDCl3) δ (ppm) = 7.8 (bs, 1H), 7.2 (s, 2H), 4.0 (s, 6H). MS (CI, 
[M+H]
+
) calc’d for C9H9NO5 : 212, found : 212. Anal Calc’d for C9H9NO5: C, 51.19, H, 
4.30, N, 6.63, found: C, 50.79, H, 4.70, N, 6.19. 
 
2.5.9.2. Synthesis of dimethyl 4-methoxypyridine-2,6-dicarboxylate
29
 (37) 
 
Dimethyl-4-hydroxypyridine-2,6-dicarboxylate (4.0 mmol, 900 mg), K2CO3 (6.6 mmol, 990 
mg) and dimethyl sulphate (4.4 mmol, 594 mg) were stirred in DMF (10 mL) at r.t. for 24 h 
(t.l.c. control). The solvent was removed under reduced pressure and the crude product was 
dissolved in DCM/water and the organic phase extracted with DCM, dried over MgSO4, 
filtered and evaporated under vacuo to afford the product as a white solid (90% yield, 825.4 
mg).  
1
H NMR (400 MHz, CDCl3) δ (ppm) = 7.8 (s, 2H), 4.0 (s, 6H), 3.9 (s, 3H). 
13
C NMR (100 
MHz, CDCl3) δ (ppm) = 167.7, 165.2, 149.8, 114.2, 56.1, 53.3. MS (CI, [M+Na]
+
) calc’d for 
C10H11NO5Na: 248, found: 248. Anal Calc’d for C10H11NO5: C, 53.33, H, 4.92, N, 6.22, 
found: C, 53.11, H, 4.84, N, 6.03. 
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2.5.9.3. Synthesis of dimethyl 2,4-dihydroxymethyl-4-methoxypyridine
30
 (38) 
4-Methoxypyridine-2,6-dicarboxylate (2.5 mmol, 560 mg) and NaBH4 (3.75 mmol, 469 mg) 
were refluxed in freshly distilled THF (22 mL) and anhydrous MeOH (6 mL) was added 
slowly dropwise to the boiling mixture over a period of 1 h. The mixture was allowed to 
reflux for an additional 2 h and then cooled to r.t. Water (12 mL) was added slowly and the 
organic solvent was removed in vacuo and the solution was extracted with ethyl acetate (3 x 
12 mL). The organic phase was evaporated to dryness and the residue was purified by silica 
gel column chromatography (9/1 DCM/MeOH) to afford the product as a white solid (80% 
yield, 338 mg). 
 
1
H NMR (400 MHz, DMSO-d6) δ (ppm) = 6.9 (s, 2H), 5.4 (d, J = 5.9 Hz, 4H), 4.4 (d, J = 
5.9 Hz, 2H), 3.8 (s, 3H). 
13
C NMR (100 MHz, DMSO-d6) δ (ppm) = 167.1, 163.4, 104.6, 
64.5, 56.1. MS (CI, [M+H]
+
) calc’d for C8H11NO3 170, found 170. 
 
2.5.9.4. Synthesis of 4-methoxypyridinedicarbaldehyde
31
 (39) 
Dimethyl 2,4-dihydroxymethyl-4-methoxypyridine (1.8 mmol, 300 mg) and SeO2 (1.8 
mmol, 200 mg) were heated overnight in xylene at 110 
°
C. The hot reaction mixture was 
filtered through Celite and the solvent was removed under vacuo. The resulting red-pink 
solid was purified by silica gel column chromatography ( 3/1 ethyl acetate/DCM) to afford 
the final product as cream needles (96% yield, 385.0 mg).  
1
H NMR (400 MHz, CDCl3) δ (ppm) = 10.1 (s, 2H), 7.7 ( s, 2H), 4.0 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ (ppm) = 191.9, 167.6, 154.8, 110.5, 56.0. 
HRMS (CI, [M+H]
+
) calc’d for C8H7NO3: 165, found :165. Anal Calc’d for 
C8H7NO3: C, 58.18, H, 4.27, N, 8.48, found: C, 58.24, H, 4.24, N, 8.35. 
 
2.5.10. General procedure for the synthesis of Pyridyl-substituted PiBisulidine ligands. 
Prepared according to the general procedure, using 4-methoxypyridine-2,6-dicarbaldehyde 
(0.5 mmol, 165 mg) and (R,R)-N-(2-amino-1,2-diphenylethyl)-4-methylbenzenesulfonamide 
(1.1 mmol, 806.5 mg), acetic acid (1.0 mmol, 50 μL) and DCM (24 mL). 
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Analytical data 
2-((2R,4R,5R)-4,5-Diphenyl-1-tosylimidazolidin-2-yl)-6-((2S,4R,5R)-4,5-diphenyl-3-
tosylpyrrolidin -2yl)-4-methoxypyridine (40) 
Transparent crystals (90% isol. yield, 775.2 mg). 
Purification by crystallisation in DCM/MeOH. 
1
H NMR 
(400 MHz, CDCl3) δ (ppm) = 7.57 (d, J = 8.0 Hz, 4H), 7.50 
(s, 2H), 7.17-7.14 (m, 20H), 6.96 (d, J = 7.1 Hz, 4H), 5.76 (s, 
2H), 4.65 (d, J = 5.9 Hz, 2H), 4.20 (d, J = 5.4 Hz, 2H), 4.02 
(s, 3H), 3.53 (bs, 2H), 2.41 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3) δ (ppm) = 167.4, 159.9, 143.7, 139.4, 139.0, 134.1, 
129.5, 128.4, 128.2, 127.8, 127.4, 127.1, 126.7, 109.7, 78.1, 
71.6, 69.1, 55.7, 21.6. IR (neat) ν = 3286, 1599, 1573, 1493, 1472, 1446, 1345, 1319, 1274, 
1161, 1135, 1091, 1055, 1035, 888, 853, 846, 798, 730, 697, 664, 600, 587, 551, 530 cm
-1
. 
HRMS (FAB, [M+H]
+) 
calc’d: 1056.5490, found: 1056.5467. Anal Calc’d for 
C55H54N6O5S2: C, 70.04, H, 5.77, N, 8.91, found: C, 70.28, H, 5.46, N, 8.94. mp: 138-139 
°C. 
 
2.5.11. General procedure for the synthesis of Bisulidine ligands 
Prepared according to the general procedure, using phthaldehyde (1.0 mmol, 134.1 mg) and 
(R,R)- N-(2-amino-1,2-diphenylethyl)-4-t-butylbenzenesulfonamide (2.05 mmol), acetic acid 
(1.0 mmol, 50 μL) and DCM (24 mL). 
Analytical data 
1-((2R,4R,5R)-1-((4-(Methyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)-2-
((2S,4R,5R)-1-((4-(methyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)benzene (42) 
White solid (60% yield, 498.7 mg). Purification by flash 
chromatography (Hexane/EtOAc: 3/1). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 6.95-7.78 (m, 32H), 6.56 (d, J = 7.1 Hz, 1H), 
5.51 (d, J= 7.1 Hz, 1H), 5.23 (d, J= 11.4 Hz, 1H), 4.97 (d, J= 7.1 
Hz, 1H), 4.71 (d, J= 11.2 Hz, 1H), 4.00 (d, J=12.2 Hz, 1H), 2.40 
(s, 3H), 2.34 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
157.8, 154.2, 153.9, 140.8, 140.6, 138.7, 137.6, 136.6, 136.5, 
129.4, 128.8, 128.7, 128.3, 128.1, 127.4, 127.1, 126.9, 
126.3,124.9, 113.4, 77.7, 66.5, 59.7, 23.4. HRMS (FAB, [M+H]
+) calc’d for 
[C50H46N4O4S2]
+
: 830.2960, found: 830.2958. mp: 181-182 °C. 
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1-((2R,4R,5R)-1-((4-(tert-Butyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)-2-
((2S,4R,5R)-1-((4-(tert-butyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)benzene 
(43) 
White solid (60% yield, 548.9 mg). Purification by flash 
chromatography (Hexane/EtOAc, 3/1). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.78 (d, J= 7.6 Hz, 1H), 7.59 (d, J=7.6 Hz, 2H), 
7.52 (d, J= 7.6 Hz, 2H), 7.19-6.94 (m, 27H), 6.57 (bs, 3H), 5.36 
(d, J= 7.4 Hz, 1H), 5.12 (d, J= 11.3 Hz, 1H), 4.86 (m, 2H), 4.06 (d, 
J=16.2 Hz, 1H), 1.23 (d, J= 7.6 Hz, 18H).  
13
C NMR (100 MHz, 
CDCl3): δ (ppm) =157.7, 154.0, 153.8, 140.9, 140.5, 137.2, 136.6, 
136.4, 136.3, 129.3, 128.4, 127.5, 127.0, 126.8, 126.4, 126.3, 
126.2, 126.1, 125.8, 125.7, 125.4, 125.3, 124.6, 123.9, 123.8, 121.7, 75.9, 64.8, 57.9, 33.4, 
29.6.   IR (neat) ν = 3257, 2958, 1629, 1454, 1400, 1321, 1211, 1157, 1110, 1087, 1058, 
1027, 927, 829, 754, 700, 636. HRMS (FAB, [M+H]
+) calc’d. for [C56H59N4O4S2]
+
: 
915.3972, found: 915.3958. Anal Calc’d for C56H58N4O4S2: C, 73.49, H, 6.39, N, 6.12, S, 
7.01; found: C, 72.99, H, 6.55, N, 6.13, S, 6.95. mp: 190-191 °C. 
1-((2R,4R,5R)-1-(4-Nitrophenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)-2-((2S,4R,5R)-
1-(4-nitrophenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)benzene (45) 
White solid (48% yield, 428.4 mg). Purification by flash 
chromatography (Hexane/EtOAc, 5/2). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.75 (m, 4H), 7.57 (m, 4H), 7.43 (d, J= 6.3, 
1.1 Hz, 2H), 7.32 (dd, J= 6.3, 1.2 Hz, 2H), 7.24-7.12 (m, 16H), 
6.92-6.89 (m, 4H), 5.87 (s, 2H), 5.24 (bs, 2H), 4.54 (d, J= 5.6 
Hz, 2H), 4.06 (d, J= 5.7 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): 
δ (ppm) = 151.4, 145.9, 138.3, 128.6, 128.3, 127.9, 127.7, 127.1, 
124.2, 78.9, 71.8, 65.8. IR (neat) ν = 3262, 1678, 1523, 1349, 
1311, 1225, 1211, 1163, 1154, 967, 946, 887, 794, 764, 732, 589, 569 cm
-1
. HRMS (FAB) 
calc’d for [C42H38N5O5S]
+
: 724.2588, found: 724.2588. mp: 192-193 °C. 
1-((2R,4R,5R)-1-(Naphthalene-1-ylsulfonyl)-4,5-diphenylimidazolidin-2-yl)-2-
((2S,4R,5R)-1-(naphthalene-1-ylsulfonyl)-4,5-diphenylimidazolidin-2-yl)benzene (46) 
White solid (50% yield, 451.1 mg). Purification by flash 
chromatography (Hexane/EtOAc, 5/2). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.42 (d, J= 8.5 Hz, 2H), 7.92 (d, J= 8.6 Hz, 
2H), 8.73 (d, J= 7.8 Hz, 2H), 8.68 (d, J= 8.0 Hz, 2H), 8.54 (d, J= 
7.9 Hz, 2H), 7.42-7.29 (m, 12H), 7.21-7.03 (m, 12H), 6.87 (m, 
2H), 6.72 (m, 2H), 5.22 (d, J= 4.5 Hz, 2H), 5.14 (bs, 2H), 4.56 
(d, J= 5.6 Hz, 2H), 3.96 (d, J= 5.6 Hz, 2H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 142.5, 138.3, 136.7, 134.0, 131.6, 131.0, 128.5, 128.3, 127.9, 127.7, 
127.1, 126.8, 126.3, 124.6, 78.8, 71.5, 65.9. Anal Calc’d for C56H46N4O4S2: C, 74.48, H, 
5.13, N, 6.20; found: C, 74.65, H, 5.22, N, 6.17. 
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2.5.12.General procedure for the synthesis of asymmetric ligands 
Prepared according to the general procedure using 6-(1H-pyrazol-1-yl)picolinaldehyde
24
 (1.0 
mmol, 134.1 mg) and (R,R)-N-(2-amino-1,2-diphenylethyl)-2,4,6-triisopropylbenzene 
sulfonamide (1.05 mmol), acetic acid (1.0 mmol, 50 μL) and DCM (24 mL). 
Analytical data 
2-((2S,4R,5R)-4,5-Diphenyl-1-((2,4,6-triisopropylphenyl)sulfonyl)imidazolidin-2-yl)-6-
(1H-pyrazol-1-yl)pyridine (53) 
White solid (98% yield, 620.9 mg). Purification by flash 
chromatography (Hexane/EtOAc, 3/1). 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 8.32 (d, J= 2.5 Hz, 1H), 8.02 (d, J= 8.2 Hz, 1H), 7.82 (t, J= 
7.5 Hz, 1H), 7.77 (d, J= 1.5 Hz, 1H), 7.43-7.28 (m, 5H), 7.22 (d, J= 
7.5 Hz, 1H), 7.09-6.94 (m, 7H), 6.43 (dd, J = 2.5, 1.6 Hz, 1H), 6.28 
(s, 1H), 5.05 (d, J= 7.4 Hz, 1H), 4.95 (d, J= 7.3 Hz, 1H), 3.90 (septet, 
J= 6.6 Hz, 2H), 3.51 (bs, 1H), 2.79 (septet, J= 6.6 Hz, 1H), 1.17 (d, 
J= 6.7 Hz, 6H), 0.99 (d, J= 6.7 Hz, 18H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 158.5, 153.9, 152.0, 151.8, 142.6, 139.8, 139.4, 138.7, 131.6, 129.1, 
128.6, 128.3, 127.8, 127.7, 127.6, 127.4, 123.9, 120.7, 112.3, 108.2, 78.2, 72.6, 70.9, 34.5, 
29.7, 25.1, 23.9. IR (neat) ν = 3355, 2955, 2870, 1600, 1578, 1455, 1389, 1307, 1293, 1200, 
1148, 1133, 1041, 944, 889, 837, 811, 749, 700, 671, 596 cm
-1
. HRMS (EI) m/z calc’d 
C38H43N5O2SNa [M + Na]
+
 : 656.3035, found, 656.3057. Anal Calc’d for C38H43N5O4S: C, 
72.01, H, 6.84, N, 11.05, found: C, 71.92, H, 6.89, N, 11.07. mp: 134-135 °C. 
2-((4R,5R)-1-Benzyl-4,5-diphenyl-3-tosylimidazolidin-2-yl)-6-(1H-pyrazol-1-yl)pyridine 
(54) 
White solid (97% yield, 593.1 mg). Purification by flash 
chromatography (Hexane/EtOAc, 3/1). 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 8.37 (d, J= 2.0 Hz, 1H), 8.04 (m, 2H), 7.77 (d, J= 8.0 Hz, 
2H), 7.55 (d, J= 8.0 Hz, 2H), 7.35-7.12 (m, 13H), 6.45 (q, J= 1.8 Hz, 
1H), 5.95 (s, 1H), 4.85 (d, J= 5.7 Hz, 1H), 4.48 (m, 1H), 3.65 (m, 1H), 
2.40 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 158.7, 151.1, 
142.2, 139.7, 138.8, 138.3, 137.5, 129.3, 128.9, 128.8, 128.6, 127.9, 
127.3, 121.6, 110.5, 107.8, 78.6, 72.7, 70.7, 49.8, 22.3. 
 
2.5.13. General procedure for the synthesis of [Fe(BF4)(NNN)(MeCN)2](BF4) (20) 
In an Schlenck tube equipped with a stirring bar, ligand 19 (0.12 mmol, 100 mg) and 
Fe(BF4)2 x 6H2O (0.12 mmol, 40.5 mg) were added. The tube was degassed and placed 
under a N2 atmosphere. Freshly distilled MeCN ( 5 mL) was added by syringe and the initial 
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transparent solution rapidly turned orange. The reaction mixture was stirred at 30 °C for 2 h 
and then filtered over Celite under a N2 atmosphere. The bright orange solution was 
concentrated to a small volume (circa 2.0 mL) and freshly distilled hexane (2.0 mL) was 
subsequently added dropwise over the MeCN layer. The biphasic mixture was left under a 
N2 atmosphere until well shaped crystals formed .The crystals were filtered and washed with 
distilled hexane and stored under a N2 atmosphere, where they were found to be stable for 
months (68% yield, 96.8 mg). 
Crystallographic data of 20 
The structure determination was performed by the Chemistry Department X-ray 
Crystallographic Service. 
Single crystals of each reported compound were mounted on a MiTeGen MicroMount using 
Fomblin oil. The data were measured at 100 K on a Bruker D8 diffractometer using Mo 
wavelengths and observed with an Apex II CCD detector. Data collection and processing 
were completed inside the APEX2 software suite
33
. Data integration and global cell 
refinement were performed with the program SAINT
34
 and data were corrected using 
SADABS
35
.  Structural solutions and least-squares refinements were conducted using the 
OLEX2 interface
36
 to the SHELX suit of packages.
37
 
(R,R)-20 
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CCDC 1005139 contains the supplementary crystallographic data for this compound. This 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
Crystal structure determination of CCDC 1005139. Crystal Data for 
C57H57B2F8FeN9O4S2 (M =1225.71): orthorhombic, space group P212121 (no. 19), a = 
10.4974(5) Å, b = 14.7463(8) Å, c = 37.618(2) Å, V = 5823.2(5) Å
3
, Z = 4, T = 110(2) K, 
μ(MoKα) = 0.411 mm-1, Dcalc = 1.398 g/mm3, 38429 reflections measured (2.96 ≤ 2Θ ≤ 
52.04), 11119 unique (Rint = 0.0329, Rsigma = 0.0394) which were used in all calculations. 
The final R1 was 0.0398 (>2sigma(I)) and wR2 was 0.0886 (all data). 
Table 1 Crystal data and structure refinement for CCDC 1005139.  
Identification code  gon429bm  
Empirical formula  C57H57B2F8FeN9O4S2  
Formula weight  1225.71  
Temperature/K  110(2)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  10.4974(5)  
b/Å  14.7463(8)  
c/Å  37.618(2)  
α/°  90.00  
β/°  90.00  
γ/°  90.00  
Volume/Å
3
  5823.2(5)  
Z  4  
ρcalcmg/mm
3
  1.398  
m/mm
-1
  0.411  
F(000)  2536.0  
Crystal size/mm
3
  0.39 × 0.32 × 0.19  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection  2.96 to 52.04°  
Index ranges  -12 ≤ h ≤ 12, -17 ≤ k ≤ 17, -41 ≤ l ≤ 46  
Reflections collected  38429  
Independent reflections  11119 [Rint = 0.0329, Rsigma = 0.0394]  
Data/restraints/parameters  11119/417/811  
Goodness-of-fit on F
2
  1.084  
Final R indexes [I>=2σ (I)]  R1 = 0.0398, wR2 = 0.0864  
Final R indexes [all data]  R1 = 0.0432, wR2 = 0.0886  
Largest diff. peak/hole / e Å
-3
  0.44/-0.26  
Flack parameter -0.002(12) 
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(S,S)-20 
 
Crystal structure determination of (S,S)-20. Crystal Data for C57H57B2F8FeN9O4S2 
(M =1225.71): orthorhombic, space group P212121 (no. 19), a = 10.4888(5) Å, b = 
14.7280(7) Å, c = 37.5951(18) Å, V = 5807.7(5) Å
3
, Z = 4, T = 100(2) K, μ(MoKα) = 0.412 
mm
-1
, Dcalc = 1.402 g/mm
3, 51590 reflections measured (3.52 ≤ 2Θ ≤ 54.96), 13288 unique 
(Rint = 0.0284) which were used in all calculations. The final R1 was 0.0309 (>2sigma(I)) and 
wR2 was 0.0714 (all data). 
Table 1 Crystal data and structure refinement for [Fe(BF4)(NNN)(MeCN)2](BF4) 
Identification code  [Fe(BF4)(NNN)(MeCN)2](BF4) 
Empirical formula  C57H57B2F8FeN9O4S2  
Formula weight  1225.71  
Temperature/K  100(2)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  10.4888(5)  
b/Å  14.7280(7)  
c/Å  37.5951(18)  
α/°  90.00  
β/°  90.00  
γ/°  90.00  
Volume/Å
3
  5807.7(5)  
Z  4  
ρcalcmg/mm
3
  1.402  
m/mm
-1
  0.412  
F(000)  2536.0  
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Crystal size/mm
3
  0.25 × 0.19 × 0.09  
2Θ range for data collection  3.52 to 54.96°  
Index ranges  -11 ≤ h ≤ 13, -19 ≤ k ≤ 19, -48 ≤ l ≤ 48  
Reflections collected  51590  
Independent reflections  13288[R(int) = 0.0284]  
Data/restraints/parameters  13288/0/811  
Goodness-of-fit on F
2
  1.025  
Final R indexes [I>=2σ (I)]  R1 = 0.0309, wR2 = 0.0701  
Final R indexes [all data]  R1 = 0.0340, wR2 = 0.0714  
Largest diff. peak/hole / e Å
-3
  0.37/-0.25  
Flack parameter 0.011(8) 
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3.1. Introduction 
3.1.1. Organic esters 
In 1848, the German chemist Leopold Gmelin introduced the concept of ester functionality 
for naming a carboxylic acid derivative in which the carbonyl group is bonded with an 
ether.
1
 Indeed, the name ester is a contraction of the German word essigäther (acetic ether) 
and is commonly used nowadays instead of the old terms oxy-acid ethers or ethers of the 
third class that were also coined for this type of functionality.
1
 Both inorganic and organic 
esters are ubiquitous functionalities in nature and are present in molecules essential for life 
itself, such as phosphoesters which act as linkers between nucleosides in DNA molecules,
2
 
or in different types of lipids which constitute natural lipid bilayers.
3
  
Among organic esters, aryl esters are particularly relevant due to their natural properties and 
industrial applications. For instance, many benzoates have sweet flavours and strong 
pleasant aromas and/or are derived from natural oils and therefore they have industrial uses 
in perfumery or as pesticides or bird repellents
4-6
(Scheme 1). 
 
Scheme 1. Examples of simple aryl esters and their applications 
Cyclic esters are commonly named lactones, a term that comes from the cyclic compound 
lactide 5 that is derived from the dehydration of lactic acid 4
7
 (Scheme 2). As its name 
suggests (from latin lactic: milk), many aliphatic lactones have important applications in 
dairy products industries, such as delta-decalactone 6 or glucono-delta-lactone 7, which are 
often employed as acidifiers or pH regulators in milk and cheeses.
8
 Additionally, many 
aliphatic lactones have fruity or sweet flavours and aromas, such as γ-heptalactone 8 or γ-
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nonalactone 9 which are frequently used in food industries due to their strong coconut 
flavour.
9 
Other applications include potential fuel and green solvent uses,
10
 such as γ-
valerolactone 10 and γ-butyrolactone 11, or prodrugs11 or natural products of medicinal 
applications,
12
 such as 11 and lactones of the sesquiterpene family 12-13 respectively 
(Scheme 3). 
 
Scheme 2. Formation of lactide from lactic acid 
 
Scheme 3. Examples of aliphatic lactones  
From a synthetic point of view, aryl lactones are particularly interesting due to the many 
natural products and biologically active compounds that contain this type of skeleton. 
Chapter 3 
 
103 
 
Coumarines,
13
  isochromanones
14
 and phthalides
15
 are three major families of aryl lactones 
that have been found in an ample variety of natural products and whose derivatives are of 
widespread use in pharmaceutical and agrochemical industries due to their biological 
properties. Scheme 4 illustrates some significant examples of these families, such as natural 
product 15, which is applied in skin diseases treatments, natural products of the ajudazol 
family 17 which exhibit antibacterial properties and the industrially relevant fungicide 19. 
 
Scheme 4. Examples of natural products and biologically active cyclic aryl esters 
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3.1.2. Methods for ester syntheses 
3.1.2.1. Benzylic esters 
Because of their simple structure and industrial properties, many methodologies have been 
described for synthesising benzyl esters. Traditional and widely employed methods include 
the synthesis of benzyl esters from carboxylic acids (Fisher esterification) or its derivatives 
such as acyl chlorides, anhydrides or even esters via transesterification.
16
 Other commonly 
applied methods include Mitsunobu reaction
17
 and Pinner reaction
18
 (Scheme 5). 
 
Scheme 5. Frequent methods for synthesing aryl esters 
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3.1.2.2. Aliphatic lactones 
Generally, aliphatic lactones can be synthesised from hydroxyacids by water removal or 
distillation.
19
 Such method is employed in the industrial production of 11 from γ-
hydroxybutyric acid 20 (Scheme 6). Nonetheless, a vast collection of methododologies have 
been reported for producing these valuable lactones from different organic precursors. 
Alkyne derivatives such as 21 and 23 can undergo electrophilic cyclisation to afford γ-
butyrolactones in good yields with specific alpha alkyl-substitution  patterns 
20,21 
(Scheme 7).  
 
Scheme 6. Synthesis of lactones from hydroxyacids 
 
Scheme 7. Lactone synthesis from alkyne derivatives via electrophilic cyclisation 
Additionally, alkenes can be used as precursors for lactones syntheses by means of different 
synthetic methodologies such as oxidative cyclisation,
22
 although high catalyst loadings, 
large amounts of additives and harsh conditions are often required for achieving good yields 
in these transformations (Scheme 8). In addition, the oxidative [3+2] cycloaddition of 
styrenes to anhydrides furnished γ-arylbutyrolactones in good yields albeit with high catalyst 
loadings and harsh reaction conditions
23
 (Scheme 8). A plausible reaction mechanism would 
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involve the nucleophilic attack of the enol of the anhydride to the Cu-coordinated styrene 
generating intermediate I. Intramolecular insertion into the enol would furnish intermediate 
II from which the γ-butyrolactone results (Scheme 9). 
 
Scheme 8. Alkenes as precursors for lactone production 
 
Scheme 9. Postulated formation of 28 via Cu-mediated carboesterification of styrenes 
 Other less widely applied methods for synthesising butyrolactones include carbene-
catalysed ring expansion and subsequent lactonisation.
24
 From a mechanistic perspective, the 
hypothetic formation of Breslow-type intermediates by reaction of N-heterocyclic carbenes 
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with tetrahdyrofuran 2-carbaldehydes would promote the ether ring opening.  The resulting 
acyclic intermediate I would easily furnish the expanded lactone via initial enol 
tautomerisation and subsequent lactonisation (Scheme 10). Aditionally, hetero-Diels –Alder 
reactions
25
 have been reported to successfully provide specific lactone type products under 
mild conditions but with significantly high catalyst loadings (Scheme 11).  
 
Scheme 10. Synthesis of lactones via ring expansion 
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Scheme 11. Synthesis of lactones by hetero Diels-Alder reaction 
3.1.2.3. Isochromanones and phthalides 
Due to the importance of isochromanones and phthalides, several synthetic methods have 
been developed for their preparation. Transition metal catalysed carbonylation of aryl 
halides is probably one of the most widely employed procedures as it allows the construction 
of regioselective ischromanones.
26
 However, this method often requires harsh reaction 
conditions (high temperatures, basic conditions) and toxic metal catalysts such as Pd or Co. 
Solid and relatively easy to handle Mo carbonyls can be used as a carbonylation source, 
albeit almost stoichiometric amounts are required to achieve good yields.
26a
  Co carbonyls 
can be used in a catalytic fashion although the reactions needed to be placed  under 1 atm of  
CO.
26b
 Multistep syntheses are required for obtaining more complex derivatives of the 
starting alcohols 33 and 35 which often limits the usefulness of the aryl halide carbonylation 
strategy for synthesising substituted isochromanones and phthalides (Scheme 12).  
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Scheme 12. Synthesis of isochromanones and phthalides via carbonylation of aryl halides 
Additionally, isochromanones and phthalides can be obtained from 2-(2-
(hydroxymethyl)phenyl)ethanol 36 or 1,2-phenylenedimethanol 37  respectively, via 
selective benzylic oxidation followed by intramolecular cyclisation (Scheme 13). Several 
oxidants such as MnO2,
27
 cetyltrimethylammonium permanganate
28
 and Cu(bpy)2/TEMPO
29
 
have been reported for undergoing this transformation. Nonetheless, stoichiometric amounts 
of oxidants are often required and the substrate scope is limited to isochromanone and 
phthalide themselves, suggesting poor functional group compatibility. 
 
Scheme 13. Synthesis of isochroman by benzylic oxidation followed by intramolecular 
cyclisation 
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Similarly, dialdehydes can be directly converted to aryl lactones (intramolecular Tishchenko 
reaction) such as isochromanone and phthalide. Traditionally, strongly basic metal 
alkoxides, amphoteric aluminium alkoxides or strong acids used to be employed for both 
inter and intramolecular Tishchenko reactions.
30
 Nonetheless, the use of Ru hydrides as 
catalysts has become a greener alternative to afford these products by direct lactonization of 
aldehydes (Scheme 14).
31
 
 
Scheme 14. Conversion of dialdehydes to lactones via hydroruthenation 
The more recent Pd-catalysed ortho-alkylation of benzoic acids with haloalkanes is a much 
more efficient and versatile method for the synthesis of isochromans and phthalides than the 
aforementioned procedures. Although this method still relies on the use of toxic transition 
metals in relatively high catalyst loadings and requires a high reaction temperature, it can be 
applied to the construction of an ample variety of isochromans and phthalides with good 
yields and good regioselectivity
32
 (Scheme 15). 
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Scheme 15. Pd-catalysed alkylation of benzoic acids to afford isochromanones and 
phthalides 
Aditionally, phthalides can be directly synthesised by reducing phthalide anhydrides with 
metal borohydrides. Nonetheless, these methods require more than stoichiometric amounts 
of borohydrides or reductants and they often result in some byproduct formation derived 
from undesired ring opening reactions
33
 (Scheme 16).
 
 
Scheme 16. Synthesis of phthalides from phthalic anhydrides 
3.2. Aims of this chapter 
The direct oxidation of ethers to esters and/or lactones is viewed as an excellent alternative 
for the synthesis of these industrially valuable products.
34
 Nonetheless, very important 
limitations such as limited substrate scope, lack of chemoselectivity and the current need of 
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additives in more than stoichiometric amounts limit the implementation of these 
transformation on industrial and laboratory scales. Therefore, the development of novel 
catalysts capable of overcoming these limitations would be of great interest. This chapter 
covers the discovery and the subsequent application of Fe(OTf)2-PyBisulidine complexes as 
powerful catalysts for the selective alpha oxidation of ethers to ester under aerobic 
conditions. 
3.3. Results and Discussion 
3.3.1. Discovery of the Fe(OTf)2-L1 catalysed aerobic oxidation of THF 
PyBisulidine type ligands covered in Chapter 2 can easily coordinate to commercially 
available iron salts under mild conditions in different organic solvents. Reacting L1 with 
Fe(OTf)2 in THF led to a THF-ligated complex [FeL1(THF)(OTf)2], the structure of which 
has been determined by X-ray diffraction (Scheme 17). The complex shows a distorted 
octahedral geometry with two axial OTf ligands and an equatorial THF. Although 
surrounded by the sterically demanding L1, the Fe-O distance of 2.042 Å is considerably 
shorter than those found in the iron porphyrine [Fe(TPP)(THF)2] type complexes,
35
 
suggesting a highly electrophilic Fe
II
 centre. Surprisingly, when investigating possible 
catalytic reactions with the complex, small amounts of γ-butyrolactone were detected in the 
bright orange THF solution of [FeL1(THF)(OTf)2]. Prompted by this observation, we set out 
to explore this complex as a potential catalyst for the aerobic oxidation of THF. 
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Scheme 17. PyBisulidine ligand L1, X-ray structure of [FeL1(THF)(OTf)2] and unexpected 
oxidation of THF to 11 
3.3.2. Optimisation of the iron-catalysed aerobic oxidation of THF  
3.3.2.1. Effect of oxidant and water 
Exposing a stirred THF solution of the [FeL1(THF)(OTf)2] complex to 1 atm of O2 indeed 
led to the isolation of γ-butyrolactone, with a TON of 98 in 24 h at 40°C. The in situ 
prepared complex Fe(OTf)2-L1 showed similar behaviour to the preformed complex under 
identical reaction conditions (Table 1, entries 1,2). Initially, the in situ prepared Fe(OTf)2-L1 
complex showed improved efficiency under a pure molecular oxygen atmosphere rather than 
under air at different temperatures (Table 1, entries 2,6 and 4,7). But more importantly, 
higher efficiency and excellent reproducibility were achieved when anhydrous (freshly 
distilled) THF was used as a solvent (Table 1, entries 2 and 3). We suspect that the superior 
catalytic performance in anhydrous THF is due to the detrimental effect of water during 
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complex formation as iron triflates are known to be highly hygroscopic and can allow the 
formation of undesired iron hydroxides. Additionally, when the reaction was performed with 
dry THF and an excess of activated 4 Å MS, no product formation was detected and no 
bright orange colour evolution was observed, suggesting that the complex formation may be 
hampered in the presence of activated molecular sieves. 
 
Table 1. Effect of the oxidant and water traces in the iron catalysed aerobic oxidation of 
THF to γ-butyrolactone 
3.3.2.2. Temperature effect 
The catalytic activity of Fe(OTf)2L1 in anhydrous THF was significantly affected by the 
reaction temperature, with the catalytic efficiency being boosted at higher temperatures and 
reaching a maximum TON of 240 at 60 
°
C (Table 2, entry 4). Nonetheless, the catalytic 
efficiency started to diminish at temperatures higher than 60 
°
C (Table 2, entry 5) and it was 
drastically reduced at temperatures closer to THF’s boiling point (Table 2, entry 6). 
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Table 2. Effect of the reaction temperature in the iron catalysed aerobic oxidation of THF to 
γ-butyrolactone 
3.3.2.3. Control experiments 
At the optimal temperature of 60 
°
C, no oxidation reaction occurred in the absence of 
PyBisulidine ligand L1, Fe(OTf)2 or molecular oxygen (Table 3, entries 1,2,3), which 
highlights that the three components are indispensable for the oxidation of THF. 
Additionally, when the oxidation reaction was performed in analogous conditions 
but using limited amounts of molecular oxygen (Table 3, entry 4) the same lactone 
product 11 was formed with lower conversion with no trace of any alcohol 
intermediate formation. These data clearly show that molecular oxygen is the real 
oxidising agent of the process and suggest that the lactone product formation does 
not occur via an initial alcohol formation followed by its overoxidation to afford the 
ketone product.  
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Table 3. Control reactions 
3.3.2.4. Optimisation of the S/C ratio  
Further optimisation of the substrate-to-catalyst ratio (S/C) showed an increase of the 
catalyst efficiency at lower catalyst loading until reaching a maximum TON of 309 at a S/C 
of 4315 (Table 4, entries 3,4). However, a further increase of the S/C ratio resulted in 
detrimental effect for the catalytic activity (Table 4, entry 5). The variation of the S/C vs the 
catalytic efficiency (TON) showed a polynomial trend line distribution of 4
th
 order (with a 
Gauss bell shaped curve similitude), with a clear maximium at 4315 (Scheme 18). 
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Table 4. Effect of the S/C ratio in the iron catalysed aerobic oxidation of THF to γ-
butyrolactone 
 
Scheme 18. Polynomial distribution of the variation of the S/C ratio vs the TON of the 
aerobic oxidation of THF to γ-butyrolactone 
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3.3.2.5. Ligand effect 
Further optimisation revealed that modification of the ligand structure resulted in the most 
significant oscillations in the catalytic activity. Among all the N-donor ligands investigated, 
PyBisulidine type ligands showed the highest efficiency under optimal reaction conditions, 
especially when electron donating groups are present in the sulfonamide skeleton (Table 5, 
entries 3-7). Nonetheless, replacement of L1 with the more electron rich but much more 
sterically demanding PyBisulidine L5 resulted in a 2.5 fold reduction of the TON (Table 5, 
entry 7) and the sterically very congested L6, in which the NH proton is replaced with a 
benzyl group, afforded no activity at all (Table 5, entry 8), indicating that both electronic 
and steric effects are important factors in modulating the catalyst activity. Using the 
conjugated L7 or L8 as ligands resulted in a significant TON reduction and lower 
selectivity; the undesired autooxidation product tetrahydrofuran α-hydroperoxide was also 
observed (Table 5, entries 9, 10). Additionally, replacement of L1 with the previously 
reported PyBidine ligand L9 significantly lowered the catalytic activity, showing the 
beneficial effect of the sulfonyl group (Table 5, entry 11). Interestingly, the asymmetric 
ligand L10, in which a sulfonamide moiety is replaced by a N-donor pyrazole moiety, and 
bidentate ligands L11-L13 with no central pyridine linker were all found inactive (Table 5, 
entries 9-12).  
Finally, prolonging of the reaction time resulted in a further improvement of the catalytic 
efficiency of Fe(OTf)2-L1 giving  a final TON of 412 after 48 hours of reaction (Table 5, 
entries 1- 3). Further increase in the reaction time showed no improvement in the catalyst 
efficiency, however. 
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Table 5. Effect of the N-donor ligand in the iron catalysed aerobic oxidation of THF to 
butyrolactone 
3.3.2.6. Solvent effect 
The Fe(OTf)2L1 catalysed aerobic oxidation of THF to γ-butyrolactone was found to be 
compatible with arene type solvents (Table 6, entries 1-6) which are not oxidised under the 
reaction conditions. Nonetheless, a much higher efficiency is obtained in a neat reaction and 
a significant reduction in the catalyst efficiency is manifested when using larger solvent 
amounts (Table 6, entries 1,2,3). In addition, halogenated (Table 6, entries 7,8) or 
coordinating solvents (Table 6, entry 9) were found to be incompatible with this reaction. 
We suspect this is because of the catalyst being capable of strongly coordinating to different 
organic solvents as shown and discussed in Chapter 2. 
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Table 6. Effect of different solvents in the iron-catalysed aerobic oxidation of THF to γ-
butyrolactone 
3.3.3. Substrate scope  
3.3.3.1. Lactone oxidation 
Using the in situ prepared Fe(OTf)2-L1 as catalyst, a wide range of cyclic ethers were 
subjected to the oxidation at 1 atm of O2 and 60 °C. THF type substrates were first 
examined, which afforded γ-butyrolactones, a structural unit found in many natural 
products.
14
 Moderate efficiencies together with good functional group tolerance were 
achieved (Table 7). However, the product yields were diminished in the presence of 
substituents (Table 7, entries 2-5). The oxidation is characterized with excellent mass 
balance with few by-products observed. The catalyst selectivity towards the lactone product 
formation was excellent, with no trace of tertiary alcohol product formation and no 
competitive oxidation occurring in the methylene positions of the substituents.  
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Table 7. Substrate scope and functional group tolerance in the Fe(OTf)2L1 catalysed aerobic 
alpha oxidation of THF type substrates 
3.3.3.2. Oxidation of isochromans 
Next, we started investigating the α-oxidation of isochromans to isochromanones which, like 
γ-butyrolactones, are common motifs in natural products and bioactive molecules,14 and 
bearing in mind that reported iron catalysts fail to undergo oxidation reactions in the 
presence of aromatic rings and electron rich functionalities.
36
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To our delight, isochromanone 53 was obtained from 52 in a 30% isolated yield with TON 
reaching 844 in an overnight reaction (Table 8, entry 1). No trace of isochroman-1-ol 83  
(vide infra) was detected even as an intermediate under conditions of limiting oxidant. 
Nonetheless, the unexpected 1,1’-oxidiisochroman product 54 was generated in low yield. 
Even thought the formation of this oxygenated dimer as byproduct has not been observed 
with other catalysts capable of undergoing aerobic α-oxidation of ethers, some authors have 
reported the formation of such product upon exposure of isochroman to radical catalysts,
37
 
radical oxidants
38
 or stoichiometric oxidants
39
 (Scheme 19). 
The catalyst operates with excellent chemoselectivity even in the presence of tertiary benzyl 
(Table 8, entry 2) or O-alkyl substituents (Table 8, entry 3) with no trace of any tertiary 
alcohol byproduct formation. In addition, the reactions proceed with excellent mass balance 
with no substrate decomposition and with the unreacted starting material being easily 
recovered upon purification by flash chromatography. Although the presence of substituents 
in the alkyl chain barely affects the reaction yields, substitution in the aromatic ring revealed 
a dramatic electronic effect, with electron withdrawing groups inducing higher TONs while 
electron donating groups exerting the opposite effect (Table 8, entries 4-12). Nonetheless, 
very electron rich isochromans can still be oxidized, albeit with reduced TONs but with very 
good mass balance (Table 8, entry 10-11). Indeed, the protected form of the natural product 
aurocitrine 
40
 was isolated in 5% yield (Table 8, entry 11), indicating the potential 
applicability of our catalyst in natural product synthesis. Additionally, the scope of the 
reaction can be extended to a thiophene derivative with moderate yield (Table 8, entry 12). 
Excellent chemoselectivity towards the formation of the isochromanone product and 
excellent mass balances were again observed for all the substrates independently of the 
electronic properties of the aromatic rings.  
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Table 8.  Steric and electronic effects in the Fe(OTf)2L1 catalysed aerobic oxidation of 
isochromans 
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Scheme 19. Formation of byproduct 54 in the presence of radical species or stoichiometric 
oxidants 
3.3.3.3. Oxidation of phthalans 
Next, we turned our attention to the oxidation of phthalans to phthalides, important building 
blocks for more complex chemicals, such as dyes,
41
 natural oils,
42
 fungicides
43
 and 
biologically active compounds.
44
 A similar strong electronic effect was observed for these 
substrates, with higher yields obtained for substrates containing electron withdrawing groups 
(Table 9). Interestingly, this electronic effect can now be harnessed to direct the 
regioselectivity of the oxidation. Thus, with a strong meta directing effect ( m = 0.34 vs p = 
0.06), the fluorine substitute induced exclusive oxidation of the meta methylene unit to 
afford the ester 85 in 60% isolated yield and 1533 TON. Similarly, 
dihydrofuro[3,4]pyridines were regioselectively oxidized at the ortho or meta position, 
leading to pyridinone skeletons of pharmaceutical interest (Table 9, entries 5-6). The higher 
TON observed for 93 than 95 is consistent with a stronger inductive effect by the nitrogen 
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on the ortho methylene. In the case of the heavier halogens, their significantly stronger para 
directing effect ( m = 0.37 for Cl and 0.39 for Br vs p = 0.23 for both) and larger size might 
result in the observed para oxidation (Table 9, entries 2-3).  The regioselectivity of the 
products was determined by 2D NMR (see appendix). 
 
Table 9. Chemo-and regioselective oxidation of phthalans catalysed by Fe(OTf)2L1. 
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3.3.3.4. Oxidation of benzyl ethers 
Aerobic oxidation of open chain benzyl ethers was also evaluated. Lower TONs were 
obtained in comparison with isochroman type substrates (Table 10). This is probably 
because of increased steric hindrance around the ether oxygen atom, which inhibits the 
oxygen coordination to the iron. In support of this view, the benzyl 
t
butyl ether afforded no 
oxidation.  In addition, the hyperconjugative effect in the α-methylene is weakened in 
comparison to the cyclic ethers due to the free rotation of the alkyl chain. For those acyclic 
ethers that reacted, a clear electronic bias was again observed, with electron-withdrawing 
substituents inducing higher TONs (Table 10, entries 5-7). The catalyst showed excellent 
chemoselectivity affording the benzoates as sole products; however, traces of the oxidation 
dimmer 108 were also detected during the oxidation of 106. 
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Table 10. Steric, electronic and hyperconjugative effects in the Fe(OTf)2L1 catalysed 
aerobic oxidation of benzyl ethers 
 
 
 
Chapter 3 
 
130 
 
3.3.4. Product inhibition and catalyst reuse 
Although the Fe(OTf)2-L1 catalyst showed high chemoselectivity and TONs, the 
oxidations above generally displayed relatively low conversions. In an attempt to increase 
the efficiency of the Fe(OTf)2-L1 catalyzed aerobic oxidations, higher catalyst loadings were 
tested. However, no significant improvement was observed in the oxidation of 42 and 52 
when the catalyst loading was increased under otherwise the same conditions. Further 
experiments revealed, surprisingly somehow, that the loss of catalytic activity at a certain 
level of conversion results from product inhibition, rather than catalyst decomposition. Thus, 
in the presence of the ester product 53 (30%, chosen according to the yield obtained under 
the normal conditions; Table 8, entry 1), the Fe(OTf)2-L1 catalyzed oxidation of 52 afforded 
only 6% of additional 53 (Scheme 20), in stark contrast with the isolated yield of 53 shown 
in Table 3. The oxidation was also inhibited by the ether byproduct 54. Most likely, the 
inhibition arises from the carbonyl coordination in the case of 53, or the ether chelation in 
the case of 54, to the iron centre, preventing the coordination of 52 and hence its oxidation. 
This is in line with the detrimental effect exerted by coordinating solvents mentioned above.  
 
Scheme 20. Product inhibition during the aerobic oxidation of 52 
Realizing the inhibition effect of product, it became possible to increase the overall yield 
of the oxidation with Fe(OTf)2-L1, particularly when the product could be readily separated 
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from the reaction mixture. This is demonstrated in the oxidation of isochromans 63 and 66 
(Scheme 21). After the initial oxidation under the same conditions as those in Table 8, the 
resulting solid products were removed, enabling the oxidation to continue for another 16 h to 
give 64 and 67 in a total isolated yield of 65% (1503 TON) and 59% (1282 TON), 
respectively, with no product over-oxidation. These results highlight the robustness of the 
iron catalyst and point to a strategy for addressing the conversion issue in question, i.e. run 
the oxidation in a continuous flow reactor. 
 
Scheme 21. Improvement in the efficiency of the aerobic oxidation by catalyst reuse  
3.4. Conclusions 
Selective α-oxidation of ethers under aerobic and additiveless conditions is a long-pursued 
transformation of industrial interest; however, a green and efficient catalytic version of this 
transformation has been challenging. We have found that our family of iron-PyBisulidine 
complexes are capable of catalysing the chemoselective α-oxidation of functionalized ethers 
with excellent mass balance and high catalytic turnover numbers under 1 atm of O2 with no 
need for any additives. Unlike other biomimetic iron catalysts, our system shows excellent 
functional group tolerance even in the case of electron rich substrates. In addition, the 
catalyst is sensitive to electronic effects and such electronic bias can be applied for 
regioselective oxidation of certain substrates such as phthalans. The operational simplicity of 
this method combined with its environmental friendliness and high efficiency results in a 
useful alternative for performing selective oxidation. 
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3.5. Experimental section 
3.5.1 General techniques 
Experiments involving air or moisture sensitive reagents were performed under an 
atmosphere of purified N2 using standard Schlenck techniques. Solvents used in these 
experiments were reagent grade or better. MeCN, DCM and CHCl3 were refluxed over 
CaH2/benzophenone and THF and Et2O were refluxed over Na/benzophenone and distilled 
under purified N2 atmosphere. Anhydrous benzene 99.9% was purchased from Aldrich and 
stored over CaH2 under N2 atmosphere. Commercial grade solvents used in the synthesis of 
non air or non moisture sensitive components were used without further purification. 
Chemicals employed in the synthesis of ligands and substrates were purchased from 
commercial suppliers and used without further purification. Previously reported ligands 
PyBox and Box and iron salts were purchased from commercial suppliers and used without 
further purification.  
3.5.2. Ligand syntheses 
PyBisulidine type ligands were synthesised according to the procedures provided in Chapter 
2 of this Thesis. Ligand L7 (Table 5, entry 9), L9 (Table 5, entry 11) and the 6-(1H-pyrazol-
1-yl)picolinaldehyde from ligand L10 ( Table 5, entry 12) were synthesised according to the 
literature. 
45,46,47
 Ligands L8 (Table 5, entry 10), L11 (Table 5, entry 13) and L12 (Table 5, 
entry 14) were purchased from commercial suppliers. 
3.5.3. Substrate syntheses and characterisation 
3.5.3.1. Tetrahydrofuran substrates 
Tetrahydrofuran type substrates were purchased from commercial suppliers apart from 
(tetrahydrofuran-2-yl) methyl acetate which was synthesised via acetylation of 
tetrahydrofurfuryl alcohol.
48
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Analytical data 
(Tetrahydrofuran-2-yl)methyl acetate
48
  
Colourless liquid. Yield: 97%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
4.20-4.10 (m, 2H), 3.99 (dd, J= 11.1 Hz, 6.8 Hz, 1H), 3.94-3.88 (m, 1H), 
3.84-3.79 (m, 1H), 2.15 (s, 3H), 2.06-1.87 (m, 3H), 1.65-1.57 (m, 2H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 171.1, 75.7, 68.5, 65.1, 27.6, 25.6, 20.3. 
 
3.5.3.2. Isochromans 
Isochroman derivatives were synthesised according to previous procedures described in the 
literature: 
 
Procedure A: Acid catalysed oxa-Pictet-Spengler reaction
49
 
In a round bottom flask equipped with a stirring bar and a reflux condenser, toluene (40 mL) 
and dimethoxymethane (6.0 mL, 2.0 equiv) were added. The corresponding β-arylethanol 
(4.0 mL, 1.0 equiv) and Y(OTf)3 (2 mol%) were subsequently added and the reaction 
mixture was allowed to stir at 80 °C for 24-48h (t.l.c. monitoring) under inert atmosphere. 
The solvents were evaporated and the liquid residue was dissolved in DCM (30 mL) and 
washed with aqueous NaHCO3 and water and dried over MgSO4. The solvents were 
removed in vacuo and the residue purified by flash column chromatography (Hexane:AcOEt 
95:5) to afford the desired isochroman in good yields (74-97% isol. yield). 
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Analytical data of substrates synthesised according to procedure A: 
4-Methylisochroman
50
 (55) 
Pale yellow oil, 65% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.35-7.31 
(m, 2H), 7.25-7.14 (m, 2H), 4.62 (dd, J = 10.0, 6.4 Hz, 2H), 3.70 (dd, J = 6.9, 
2.0 Hz, 1H), 3.62 (dd, J = 7.1, 2.3 Hz, 1H), 3.06 (m, 1H), 1.33 (d, J = 6.8 Hz, 
3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 144.7, 128.7, 126.9, 126.4, 96.8, 
71.8, 68.8, 32.3, 19.6. HRMS (EI) m/z calc’d C10H13O [M + H]
+
: 149.0961, found: 
149.0960.  
3-Methylisochroman
50
 (57) 
Colourless oil, 74% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.16 (m, 
2H), 7.10, (m, 1H), 7.00 (m, 1H), 4.83 (d, J = 15.2 Hz, 2H), 3.81 (sextuplet, 
J = 6.8 Hz, 1H), 2.71 (d, J = 6.8 Hz, 2H), 1.35 (d, J = 6.4 Hz, 3H). 
13
C NMR 
(100 MHz, CDCl3): δ (ppm) = 135.0, 133.9, 129.1, 126.7, 126.3, 124.6, 71.4, 68.6, 36.2, 
22.0. HRMS (EI) m/z calc’d C10H13O [M + H]
+
: 149.0961, found: 149.0958.  
7-Methylisochroman
50
 (72) 
Colourless oil, 68% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.08 (m, 
1H), 6.93 (m, 1H), 6.72 (s, 1H), 4.66 (s, 2H), 3.88 (t, J = 5.6 Hz, 2H), 2.74 
(t, J = 5.6 Hz, 2H), 2.22 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
135.9, 135.1, 130.5, 129.6, 129.1, 128.7, 68.3, 65.9, 28.3, 21.4. HRMS (EI) m/z calc’d 
C10H13O [M + H]
+
: 149.0961, found: 149.0959. 
7-Methoxyisochroman (75) 
White solid, 42% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.00 (d, 
J = 8.4 Hz, 1H), 6.66 (dd, J = 8.0, 2.8 Hz, 1H), 6.46 (d, J = 2.4 Hz, 1H), 
4.71 (s, 2H), 4.69 (s, 3H), 3.95 (t, J = 6.0 Hz, 2H), 2.78 (t, J = 5.8 Hz, 
2H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 154.0, 136.6, 130.4, 114.2, 111.1, 68.3, 66.0, 
55.7, 27.9.  HRMS (EI) m/z calc’d C9H11O2 [M + H]
+
: 151.0754, found: 151.0751. 
7,8-Dimethoxyisochroman
50
 (77) 
White solid, 74% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 6.54 (s, 
1H), 6.40 (s, 1H), 4.63 (s, 2H), 3.88 (t, J = 5.6 Hz, 2H), 3.80 (s, 3H), 3.77 
(s, 3H), 2.70 (t, J = 5.6 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
148.0, 147.9, 127.0, 125.4, 112.0, 107.7, 68.0, 65.8, 56.3, 28.2. HRMS 
(EI) m/z calc’d C11H15O3 [M + H]
+
: 195.1016, found, 195.1017.  
4,5-Dihydro-4H-thieno[2,3c]pyran (81) 
Yellow oil, 65% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.08 (d, J = 5.2 
Hz, 1H), 6.76 (d, J = 5.2 Hz, 1H), 4.76 (s, 2H), 3.88 (t, J = 5.6 Hz, 2H), 2.69 (t, 
J = 5.6 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 133.1, 133.1, 127.4, 
122.9, 66.0, 65.4, 26.5. IR ν (neat) = 2962, 2908, 2837, 1675, 1460, 1442, 1431, 1392, 1379, 
1282, 1233, 1213, 1154, 1094, 1083, 1066, 1020, 985, 971, 895, 848, 821, 755, 700, 645, 
611, 574 cm
-1
.HRMS (EI) m/z calc’d C7H9OS [M + H]
+
: 141.0369, found, 141.0366. 
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Procedure B: intramolecular oxonium cyclisation of MEM-protected phenethyl 
alcohols 
Synthesis of the MEM ethers 
51
 
In a round bottom flask equipped with a stirring bar, the corresponding β-arylethanol (0.8 
equiv) was dissolved in freshly distilled DCM (30 mL) and the reaction mixture was cooled 
to 0 
°
C. Diisopropylethylamine (1.2 equiv) was subsequently added to the flask and finally 
MEMCl (1.0 equiv) was added dropwise to the reaction mixture which was allowed to stir 
overnight at r.t. The reaction was washed with aqueous HCl solution and water and dried 
over MgSO4. After filtration, the volatiles were evaporated and the residue was purified by 
flash column chromatography (Hexane: EtOAc 8:1) to afford the MEM ether in excellent 
yields (94-98% isol. yield). 
TiCl4 promoted acetal cyclisation 
51 
A two necked round bottom flask equipped with a stirring bar was placed under inert 
atmosphere on an ice bath. TiCl4 (1.0 M in DCM solution, 1.2 equiv) was added by syringe 
and the corresponding MEM ether was subsequently added dropwise at 0 
°
C. The reaction 
was allowed to stir for 4 h before being quenched with 1.0M HCl solution. The organic 
phase was extracted in DCM and washed with diluted NaHCO3 solution and water. The 
organic phase was dried over MgSO4, filtrated and volatiles evaporated in vacuo. The 
residue was purified by silica gel column chromatography (Hexane: AcOEt 8:1) to afford the 
desired isochroman substrate with high yield (75-92%). 
Analytical data of substrates synthesised according to procedure B 
7-(Trifluoromethyl)isochroman (60)  
Colourless liquid, 45% abs. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.41 (d, J = 8.0 Hz, 1H), 7.24 (m, 3H), 4.80 (s, 2H), 3.99 (t, J = 6.0 Hz, 
2H), 2.91 (t, J = 5.8 Hz, 2H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 
137.7, 136.0, 129.8 (d,
 2
JC-F = 31.9 Hz), 125.1 (t, 
1
JC-F = 127.6 Hz), 123.5 (d, 
3
JC-F = 3.6 Hz), 
121.8 (d, 
3
JC-F = 3.9 Hz), 68.1, 65.4, 28.7. IR ν (neat) = 1626, 1432, 1380, 1330, 1307, 1277, 
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1250, 1228, 1187, 1161, 1115, 1073, 1036, 990, 960, 895, 823, 784, 749, 718, 670, 660, 630, 
603 cm
-1
. HRMS (EI) m/z calc’d C10H10F3O [M + H]
+
: 203.0678, found: 203.0679. 
7-Fluoroisochroman
50
 (63)  
Colourless liquid, 78% abs. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.07 (dd, J = 8.4, 5.6 Hz, 1H), 6.86 (dt, J = 8.6, 2.6 Hz, 1H), 6.70 (dd, J = 
9.2, 2.6 Hz, 1H), 4.74 (s, 2H), 3.96 (t, J = 6.8 Hz, 2H), 2.81 (t, J = 6.8 Hz, 
2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 161.2 (d, 
1
JC-F = 242.9 Hz), 137.0 (d, 
3
JC-F = 
6.9 Hz), 130.7 (d, 
3
JC-F = 7.6 Hz), 129.1 (d, 
4
JC-F = 3.0 Hz), 114.0 (d, 
2
JC-F = 21.2 Hz), 111.4 
(d, 
2
JC-F = 21.4 Hz), 68.1, 65.8, 28.0. HRMS (EI) m/z calc’d C9H10FO [M + H]
+
: 153.0711, 
found: 153.0713. 
7-Chloroisochroman
50
 (66)  
Colourless liquid, 68% abs. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.15 (m, 1H), 7.05 (m, 1H), 6.98 (m, 1H), 4.72 (s, 2H), 3.97 (t, J = 6.4 Hz, 
2H), 2.87 (t, J = 6.8 Hz, 2H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 
136.6, 131.6, 131.5, 130.2, 126.5, 124.4, 67.5, 65.2, 27.7. HRMS (EI) m/z calc’d C9H10ClO 
[M + H]
+
: 169.0415, found: 169.0415. 
Synthesis of isochroman-7-yl acetate 
Isochroman-7-yl acetate was synthesised according to the following previously reported 
steps.
52
 
 
Synthesis of 3-acetoxybenzyl alcohol 
To a stirred solution of  3-hydroxybenzyl alcohol (3.72 g, 30 mmol) in 6.4N aqueous KOH 
(7 mL) at room temperature was added ice (15 g) followed by acetic anhydride (3.55 mL, 
1.25 equiv.). After stirring for 45 min, water (250 mL) was added and the mixture was 
stirred for a further 30 min before extracting with dichloromethane (3×100 mL). The 
combined extracts were washed with water, brine and dried over MgSO4. Evaporation of the 
solvent gave a brown oil which was purified by flash column chromatography (Hexane: 
AcOEt 6:1) to give the desired product as a colourless oil (3.24 g, 65%). 
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Analytical data 
Isochroman-7-yl acetate
52
 (69)  
Colourless oil, 74% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.13 
(d, J = 8.4 Hz, 2H), 6.88 (dd, J = 8.0, 2.0 Hz, 2H), 6.72 (d, J = 2.2 Hz, 
1H), 4.75 (s, 2H), 3.96 (t, J = 5.6 Hz, 2H), 2.84 (t, J = 5.6 Hz, 2H), 2.28 
(s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 170.1, 149.0, 136.5, 131.2, 130.3, 120.0, 
117.7, 68.1, 65.7, 28.2, 21.5. HRMS (EI) m/z calc’d C11H13O3 [M + H]
+
: 193.0860, found: 
193.0859. 
Synthesis of 5,8-dimethoxy-3-methylisochroman 
5,8-Dimethoxy-3-methylisochroman was synthesised as reported in the literature:
53
 
 
Synthesis of (±)-1-(2,5-dimethoxyphenyl)-2-propanol 
In a two necked round bottom flask equipped with a magnetic bar and placed under inert 
atmosphere, 1,4-dimethoxybenzene (7.0 g, 68.5 mmol) was added to freshly distilled THF 
(20 mL) and placed on an ice bath. N-butyllithium (5.7 mL, 59.8 mmol, 10.5 M in hexanes) 
was added dropwise and the reaction mixture was refluxed for 48 h under inert atmosphere. 
Then, the dark reddish solution was cooled to 0 
°
C and propylene oxide (4.2 mL, 29 mmol) 
was added dropwise. The reaction mixture was stirred at 0 
°
C (1 h), then warmed to 25 
°
C 
(50 min) and refluxed for 2.5 h. The reaction mixture was cooled to r.t. and quenched with 
water (15 mL) forming a white suspension that was diluted with THF (25 mL) and then 
water (50 mL). The THF was evaporated in vacuo and the organic phase was extracted with 
DCM. The extract was washed with brine and water and dried over MgSO4. The solution 
was filtered and the solvent eliminated in vacuo to afford a crude oil that was purified by 
flash column chromatography (Hexane /AcOEt, 5/1) to afford the desired product as a clear 
oil in good yield (60%). 
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Analytical data 
5,8-Dimethoxy-3-methylisochroman
53
 (79)  
White solid, 73% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 6.56 (dd, J = 
16.0, 8.8 Hz, 2H), 6.55 (d, J = 8.8 Hz, 1H, overlapped), 4.85 (d, J = 16.0 Hz, 
1H), 4.53 (d, J = 16.0 Hz, 1H), 3.72 (s, 3H), 3.71 (s, 3H), 3.67-3.58 (m, 1H), 
2.71 (dd, J = 2.8, 1.2 Hz, 1H), 2.66 (dd, J = 3.2, 1.6 Hz, 1H), 2.28 (d, J = 6.4 
Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 151.3, 149.8, 125.1, 124.4, 
107.8, 107.2, 70.5, 64.9, 60.8, 56.0, 55.8, 30.7, 22.0. HRMS (EI) m/z calc’d 
C12H17O3 [M + H]
+
: 209.1172, found, 209.1173. 
 
3.5.3.3. Synthesis of phthalans 
1,3-dihydroisobenzofurans derivatives (phthalans) were synthesised following the same 
procedure described for the synthesis of 4-nitro-1,3-dihydroisobenzofuran.
54
 
 
Synthesis of 1,2-bis(bromomethyl)-4-halobenzenes 
A two necked round bottom flask equipped with a stirring bar and a reflux condenser was 
placed under inert atmosphere. CHCl3 (40 mL), 1,2-dimethyl-4-halobenzene (1.0 equiv), 
NBS (2.1 equiv) and benzoyl peroxide (1 mol%) were added sequentially. The reaction was 
heated up to 65 
°
C and small amounts of benzoyl peroxide (50 mg) were added every 30 min 
for a period of 2 h. The reaction was heated up for another 4 h and then cooled to r.t. The 
reaction was filtered to remove the white precipitate and washed with CHCl3. The solvent 
was evaporated in vacuo to afford the desired product as a yellowish oil (87% isol. yield). 
Synthesis of the 1,3-dihydroisobenzofurans 
In a round bottom flask equipped with a stirring bar, the corresponding 1,2-
bis(bromomethyl)-4-halobenzene (1.0 equiv) was dissolved in toluene (40 mL). Alumina (40 
equiv) was added and the mixture was heated up to 120 
°
C overnight. The reaction mixture 
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was filtered to remove the alumina and washed with AcOEt. The solvents were evaporated 
and the residue was purified by flash column chromatography (Hexane /AcOEt 100/0 to 
94/6) to afford the desired product as a bright oil (67-88% isol. yields). 
Analytical data 
5-Fluoro-1,3-dihydroisobenzofuran
55
 (84) 
Pale yellow liquid, 45% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.28-7.23 (m, 1H), 7.00 (d, J = 7.6 Hz, 1H), 6.93 (t, J = 8.0 Hz, 1H), 5.17 (s, 
2H), 5.13 (s, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 156.4, 143.3, 
130.0 (d, 
3
JC-F = 6.5 Hz), 126.1, 117.0 (d, 
2
JC-F = 13.5 Hz), 114.4 (d, 
2
JC-F = 19.8 Hz), 74.2, 
71.4. HRMS (EI) m/z calc’d C8H8FO [M + H]
+
: 139.1464, found: 139.1462. 
5-Chloro-1,3-dihydroisobenzofuran
56
 (86) 
White wax, 46% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.25-7.22 
(m, 2H), 7.17 (d, J = 8.0 Hz, 1H), 5.08 (s, 4H).
 13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 141.6, 137.9, 133.5, 127.8, 122.4, 121.7, 73.5. HRMS 
(EI) m/z calc’d C8H8ClO [M + H]
+
: 155.0259, found: 155.0262. 
5-Bromo-1,3-dihydroisobenzofuran
55
 (88) 
White wax, 44% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.4 (d, J = 
7.2 Hz, 1H), 7.17-7.06 (m, 2H), 5.10 (s, 2H), 5.08 (s, 2H).
 13
C NMR (100 
MHz, CDCl3): δ (ppm) = 138.5, 130.7, 124.7, 122.8, 121.4, 73.5, 73.4. 
C8H8BrO [M + H]
+
: 198.9754, found: 198.9751. 
4.4.3. 4. Synthesis of 1,3-dihydrofuropyridines 
1,3-Dihydrofuropyridines were synthesised in a similar fashion as reported in the literature.
57
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Alternative procedure for the reduction of methyl 2-pyrazinecarboxylate to pyrazin-2-
yl methanol 
In a 500 mL round bottom flask equipped with a magnetic stirring bar, methyl 2-
pyrazinecarboxylate (8.5 g) was added and dissolved in distilled water (200 mL). The flask 
was cooled to 0 
°
C and LiBH4 (6.7 g) was added constantly in small portions (20 mg) over a 
period of approximately 1.5-2 h. (Note: this process must be performed extremely carefully 
as it is a very exothermic reaction and the addition should be done constantly and in very 
small portions. A single portion addition of the borohydride is extremely dangerous and 
should not be done under any circumstance). Once the addition is finished, the reaction 
mixture was allowed to stir for additional 30 min. EtOH (80 mL) and K2CO3 sat solution 
(150 mL) were then added to the reaction mixture which was stirred for an additional 30 min 
period. The reaction was extracted with AcOEt (5 x 150 mL) and DCM (5 x 150 mL) and 
the organic extracts combined and dried over MgSO4. The extract was filtered and the 
solvents removed in vacuo to afford the product as a yellow oil. 
O-propargylation of pyrazyn-2-yl methanol 
Pyrazyn-2-yl methanol (1.0 equiv) was slowly added into a suspension of NaH (1.1 equiv) in 
dried THF (30 mL) at 0 
°
C. The mixture was stirred until the evolution of hydrogen ceased 
(circa 10-15 min). Then propargyl bromide (2.0 equiv) was added and the reaction mixture 
was refluxed for 3 h. The reaction was quenched with water (50 mL) and extracted with 
diethyl ether. The organic layer was dried over MgSO4, filtered and the solvents removed in 
vacuo. The residue was purified by flash column chromatography (Hexane/Et2O 2/1) to 
afford the desired product as a light oil (89% yield). 
Cyclisation of the 5-(2-propynyloxymethyl)pyrimidine 
In a round bottom flask equipped with a stirring bar and a reflux condenser, 5-(2-
propynyloxymethyl)pyrimidine (10 equiv) was dissolved in nitrobenzene (5 mL). There 
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action mixture was heated up to 140 
°
C overnight under inert atmosphere. The reaction 
products were isolated by flash column chromatography (Hexane/Et2O 3/1 to 2/1) to afford 
both regioisomers in good yields (65 and 35%). 
5,7-Dihydrofuro[3,4b]pyridine
57
 (92) 
White solid, 35% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 8.53 (m, 
2H), 7.22 (d, J = 4.8 Hz, 1H), 5.16 (s, 2H), 5.11 (s, 2H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 161.0, 148.1, 142.7, 116.2, 72.7, 71.5. HRMS (EI) m/z 
calc’d C7H8NO [M + H]
+
: 122.0597, found: 122.0600. 
1,3-Dihydrofuro[3,4-c]pyridine
57
 (94) 
White solid, 65% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 8.48 (d, 
J = 4.8 Hz, 1H), 7.55 (d, J = 7.6 Hz, 1H), 7.17 (dd, J = 7.6, 5.0 Hz, 1H), 5.17 
(s, 2H), 5.03 (s, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 161.0, 149.3, 
132.3, 129.5, 122.2, 73.2, 72.6. HRMS (EI) m/z calc’d C7H8NO [M + H]
+
: 122.0600, found: 
122.0598. 
3.5.3.5. Synthesis of alkyl benzyl ethers
58 
Alkyl benzyl ethers were purchased from commercial suppliers or synthesised according to 
the literature 
 
as follows: In a round bottom flask equipped with a stirring bar and a reflux 
condenser, 4-bromobenzyl bromide (7.0 g, 1.0 equiv) was dissolved in MeOH (60 mL). 
Sodium methoxyde (1.62 g, 1.2 equiv.) was added slowly to the reaction mixture and then 
the reaction was refluxed overnight. The reaction was allowed to cool to r.t. and water (100 
mL) and DCM (75 mL) were added. The organic layer was extracted and washed with water 
and brine and dried over MgSO4. The solution was filtered and solvents were removed in 
vacuo. The residue was purified by flash column chromatography (Hexane/DCM 2/1) to 
afford the desired ether as a colourless light oil (96% yield). 
(Ethoxymethyl)benzene
59
 (98) 
Colourless liquid. Yield: 94%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.43-7.28 (m, 5H), 4.44 (s, 2H), 3.48 (q, J = 7.2 Hz, 2H), 1.18 (t, J = 7.2 
Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 139.0, 128.9, 128.0, 
127.9, 73.1, 66.1, 15.6. 
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1-(tert-Butyl)-4-(methoxymethyl)benzene
60
 (102) 
Colourless liquid. Yield: 95%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.34-7.29 (m, 2H), 7.25-7.18 (m ,2H), 4.36 (s, 2H), 3.31 (s, 3H), 1.25 
(s, 9H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 150.0, 134.2, 126.9, 
125.1, 74.5, 58.7, 34.8, 31.3. 
1-(Methoxymethyl)-4-nitrobenzene
61
 (104) 
Pale yellow solid. Yield: 94%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
8.16-8.13 (m, 2H), 7.45-7.41 (m, 2H), 4.49 (s, 2H), 3.38 (s, 3H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 146.2, 128.0, 124.0, 73.7, 59.0. 
1-(Bromo)-4-(methoxymethyl)benzene
62
 (106) 
Colourless liquid. Yield: 93%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.41-7.38 (m, 2H), 7.17-7.13 (m, 2H), 4.33 (s, 2H), 3.31 (s, 3H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 137.6, 131.9, 129.7, 121.8, 74.3, 
58.5. 
1-(Chloro)-3-(methoxymethyl)benzene
63
 (109) 
Colourless liquid. Yield: 95%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.20 
(s, 1H), 7.19-7.04 (m, 3H), 4.28 (s, 2H), 3.25 (s, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 140.7, 134.7, 130.0, 128.1, 128.0, 125.9, 74.2, 58.7. 
 
3.5.4. Representative procedure for the aerobic α-oxidation of ethers catalysed by 
Fe(OTf)2L1  
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.6 x 10-3 mmol, 5.2mg) and 
Fe(OTf)2 (5.6 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed and left 
under inert atmosphere (3 times). The corresponding ether (2.0 mL) was added by syringe; 
the reaction tube was degassed, charged with dioxygen gas (1 atm, 3 times) and keep under 
oxygen (1 atm) by using a balloon. The reaction mixture was heated to 60 
°
C and left 
overnight. The reaction was purified by silica gel column chromatography (Hexane/EtOAc, 
gradient: 10/1 to 4/1) to afford the unreacted starting material and the reaction products. 
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Analytical data 
γ-Butyrolactone64 (43) 
Colourless oil (9.5% isol. yield, 200.5 mg, 2.33 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 4.37 (t, J = 7.0 Hz, 2H), 2.53 (t, J = 7.0 Hz, 2H), 2.30 (q, J = 
7.0 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 178.1, 68.9, 28.2, 22.6. IR 
ν (neat) = 1764, 1375, 1162, 1034, 990 cm-1. HRMS (EI) m/z calc’d C4H10O2N [M+NH4]
+
: 
104.0706, found: 104.0707. Anal Calc’d for C4H6O2: C, 55.81, H, 7.02; found: C, 55.87, H, 
7.07. 
5-Methyldihydrofuran-2(3H)-one
64
 (45) 
Colourless oil (9% isol. yield, 210.2 mg, 2.10 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 4.64 (sextet, J = 6.5 Hz, 1H), 2.57-2.51 (m, 2H), 2.49-2.32 
(m, 1H), 1.86-1.83 (m, 1H), 1.45 (d, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 177.6, 67.2, 30.1, 29.3, 21.4. IR (neat) ν = 1774, 1345, 1175, 941 cm
-1
. 
HRMS (EI) m/z calc’d C5H12O2N [M+NH4]
+
: 118.0863, found: 118.0863. Anal Calc’d for 
C5H8O2: C, 59.98, H, 8.05; found: C, 59.81, H, 8.27. 
(5-Oxotetrahydrofuran-2-yl)methyl acetate
65
 (47) 
Colourless oil (5.4%  isol. yield, 118.6 mg, 0.75 mmol).
 1
H NMR (400 
MHz, CDCl3): δ (ppm) = 4.77-4.71 (m, 1H), 4.32 (dd, J = 12.4, 3.2 Hz, 
1H), 4.15 (d, J = 12.0, 5.2 Hz, 1H), 2.62-2.51 (m, 2H), 2.39-2.32 (m, 
1H), 2.12-2.03 (m, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 176.8, 171.0, 65.7, 28.5, 
24.3, 21.1. IR (ATR) ν = 2952, 1774, 1733, 1461, 1419, 1371, 1232, 1160, 1041, 941, 919, 
804, 649. HRMS (EI) m/z calc’d C7H13O3 [M+H]
+
: 145.0859, found: 145.0855. Anal 
Calc’d for C7H12O3: C, 53.16, H, 6.37, found: C, 52.89, H, 6.04. 
5-(Chloromethyl)dihydrofuran-2(3H)-one
66 
(49) 
Colourless oil (4.2%  isol. yield, 93.5 mg, 0.70 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 4.74-4.69 (m, 1H), 3.69-3.60 (m, 2H), 2.64-2.48 
(m, 2H), 2.43-2.341 (m, 1H), 2.29-2.17 (m, 1H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 176.6, 78.5, 46.4, 28.6, 25.3. IR ν (neat) = 2962, 1770, 1421, 1344, 1166, 
1141, 1037, 919, 740, 653. HRMS (EI) m/z calc’d C5H11ClO2N [M+NH4]
+
: 135.0207, 
found: 135.0204.  Anal Calc’d for C5H8ClO2: C, 44.63, H, 5.24; found: C, 45.04, H, 5.50. 
2-(5-Oxotetrahydrofuran-2-yl)acetonitrile
67 
(51) 
Colourless oil (3%  isol. yield, 66.3 mg, 0.53 mmol).  
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 4.77-4.70 (m, 1H), 2.82 (d, J= 5.7 Hz, 2H), 
2.77-2.49 (m, 3H), 2.13-2.11 (m, 1H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 175.5, 115.6, 74.5, 28.5, 27.3, 24.5. IR ν (neat) = 2965, 2933, 2254, 1770, 1461, 
1421, 1349, 1178, 1149, 1037, 923, 800, 646. HRMS (EI) m/z calc’d for C6H8NO2 [M+H]
+
: 
126.0550, found: 126.0548.  Anal Calc’d for C6H7NO2 : C, 57.59, H, 5.64, N, 11.19, found: 
C, 57.47, H, 5.73, N, 11.05. 
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Isochroman-1-one
68
 (53) 
  Colourless liquid (30% isol. yield, 706.8 mg, 4.77 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 8.12 (d, J = 7.7 Hz, 1H), 7.57 (t, J = 6.3 Hz, 1H), 7.41 
(t, J = 7.6 Hz, 1H), 7.28 (d, J = 7.4 Hz, 1H), 4.56 (t, J = 6.2 Hz, 2H), 3.08 (t, J 
= 6.0 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 165.1, 139.5, 133.6, 
127.7, 125.3, 124.0, 67.3, 27.8. IR ν (neat) = 1714, 1602, 1459, 1386, 1294, 1240, 1116, 
1087, 1024, 954, 744, 693, 636 cm
-1
. HRMS (EI) m/z calc’d C9H9O2 [M + H]
+
: 149.0597, 
found: 149.0597. Anal Calc’d for C9H8O2 : C, 72.96, H, 5.44, found: C, 73.37, H, 5.60. 
1,1’-Oxydiisochroman37-39 (54) 
Colourless crystals (10% isol. yield, 448.7 mg, 1.59 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.28-7.22 (m, 6H), 7.14 (t, J = 4.9 Hz, 2H), 6.15 
(s, 2H), 4.37 (dt, J = 11.7, 3.2 Hz, 2H), 4.10 (dd, J = 11.0, 5.9 Hz, 2H), 
3.18-3.10 (m, 2H), 2.68 (dd, J = 16.5, 2.7 Hz, 2H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 132.7, 132.4, 130.3, 126.8, 126.6, 124.8, 91.3, 56.9, 
26.4. IR ν (neat) = 1720, 1488, 1455, 1421, 1373, 1321, 1275, 1201, 1088, 
1062, 1032, 1002, 950, 868, 779, 745 cm
-1
. HRMS (EI) m/z calc’d 
C18H18O3Na [M + Na]
+
: 305.1148, found: 305.1151. Anal Calc’d for C18H17O3: C, 76.57, H, 
6.43, found: C, 76.34, H, 6.45. 
4-Methylisochroman-1-one
69
 (56) 
White solid (24% isol. yield, 525.2 mg, 3.24 mmol).
 1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.04 (d, J = 6.4 Hz, 1H), 7.52 (t, J = 7.6 Hz, 1H), 7.33 (t, J = 
7.6 Hz, 1H), 7.23 (d, J = 7.6 Hz, 1H), 4.45 (dd, J = 10.8, 4.0 Hz, 1H), 4.18 (dd, 
J= 10.8, 6.8 Hz, 1H), 3.12-3.07 (m, 1H), 1.30 (d, J = 7.2 Hz, 3H).
 13
C NMR 
(100 MHz, CDCl3): δ (ppm) = 165.5, 144.9, 134.3, 130.9, 127.9, 126.1, 124.8, 
72.8, 32.1, 17.1. IR ν (neat) = 2969, 2933, 1720, 1604, 1461, 1396, 1282, 1236, 1124, 1083, 
1020, 987, 757, 696. HRMS (EI) m/z calc’d C10H11O2 [M + H]
+
: 163.0754, found: 
163.0750. Anal Calc’d for C10H10O2 : C, 74.06, H, 6.21; found: C, 73.76, H, 6.28. 
3-Methylisochroman-1-one
69
 (58) 
White solid (28% isol. yield, 612.6 mg, 3.78 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.10 (d, J = 7.6 Hz, 1H), 7.53 (dt, J = 7.6, 1.6 Hz, 1H), 
7.39 (t, J = 7.6 Hz, 1H), 7.26 (t, J = 6.8 Hz, 1H), 4.73-4.64 (m, 1H), 2.99-
2.89 (m, 2H), 1.54 (d, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 166.0, 139.5, 134.0, 130.7, 128.0, 127.7, 125.4, 75.5, 35.3, 21.3. IR ν (neat) = 1704, 
1609, 1455, 1392, 1355, 1282, 1239, 1121, 1088, 1029, 747 cm
-1
. HRMS (EI) m/z calc’d 
C10H11O2 [M + H]
+
: 163.0754, found: 163.0752. Anal Calc’d for C10H10O2 : C, 74.06, H, 
6.21, found: C, 73.86, H, 6.15.  
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1,1’-Oxybis(3-methylisochroman) (59) 
Colourless crystals (10% isol. yield, 418.5 mg, 1.35 mmol). 
1
H NMR 
(400 MHz, CDCl3): δ (ppm) = 7.25-7.14 (m, 6H), 7.10-7.07 (m, 2H), 
6.16 (s, 2H), 4.49-4.41 (m, 2H), 2.78-2.67 (m, 4H), 1.52 (d, J = 6.0 Hz, 
3H), 1.48 (d, J = 6.0 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
134.9, 134.1, 128.6, 128.3, 127.6, 126.7, 94.2, 64.1, 35.9, 21.7. IR ν 
(neat) = 1389, 1363, 1319, 1253, 1202, 1080, 1040, 1007, 948, 934, 802, 
751 cm
-1
. HRMS (EI) m/z calc’d C20H22O3Na [M + Na]
+
: 333.1461, 
found: 333.1463. Anal Calc’d for C20H22O3: C, 77.39, H, 7.14; found: C, 77.37, H, 7.23. 
7-(Trifuoromethyl)isochroman-1-one (61) 
White solid (67% isol. yield, 1.433 g, 6.63 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.67 (d, J = 2.4 Hz, 1H), 8.11 (dd, J = 8.4, 2.4 Hz, 1H), 
7.41 (d, J = 8.0 Hz, 1H), 4.58 (t, J = 6.0 Hz, 2H), 3.14 (t, J = 6.0 Hz, 2H).  
13
C NMR (100 MHz, CDCl3): δ (ppm) = 164.1, 143.5, 130.4 (q, 
3
JC-F = 
3.4 Hz), 128.5 (q,
 2
JC-F = 32.5 Hz), 127.9, 126.4, 122.4 (q,
1
JC-F = 270.3 Hz), 67.4, 28.1 (t,
 
JC-F 
=  2.7 Hz) . IR ν (neat) = 1724, 1627, 1475, 1432, 1390, 1332, 1274, 1224, 1170, 1024, 
1066, 1033, 958, 919, 848, 836, 779, 719, 661. HRMS (EI) m/z calc’d C10H8F3O2 [M + H]
+
: 
217.0471, found: 217.0467.  
1,1’-Oxybis(7-(Trifluoromethyl)isochroman) (62) 
Colourless crystals (15% isol. yield, 620.4 mg, 1.483 mmol).
 1
H NMR 
(400 MHz, CDCl3): δ (ppm) = 7.68 (s, 2H), 7.57 (d, J = 8.0 Hz, 2H), 
7.32 (d, J = 8.0 Hz, 2H), 6.38 (s, 2H), 4.32 (dt, J = 11.8, 3.0 Hz, 2H), 
4.13 (dd, J = 11.3, 6.0 Hz, 2H), 3.14 (dt, J = 11.7, 6.2 Hz, 2H), 2.75 (d, 
J = 16.9 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 139.0, 
131.2, 130.6, 129.5, 129.2, 126.1, 122.3, 100.8, 58.5, 28.1. IR ν (neat) 
= 1627, 1428, 1336, 1311, 1270, 1187, 1162, 1116, 1083, 1002, 944, 
912, 848, 819. 
7-Fluoroisochroman-1-one (64) 
Colourless crystals (54% isol. yield, 1.178 g, 7.09 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.77 (d, J = 8.0 Hz, 1H), 7.29-7.22 (m, 2H), 4.54 
(t, J = 6.0 Hz, 2H), 3.04 (t, J = 6.0 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 163.5, 162.2 (d, 
1
JC-F = 245.9 Hz), 135.6 (d, 
3
JC-F = 3.3 Hz), 129.5 
(d, 
3
JC-F = 7.3 Hz), 127.4 (d, 
3
JC-F = 7.5 Hz), 121.4 (d, 
2
JC-F = 21.8 Hz), 117.2 (d, 
2
JC-F = 23.0 
Hz), 67.8, 27.5. IR ν (neat) = 1725, 1620, 1594, 1496, 1437, 1390, 1306, 1273, 1240, 1197, 
1128, 1083, 923, 887, 828, 781, 715 cm
-1
. HRMS (EI) m/z calc’d C9H8FO2 [M + H]
+
: 
167.0503, found: 167.0503.  
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1,1’-Oxybis(7-fluoroisochroman) (65) 
Colourless crystals (16% yield, 669.2 mg, 2.10 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.11-7.01 (m, 2H), 6.96-6.90 (m, 8H), 6.06 (s, 
2H), 4.26 (dt, J = 11.6, 3.2 Hz, 2H), 4.12-4.07 (m, 2H), 3.09-3.00 (m, 
2H), 2.66 (dd, J = 16.4, 2.8 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 161.5 (d, 
1
JC-F = 243.0 Hz), 135.6 (d, 
3
JC-F = 6.9 Hz), 130.5 (d, 
3
JC-F = 7.7 Hz), 130.2 (d, 
3
JC-F = 3.1 Hz), 115.9 (d, 
2
JC-F = 21.5 Hz), 114.3 
(d, 
2
JC-F = 21.5 Hz), 92.8, 58.7, 27.6. IR ν (neat) = 1752, 1719, 1497, 
1426, 1370, 1193, 1092, 1013, 942, 908, 877, 731 cm
-1
.HRMS (FAB) calc’d C18H16F2O3 [M 
+ H]
+
: 138.1062, found: 138.1058. 
7-Chloroisochroman-1-one
70
 (67) 
White solid (42% isol. yield, 931.0 mg, 5.10 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.09 (s, 1H), 7.51 (dd, J = 8.4, 2.4 Hz, 1H), 7.24 (d, J = 
8.0 Hz, 1H), 4.54 (t, J = 6.0 Hz, 2H), 3.04 (t, J = 6.0 Hz). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 164.3, 138.1, 134.1, 130.6, 129.1, 127.1, 67.6, 
27.7. IR ν (neat) = 1714, 1598, 1485, 1422, 1298, 1268, 1235, 1194, 1137, 1085, 1033, 954, 
831, 782, 700, 651 cm
-1
. HRMS (EI) m/z calc’d C9H8ClO2 [M + H]
+
: 183.0207, found: 
183.0206. Anal Calc’d for C9H7ClO2: C, 59.20, H, 3.86; found: C, 59.31, H, 3.90.  
1,1’-Oxybis(7-chloroisochroman) (68) 
Colourless solid (12% isol. yield, 499.2 mg, 1.42 mmol). 
1
H NMR 
(400 MHz, CDCl3): δ (ppm) = 7.43 (d, J = 2.0 Hz, 2H), 7.29 (dd, J = 
8.0, 2.1 Hz, 2H), 7.12 (d, J = 8.2 Hz, 2H), 6.30 (s, 2H), 4.27 (dt, J = 
11.6, 8.7 Hz, 2H), 4.09 (m, 2H), 3.05 (m, 2H), 2.64 (dd, J = 16.6, 2.5 
Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 135.6, 133.1, 132.3, 
130.6, 130.3, 129.8, 92.4, 58.5, 27.7. IR ν (neat) = 2929, 2850, 1602, 
1482, 1421, 1378, 1336, 1307, 1261, 1191, 1091, 1012, 983, 948, 883, 
844, 811, 682, 665. Anal Calc’d for C18H16Cl2O3: C, 61.55, H, 4.59; found: C, 61.20, H, 
4.72. 
1-Oxoisochroman-7-yl acetate (70) 
Colourless oil (40% isol. yield, 643.3 mg, 3.12 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.81 (d, J = 1.2 Hz, 1H), 7.29 (m, 2H), 4.55 (t, J 
= 5.6 Hz, 2H), 3.06 (t, J = 5.6 Hz, 2H), 2.17 (s, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) =169.7, 164.7, 150.3, 137.4, 128.8, 123.7, 67.7, 
27.7, 21.3. IR ν (neat) = 1755, 1719, 1611, 1496, 1429, 1375, 1300, 1200, 1122, 1093, 1011, 
941, 896, 878, 830, 781, 733, 667, 630 cm
-1
. HRMS (EI) m/z calc’d C11H11O4 [M+H]
+
: 
207.0652, found: 207.0652.  Anal Calc’d for C11H10O4: C, 64.07, H, 4.89; found: C, 63.69, 
H, 5.00. 
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1,1’-Oxybis(isochroman-7,1-diyl) acetate (71) 
White solid (12% isol. yield, 372.9 mg, 0.956 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.13 (d, J = 9.2 Hz, 2H), 6.97-6.95 (m, 4H), 
6.07 (s, 2H), 4.30-4.09 (m, 2H), 4.08-4.04 (m, 2H), 3.03 (dd, J = 
11.6, 5.2 Hz, 2H), 2.65 (dd, J = 16.4, 2.0 Hz, 2H), 2.63 (s, 6H).
 13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 169.9, 149.3, 133.6, 131.1, 
130.0, 123.1, 121.9, 99.2, 58.8, 27.7. IR ν (neat) = 1759, 1500, 1429, 
1375, 1311, 1192, 1093, 1011, 941, 904, 856, 815, 729 cm
-1
. HRMS 
(EI) m/z calc’d C22H22O7NH4 [M+ NH4]
+
: 416.1704, found: 416.1703.  Anal Calc’d for 
C22H22O7: C, 66.32, H, 5.57; found: C, 66.14, H, 5.19. 
7-Methylisochroman-1-one
68
 (73) 
Colourless oil (25% isol. yield, 546.9 mg, 3.37 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.93 (d, J = 0.8 Hz, 1H), 7.37 (dd, J = 8.0, 1.6 Hz, 1H), 
7.17 (d, J = 7.6 Hz, 1H), 4.54 (t, J = 6.0 Hz, 2H), 3.03 (t, J = 6.0 Hz, 2H), 
2.40 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 165.8, 137.9, 136.9, 
134.9, 131.0, 127.5, 125.4, 67.8, 27.8, 21.4. IR ν (neat) = 1716, 1619, 1504, 1421, 1384, 
1301, 1283, 1241, 1175, 1137, 1096, 1058, 1036, 958, 827, 782, 640 cm
-1
.HRMS (EI) m/z 
calc’d C10H11O2 [M + H]
+
: 163.0754, found: 163.0753. Anal Calc’d for C10H10O2 : C, 74.06, 
H, 6.21, found: C, 74.51, H, 6.35. 
1,1’-Oxybis(7-methylisochroman) (74) 
Colourless crystals (10% isol. yield, 418.2 mg, 1.35 mmol). 
1
H NMR 
(400 MHz, CDCl3): δ (ppm) = 7.03-6.98 (6H), 6.07 (2H), 4.36-4.09 (m, 
2H), 4.09-4.05 (m, 2H), 3.10-3.02 (m, 2H), 2.61 (dd, J= 16.4, 2.4 Hz, 
2H), 2.29 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 136.2, 
134.0, 131.5, 129.3, 128.6, 128.3, 92.9, 58.7, 28.0, 21.5. IR ν (neat) = 
2927, 1500, 1421, 1378, 1311, 1270, 1232, 1157, 1132, 1091, 1012, 
952, 883, 819, 624. HRMS (EI) m/z calc’d C20H22O3Na [M+Na]
+
: 
333.1461, found, 333.1462. Anal Calc’d for C20H22O3: C, 77.39, H, 7.14; found: C, 77.28, 
H, 7.22.  
7-Methoxyisochroman-1-one
71
 (76) 
Colourless liquid (18% isol. yield, 390.3 mg, 2.19 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.59 (d, J = 2.8 Hz, 1H), 7.17 (d, J = 8.4 Hz, 
1H), 7.10 (dd, J = 8.0, 2.8 Hz, 1H), 4.52 (t, J = 5.6 Hz, 2H), 2.99 (t, J = 
5.6 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 165.6, 159.4, 
132.2, 128.8, 126.5, 122.0, 113.3, 68.0, 56.0, 27.4. IR ν (neat) = 2950, 2905, 2836, 1710, 
1605, 1511, 1451, 1421, 1387, 1276, 1228, 1203, 1161, 1087, 1062, 968. HRMS (EI) m/z 
calc’d C10H10O3 [M + H]
+
: 179.0703, found: 179.0709. Anal Calc’d for C10H9O3: C, 67.41, 
H, 5.66; found: C, 67.53, H, 5.74. 
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6,7-Dimethoxyisochroman-1-one
72
 (78) 
White solid (8% isol. yield, 128.2 mg, 0.616 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.54 (s, 1H), 6.69 (s, 1H), 4.51 (t, J = 6.0 Hz, 2H), 3.94 
(s, 3H), 3.87 (s, 3H), 2.99 (t, J = 6.0 Hz, 2H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 165.6, 154.0, 148.8, 134.3, 117.8, 112.2, 109.5, 67.7, 
56.5, 27.9. IR ν (neat) = 2952, 2911, 2836, 1706, 1602, 1511, 1461, 1421, 1394, 1336, 1270, 
1240, 1203, 1157, 1087, 1058, 1027, 962. HRMS (EI) m/z calc’d C11H13O4 [M + H]
+
:  
209.0808, found: 209.0811. Anal Calc’d for C11H12O4 : C, 63.45, H, 5.81, found: C, 63.67, 
H, 5.98.  
5,8-Dimethoxy-3-methylisochroman-1-one
73
 (80) 
White crystalline solid (5% isol. yield, 79.7 mg, 0.358 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 6.70 (d, J = 8.8 Hz, 1H), 6.59 (d, J = 8.0 Hz, 1H), 
4.38 (m,1H), 3.77 (s, 3H), 3.71 (s, 3H), 2.80 (dd, J = 13.6, 3.6 Hz, 1H), 2.34 
(ddd, J = 15.2, 11.6, 0.7 Hz, 1H), 1.42 (d, J = 6.4 Hz, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 169.0, 149.9, 148.7, 131.1, 116.0, 113.2, 112.5, 77.0, 
55.8, 56.1, 33.9, 21.1. IR ν (neat) = 1721, 1604, 1485, 1452, 1437, 1311, 1263, 1200, 1122, 
1067, 970, 948, 819, 800, 711 cm
-1
.HRMS (EI) m/z calc’d C12H15O4 [M + H]
+
: 223.0965, 
found: 223.0965. Anal Calc’d for C12H14O4 : C, 64.85, H, 6.35; found: C, 64.36, H, 6.84. 
4H-Thieno[2,3-c]pyran-7(5H)-one
74
 (82) 
White solid (18% isol. yield, 395.4 mg, 2.56 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.59 (d, J = 4.8 Hz, 1H), 6.94 (d, J = 4.8 Hz, 1H), 4.52 (t, J = 
6.0 Hz, 2H), 2.96 (t, J = 6.0 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
161.6, 147.8, 134.8, 127.1, 126.9, 68.7, 25.5. IR ν (neat) = 1755, 1492, 1426, 
1200, 1163, 1122, 1085 cm
-1
.HRMS (EI) m/z calc’d C7H7O2S [M + H]
+
:  155.0161, found: 
155.0159. Anal Calc’d for C7H6O2S: C, 54.53, H, 3.92; found: C, 54.98, H, 41.7. 
6-Fluoroisobenzofuran-1(3H)-one
75
 (85) 
White solid (60% isol. yield, 1.318 g, 8.66 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.75 (d, J = 7.5 Hz, 1H), 7.74-7.52 (m, 1H), 7.38 (t, J = 
8.6 Hz, 1H), 5.38 (s, 2H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 170.1, 
158.5 (d, 
1
JC-F  = 253.6 Hz), 133.1 (d, 
2
JC-F  = 19.1 Hz), 131.8 (d, 
3
JC-F = 7.8 
Hz), 129.2, 122.1 (d, 
3
JC-F  = 4.1 Hz),121.0 (d,
 2
JC-F  = 20.3 Hz ) 67.2. IR ν (neat) = 1756, 
1633, 1602, 1479, 1365, 1307, 1241, 1070, 1049, 1016, 937, 869, 779, 754, 646. HRMS 
(EI) m/z calc’d for C8H6O2F [M+ H]
+
: 153.0346, found: 153.0346.  
5-Chloroisobenzofuran-1(3H)-one
68
 (87) 
White solid (51% isol. yield, 1.109 g, 6.57 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.86 (d, J = 8.0 Hz, 1H), 7.53-7.50 (m, 2H), 5.30 (s, 
2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 170.3, 148.5, 141.2, 130.3, 
127.4, 124.7, 122.9, 69.3. IR ν (neat) = 1749, 1612, 1583, 1454, 1428, 
1349, 1311, 1265, 1211, 1116, 1049, 995, 887, 833, 757. HRMS (EI) m/z calc’d for 
C8H6O2Cl [M+ H]
+
: 169.0046, found: 169.0051. Anal Calc’d for C8H5BrO2: C, 57.00, H, 
2.99; found: C, 57.13, H, 3.02.  
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5-Bromoisobenzofuran-1(3H)-one
68
 (89) 
White solid (40% isol. yield, 856.0 mg, 4.02 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.79 (dd, J = 6.7, 1.5 Hz, 1H), 7.69-7.67 (m, 2H), 5.30 
(s, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 170.4, 148.6, 133.1, 
129.7, 127.5, 126.0, 125.1, 69.3. IR ν (neat) = 1745, 1604, 1579, 1454, 
1419, 1353, 1307, 1261, 1213, 1116, 1052, 995, 875, 840, 769. HRMS (EI) m/z calc’d for 
C8H6O2Br [M+ H]
+
: 212.9546, found: 212.9545. Anal Calc’d for C8H5BrO2: C, 45.10, H, 
2.37; found: C, 44.88, H, 2.69.   
Phthalide
68
 (91) 
Colourless crystals (17% isol. yield, 379.1 mg, 2.83 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.86 (d, J = 7.6 Hz, 1H), 7.62 (t, J = 7.6 Hz, 1H), 7.49-
7.42 (m, 2H), 5.26 (s, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 171.5, 
146.9, 134.4, 129.4, 126.2, 126.1, 122.5, 70.0. IR ν (neat) = 1744, 1050, 998, 
736 cm
-1
. HRMS (EI) m/z calc’d C8H7O2 [M + H]
+
: 135.0441, found: 135.0441. Anal 
Calc’d for C8H6O2: C, 71.64, H, 4.51; found: C, 71.54, H, 4.45. 
Furo[3,4-b]pyridine-7(5H)-one
76
 (93) 
Colourless crystals (52% isol. yield, 1.158 g, 8.57 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.97 (s, 1H), 8.88 (d, J = 5.0 Hz, 1H), 7.82 (dd, J = 5.0, 0.5 
Hz, 1H), 5.40 (s, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 169.3, 150.0, 
145.1, 140.3, 133.4, 118.9, 68.7. IR ν (neat) = 1758, 1587, 1454, 1421, 1357, 
1299, 1267, 1240, 1182, 1106, 1056, 1037, 1002, 825, 750, 700. HRMS (EI) m/z calc’d for 
C7H6NO2 [M+H]
+
: 136.0393, found: 136.0390. Anal Calc’d for C7H5NO2: C, 62.22, H, 
3.73, N, 10.37; found: C, 62.54, H, 3.80, N, 10.41.  
Furo[3,4-c]pyridine-1(3H)-one
77
 (95) 
Pale yellow crystals (19% isol. yield, 423.6 mg, 3.13 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 8.89 (dd, J = 4.8, 1.6 Hz, 1H), 8.23 (dd, J = 7.6, 1.2 
Hz, 1H), 7.52-7.49 (m, 1H), 5.36 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 166.9, 155.8, 134.5, 124.4, 120.1, 70.99. IR ν (neat) = 1749, 1612, 
1587, 1448, 1421, 1346, 1307, 1224, 1187, 1058, 1020, 991, 854, 773, 694.  HRMS (EI) 
m/z calc’d for C7H6NO2 [M+H]
+
: 136.0393, found, 136.0392. Anal Calc’d for C7H5NO2: C, 
62.22, H, 3.73, N, 10.37; found: C, 62.38, H, 3.79, N, 10.40.  
Methyl benzoate
78
 (97) 
Colourles liquid (4% isol. yield, 89.3 mg, 0.65 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.08-8.05 (m, 2H), 7.60-7.56 (m, 1H), 7.48-7.44 (m, 2H), 
3.94 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 167.5, 133.3, 130.5, 
129.9, 128.7, 52.5. IR ν (neat) = 1720, 1600, 1451, 1436, 1317, 1271, 1189, 
1175, 1111, 1066, 1022, 965, 823, 703 cm
-1
. HRMS (EI) m/z calc’d C8H9O2 [M + H]
+
: 
137.0597, found: 137.0597. Anal Calc’d for C8H8O2: C, 70.57, H, 5.92; found: C, 70.68, H, 
5.96.  
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Ethyl benzoate
78
 (99) 
Yellow liquid (2% isol. yield, 44.3 mg, 0.29 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.06-8.04 (m, 2H), 7.57-7.52 (m, 1H), 7.45-7.41 (m, 
2H), 4.38 (t, J = 7.2 Hz, 2H), 1.39 (t, J = 7.2 Hz, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 167.0, 133.2, 130.9, 129.9, 129.8, 128.7, 61.3, 
14.7. IR ν (neat) = 1716, 1608, 1582, 1451, 1369, 1313, 1271, 1182, 1111, 1070, 1028, 703 
cm
-1
. HRMS (EI) m/z calc’d C8H9O2 [M + H]
+
: 151.0754, found: 151.0761. Anal Calc’d for 
C9H10O2: C, 71.98, H, 6.71; found: C, 72.32, H, 6.84.  
Methyl 2-phenylacetate
78
 (101) 
Colourless oil (2% isol. yield, 44.1 mg, 0.29 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.35-7.25 (m, 5H), 3.69 (s, 3H), 3.63 (s, 2H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 172.4, 134.4, 129.6, 129.0, 127.5, 
52.4, 41.6. IR ν (neat) = 1731, 1500, 1455, 1436, 1347, 1305, 1253, 1223, 1156, 1145, 1010, 
726, 693 cm
-1
. HRMS (EI) m/z calc’d C9H11O2 [M + H]
+
: 151.0754, found: 151.0750. Anal 
Calc’d for C9H10O2: C, 71.98, H, 6.71; found: C, 71.80, H, 6.70.  
Methyl 4-(tert-butyl)benzoate
78
 (103) 
Colourless oil (2% isol. yield, 43.3 mg, 0.22 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.96 (dd, J = 6.4, 2.0 Hz, 2H), 7.45 (dd, J = 
6.4, 2.0 Hz, 2H), 3.9 (s, 3H), 1.34 (s, 9H).
 13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 167.5, 156.9, 129.8, 127.7, 125.7, 52.3, 35.5, 31.5. 
IR ν (neat) = 1724, 1612, 1436, 1410, 1365, 1279, 1186, 1118, 1022, 
969, 857, 779, 711   cm
-1
. HRMS (EI) m/z calc’d for C12H17O2 [M+H]
+
: 193.1223, found: 
193.1220. Anal Calc’d forC12H16O2: C, 74.97, H, 8.39; found: C, 75.33, H, 8.46.  
Methyl 4-nitrobenzoate
78
 (105) 
Pale yellow solid (8% isol. yield, 173.8 mg, 0.96 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 8.31-8.28 (m, 2H), 8.26-8.20 (m, 2H), 3.98 (s, 
3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 165.6, 150.9, 135.8, 
131.1, 123.9, 53.2. IR ν (neat) = 1715, 1613, 1597, 1521, 1444, 1345, 
1267, 1242, 1103, 1011, 960, 879, 853, 820, 783, 722 cm
-1
. HRMS (EI) m/z calc’d 
C8H8NO4 [M + H]
+
: 182.0448, found: 182.0446. Anal Calc’d for C8H7NO4: C, 53.04, H, 
3.89, N, 7.73; found: C, 52.83, H, 3.78, N, 7.65. 
Methyl 4-bromobenzoate
78
 (107) 
Colourless solid (15% isol. yield, 240.8 mg, 1.12 mmol). 
1
H NMR (400 
MHz, CDCl3): δ (ppm) = 7.89 (dt, J = 9.2, 4.4, 2.4 Hz, 2H), 7.58 (dt, J = 
9.0, 4.4, 2.4 Hz, 2H), 3.91 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 166.7, 132.1, 131.5, 129.4, 128.4, 52.6. IR ν (neat) = 1708, 
1583, 1436, 1396, 1270, 1195, 1170, 1106, 1066, 1008, 954, 848, 825, 750, 686. HRMS 
(EI) m/z calc’d C8H8BrO2 [M+H]
+
: 214.9700, found: 214.9702. Anal Calc’d for C8H7BrO2: 
C, 44.68, H, 3.28; found: C, 44.79, H, 3.24.  
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4,4’-(Oxybis(methoxymethylene))bis(bromobenzene) (108) 
White solid (1.5% isol. yield, 46.6 mg, 0.11 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.47 (dd, J = 7.4, 2.4 Hz, 2H), 7.27-7.24 (m, 2H), 5.71 
(s, 2H), 3.54 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 135.2, 
131.8, 129.0, 123.6, 107.1, 56.8. IR ν (neat) = 1590, 1482, 1444, 1396, 
1346, 1315, 1191, 1099, 1062, 977, 890, 800. Anal Calc’d for 
C16H16Br2O3: C, 46.18, H, 3.88; found: C, 46.48, H, 3.71.  
 
Methyl 3-chlorobenzoate
78
 (110) 
Colourless oil (14% isol. yield, 305.4 mg, 1.79 mmol). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 8.02 (d, J = 2.0 Hz, 1H), 7.93 (dt, J = 8.0, 0.8Hz, 1H), 
7.54-7.51 (m, 1H), 7.38 (t, J = 8.0 Hz, 1H), 3.93 (s, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 166.3, 134.9, 133.3, 132.2, 130.1, 128.1, 52.8. IR ν 
(neat) = 1724, 1573, 1436, 1286, 1253, 1195, 1124, 1078, 977, 902, 840, 808, 
740, 674. HRMS (EI) m/z calc’d for C8H7ClO2 [M+H}
+
: 171.0208, found: 171.0211. Anal 
Calc’d for C8H7ClO2: C, 56.32, H, 4.14; found: C, 56.79, H, 4.11.  
Compounds 43, 53, 91, 97, 99, 101, 103, 105, 107 and 110 are commercially available and 
the analytical data obtained is in agreement with the data reported by the manufacturers. 
3.5.5. Inhibition experiments: general procedures 
3.5.5.1. Inhibition by isochromanone 
In a Radley’s tube equipped with a magnetic stir bar, isochromanone (706.8 mg, 4.77 
mmol), [Fe(OTf)2L1(THF)] (5.67 x 10
-3
 mmol, 8.0 mg) and isochroman (1.4 mL) were 
added. The reaction tube was degassed (3 times), charged with dioxygen gas (1 atm) and 
kept under oxygen atmosphere (1 atm) by using a balloon. The reaction mixture was heated 
to 60 °C and stirred overnight. The reaction was purified by silica gel column 
chromatography (Hexane/EtOAc, gradient: 10/1 to 4/1) to afford the unreacted starting 
material, isochromanone (30 + 6% isol. yield, 847.9 mg) and 1,1’-oxydiisochroman (2% 
isol. yield, 90.3 mg). 
3.5.5.2. Inhibition by 1,1-oxydiisochroman 
In a Radley’s tube equipped with a magnetic stir bar, 1,1-oxydiisochroman (448.7 mg, 1.59 
mmol), [Fe(OTf)2L1(THF)] (5.67 x 10
-3
 mmol, 8.0 mg) and isochroman (1.8 mL) were 
added. The reaction tube was degassed (3 times), charged with dioxygen gas (1 atm) and 
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kept under oxygen atmosphere (1 atm) by using a balloon. The reaction mixture was heated 
to 60 °C and stirred overnight. The reaction was purified by silica gel column 
chromatography (Hexane/EtOAc, gradient: 10/1 to 4/1) to afford the unreacted starting 
material, isochromanone (16 % isol. yield, 377.3 mg) and 1,1’-oxydiisochroman (10 + 3% 
isol. yield, 584.6 mg).  
3.5.6. Catalyst recycling experiments 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. 4-Chloroisochroman (2.0 mL) was 
added by syringe; the reaction tube was degassed (3 times), charged with dioxygen gas (1 
atm) and kept under oxygen atmosphere (1 atm) by using a balloon. The reaction mixture 
was heated to 60 °C and stirred overnight. Next morning, the reaction was stopped and 
cooled down to r.t. and the reaction products were allowed to crystallize inside the tube (no 
solvents were added). The supernadant liquid was extracted by syringe, transferred to a clean 
Radley’s tube and allowed to react overnight at 60 °C under O2 (1 atm). All organics were 
combined together and purified by silica gel column chromatography (Hexane/EtOAc, 
gradient: 10/1 to 4/1) to afford a small amount of the unreacted starting material, 4-
chloroisochromanone (59% isol. yield, 1312.2 mg) and  1,1’-oxybis(7-chloroisochroman) 
(16% isol. yield, 665.0 mg). The same procedure was repeated using 4-fluoroisochroman 
affording 4-fluoroisochromanone (65% isol. yield) and 1,1’-oxybis(7-fluoroisochroman) 
(21% isol. yield). 
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3.5.7. Crystallisation of Fe(OTf)2 L1 (THF)  
In a Schlenck tube equipped with a magnetic stirring bar, Fe(OTf)2 (70.0 mg, 0.2  mmol) and 
L1 (182.0 mg, 0.2 mmol) were added. The tube was degassed (3 times) and placed under N2 
atmosphere. Freshly distilled THF (2.0 mL) was added by syringe and the mixture was 
stirred at 35 
°
C overnight. Next morning, the maroon coloured solution was filtered over 
Celite under N2 atmosphere and concentrated to a final volume of 1.0 mL approximately. 
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Freshly distilled Et2O (1.0 mL) was slowly added by syringe and the biphasic system was 
left at ambient temperature under a N2 atmosphere until well shaped white crystals formed.  
3.5.8. Crystallographic data of Fe(OTf)2L1(THF) (CCDC 945601) 
The structure determination was performed by the Chemistry Department X-ray 
Crystallographic Service.Single crystals of each reported compound were mounted on a 
MiTeGen MicroMount using Fomblin oil. The data were measured at 100 K on a Bruker D8 
diffractometer using Mo wavelengths and observed with an Apex II CCD detector. Data 
collection and processing were completed inside the APEX2 software suite.
79
 Data 
integration and global cell refinement were performed with the program SAINT
80
 and data 
were corrected using SADABS.
81
  Structural solutions and least-squares refinements were 
conducted using the OLEX2 interface
82
 to the SHELX suit of packages.
83 
 
Crystal Data for C61H67F6FeN5O11S4 (M =1344.29): tetragonal, space group P41212 (no. 92), 
a = 10.9840(8) Å, c = 52.464(4) Å, V = 6329.7(8) Å
3
, Z = 4, T = 100.0 K, μ(MoKα) = 0.450 
mm
-1
, Dcalc = 1.411 g/mm
3, 79786 reflections measured (3.78 ≤ 2Θ ≤ 52.82), 6501 unique 
(Rint = 0.0422) which were used in all calculations. The final R1 was 0.0395 (>2sigma(I)) and 
wR2 was 0.0985 (all data). 
Table 1 Crystal data and structure refinement for CCDC 945601 
Identification code  CCDC 945601 
Empirical formula  C61H67F6FeN5O11S4  
Formula weight  1344.29  
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Temperature/K  100.0  
Crystal system  tetragonal  
Space group  P41212  
a/Å  10.9840(8)  
b/Å  10.9840(8)  
c/Å  52.464(4)  
α/°  90.00  
β/°  90.00  
γ/°  90.00  
Volume/Å
3
  6329.7(8)  
Z  4  
ρcalcmg/mm
3
  1.411  
m/mm
-1
  0.450  
F(000)  2800.0  
Crystal size/mm
3
  0.32 × 0.26 × 0.16  
2Θ range for data collection  3.78 to 52.82°  
Index ranges  -13 ≤ h ≤ 13, -13 ≤ k ≤ 13, -65 ≤ l ≤ 65  
Reflections collected  79786  
Independent reflections  6501[R(int) = 0.0422]  
Data/restraints/parameters  6501/48/402  
Goodness-of-fit on F
2
  1.186  
Final R indexes [I>=2σ (I)]  R1 = 0.0395, wR2 = 0.0976  
Final R indexes [all data]  R1 = 0.0411, wR2 = 0.0985  
Largest diff. peak/hole / e Å
-3
  0.35/-0.49  
Flack parameter 0.013(19) 
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4.1. Introduction 
Natural iron metalloenzymes are capable of using molecular oxygen for selective oxidations 
with water being released as the sole byproduct of the reaction.
1
 Because dioxygen 
activation is still a major challenge in research, biomimetic iron catalysts often employ 
hydrogen peroxide as oxidant for attempting naturally occurring oxidations.
1
 The use of 
hydrogen peroxide is a shuttle to achieve a relatively clean oxidation reaction as water is 
once again the only byproduct released from the process; however, additives and specific 
reaction protocols are often necessary for achieving good reactivity under these conditions.
2
 
In contrast, the Fe(OTf)2-PyBisulidine complexes have shown high efficiency for activating 
molecular oxygen under mild and additiveless conditions as presented in Chapter 3 (Scheme 
1). 
 
Scheme 1. Comparison between the oxidation conditions required by iron metalloenzymes, 
biomimetic Fe(PDP) catalyst
2
 and Fe(OTf)2L1 complex 
Because of the reaction conditions required, biomimetic iron catalysts can only tolerate a 
limited variety of functional groups, and electron rich functionalities (for instance: π rich 
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aromatic rings, olefins and N-based groups) are considered a big remaining challenge.
3
 
However, the Fe(OTf)2L1 catalyst can tolerate an ample variety of functional groups 
including several electron rich functionalities with excellent chemoselectivity and mass 
balance. In addition, no alcohol formation was observed during the Fe(OTf)2L1 catalysed 
oxidation of ethereal substrates even under conditions of limiting oxidant. In contrast, Gif 
type catalysts often afford a mixture of ketone and alcohol type products in different ratios 
(chapter 1) and the biomimetic Fe(PDP) complex, which can catalyse the oxidation of THF 
to γ-butyrolactone, is known to undergo an initial oxidation of the methylene group to an 
alcohol which is subsequently oxidised to the ketone product.
2
 
4.2. Aims of this chapter 
Previously reported aerobic oxidations of ethers to esters catalysed by a myriad of catalysts 
suffer from serious limitations in terms of their potential industrial and laboratory 
applicability.
4
 In addition, very little mechanistic investigations have been provided for those 
reactions, which hamper their improvement. This lack of mechanistic understanding in 
combination with the aforementioned observations that clearly differ from those made with 
other catalysts prompted us to perform some mechanistic studies of the Fe(OTf)2L1 
catalysed aerobic oxidation of ethers.  
This chapter covers all the experimental observations gained from different mechanistic 
experiments which are discussed and compared with other relevant catalysts. A catalytic 
cycle is finally hypothesised on the basis of these experimental data.  
4.3. Results and discussion 
4.3.1. Radical trapping experiments 
The excellent chemoselectivity and mass balance observed in the substrate scope of the 
Fe(OTf)2L1 catalysed aerobic oxidation of ethers initially suggest that no free radical 
formation takes place during the reaction.  In order to elucidate whether radical species are 
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formed and/or involved during this oxidation reaction, we initially conducted the oxidation 
of THF under optimal conditions in the presence of a radical trapping reagent. 
Unfortunately, THF had to be discarded as model substrate for this study due to the 
uncontrolled formation of the autooxidation product 2 in the presence of small amounts of 
radical traps, even in the absence of catalyst (Scheme 2). 
 
Scheme 2. Uncontrolled autooxidaiton of THF in the presence of radical traps 
Isochroman was then selected as a model substrate, as no uncontrolled autooxidation occurs 
upon addition of C-selective (2,6-di-tert-butyl-4-methylphenol, BrCCl3, TEMPO, p-
benzoquinone) and O-selective (Ph2NH) radical trapping agents.
5
 Addition of equimolecular 
amounts of catalyst and 6 did not alter the catalyst efficiency or the product distribution; 
however, a 3- to 5-fold increase in the radical trap concentration strongly inhibited the 
reaction and affected the product distribution towards the formation of byproduct 5 (Table 1, 
entries 1-5). At this point, a further increase in the radical trap concentration led to complete 
reaction inhibition (Table 1, entries 6-8). A similar trend was observed in the presence of the 
other radical traps that caused strong to complete inhibition of the oxidation reaction (Table 
1, entries 9-17). Interestingly, no substrate-trap adducts were observed when the reaction 
was conducted in the presence of these radical trapping agents. Moreover, the alcohol 
product 11 was not formed in the presence of any radical trapping reagent and the alkyl 
bromide byproduct 12, which can be easily identified in Gif type oxidations performed in the 
presence of radical trap 7, was not detected either.6 These observations in combination with 
the lack of alcohol product formation suggest that the mechanism of the Fe(OTf)2L1 
catalysed aerobic oxidation of ethers to esters differs from that of Gif type oxidations.  
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However, the absence of substrate-trap adducts may suggest that the inhibition of the 
reaction might not be due to radical species formation but it might stem from interactions 
between the catalyst and the radical trap (i.e. coordination of the radical trap to the catalyst). 
 
Table 1. Fe(OTf)2L1 catalysed aerobic oxidation of isochroman in the presence of C- and 
O-selective radical trapping reagents 
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4.3.2. Oxidation of 3-methyl-3,4-dihydro-1H-isochromene-5,8-dione 
In an attempt to identify whether radical species are formed during the oxidation reaction 
and to intercept any possible substrate-radical trap adduct, 3-methyl-3,4-dihydro-1H-
isochromene-5,8-dione 13 bearing a p-benzoquinone moiety was subjected to the oxidation 
reaction (Scheme 3).  Surprisingly, the 1,1’-oxydiisochromene-5,8-dione derivative 14 was 
obtained as the single reaction product with 5% yield, with no substrate decomposition or 
product 15 formation. When reacted with a radical, quinones can give rise to a variety of 
products 16-18; however, no products commonly derived from radicals were detected.
7-9
 
These results point towards that freely diffusing radical species are not generated during the 
oxidation reaction and suggest that the formation of the 1,1’-oxydiisochroman byproduct 5 is 
the result of a different competitive process. 
 
Scheme 3. 3-Methyl-3,4-dihydro-1H-isochromene-5,8-dione as substrate incorporating a p-
benzoquinone moiety 
4.3.3. Effect of a radical initiator 
To examine further the possible formation of radicals, the aerobic oxidation of isochroman 
was conducted in the presence of a radical initiator, benzoyl peroxide,
10
 at 35 °C. The 
presence of the initiator did not affect the oxidation of isochroman to isochromanone (16% 
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in its presence vs 17% in its absence); however a small amount of radical-derived 
isochroman hydroperoxide 20 (ca 2%) was detected (Scheme 4). Notably, the hydroperoxide 
product gained significance in the absence of L1 and became the sole product when the 
catalyst was omitted. Formation of the oxidation dimer 5 was also observed in the presence 
of the Fe(OTf)2-L1 catalyst . Although no clear evidence of the mechanism of its formation 
has been obtained, it is likely that 5 is formed via a competitive, Fe(OTf)2-L1 catalysed 
process. 
From these results it can be concluded that radical intermediate species are generated during 
the oxidation process; however, its formation is the result of a metal-centre based process in 
which the iron catalyst does not seem to act as a mere radical initiator.  
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Scheme 4. Fe(OTf)2L1 catalysed aerobic oxidation of isochroman in the presence of a 
radical initiator. The 
1
H NMR resonances corresponding to the methylene protons of 
isochromenone are highlighted under the black arrow whereas the 
1
H NMR resonances 
corresponding to the methyne and hydroperoxy protons corresponding to isochroman 
hydroperoxide are highlighted under a yellow arrow. 
4.3.4. Oxidation of a radical clock 
The ability of benzoyl peroxide to initiate radical reactions with such ethereal substrates is 
also seen in the ultra fast radical clock (±)-trans-(2-methoxymethyl)cyclopyl)benzene,
11
 
which underwent rapid ring opening when exposed to small amounts of benzoyl peroxide 
under 1 atm of O2 (Scheme 5). In contrast, no reaction occurred when the radical initiator 
was replaced with Fe(OTf)2L1. Even though the inertness of the catalyst towards the 
oxidation of 21 is unclear to us, we hypothesise that it can be probably due to the steric 
Entry 1. Catalyst only 
Entry 2. Catalyst and 
benzoyl peroxide 
Entry 3. Fe(OTf)2 and 
benzoyl peroxide 
Entry 4. Benzoyl 
peroxide only 
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bulkiness of the radical clock, as no reaction was observed either when the less sterically 
hindered ether 22 was used as substrate.  
The formation of 23 from the reaction of the radical clock and benzoyl peroxide is also 
surprising, as the opening of the cyclopropyl ring to furnish benzyl radical 26 followed by its 
subsequent trapping with other radical species generated during the reaction was expected. 
Although we have no clear understanding of the mechanism behind the formation of 23 we 
can hypothesise that it might start with the formation of radical 25. At higher temperatures 
(40 °C) the 1,3-radical abstraction of the benzylic hydrogen in cis-position would be 
possible. Ring opening from the resulting benzyl radical can be proposed, leading to the 
formation of a α-styrene type radical which can be captured by hydroxyl or benzoyloxyl 
radicals generated in situ (Scheme 6). 
Taken together these experimental results indicate that whilst radicals may be generated in 
the Fe(OTf)2-L1 catalysed oxidation, freely diffusing carbon or oxygen-based radicals are 
not involved. 
 
Scheme 5. Aerobic oxidation using a radical clock. Ring opening of the radical clock  (±)-
trans-(2-methoxymethyl)cyclopyl)benzene took place after exposure to the radical initiator 
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benzoyl peroxide under aerobic conditions. However, no reaction took place after its 
exposure to Fe(OTf)2L1. 
 
Scheme 6. Hypothesised formation of products 23 and 24 
4.3.5. Identification of a peroxide intermediate 
The catalytic efficiency of Fe(OTf)2L1 was found dependent on the S/C ratio following an 
approximate Gaussian distribution with a maximum efficiency found at a S/C of 4315 in the 
neat reaction. It was also observed that the catalytic efficiency diminishes by increasing the 
dilution with arene type solvents. In order to understand this concentration effect, some 
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kinetic studies of the Fe(OTf)2L1 catalysed oxidation of isochroman were conducted in a 
benzene solution of different concentrations (Scheme 7). When the oxidation was stopped 
after 1 h reaction, 1,1’-peroxydiisochroman12  was detected, apart from the expected 
isochromanone and the 1,1’-oxydiisochroman byproduct (Scheme 7, entries 3-5). The 
peroxy species disappeared, being accompanied with an increase in the yield of 
isochromanone, following further reacting overnight (Scheme 7, entries 1, 2, 6). Therefore, 
the peroxy species appears to be an intermediate in the oxidation of isochroman. X-ray 
crystallographic analysis of the isolated mixture confirmed the structure of 1,1’-
oxydiisochroman existing as two conformational isomers and that of 1,1’-oxydiisochroman 
(Scheme 8). These observations suggests that Fe(OTf)2L1 is capable of catalysing rapid and 
selective formation of 1,1’-peroxyisochroman, from which the isochromanone results.   
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Scheme 7. Kinetic studies of the Fe(OTf)2L1 catalysed oxidation of isochroman. 
Evidence of 1,1’-peroxyisochroman formation in the crude 1H NMR is highlighted with a 
black arrow and it suggest a two step reaction mechanism. 
Entry 1.  
Entry 2. 
Entry 3. 
Entry 4. 
Entry 5. 
Entry 6. 
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Scheme 8. Structures of the cis and trans-peroxydiisochroman intermediate isomers and the 
oxydiisochroman byproduct based on X-ray crystallographic analyses 
4.3.6. Conversion of 1,1’-peroxyisochroman to chromanone 
To gain more evidence of the intermediacy of 1,1’-peroxyisochroman, an isolated mixture of 
1,1’-peroxydiisochroman and 1,1’-oxydiisochroman (1.0:0.6 molar ratio, 8.0M in C6H6 
solution) was exposed to a catalytic amount of Fe(OTf)2-L1 at 45 °C (Scheme 9). Crude 
1
H 
NMR spectra revealed a clean reaction in which the peroxide was fully converted into two 
equivalents of isochromanone under an O2 atmosphere, whereas 1,1’-oxydiisochroman 
remained intact, establishing the intermediacy of the peroxide to isochromanone. 
Surprisingly, this clean transformation was also observed under a N2 atmosphere; however, 
no reaction occurred in the absence of the iron catalyst. Interestingly, the reaction was not 
affected by the addition of either an excess of a radical inhibitor para-benzoquinone or the 
radical initiator benzoyl peroxide (Scheme 10), indicating that no radical species are 
involved at this stage of the isochroman oxidation. The presence of isochroman did not 
Cis-peroxydiisochroman 
1,1’-oxydiisochroman 
Trans-peroxydiisochroman 
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affect this transformation either (Scheme 11), nor was isochroman oxidized under the N2 
atmosphere, reinforcing that the oxidation of isochroman to the peroxide involves O2 whilst 
the conversion of the peroxide to the ester does not. 
 
 
Scheme 9. 1,1’-Peroxydiisochroman as a intermediate in the Fe(OTf)2L1 catalysed 
conversion of isochroman to ischromanone. The presence of 
1
H NMR resonances 
corresponding to chromanone in the crude NMRs after catalytic exposure of the initial 
mixture is highlighted with a black arrow. Note that only the 
1
H NMR signal corresponding 
to the methyne protons of 1,1-peroxydiisochroman is missing after catalyst exposure. 
1. Initial mixture of 1,1’-
oxydiisochroman and 1,1’-
peroxydiisochroman 
2. Conversion of 1,1’-
peroxidiisochroman to 
chromanone after 
catalyst exposure under 
1 atm O2 
3. Conversion of 1,1’-
peroxydiisochroman to 
chromanone after catalyst 
exposure under 1 atm N2 
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Scheme 10. Effect of radical reagents in the catalytic conversion of 1,1’-
peroxydiisochroman into chromanone. No difference in the reactivity was observed when 
the catalytic reaction was exposed to an excess of a radical inhibitor (p-benzoquinone) or a 
radical initiator (benzoyl peroxide). 
 
 
 
1. Initial mixture of 1,1’-
peroxydiisochroman and 
1,1’-oxydiisochroman 
2. Conversion of 1,1’-
peroxydiisochroman to 
chromanone after catalyst 
exposure in the presence of 
benzoyl peroxide 
3. Conversion of 1,1’-
peroxydiisochroman to 
chromanone after catalyst 
exposure in the presence of 
p-benzoquinone 
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Scheme 11. Conversion of 1,1-peroxydiisochroman to chromanone in the presence of 
an excess of isochroman under N2 atmosphere. The 
1
H NMR resonances corresponding to 
chromanone in the crude NMRs after catalytic exposure of the initial mixture are highlighted 
with a black arrow. No reaction was observed between the isochroman and the peroxide 
intermediate. 
4.3.7. Ligand effect in the conversion of 1,1’-peroxidiisochroman to chromanone 
The activity of Fe(OTf)2-PyBidine and Fe(OTf)2L1 complexes towards the aerobic oxidation 
of THF was compared, with the latter showing a 7.5 fold increase in the formation of the 
1. Initial solution of 1,1’-
peroxidiisochroman and 
1,1’-oxydiisochroman in an 
excess of isochroman under 
N2 atmosphere 
2. After catalyst exposure 1,1’-
peroxidiisochroman is 
converted into chromanone 
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desired γ-butyrolactone product. When the aerobic oxidation of isochroman 3 was performed 
using Fe(OTf)2-PyBidine as catalyst under optimal reaction conditions, several products 
were observed with the isochromanone product 4 obtained in poor yields and the peroxide 
species 27 was isolated in 3% yield. These data suggests that the superior catalytic efficiency 
of Fe(OTf)2L1 relies on its capability to easily promote both the formation of the peroxide 
species 27 and its transformation into two equivalents of lactone product 4. 
 
Scheme 12. Aerobic oxidation of isochroman catalysed by Fe(OTf)2-PyBidine type complex 
under optimal reaction conditions 
4.3.8. Selective formation of the peroxide intermediate 
When phthalan type substrates such as 28 were subjected to the Fe(OTf)2L1 catalysed 
aerobic oxidation reaction in benzene solution, an analogous peroxide intermediate 29 was 
formed together with the lactone product 30. Indeed, upon modifying the reaction conditions 
to lower temperatures and higher dilution with benzene, the reaction was driven towards the 
exclusive formation of the peroxide species 29, with no formation of the lactone product 30. 
The autooxidation product 31 was also detected in small amounts (Scheme 13). 
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Scheme 13. Formation of the peroxide intermediate from phthalan type substrates under 
kinetically controlled conditions 
4.3.9. Formation of hydroperoxides under high dilution conditions  
When reacting isochroman 3 or phthalan 28 in lower concentrated benzene solutions, 
formation of the hydroperoxide byproducts 20 and 31 was observed, respectively. Because 
these hydroperoxide byproducts were not generated under optimal reaction conditions, 
further studies were conducted to shed light into their formation in benzene solution. Thus, 
when a 4.5 M solution of the isolated mixture of 1,1-peroxydiisochroman and 1,1’-
oxydiisochroman (1.0 : 0.5 ratio) in benzene was subjected to the catalytic oxidation 
reaction, formation of both isochromanone and isochroman hydroperoxide was observed 
with an overall yield of 68% (Scheme 14). The 
1
H NMR showed that the formation of these 
two products stem from the 1,1-peroxydiisochroman species, whereas the 1,1’-
oxydiisochroman 4 remained intact. Analogous results were obtained when the oxidation 
was performed in the presence of the radical initiator benzoyl peroxide. 
Chapter 4 
 
179 
 
These data suggest that the Fe(OTf)2L1 catalysed conversion of 1,1’-peroxydiisochroman 
into isochromanone is less efficient when the substrate concentration is low and thus, a 
higher efficiency was observed under neat substrate conditions. It also indicates that the 
formation of the hydroperoxides species during the catalytic oxidation under high dilution is 
not due to free radical reactions of the ether, but the result of different reactivity from the 
peroxide species. 
 
 
Scheme 14. Conversion of 1,1’-peroxydiisochroman into isochromanone and 
isochroman hydroperoxide in diluted benzene solution. The 
1
H NMR resonances 
corresponding to chromanone in the crude NMRs after catalytic exposure of the initial 
mixture are highlighted with a black arrow, whereas the methyne proton of isochroman 
hydroperoxide is highlighted with a thick green arrow. 
3. Conversion of 1,1’-
peroxydiisochroman into 
isochromanone and 
isochroman hydroperoxyde 
in benzene solution under N2 
atmosphere. 
2. Conversion of 1,1’-
peroxydiisochroman into 
isochromanone and 
isochroman hydroperoxide 
under O2 atmosphere. 
1. Starting 1,1’-
peroxydiisochroman and 
1,1’-oxydiisochroman 
mixture 
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4.3.10. Rate limiting step 
The results obtained in the oxidation of isochroman and phthalan suggest that the 
Fe(OTf)2L1 catalysed oxidation of ethers is turnover-limited by the step of the peroxide 
conversion to the ester product. Some additional experiments were conducted in order to 
further confirm the rate limiting step of the aerobic oxidation of ethers to esters. The 
Fe(OTf)2L1 catalysed aerobic oxidation of THF results in the predominant formation of γ-
butyrolactone. Nonetheless, minor byproducts such as 32 and 33 were also detected (Scheme 
15). In addition, formation of an analogous peroxide intermediate 50 easily occurred at 
temperatures lower than 60 
°
C and/or when stopping the oxidation process before 48 h. 
These observations are consistent with the formation of the peroxide intermediate 50 being a 
rapid step. Moreover, when an isolated mixture of the peroxide species 50 and the additional 
reaction byproducts were reacted under catalytic conditions at 45
°
C, formation of γ-
butyrolactone 51 occurred smoothly; however, the process did not reached completion until 
heating for 42 h (Scheme 16). These data clearly contrast with the reactivity of peroxides 28 
and 32 which can only be isolated under high dilution conditions. These results again point 
towards the peroxide conversion to the ester product as the rate-limiting step. Additionally, 
this is consistent with the sharp electronic effect observed in the substrate scope. 
 
Scheme 15. Byproducts isolated from the Fe(OTf)2L1 catalysed aerobic oxidation of THF  
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Scheme 16. Conversion of the peroxide intermediate 34 into the lactone product 35 
4.3.11. Evidence of H2 gas release during the oxidation reaction 
Further study into how the oxidation proceeds revealed, much to our surprise, that the 
oxidation is accompanied with release of H2. Quantitative GC analysis indeed established 
the stoichiometric formation of H2 in the Fe(OTf)2L1 catalysed oxidation of phthalan 28 to 
phthalide 30, and showed that the H2 formation took place in each individual step, i.e. 
oxidation to afford the peroxide and its subsequent conversion to phthalide (Scheme 17). 
Therefore, the conversion of 28 to the intermediate peroxide 29 is a dehydrogenative 
oxidation process whereas the subsequent conversion of the peroxide 29 to the phthalide 
product 30 is an unusual iron-catalysed dehydrogenation.  
3. γ-butyrolactone 
formation after 24 h 
under catalyst exposure 
2. γ-butyrolactone 
formation after 12 h 
under catalyst exposure 
1. Initial mixture of 
peroxide intermediate 
and unidentified 
byproducts 
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Scheme 17. Detection of H2 gas during the oxidation of phthalan to phthalide 
4.3.12. Absence of water formation 
Because iron based catalysts that oxidise organic substrates with H2O2 as oxidant generate 
H2O as sole byproduct, the possibility of water formation during the Fe(OTf)2L1 catalysed 
oxidation reaction was next examined. To determine whether water formation occurs during 
the initial formation of the peroxide intermediate, phthalan 28 was oxidised under high 
dilution conditions to a mixture of the peroxide species 29 and traces of the autooxidation 
byproduct 31. Remarkably, quantitative analysis with 
1
H NMR showed that no water was 
formed in the oxidation of 28 to 29 (Scheme 18). Similarly, no water formation was revealed 
in the completed oxidation of 4-fluoroisochroman 36 to 4-fluoroisochromanone 37 (Scheme 
19).  
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These results in combination with the H2 formation indicate that unlike common enzymatic 
oxidations, the oxidation in question proceeds via an unusual, sequential dehydrogenative 
oxygenation process. In fact, to the best of our knowledge, there appears to be no literature 
report of oxygenation coupled with dehydrogenation in enzymatic or biomimetic catalysis.   
 
Scheme 18. No water byproduct formation was detected during the conversion of the 
ethereal substrate 28 to the peroxide intermediate 29 in the water calibration experiments. 
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Scheme 19. Water formation in the conversion of 4-fluoroisochroman to 4-
fluoroisochromanone. On the basis of the calibration, the crude 
1
H NMR above shows no 
water was formed during the oxidation of 4-fluoroisochroman. The 
1
H NMR resonances 
corresponding to the methylene protons of chromanone in the crude 
1
H NMR are highlighted 
with a black arrow whereas the water peak is highlighted under the red arrow. 
4.3.13. Isotope labelling experiments 
 In biomimetic iron complexes capable of undergoing oxidation with H2O2, the formation of 
the active electrophilic iron-oxo oxidant is the result of the peroxide O-O bond cleavage, in 
which a molecule of water is released as byproduct. Having confirmed that no water 
formation occurs during the catalytic oxidation and having confirmed that there are radical 
species involved during the formation of the peroxide intermediate, the origin of the O-O 
bond of the peroxide intermediate was next investigated by isotopic labelling experiments. 
Thus, the oxidation of phthalan 28 to 1,1’-peroxybis(1,3-dihydroisobenzofuran) with a 
mixture of 
18
O2 and 
16
O2 afforded 
16
O-
16
O and 
18
O-
18
O containing peroxides; however, no 
cross-over 
16
O-
18
O peroxy species were detected in the MS analysis (Scheme 20). The 
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preservation of the O-O bond in the formation of the peroxide suggests that an iron-oxo 
intermediate is not involved in the oxidation mediated by Fe(OTf)2L1. 
 
Scheme 20. No observation of cross-over peroxide products during the formation of the 
peroxide intermediate indicates that the O-O bond comes from a single dioxygen molecule 
4.3.14. H/D exchange experiments 
Having confirmed the formation of hydrogen gas in both steps, obtaining additional data that 
could shed light on the mechanism of the oxidation reaction was aimed by performing H/D 
exchange experiments. The cleavage of the peroxide 29 to give off H2 (Scheme 17) could 
involve a Fe-H hydride intermediate. Likewise, a Fe-D deuteride may form in the case of the 
deuterium-labelled peroxide 29-d6, which afforded D2. And if so, it is likely that the iron 
hydride may undergo H-D exchange with D2O. However, no HD or D2 formation was 
observed when the oxidation of 29 to 30 was performed in the presence of D2O (Scheme 
21). We noted that kinetic studies of the pyrolysis of 1-hydroxyalkyl alkyl peroxide 39 are 
consistent with the formation of H2 gas as a result of a cyclic concerted mechanism.
13
 In this 
study, a radical-cage mechanism is proposed in which the homolytic O-O cleavage results in 
the formation of two radical species that can react with each other at a much higher rate than 
with solvent molecules according to the principles of primary recombination of radicals
14
 
(Scheme 22). Therefore, no HD or D2 evolution is observed when undergoing the same 
reaction in the presence of deuterated species. 
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Scheme 21. Deuterium labeling experiments revealing no HD or D2 formation in the 
dehydrogenation of 29 in the presence of D2O. 
 
Scheme 22. Radical cage mechanism proposed to explain the H2 release during the pyrolysis 
of 1-hydroxyalkyl alkyl peroxides. 
To gain further insight into the conversion of the peroxide intermediate to the ester product, 
a mixture of peroxides 29 and 29-d6 was exposed to the Fe(OTf)2-L1 catalyst (Scheme 23). 
GC-MS monitoring of the reaction revealed the exclusive formation of H2 and D2, 
suggesting that the cleavage of the peroxide is likely to occur within the coordination sphere 
of the iron center, involving no free alkoxide ion or free alkoxy radical in the solution. 
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Scheme 23. No HD formation was observed in the reaction of a mixture of 29 and 29-d6. 
4.3.15. Postulated mechanism 
The experimental evidence collected point to the Fe(OTf)2-L1 catalysed α-oxidation of 
ethers follows an unprecedented tandem dehydrogenative-oxygenation process involving the 
formation of a peroxide intermediate, and the peroxide cleavage appears to be the turnover-
limiting step of the catalytic process (Scheme 24). 
 
Scheme 24.  Fe(OTf)2-L1 catalysed α-oxidation of ethers via a tandem dehydrogenative-
oxygenation process. 
Even though the formation of the peroxide intermediate is unclear mechanistically, the 
preservation of the O-O bond in the peroxide species 
18
O2-29 and 
16
O2-29 and the absence of 
water formation during the oxidation point towards an oxidation process that does not 
involve the formation of a high valent oxo-iron species as in reported biomimetic iron 
complexes. In addition, radical trapping experiments and the excellent chemoselectivity 
observed in the substrate scope suggest that no autooxidation or freely diffusing radical 
processes are involved during the oxidation reaction. Iron-induced CH activation of the 
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ethereal substrate followed by O2 attack appears also unlikely
15
 due to instability of 
metalated ethers and the easy formation of cleavage products.
16
 This is particularly the case 
of cyclic ethers like THF as metalation at the α-position localises a significantly high 
negative charge on the α-carbon adjacent to the electron rich oxygen atom causing 
significant destabilisation that can lead to ring opening (Scheme 25). Thus, such reactivity 
contradicts with the excellent mass balance observed in the substrate scope. 
 
Scheme 25. Possible pathways that are in disagreement with experimental observations 
Therefore, a non-classical C-H activation of the ethereal substrate by the Fe(OTf)2L1 
catalyst was considered as a possible starting point in the formation of the peroxide 
intermediate (Scheme 26). Support for this hypothetic mechanism is also found in the 
literature as the CH activation of ethers via the classic β-hydrogen (α- to the oxygen) 
elimination following the ether coordination to a metal is known; For instance, β-imidato 
complexes of Pt were found capable of activating CH bonds of simple ethers such as THF 
and Et2O and induce their subsequent dehydrogenation via β-hydride elimination.
17
 
Similarly, the amidophosphine pincer (PNP)Ir complexes, where PNP = [N(2-P
i
Pr2-4-
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MeC6H3)2]
-
, was found to dehydrogenate Et2O and 1,4-dioxane to their vinyl ethers form via 
an analogue CH activation/β-hydride elimination sequence.18 
 
Scheme 26. Possible pathways to explain the formation of the peroxide intermediate 
In order to gain evidence of whether the Fe(OTf)2L1 complex is capable of promoting CH 
activation, some additional H/D exchange experiments were performed. Initially, when 
isochroman 3 was treated with the Fe(OTf)2L1 complex in the presence of small amounts of 
D2O  under an inert atmosphere no H/D exchange was observed by 
1
H NMR. This result 
suggests that the iron complex cannot undergo CH activation of the ethereal substrate 
conditions when exposed to N2. When the same experiment was performed under aerobic 
atmosphere, formation of peroxide 27, lactone 4 and oxidation dimer 5 products was 
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observed in the presence of D2O. Nonetheless, 
1
H NMR analyses revealed no H/D exchange 
either in the unreacted isochroman 3 or in the peroxide species 27 (Scheme 27). These 
results are not consistent with the iron catalyst being capable of forming the peroxide species 
by inducing an initial anaerobic breakage of the CH bond of the ethereal substrate. 
 
Scheme 27. Additional H/D exchange experiments which suggest no C-H activation of the 
ethereal substrate by the iron complex 
The generation of oxonium ions from ethereal substrates under the reaction conditions was 
also postulated, as some isochroman and phthalan oxidations to esters have been reported to 
involve the formation of oxonium ions via hydride abstraction
19
 or via a radical formation
20
 
(Scheme 28). Oxonium ions can be easily trapped by nucleophiles such as water or 
alcohols;
19,20
 however, no lactol formation was observed when the isochroman 3a was 
oxidized in the presence of H2O or D2O (Scheme 27). These results suggest that oxonium 
ions are not generated during the iron-catalysed oxygenation of ethers. 
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Scheme 28. Formation of oxonium ions and their trapping with nucleophiles 
Considering the coordination mode of [FeL1(THF)(OTf)2] and particularly the short Fe-O3 
(THF) distance (see chapter 3), we hypothesized that under the reaction conditions, the iron 
complex may coordinate to one or two ethereal substrates. Exposure to O2 atmosphere would 
easily result in the formation of a Fe
III
 superoxo species 16 in a similar fashion as with 
metalloenzymes
3a
 and related biomimetics.
21
 The Fe
III
 superoxo species could initiate the 
cleavage of the α-CH bond of the Fe-bound ether substrate; hydrogen atom transfer to the 
Fe
III
 center followed by, or concurrent with, the attack of the superoxo radical at the α- 
carbon leads to a radical-ligated Fe
III
-H hydride or a tight hydride-radical pair 17 (Scheme 
28). From the species 17, a second hydrogen atom transfer and radical combination affords 
12 and a Fe
IV
-(H)2 dihydride, which undergoes reductive elimination to give off H2. This 
hypothetic mechanism is consistent with the presence of radical species, the high 
chemoselectivity of the oxidation, and the strong electronic as well as steric bias manifested 
in the substrate scope. Support for the mechanism is also found in the literature. In 
particular, hydrogen transfer from a sp
3
 carbon α to oxygen followed by the formation of 
Fe
IV
-H hydride-radical pair has been suggested for the coupling of alcohols with alkenes
22
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(Scheme 29). Many transition metals, including Fe
IV
, are known to form metal-dihydride and 
metal-dihydrogen complexes, from which hydrogen release can occur.
23 
       
 
Scheme 28. Hypothetic formation of the peroxide intermediate 
 
Scheme 29. Coupling of styrenes with alcohols by the postulated formation of a Fe
IV
-H 
hydride-radical pair 
The cleavage of the peroxy bond to form the ester product could proceed via the oxidative 
addition of the peroxide on the Fe centre followed by β-hydrogen abstraction, giving off H2 
(Scheme 30). It is known that metal complexes of Pt
24
 and Cu
25
 can undergo oxidative 
addition of benzoyl peroxides via O-O bond cleavage (Scheme 31). This cleavage may 
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involve polar addition of the RO-OR bond to a metal center generating a M
+
-OR cation and 
a RO
-
 anion, or concerted non-polar addition of the peroxide bond to give two M-OR bonds, 
or a radical mechanism giving rise to a M
.
-OR and a RO
.
 radical.
26
 Since the oxidation with 
Fe(OTf)2-L1 results in no formation of HD (Scheme 23), it readily takes place in non-polar 
solvents such as benzene, and the catalytic conversion of 12 to 4a is insensitive to radical 
inhibitors, the oxidative addition of the peroxide to the iron catalyst is likely to proceed via 
the concerted pathway.     
 
Scheme 30. Conversion of 27 to 4 via a hypothetic oxidative addition – hydrogen 
abstraction sequence 
 
Scheme 31. Oxidative addition of peroxides on transition metals 
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Bearing in mind the observations made with the isotope labeling, the dehydrogenation step 
shown in Scheme 23 may involve consecutive β-hydrogen migration to the iron followed by 
fast reductive elimination to release H2. Literature examples are known of hydrogen abstract 
from iron-alkoxo species, leading to dehydrogenation including release of H2, in catalysis by 
both metal complexes and enzymes.
27 
For instance, an iron piano-stool complex has recently 
been applied to the dehydrogenation of pyridyl alcohols with concomitant formation of H2 
gas (Scheme 32). A mechanism involving the β-hydride elimination from an intermediate 
iron-alkoxo species was postulated. In addition, under pyrolytic conditions, hydroxyl
28
 and 
bis-hydroxyalkyl
29
 peroxides can give off hydrogen gas.  
 
Scheme 32. Iron-catalysed dehydrogenation of pyridyl alcohols via hydride elimination 
from an iron-alkoxo intermediate species 
4.3.16. Catalytic cycle 
On the basis of these mechanistic investigations, a catalytic cycle involving the inner-sphere 
formation of a peroxide intermediate via the attack of an iron-superoxo radical at 
coordinated ethers is postulated (Scheme 33). Subsequent conversion of the isolable 
peroxide intermediate to the ester product may proceed through a concerted oxidative 
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addition-hydrogen abstraction sequence. The release of H2 is likely to be a result of fast 
reductive elimination of hydrides at a Fe
IV
 center.     
 
Scheme 33. Proposed catalytic cycle for the Fe(OTf)2-L1 catalyzed aerobic oxidation of 
ethers to esters.   
4.4. Conclusions 
In conclusion, evidence of an unconventional oxidation mechanism has been found. 
Molecular oxygen is activated without initial O-O cleavage to form an oxo-iron species and 
the unprecedented release of H2 gas as the sole byproduct of the whole transformation is 
identified. The mechanistic studies also explain the reasons behind the sharp electronic 
effect and unprecedented chemoselectivity and functional group tolerance of this family of 
iron catalysts discussed in Chapter 3. We anticipate that these mechanistic studies may 
inspire new thinking in understanding and mimicking iron-based mono and di-oxygenases. 
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4.5. Experimental section 
4.5.1. Radical trapping experiments: General procedure 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 
times) and left under an inert atmosphere. Isochroman (2.0 mL) was added by syringe and 
the reaction mixture was stirred under N2 atmosphere for 30 min at 35 
°
C. Next, the 
corresponding amount of radical trapping agent was added and the tube charged with O2 gas 
and kept under O2 (1 atm) by using a balloon. The reaction mixture was then heated up to 60 
°
C and allowed to react overnight. Product formation was determined by 
1
H NMR 
conversion and isolated yield after purification by silica gel flash column chromatography. 
Apart from possible radical reactions, the observed inhibition may also stem from interaction 
of the radical trap with the iron centre. 
4.5.2. Intercepting radical trap adducts: oxidation of 3-methyl-3,4-dihydro-1H-
isochromene-5,8-dione 
4.5.2.1 Procedure for the oxidation of 3-methyl-3,4-dihydro-1H-isochromene-5,8-dione 
Ligand L1 (5.67 x 10
-3
 mmol, 5.2 mg) and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were placed 
in a Radley’s tube equipped with a magnetic stir bar. The tube was degassed (3 times) and 
placed under N2 atmosphere and C6H6 (0.5 mL) was added by syringe. The catalyst was 
formed in situ after stirring the reaction mixture for 30 min at 35 
°
C. Then, 3-methyl-3,4-
dihydro-1H-isochromene-5,8-dione (1.2 g) and C6H6 (0.2 mL) were added and the Radley’s 
tube heated to 50 
°
C for a few minutes (until complete solution of the substrate). The tube 
was degassed and charged with O2 and kept under O2 (1 atm) with a balloon. The mixture 
was allowed to react at 60 
°
C for 24 h with two other additions of C6H6 (0.2 mL) done after 6 
and 18 h. Product formation was determined by 
1
H NMR conversion and isolated yield after 
silica gel flash column chromatography purification (Hexane/AcOEt, 7/1 to 4/1).  
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4.5.2.2. Synthesis of 3-methyl-3,4-dihydro-1H-isochromene-5,8-dione 
3-Methyl-3,4-dihydro-1H-isochromene-5,8-dione was synthesised according to the literature 
by smooth oxidation of 5,8-dimethoxy-3-methylisochroman with CAN.
30
 
Analytical data  
3-methyl-3,4-dihydro-1H-isochromene-5,8-dione
30
 (13) 
Tanned solid, 98% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 6.65 (dd, 
J = 10.0, 8.4 Hz, 2H), 4.34 (dd, J = 18.4,2.4 Hz, 1H), 4.33 (ddd, J = 7.6, 4.4, 3.6 
Hz, 1H), 3.61-3.53 (m, 1H), 2.54-2.48 (m, 1H), 2.15-2.12 (m, 1H), 1.28 (d, J = 
7.0 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 186.4, 186.2, 140.7, 140.0, 
136.8, 136.5, 69.9, 63.2, 29.3, 21.5. 
1,1’-oxybis(3-methyl-3,4-dihydro-1H-isochromene-5,8-dione) (14) 
White solid, 5% isolated yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
6.68 (d, J = 4.5 Hz, 2H), 6.63 (d, J = 4.8 Hz, 2H), 5.97 (s, 2H), 4.33-4.25 
(m, 2H), 2.54 (dd, J = 19.6, 3.6 Hz, 2H), 2.18-2.12 (m, 2H), 1.49 (s, 3H), 
1.48 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 186.9, 185.2, 142.8, 
137.4, 136.7, 136.5, 87.6, 63.6, 29.1, 21.0. IR (ATR) ν = 1654, 1594, 1450, 
1403, 1299, 1261, 1145, 1128, 1062, 1002, 962, 848, 808, 740. HRMS (EI) 
m/z calc’d C20H19O7 [M+H]
+
: 371.1125, found: 371.1120. 
 
4.5.3. Effect of a radical initiator: General procedure 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 
times) and left under inert atmosphere. Isochroman (2.0 mL) was added by syringe and the 
reaction mixture was stirred under N2 atmosphere for 30 min at r.t. Next, radical initiator 
benzoyl peroxide (0.02 mmol) was added and the tube was degassed and charged with O2 
and kept under O2 (1 atm) with a balloon. The reaction mixture was stirred at 35 
°
C 
overnight and product formation was determined by 
1
H NMR and isolated yield after 
purification by silica gel flash column chromatography. The same procedure was repeated in 
the absence of ligand, benzoyl peroxide and catalyst. 
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Analytical data of the isolated isochroman hydroperoxide
31 
Colourless liquid. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 9.01 (bs, 1H), 7.43-
7.14 (m, 4H), 6.06 (s, 1H), 4.21-4.14 (m, 1H), 4.07-3.99 (m, 1H), 3.11-3.02 
(m, 1H), 2.62 (dd, J = 16.6, 2.2 Hz, 1H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 135.6, 129.3, 128.9, 126.9, 101.1, 58.8, 28.2. IR (ATR) ν = 3328, 
2940, 2888, 1489, 1453, 1423, 1386, 1312, 1275, 1197, 1083, 1057, 1002, 983, 954, 902, 
851, 769, 747, 680, 621, 599. HRMS (EI) m/z calc’d C9H11O3 [M+H]
+
: 167.0703, found: 
167.0708. 
 
4.5.4. Oxidation of a radical clock  
4.5.4.1. Fe(OTf)2L1 catalytized oxidation of the radical clock 
In a Radley’s tube equipped with a magnetic stir bar, L1 (5.67 x 10-3 mmol, 5.2 mg) and 
Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 times) 
and left under inert atmosphere. The radical clock (±)-trans-(2-
methoxymethyl)cyclopyl)benzene
11
 (2.0 mL) was added by syringe and the tube was 
degassed and charged with O2 and kept under O2 (1 atm) with a balloon. The mixture was 
allowed to react at 60 
°
C overnight and the product formation was determined by 
1
H NMR 
and isolated yield after purification by silica gel flash column chromatography. The same 
procedure was followed using (1-methoxypropan-2-yl)benzene as substrate. 
4.5.4.2. Radical rock reactivity in the presence of radical initiators 
In a small Schlenck tube equipped with a magnetic stir bar, Luperox (2.0 mg) was added. 
The tube was sealed, degassed (3 times) and left under inert atmosphere. (±)-trans-(2-
methoxymethyl)cyclopyl)benzene (50 μL) was added by syringe and the tube was degassed 
and charged with O2 and kept under O2 (1 atm) with a balloon. The mixture was allowed to 
react at 50 
°
C overnight and the product formation was determined by 
1
H NMR and isolated 
yield after purification by silica gel flash column chromatography.  
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4.5.4.3. Synthesis of the ((±)-2-(methoxymethyl)cyclopropyl)benzene substrate 
(±)-trans-(2-Methoxymethyl)cyclopyl)benzene was synthesised via reduction of (±)-trans-2-
phenylcyclopropanecarboxylic acid to its alcohol form followed by its subsequent 
methylation.
32, 33
 
 
(±)-trans-(2-Methoxymethyl)cyclopyl)benzene
34 
Colourless liquid, 92% overall yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.27-7.22 (m, 2H), 7.16-7.12 (m, 1H), 7.08-7.06 (m, 2H), 4.42 
(dd, J = 10.4, 6.8 Hz, 1H), 3.38 (s, 3H), 3.36 (dd, J = 10.4, 6.8 Hz, 1H, 
overlapped), 1.80 (quintet, J = 4.8 Hz, 1H), 1.44-1.37 (m, 1H), 0.99-
0.91 (m, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 142.9, 128.7, 126.2, 125.9, 58.7, 
22.8, 21.8, 14.3. HRMS (EI) m/z calc’d C11H15O [M+H]
+
: 163.1118, found: 163.1116. 
4.5.4.4.Synthesis of (1-methoxypropan-2-yl)benzene 
(±)-(1-methoxypropan-2-yl)benzene was synthesized by methylation of (±)-2-phenylpropan-
1-ol.
33 
(1-Methoxypropan-2-yl)benzene
35 
Colourless liquid, 98% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.32-7.22 (m, 5H), 3.51 (t, J = 8.8 Hz, 1H), 3.44 (t, J = 8.8 Hz, 1H), 3.33 (s, 
3H), 3.03 (q, J= 7.0 Hz, 1H), 1.28 (d, J = 7.0 Hz, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 144.4, 128.4, 127.2, 126.3, 78.7, 58.8, 39.8, 30.9, 
18.4. HRMS (EI) m/z calc’d C9H13O [M+H]
+
: 137.0961, found: 137.0958. 
4.5.4.5. Analytical data of the products 
1-Methoxy-3-phenylbut-3-en-2-ol  
Colorless liquid. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.44-7.26 (m, 
5H), 5.81-5.71 (m, 1H), 5.07 (s, 1H, overlapped), 5.02 (m, 1H, 
overlapped), 4.16 (t, J = 6.9 Hz, 1H), 3.22 (s, 3H), 2.60-2.53 (m, 1H), 
2.44-2.37 (m, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) =141.6, 
134.3, 128.4, 128.3, 126.7, 116.9, 83.6, 65.6, 42.5. HRMS (EI) m/z calc’d C10H13O2 
[M+H]
+
: 165.0911, found: 165.0907. 
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1-Methoxy-3-phenylbut-3-en-2-yl benzoate  
Colorless liquid. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 8.12 (d, J = 8.0 
Hz, 2H), 7.61-7.58 (m, 1H), 7.5 (m, 2H), 7.44-7.26 (m, 5H, overlapped), 
6.09-6.04 (m, 1H), 5.07 (s, 1H, overlapped), 5.03 (t, 1H, overlapped), 
3.22 (s, 3H, overlapped), 2.86-2.78 (m, 1H), 2.75-2.63 (m, 1H). 
 
4.5.5. Isolation of the 1,1’-peroxydiisochroman intermediate  
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 
times) and left under inert atmosphere. Isochroman (1.0 mL) and C6H6 (2.0 mL) were added 
by syringe and the tube degassed and charged with O2 and kept under O2 (1 atm) with a 
balloon. The reaction mixture was stirred at 60 
°
C for 1 h or overnight. Then, C6H6 was 
removed in vacuo and product formation was determined by 
1
H NMR and isolated yield 
after purification by silica gel flash column chromatography (Hexane/AcOEt, 12/1 to 4/1). 
1,1’-Peroxyisochroman and 1,1’-oxydiisochroman were eluted and crystallized together in 
Et2O/Hexane. 
4.5.6. Conversion of 1,1’- peroxyisochroman to chromanone 
4.5.6.1. General procedure 
In a small Schlenck tube equipped with a magnetic stirring bar the 1.0:0.56 mixture of 1,1’-
peroxyisochroman and 1,1’-oxydiisochroman (250 mg) was dissolved in C6H6 (300 μL) 
under N2 atmosphere. An aliquot of the stock solution (100 μL) was added to a Schlenck 
tube containing [Fe(OTf2)L1] (1.2 mg, 8.94 x 10
-4
 mmol) and the Schlenck tube was 
degassed and charged with O2 (1 atm). The reaction mixture was stirred overnight at 45 
°
C 
and the reaction products monitored by 
1
H NMR and isolated yield. The same reaction was 
performed under air and under N2. The reaction under N2 was performed in a glove box with 
the NMR sample prepared inside the glove box. 
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4.5.6.2. Reaction in the presence of a radical trapping reagent or a radical initiator  
In a small Schlenck tube equipped with a magnetic stirring bar the 1.0:0.56 mixture of 1,1’-
peroxyisochroman and 1,1’-oxydiisochroman (250 mg) was dissolved in C6H6 (300 μL) 
under N2 atmosphere. An aliquot of this stock solution (100 μL) was added to a Schlenck 
tube containing [Fe(OTf2)L1] (1.0 mg, 7.45 x 10
-4
 mmol) and p-benzoquinone (3.5 mg, 
n(rad trap/cat) : 25/1) or benzoyl peroxide (0.25 mg, 1.03 x 10
-3
 mmol). The reaction 
mixture was degassed (3 times), left under N2 atmosphere and stirred overnight at 45 
°
C. The 
reaction products were monitored by 
1
H NMR and isolated yield.  
4.5.6.3. Reaction in the presence of an excess of isochroman under inert atmosphere 
In a small Schlenck tube equipped with a magnetic stirring bar the 1.0:0.56 mixture of 1,1’-
peroxyisochroman and 1,1’-oxydiisochroman (75 mg) was dissolved in isochroman (200 
μL) under N2 atmosphere. An aliquot of this stock solution (110 μL) was added to a 
Schlenck tube containing [Fe(OTf2)L1] (1.0 mg, 7.45 x 10
-4
 mmol) under N2 atmosphere. 
The reaction mixture was stirred overnight at 45 
°
C. The reaction products were monitored 
by 
1
H NMR and isolated yield. A second experiment was run by the same procedure in the 
absence of catalyst. 
4.5.7. Effect of the sulfonamide: Comparison between Fe(OTf)2PyBisulidine and 
Fe(OTf)2PyBidine in isochroman oxidation 
In a Radley’s tube equipped with a magnetic stir bar PyBidine ligand L9 (5.67 x 10-3 mmol, 
5.0 mg) and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, 
degassed and left under inert atmosphere (3 times). Isochroman (2.0 mL) was added by 
syringe and the reaction tube was degassed, charged with dioxygen gas (1 atm, 3 times) and 
keep under oxygen (1 atm) by using a balloon. The reaction mixture was heated to 60 
°
C and 
left overnight. The reaction was purified by silica gel column chromatography 
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(Hexane/EtOAc, gradient: 10/1 to 4/1) to afford the unreacted starting material and the 
reaction products. 
4.5.8. Selective formation of the peroxide intermediate 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 
times) and left under inert atmosphere. Phthalan (1.0 mL) and C6H6 (1.5 mL) were added by 
syringe and the tube degassed and charged with O2 and kept under O2 (1 atm) with a balloon. 
The reaction mixture was stirred at 42 
°
C overnight. Then, C6H6 was removed in vacuo and 
product formation was determined by 
1
H NMR and isolated yield after purification by silica 
gel flash column chromatography (Hexane/AcOEt, 12/1). 
4.5.9. Formation of hydroperoxides under high dilution 
The reactions were performed according to the procedure specified in section 4.5.6. using 
100 mg of the starting 1,1’-oxydiisochroman and 1,1’-peroxydiisochroman mixture in C6H6 
solution (4.5 M). 
4.5.10. Oxidation of THF to γ-butyrolactone: identifying the rate-limiting step 
4.5.10.1.General procedure for the isolation of the peroxide intermediate and a 
byproduct 
In a Radley’s tube equipped with a magnetic stirring bar, Fe(OTf)2 (2.0 mg, 5.67 x 10
-3
 
mmol) and L1 (5.2 mg, 5.65 x 10
-3
 mmol) were added. Freshly distilled THF (2.0 mL) was 
added to the sealed tube by syringe. Next, the tube was degassed and charged with O2 (1 
atm, 3 times) and kept under excess of O2 (1 atm) by using a balloon. The reaction mixture 
was heated to 60 
°
C for 24h and the products isolated by flash column chromatography 
(Hexane/AcOEt, 6/1 to 4/1 to 2/1). 
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Analytical data and characterisation of compounds 
2,2’-peroxybis(tetrahydrofuran) 
Colourless liquid, (96% purity). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
5.68 (dd, J = 6.1, 2.0 Hz, 2H), 3.91-3.88 (m, 4H), 2.03-1.77 (m, 8H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 108.0, 67.8, 29.9, 24.2. HRMS 
(EI) m/z calc’d C8H15O4 [M + H]
+
: 175.0965, found: 175.0962. 
 
3-(1,3-dioxan-2-yl)propyl formate 
Colourless liquid (aprox. 95% purity). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 8.05 (s, 1H), 4.55 (t, J = 6.0 Hz, 1H), 4.18 (dt, J = 6.5, 1.0 Hz, 
2H), 4.12-4.08 (m, 2H), 3.78 (t, J = 12 Hz, 2H), 2.08-2.05 (m, 1H), 
1.80-1.75 (m, 2H), 1.70-1.65 (m, 2H), 1.37-1.32 (m, 1H). 
13
C NMR 
(100 MHz, CDCl3): δ (ppm) = 161.5, 101.9, 67.2, 64.1, 31.7, 26.1, 23.4. IR (ATR) ν = 
2965, 2854, 1720, 1468, 1382, 1174, 1137, 1091, 991, 919, 858. HRMS (EI) m/z calc’d 
C8H15O4 [M + H]
+
: 175.0965, found: 175.0967.  Anal Calc’d for C8H14O4: C, 55.16, H, 
8.10; found: C, 54.99, H, 8.01. 
4.5.10.2. Conversion of the peroxide intermediate to γ-butyrolactone 
In a Schlenck tube equipped with a magnetic stirring bar, Fe(OTf)2 (1.0 mg, 2.85 x 10
-3
 
mmol) and L1 (2.6 mg, 2.85 x 10
-3
 mmol) were added. The tube was degassed (3 times) and 
placed under N2 atmosphere. Next, an isolated mixture of 2,2’-peroxybis(tetrahydrofuran) 
and other unidentified byproducts (150 μL) was added and the reaction mixture heated to 60 
°
C for 24h. Aliquots of the sample were extracted after 12 and 24 h of reaction and submitted 
to 
1
H NMR analysis.  
4.5.11. Identification and quantification of hydrogen gas in the aerobic oxidation of 
ethers 
4.5.11.1. General procedures for hydrogen identification 
A. Complete reaction: from phthalan to phthalide 
In a Radley’s tube equipped with a magnetic stirring bar and a new rubber septum, 
Fe(OTf)2 (0.8 mg, 2.3 x 10
-3
 mmol), L1 (2.0 mg, 2.3 x10
-3
 mmol) and phthalan (0.75 
mL) were added. The tube was sealed, degassed and charged with dioxygen gas (1 
atm, 3 times) and kept under excess of oxygen (1 atm) by using a balloon. The 
 
 
Chapter 4 
 
204 
 
reaction mixture was heated to 60 
°
C and stirred overnight. Next morning the 
reaction was stopped and cooled to r.t. (23°C). For the GC analysis, a gas syringe 
was degassed with pure N2 gas (5 times) and then a sample (300 μL volume) of the 
gas phase contained inside the sealed Radley’s tube was taken and injected in the 
GC.  
B. First step: from phthalan to 1,1’-peroxybis(1,3-dihydrobenzofuran) 
In a Radley’s tube equipped with a magnetic stirring bar and a new rubber septum, 
Fe(OTf)2 (2.0 mg, 5.65 x 10
-3
 mmol), L1 (5.2 mg, 5.67 x 10
-3
 mmol), phthalan (1.0 
mL) and benzene (1.5 mL) were added. The tube was sealed, degassed and charged 
with dioxygen gas (1 atm, 3 times) and kept under excess of oxygen (1 atm) by 
using a balloon. The reaction mixture was heated to 42 
°
C and stirred overnight. 
Next morning the reaction was stopped and cooled to r.t. (23 °C). For the GC 
analysis, a gas syringe was degassed with pure N2 gas (5 times) and then a sample 
(400 μL volume) of the gas phase contained inside the sealed Radley’s tube was 
taken and injected in the GC.   
C. Second step: from 1,1’-peroxybis(1,3-dihydrobenzofuran) to phthalide 
In a Radley’s tube equipped with a magnetic stirring bar and a new rubber septum, 
[Fe(OTf)2L1] (1.0 mg, 5.65 x 10
-3
 mmol) and 1,1’-peroxybis(1,3-
dihydrobenzofuran) (50 mg) and benzene (50 μL) were added. The tube was sealed, 
degassed and charged with dioxygen gas (1 atm, 3 times) and kept under excess of 
oxygen (1 atm) by using a balloon. The reaction mixture was heated to 60 
°
C and 
stirred overnight. Next morning the reaction was stopped and cooled to r.t. (23 °C). 
For the GC analysis, a gas syringe was degassed with pure N2 gas (5 times) and then 
a sample (400 μL volume) of the gas phase contained inside the sealed Radley’s 
tube was taken and injected into the GC. 
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D. Blank reaction for GC analysis 
 
A Radley’s tube equipped with a magnetic stirring bar and a new rubber septum was 
degassed and charged with dioxygen gas (1 atm, 3 times). A gas syringe was 
degassed with pure N2 gas (5 times) and then a sample (300 μL volume) of the gas 
phase contained inside the sealed Radley’s tube was taken and injected into the GC. 
4.5.11.2. Chromatograms collected in the hydrogen identification 
A. Complete reaction: from phthalan to phthalide 
 
 
Retention times: rt (H2): 0.873, rt (N2): 1.508, rt (O2): 2.362 
 
B. First step: from phthalan to 1,1’-peroxybis(1,3-dihydrobenzofuran) 
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Retention times: rt (H2): 0.667, rt (N2): 1.294, rt (O2): 2.267 
 
C. Second step: from 1,1’-peroxybis(1,3-dihydrobenzofuran) to phthalide 
 
 
Retention times: rt (H2): 0.777, rt (N2): 1.309, rt (O2): 1.985 
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D. Blank reaction 
 
 
 
Retention times: rt (N2): 1.412, rt (O2): 2.290. No H2 peak is observed. 
 
4.5.11.3. General procedures for hydrogen quantification 
4.5.11.3.1. General procedure for calibration  
A Radley’s tube (same used in 7.9) equipped with a magnetic stirring bar and a new rubber 
septum was sealed, degassed and charged with dioxygen gas (1 atm, 3 times) and kept under 
excess of oxygen (1 atm) by using a new balloon. A Schlenk tube was sealed, degassed and 
charged with hydrogen gas (1 atm, 3 times) and kept under excess of hydrogen (1 atm) by 
using a balloon. For the GC analyses, hydrogen gas (3.0 mL) was added into the Radley’s 
tube with a gas syringe previously degassed with pure N2. A sample (300 μL) of the gas 
phase from that Radley’s tube at r.t. (23°C) was taken with a previously degassed gas 
syringe and injected into the GC spectrometer. The same procedure was repeated for the 
complete calibration by doing subsequent hydrogen additions (3.0 ml each) on the same 
Radley’s tube. 
4.5.11.3.2.Calibration curve 
The following calibration curve was constructed from the data obtained by following the 
aforementioned calibration procedure. 
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4.5.11.3.3. Sample analysis: chromatogram and calculations 
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Retention times: rt (H2): 0.664, rt (N2): 1.300, rt (O2): 2.159 
Area: 42844, V (H2, 23 
°
C, 1 atm): 21.44 ml 
Calculated V (H2, 23 
°
C, 1 atm): 23.16 ml:  15% conversion of phthalan to phthalide and 1 
equivalent of H2 gas being released per equivalent of phthalide. 
MW: 120.15 g mol
-1, ρ: 1.098 g ml-1 for phthalan.  
Therefore the quantification of H2 by GC indicates that 1 equivalent of H2 is released in the 
complete reaction of phthalan to phthalide, which is consistent with H2 gas being released in 
the two reaction steps of phthalan oxidation. 
The calculation of the volume occupied by 1 mol of H2 at 23 
°
C was carried out according to 
Van der Waals equation shown below: 
 
 
Where: 
R: 8.3145 m
3
 Pa mol
-1
 K
-1
  T: 296.15 K  p: 101,325 Pa 
a (H2): 0.002476 m
6
 Pa mol
-2
  b (H2): 0.02661 10
-3
 m
3
 mol
-1
   
Hence, V (H2, 23 
°
C, 1 atm): 22.53 L mol
-1 
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4.5.12. Water quantification 
4.5.12.1. General procedure 
This experiment was attempted to show that no water is formed in the oxidation catalysed by 
Fe(OTf)2-L1. In a Radley’s tube equipped with a magnetic stirring bar and a new rubber 
septum, Fe(OTf)2 (2.0 mg, 5.65 x 10
-3
 mmol), L1 (5.2 mg, 5.67 x 10
-3
 mmol), phthalan (1.0 
mL) and C6H6 (1.5 mL) were added. The tube was sealed, degassed and charged with 
dioxygen gas (1 atm, 3 times) and kept under excess of oxygen (1 atm) by using a balloon. 
The reaction mixture was heated to 42 
°
C and stirred overnight. The reaction was cooled at 
r.t. and the solvent removed under reduced pressure. The crude reaction mixture was 
analyzed by 
1H NMR, showing formation of 1,1’-peroxybis(1,3-dihydrobenzofuran) without 
any phthalide formation. Distilled water (4 μL) was added and the mixture stirred for 10 min 
before 
1
H NMR submission. Subsequent water additions were done under the same 
procedure. The calibration shows that no water is formed in the oxidation of phthalan. 
4.5.12.2. Calibration curve 
The following calibration curve was constructed by following the aforementioned procedure 
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4.5.13. Isotope labelling experiments 
4.5.13.1. General procedures 
A. Reaction under 16O2 
In a Radley’s tube equipped with a magnetic stirring bar and a new rubber septum, 
Fe(OTf)2 (2.0 mg, 5.65 x 10
-3
 mmol), L1 (5.2 mg, 5.67 x 10
-3
 mmol), phthalan (1.0 
mL) and benzene (1.5 mL) were added. The tube was sealed, degassed and charged 
with 
16
O2 (1 atm, 3 times) and stirred under excess of 
16
O2 (1 atm) by using a 
balloon. The reaction mixture was heated to 60 
°
C overnight and the products 
isolated by flash column chromatography (Hexane/EtOAc, 12/1 to 8/1 to 4/1) and 
fully characterized. 
B. Reaction under 18O2 (98%) 
In a Radley’s tube equipped with a magnetic stirring bar and a new rubber septum, 
Fe(OTf)2 (2.0 mg, 5.65 x 10
-3
 mmol), L1 (5.2 mg, 5.67 x 10
-3
 mmol), phthalan (1.0 
mL) and benzene (1.5 mL) were added. The tube was sealed, degassed and charged 
with 
18
O2 (1 atm, 2 times) and kept under excess of 
18
O2 (1 atm) by using a balloon. 
The reaction mixture was heated up to 60 
0
C overnight and the products isolated by 
flash column chromatography (Hexane/EtOAc, 12/1 to 8/1 to 4/1) and fully 
characterized. 
C. Reaction under 16O2 and 
18
O2 (98%): 
In a Radley’s tube equipped with a magnetic stirring bar and a new rubber septum, 
Fe(OTf)2 (2.0 mg, 5.65 x 10
-3
 mmol), L1 (5.2 mg, 5.67 x 10
-3
 mmol), phthalan (1.0 
ml) and benzene (1.5 ml) were added. The tube was sealed, degassed (1 atm, 2 
times) and charged with a balloon containing similar amounts of 
16
O2 and 
18
O2 and 
kept under excess of the same gas mixture by using a balloon. The reaction mixture 
was heated to 60 
°
C overnight and the products isolated by flash column 
chromatography (Hexane/EtOAc, 12/1 to 8/1 to 4/1) and fully characterized. 
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4.5.13.2. Characterisation and spectra of the peroxide products 
A. Synthesis of 1,1-peroxydiisochroman under 
16
O2 atmosphere 
 
1,1-Peroxydiisochroman: White solid, 9% isolated yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.44-7.23 (m, 8H), 6.74 (d, J = 2.0 Hz, 2H), 5.30 (d, J = 12.8 Hz, 2H), 5.09 (d, J = 
12.8 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 141.4, 134.3, 130.3, 128.0, 124.2, 
121.4, 110.8, 73.1. IR (ATR) ν = 2865, 1752, 1461, 1365, 1340, 1315, 1257, 1211, 1041, 
958, 923, 754. IR ν (neat) = 2937, 2919, 2865, 1752, 1461, 1365, 1340, 1315, 1257, 1211, 
1041, 958, 923, 754. Anal Calc’d for C16H14O4 : C, 71.10, H, 5.22, found: C, 70.85, H, 5.06. 
HRMS (EI) m/z calc’d C16H14O
16
4K [M+K]
+ 
: 309.0529, found: 309.0529. HRMS(EI) m/z 
calc’d C16H14O
16
4Na[M+Na]
+
: 293.0790, found: 293.0783. 
HRMS spectra: 
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B. Synthesis of 1,1-peroxydiisochroman under 
18
O2 atmosphere 
 
 
1,1-Peroxydiisochroman: White solid, 9% isolated yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.43-7.23 (m, 8H), 6.74 (d, J = 2.0 Hz, 2H), 5.31 (d, J = 12.8 Hz, 2H), 5.09 (d, J = 
12.8 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 141.4, 134.3, 130.3, 128.0, 124.2, 
121.4, 110.8, 73.1. IR (ATR) ν = 1461, 1367, 1340, 1315, 1253, 1039, 956, 919, 752, 715. 
IR ν (neat) =2937, 2919, 2865, 1461, 1367, 1340, 1315, 1253, 1039, 956, 919, 752, 715. 
Anal Calc’d for C16H14O
16
2O
18
2: C, 70.07, H, 5.14, found: C, 70.29, H, 5.09. 
HRMS (EI) m/z calc’d C16H14O
16
2O
18
2K [M+K]
+ 
: 313.0614, found: 313.0607. HRMS (EI) 
m/z calc’d C16H14O
16
2O
18
2Na [M+Na]
+ 
: 297.0875, found: 297.0868. 
HRMS spectra: 
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C. Synthesis of 1,1-peroxydiisochroman under 
16
O2 and 
18
O2 atmosphere. 
 
C1. MS analysis of 1,1-peroxydiisochroman, made under 
16
O2  and 
18
O2 : White solid, 
9% isolated yield. 
 
HRMS (EI) m/z calc’d C16H14O
16
4K [M+K]
+
 : 309.0524, found: 309.0539.HRMS (EI) m/z 
calc’d C16H14O
16
2O
18
2K [M+K]
+
: 313.0614, found: 313.0611 
HRMS spectra: 
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Theoretical fragmentations for the three peroxide species as [M + K]
+
 ions 
 
 
 
D. Control experiments: MS analysis of 1,1-peroxydiisochroman, mixing similar 
amounts of 
16
O2 peroxide (A) and 
18
O2 peroxide (B) 
 
HRMS (EI) m/z calc’d C16H14O
16
4K [M+K]
+
: 309.0524, found: 309.0526. HRMS (EI) m/z 
calc’d C16H14O
16
2O
18
2K [M+K]
+
: 313.0614, found: 313.0605. 
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4.5.14. H/D exchange experiments 
A. Reaction under N2 atmosphere 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed and left 
under inert atmosphere (3 times). Isochroman (2.0 mL) was added by syringe and the 
reaction mixture was stirred under N2 atmosphere overnight at 60 
°
C. Product formation was 
determined by 
1
H NMR conversion and isolated yield after silica gel flash column 
chromatography purification. The same procedure was repeated in the presence of D2O (300 
μL). 
B. Reaction under O2 atmosphere 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed and left 
Chapter 4 
 
217 
 
under inert atmosphere (3 times). Isochroman (2.0 mL) was added by syringe and the 
reaction mixture was stirred under N2 atmosphere for 30 min at 35 
°
C. Next, D2O (300 μL) 
was added and the tube charged with O2 gas and kept under O2 (1 atm) by using a balloon. 
The reaction mixture was then heated to 60 
°
C and allowed to react overnight. Product 
formation was determined by 
1
H NMR conversion and isolated yield after silica gel flash 
column chromatography purification. 
B. Conversion of 1,1’-peroxybis(1,3-dihydroisobenzofuran) to phthalide 
In a Young’s tube equipped with a GC-MS connector and a magnetic stir bar 
[Fe(OTf)2L1(THF)] (7.45 x 10
-4
 mmol, 1.0 mg), C6H6 (100 μL) and peroxide 13 (80 mg) 
were added. The tube was sealed and the reaction mixture was stirred overnight at 45 
°
C. 
The Young’s tube was connected to the GC-MS equipment and cooled to -78 °C to solidify 
the liquid phase. Gases released during the reaction were monitored in the MS spectrum by 
slowly opening the detector valve. The same procedure was repeated in the presence of D2O 
(30 μL). Although H2 gas formation was clearly observed in both cases, HD or D2 formation 
was not detected in the presence of D2O. 
4.5.15. Experiments with 
2
H-labelled peroxides 
Synthesis of Phthalan-d4 
Phthalan-d4 was synthesized from the deuterated-diol as reported in the literature.
28 
 
Deuterated 1,1’-peroxybis(1,3-dihydroisobenzofuran) was synthesized from phthalan-d4 
according to the procedure described in section 7.13. 
1,1’-Peroxybis(1,3-dihydroisobenzofuran)-d6: White solid, 7% isol. yield. 1H NMR (400 
MHz, CDCl3): δ (ppm) = 7.43-7.24 (m, 8H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 139.0, 
132.2, 130.9, 130.1, 127.2, 120.9 (d, 
3
JC-D = 2.4 Hz). HRMS (EI) m/z calc’d C16H9D6O4 
[M+H]
+
: 277.1342, found: 277.1345. 
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Procedure for the GC-MS analysis 
In a Young’s tube equipped with a GC-MS connector and a magnetic stir bar 
[Fe(OTf)2L1(THF)] (7.45 x 10
-4
 mmol, 1.0 mg), C6H6 (60 μL) and peroxide 13 (25 mg) and 
14 (35 mg) were added. The tube was sealed and the reaction mixture was stirred overnight 
at 45 
°
C. The Young’s tube was connected to the GC-MS equipment and cooled to -78 °C to 
solidify the liquid phase. Gases released during the reaction were monitored in the MS 
spectrum by slowly opening the detector valve. The same procedure was repeated for each 
peroxide. 
Synthesis of Phthalan-d3 
Phthalan-d3 was synthesized from the deuterated-diol as reported in the literature.
29
 
 
Pthalan-d3: Pale yellow liquid. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.26-7.23 (m, 4H, 
overlapped), 5.10 (s, 1H). HRMS (EI) m/z calc’d C8H6D3O [M+H]
+
: 124.0836, found: 
124.0832. 
Procedure for the GC-MS analysis 
In a Young’s tube equipped with a GC-MS connector and a magnetic stir bar 
[Fe(OTf)2L1(THF)] (7.45 x 10
-4
 mmol, 1.0 mg), C6H6 (15 μL) and phthalan-d1 (40  μL) 
were added. The tube was charged with O2 (1 atm) and sealed and the reaction mixture was 
stirred 8h at 60 
°
C. The Young’s tube was connected to the GC-MS equipment and cooled to 
-78 
°
C to solidify the liquid phase. Gases released during the reaction were monitored in the 
MS spectrum by slowly opening the detector valve.  
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Gas evolution monitored from the catalytic reactions (Pressure/mbar vs mass) 
 
Sample 10: D2 evolution from the deuterated 1,1’-peroxybis(1,3-dihydroisobenzofuran)  
Samples 9, 8, 7: H2 and D2 evolution from the mixture of 1,1’-peroxybis(1,3-
dihydroisobenzofuran) and deuterated 1,1’-peroxybis(1,3-dihydroisobenzofuran)  
Sample 6: H2 evolution from 1,1’-peroxybis(1,3-dihydroisobenzofuran)  
Sample 4: H2, HD and D2 evolution from the oxidation of phthalan-d3 to phthalides 
 
4.5.16. Crystallisation of 1,1’-peroxydiisochroman and 1,1’-oxydiisochroman 
In a test tube a mixture of 1,1’-peroxydiisochroman and 1,1’-oxydiisochroman (200 mg) was 
dissolved in Et2O (0.5 ml). Hexane (0.75 ml) was slowly added and the closed tube was left 
at ambient temperature until well shaped transparent crystals formed. 
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4.5.17.Crystallographic data of compounds 
Cis 1,1’-peroxydiisochroman 
 
CCDC 945602 contains the supplementary crystallographic data for this compound. This 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
Crystal Data for C36H36O8 (M =596.65): monoclinic, space group C2/c (no. 15), a = 
14.926(3) Å, b = 12.592(3) Å, c = 7.6268(16) Å, β = 90.730(6)°, V = 1433.3(5) Å3, Z = 2, 
T = 100.0 K, μ(MoKα) = 0.097 mm-1, Dcalc = 1.383 g/mm3, 5377 reflections measured 
(4.24 ≤ 2Θ ≤ 52.84), 1473 unique (Rint = 0.0271) which were used in all calculations. The 
final R1 was 0.0373 (>2sigma(I)) and wR2 was 0.0950 (all data). 
Table 1 Crystal data and structure refinement for CCDC 945602 
Identification code  CCDC 945602 
Empirical formula  C36H36O8  
Formula weight  596.65  
Temperature/K  100.0  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  14.926(3)  
b/Å  12.592(3)  
c/Å  7.6268(16)  
α/°  90.00  
β/°  90.730(6)  
γ/°  90.00  
Volume/Å
3
  1433.3(5)  
Z  2  
ρcalcmg/mm
3
  1.383  
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m/mm
-1
  0.097  
F(000)  632.0  
Crystal size/mm
3
  0.5 × 0.12 × 0.1  
2Θ range for data collection  4.24 to 52.84°  
Index ranges  -18 ≤ h ≤ 18, -15 ≤ k ≤ 15, -8 ≤ l ≤ 9  
Reflections collected  5377  
Independent reflections  1473[R(int) = 0.0271]  
Data/restraints/parameters  1473/0/136  
Goodness-of-fit on F
2
  1.033  
Final R indexes [I>=2σ (I)]  R1 = 0.0373, wR2 = 0.0890  
Final R indexes [all data]  R1 = 0.0446, wR2 = 0.0950  
Largest diff. peak/hole / e Å
-3
  0.21/-0.26  
 
Trans 1,1’-peroxydiisochroman 
 
CCDC 945603 contains the supplementary crystallographic data for this compound. This 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
Crystal Data for C36H36O8 (M =596.65): monoclinic, space group P21/c (no. 14), a = 
7.2839(14) Å, b = 7.6923(15) Å, c = 26.517(5) Å, β = 90.255(3)°, V = 1485.7(5) Å3, Z = 2, 
T = 100.0 K, μ(MoKα) = 0.094 mm-1, Dcalc = 1.334 g/mm3, 18112 reflections measured 
(5.52 ≤ 2Θ ≤ 52.96), 3058 unique (Rint = 0.0370) which were used in all calculations. The 
final R1 was 0.0458 (>2sigma(I)) and wR2 was 0.1153 (all data). 
Table 1 Crystal data and structure refinement for CCDC 945603 
Identification code  CCDC 945603 
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Empirical formula  C36H36O8  
Formula weight  596.65  
Temperature/K  100.0  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  7.2839(14)  
b/Å  7.6923(15)  
c/Å  26.517(5)  
α/°  90.00  
β/°  90.255(3)  
γ/°  90.00  
Volume/Å
3
  1485.7(5)  
Z  2  
ρcalcmg/mm
3
  1.334  
m/mm
-1
  0.094  
F(000)  632.0  
Crystal size/mm
3
  0.5 × 0.49 × 0.1  
2Θ range for data collection  5.52 to 52.96°  
Index ranges  -9 ≤ h ≤ 9, -9 ≤ k ≤ 9, -33 ≤ l ≤ 33  
Reflections collected  18112  
Independent reflections  3058[R(int) = 0.0370]  
Data/restraints/parameters  3058/0/199  
Goodness-of-fit on F
2
  1.022  
Final R indexes [I>=2σ (I)]  R1 = 0.0458, wR2 = 0.1082  
Final R indexes [all data]  R1 = 0.0573, wR2 = 0.1153  
Largest diff. peak/hole / e Å
-3
  0.32/-0.29  
 
1,1’-oxydiisochroman  
 
CCDC 945604 contains the supplementary crystallographic data for this compound. This 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
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www.ccdc.cam.ac.uk/data_request/cif. The X-ray structure of this compound (with a 
different space group) was reported before.
20 
Crystal Data for C18H18O3 (M =282.32): monoclinic, space group I2/a (no. 15), a = 
15.852(3) Å, b = 4.2770(8) Å, c = 21.043(4) Å, β = 103.334(5)°, V = 1388.2(5) Å3, Z = 4, 
T = 100.0 K, μ(MoKα) = 0.091 mm-1, Dcalc = 1.351 g/mm3, 7386 reflections measured 
(3.98 ≤ 2Θ ≤ 52.68), 1421 unique (Rint = 0.0342) which were used in all calculations. The 
final R1 was 0.0359 (>2sigma(I)) and wR2 was 0.0937 (all data). 
Table 1 Crystal data and structure refinement for CCDC 945604 
Identification code  CCDC 945604 
Empirical formula  C18H18O3  
Formula weight  282.32  
Temperature/K  100.0  
Crystal system  monoclinic  
Space group  I2/a  
a/Å  15.852(3)  
b/Å  4.2770(8)  
c/Å  21.043(4)  
α/°  90.00  
β/°  103.334(5)  
γ/°  90.00  
Volume/Å
3
  1388.2(5)  
Z  4  
ρcalcmg/mm
3
  1.351  
m/mm
-1
  0.091  
F(000)  600.0  
Crystal size/mm
3
  0.44 × 0.4 × 0.12  
2Θ range for data collection  3.98 to 52.68°  
Index ranges  -19 ≤ h ≤ 19, -5 ≤ k ≤ 5, -26 ≤ l ≤ 26  
Reflections collected  7386  
Independent reflections  1421[R(int) = 0.0342]  
Data/restraints/parameters  1421/0/132  
Goodness-of-fit on F
2
  1.059  
Final R indexes [I>=2σ (I)]  R1 = 0.0359, wR2 = 0.0911  
Final R indexes [all data]  R1 = 0.0389, wR2 = 0.0937  
Largest diff. peak/hole / e Å
-3
  0.18/-0.30 
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Fe(OTf)2-PYBISULIDINE CATALYSED 
SELECTIVE AEROBIC CLEAVAGE OF 
ALIPHATIC C-O AND C-C BONDS  
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5.1. Introduction 
5.1.1. Selective cleavage of aliphatic C-C bonds 
The cleavage and subsequent functionalisation of C-C bonds with transition metals is an 
extensive area of research due to the natural inertness of these bonds and the attractiveness 
of developing more efficient methodologies for the synthesis of complex molecular 
skeletons.
1
 The development of catalytic methods for cleaving strained C-C bonds has been 
particularly explored and efficient methodologies that even allow the construction of 
stereocentres have been reported 
2
 (Scheme 1 a). The cleavage of unstrained C-C bonds is 
more challenging as a strong thermodynamic driving force is needed to break the stable C-C 
bond.
1a 
  However, other alternatives to selectively cleave unstrained C-C bonds such as 
metal chelation
3
 (Scheme 1b) or the use of carbonyl groups
4
 to direct the cleavage to the 
weaker  α-C-C bond (Scheme 1c) have been reported. 
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Scheme 1. Examples of transition metal-mediated selective C-C cleavages 
5.1.2. Iron-catalysed selective cleavage of aliphatic C-C bonds 
In 2004 the group of Nakazawa reported the activation of the C-C bond in acetonitrile by the 
iron complex 1 bearing a trimethylsilyl ligand.
5
 On the basis of DFT calculations, the C-C 
cleavage is proposed to occur via the insertion of the CN bond of acetonitrile into the Fe-Si 
bond followed by the migration of the methyl group to the iron centre (Scheme 2). The 
presence of the silyl ligand was found essential to lower the energy barriers of the CN 
insertion and methyl migration. 
More recent investigations from Jiao and co-workers demonstrated the use of FeCl2 for 
promoting the conversion of hydrocarbons to amides via selective C-H and C-C cleavage.
6
 
The reactions proceeded with good yields but required more than stoichiometric amounts of 
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DDQ as an oxidant to activate the benzylic C-H bond and an excess of azide as a nitrogen 
source. When cyclic substrates such as 9 were investigated, ring expansions with 
concomitant C-C bond cleavage were successfully achieved (Scheme 3). 
 
Scheme 2. Iron-based activation of the C-C bond of acetonitrile 
 
Scheme 3. Iron promoted C-H and C-C cleavage of hydrocarbons 
A combined C-C cleavage and C-H activation strategy has been reported by the group of 
Wang to convert styrene epoxides and anilines into 3-arylquinolines using FeCl3 as a 
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promoter
7 
(Scheme 4).
 
A broad substrate scope was demonstrated affording quinolines with 
good to moderate yields, although a high iron loading (25 mol%) and high temperatures 
were used. However, mechanistic investigations for this transformation have not been 
reported so far. 
 
Scheme 4. Iron-promoted tandem reaction of styrene epoxides and anilines to afford 
quinolines 
The FeCl3 catalysed cleavage of an aliphatic C-C bond in 1,3-dicarbonyl compounds 
combined with a subsequent C-N bond formation with anilines and sulfonamides to afford 
amines has been investigated by Li and co-workers.
8
 The reactions proceed at 100 °C, with 
the 1,3-dicarbonyl moiety 15 acting as a leaving group to thermodynamically favour the C-C 
cleavage (Scheme 5). 
 
Scheme 5. FeCl3-catalysed C-C cleavage and C-N bond formation  
5.1.3. Iron-catalysed selective cleavage of aliphatic C-O bonds  
When investigating the (bis)iminopyridine iron-catalysed hydrogenation of ester-containing 
olefins, the group of Chirik identified that the iron-promoted C-O cleavage of the ester 
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functionality was the main factor in deactivating the catalyst.
9
 For ethyl vinyl ether, clean 
stoichiometric formation of the iron-ethoxyde complex 18 was detected with loss of the 
vinyl fragment (Scheme 6). 
 
Scheme 6. Iron-promoted C-O cleavage of vinyl ether 
More recently, the group of Fan demonstrated the cross coupling of benzylic and allylic 
ethers with allyl silanes via FeCl3 catalysed selective C-O bond cleavage.
10
 An ample variety 
of benzyl and allyl ethers were transformed into allylic hydrocarbons with good yields and 
mild conditions (Scheme 7). However, the reaction can only be applied to secondary benzyl 
ethers, and a high catalyst loading (10 mol%) was needed to achieve good yields. No 
mechanistic investigations have been reported.  
 
Scheme 7. Iron-catalysed C-O cleavage of benzyl ethers 
The use of FeCl2 as catalyst for the selective C-O cleavage of allyl benzyl ethers to afford 
phenols in the presence of ethyl magnesium chloride has been recently reported.
11
 The 
reactions proceeded with good yields under mild conditions in the presence of several 
functional groups with the allyl fragment being degraded to volatile hydrocarbons; however, 
stoichiometric amounts of the ethylmagnesium chloride were required (Scheme 8). 
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Scheme 8. Iron-catalysed cleavage of allylic C-O bonds 
5.2. Aims of the chapter 
Natural metalloenzymes such as dioxygenases are capable of selectively cleaving C-C bonds 
of organic substrates with incorporation of two oxygen atoms into the final product
12
. High 
complexity and/or significant structural modifications are introduced in organic substrates 
by such elegant enzymatic cleavages. Thus, such reactions often take place in bacteria or 
metabolism and, in contrast with transition metal mediated C-C cleavages, they occur under 
very mild conditions. Even though few iron complexes capable of mimicking some of these 
cleavages have been developed, they are often seen as tools to investigate and understand 
enzymatic processes. Their application as potential catalysts in chemical processes is mostly 
limited to bioremediation processes or biomass degradation. 
Our efforts to highlight the potential application of selective iron-catalysed aerobic cleavage 
of C-O bonds and unstrained aliphatic C-C bonds in general organic syntheses are presented 
in this chapter, with the main goals being: 
1. To provide alternative synthetic pathways for synthesising complex oxygenated 
compounds that cannot be obtained by iron-catalysed selective oxidation methods. 
2. To show that classical synthetic methodologies can be replaced by greener and 
economical selective aerobic C-C and C-O cleavages. 
3. To develop novel synthetic methodologies in the area of selective C-C and C-O 
cleavage. 
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5.3. Results and discussion 
5.3.1. Selective cleavage of Csp
3
-O bonds 
5.3.1.1. Discovery and scope of the Fe(OTf)2L1 catalysed aerobic cleavage of Csp
3
-O 
bonds 
Chen and White demonstrated that the Fe(PDP) complex can oxidise unactivated CH bonds 
in non functionalised compounds. The catalyst preferentially oxidises tertiary CH bonds to 
alcohols; however, secondary electron rich CH bonds could be oxidised to their keto form in 
compounds containing sterically hindered, tertiary CH bonds.
13
 On the contrary, Fe(OTf)2-
PyBisulidine complexes were found to selectively oxidise secondary CH bonds, even in 
substrates containing tertiary CH bonds in benzylic position or in α-position to the ether 
functionality (Chapter 3). As this methylene oxidation involves the initial formation of a 
peroxybisether intermediate followed by its dehydrogenative cleavage (Chapter 4), we next 
wondered whether the Fe(OTf)2-PyBisulidine  promoted cleavage of peroxide 27 would lead 
to the formation of the enantioenriched hemiacetal product 28 if the 1-substituted 
isochroman 26 was used as substrate (Scheme 9). 
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Scheme 9. Hypothesised reactivity of 1-substituted isochroman substrates under Fe(OTf)2L1 
catalysed aerobic conditions 
In order to investigate whether the Fe(OTf)2-PyBisulidine complexes could catalyse the 
oxidation of tertiary CH bonds to alcohols, the 1-arylisochroman 29 was subjected to the 
Fe(OTf)2L1 catalysed aerobic oxidation reaction (Scheme 10). Unexpectedly, reaction of 29 
afforded the aryl ketone 30 in a 15% yield as the sole reaction product, with the starting 
material being easily recovered and no formation of the expected hemiacetal.  
 
Scheme 10. Fe(OTf)2L1 catalysed aerobic Csp
3
-O bond cleavage of 29  
This result indicates that the Fe(OTf)2L1 complex is capable of selectively cleaving the 
Csp
3
-O bond in α-position to the ether functionality under very mild reaction conditions and 
in a catalytic fashion. Like dioxygenases capable of cleaving aliphatic C-C bonds, the 
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Fe(OTf2)L1 promotes a significant structural modification of an organic substrate with the 
incorporation of an oxygen-based functionality into the final product.  
From a synthetic perspective, this transformation allows the formation of bulky and 
functionalised, open chain aromatic ketones whose preparation via iron-catalysed selective 
oxidation methods has been challenging. For instance, Chen and White’s Fe(PDP) complex 
was found to degradate compounds bearing aromatic rings,
13b
 whereas the Fe(OTf)2L1 
complex was not found capable of directly oxidising non-etheral aromatics (Scheme 11). In 
addition, a facile one-step synthesis of highly functionalised hydrocarbons can be 
problematic without introducing protection and deprotection steps (such as Friedel-Crafts 
reactions); however, 1-arylisochromans can be facilely synthesised from commercially 
available phenethyl alcohols and benzaldehydes in a simple one-step, Lewis acid-catalysed 
reaction.  
As the Fe(OTf)2L1 catalysed aerobic cleavage of 1-arylisochromans appears to be a good 
alternative for synthesising valuable 2-(hydroxyethyl)benzophenone derivatives, the scope 
of this reaction was further investigated (Scheme 11). The catalyst was found capable of 
selectively cleaving a variety of 1-arylisochromans containing either electron rich or electron 
deficient aryl groups with moderate yields (entries 1,2). Other heterocyclic groups (entries 3-
5) were also tolerated, providing an ample and versatile substrate scope for this 
transformation. 
Even though aryl ketones can be synthesised by different methods, methodologies for 
obtaining 2-(hydroxyethyl)benzophenone derivatives are scarce and often involve SnCl4 
mediated Friedel-Crafts reactions. However, this type of compounds are key intermediates 
for the synthesis of benzodiazepine-4-ones,
14
 which are potent antagonist for AMPA 
receptors, and often used as photochemically removable protecting groups,
15
 which can be 
used in the fabrication of DNA microarrays. Therefore, the Fe(OTf)2L1 catalysed aerobic 
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cleavage of 1-arylisochromans appears to be a efficient and selective method for obtaining 
this class of compounds. 
 
Scheme 11. Selective aerobic cleavage of 1-arylisochromans as an alternative to the iron-
catalysed oxidation of benzyl ethers 
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5.3.1.2. Mechanistic investigations of the Fe(OTf)2L1 catalysed aerobic cleavage of 
Csp
3
-O bonds 
In order to determine whether radical species are generated during the catalytic reaction, the 
1-cyclopropyl substituted compound 41 was subjected to the Fe(OTf)2L1 catalysed aerobic 
cleavage. Compound 42 was generated in 56% yield as the sole reaction product with no 
decomposition of the starting material being observed (Scheme 12). This result indicates that 
the catalytic reaction does not involve the formation of C-based radical species. 
 
Scheme 12. The aerobic cleavage of a radical trap showing no side reactivity 
On the basis of these results and the mechanistic observations presented in Chapter 4, the 
initial dehydrogenative formation of a peroxybisether species was postulated. Subsequent 
oxidative addition of the peroxide to the iron centre, followed by the cleavage of the Csp
3
-O 
bond with the concomitant formation of the conjugated ketone as the thermodynamic driving 
force of the process seems plausible (Scheme 13).  In agreement with this hypothesis, no 
lactol formation was manifested during the aerobic cleavages even in conditions of limiting 
oxidant or shorter reaction times. Attempts to identify and isolate the hypothesised peroxide 
intermediate and isotopic labelling experiments with a O2/D2 gas mixture and with 
deuterated substrates are in current progress to shed some light into this reaction mechanism. 
Such mechanistic experiments are very relevant for ascertaining whether the Fe(OTf)2L1 
catalyst is actually activating both O2 and H2 gases during the reaction. To the best of our 
knowledge, there are no examples in the literature of an iron catalyst capable of activating 
both O2 and H2 during the same catalytic process. 
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Scheme 13. Proposed pathway for the Fe(OTf)2L1 catalysed selective Csp
3
- O cleavage of   
1-arylisochromans 
5.3.2. Selective cleavage of Csp
3
-Csp
3
 bonds 
5.3.2.1. Conversion of isochromans into isochromanones via selective aerobic cleavage 
of exocyclic Csp
3
-Csp
3
 bonds 
In an attempt to expand the aerobic Csp
3
-O cleavage to the synthesis of aliphatic ketones, 1-
alkyl substituted isochromans were next subjected to the Fe(OTf)2L1 catalysed aerobic 
reaction (Scheme 14). Surprisingly, isochromanone 44 was generated in moderate yields 
from isochromans 43 and 45 with no formation of the corresponding aliphatic ketones being 
detected by 
1
H NMR (entries 1,2). In fact, isochromanone 47 was generated as the reaction 
product from a variety of isochromans bearing different aliphatic substituents (entries 3-6). 
Therefore, the Fe(OTf2)L1 complex is also capable of selectively catalysing the aerobic 
cleavage of the unstrained exocyclic Csp
3
-Csp
3
 bonds when 1-alkylsubstituted isochromans 
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are used as substrates and under surprisingly mild conditions.  This preferential cleavage of 
the exocyclic Csp
3
-Csp
3
 bond in 1-alkyl isochromans allows the formation of a conjugated 
cyclic benzoate which can act as the thermodynamic driving force of the process, and thus it 
can be seen as the main factor in defining the selectivity of this cleavage. 
From a synthetic perspective, the selective cleavage of unstrained Csp
3
-Csp
3
 bonds under 
mild conditions can be of upmost interest. As an example of the potential of such type of 
reactions, electron rich, highly functionalised isochromans 51 and 53 with a molecular 
skeleton analogous to those found in isochromans isolated from softwood lignings were 
subjected to the Fe(OTf)2L1 catalysed aerobic cleavage. These molecules are particularly 
challenging because the cleavage of the exocyclic C2-C2’ bond or the endocyclic C3-C4 
bond would result in the formation of a conjugated benzoate that could potentially act as the 
thermodynamic force of the process. However, only the selective C2-C2’ bond cleavage 
would allow the direct synthesis of biologically active 3-aryl-3,4-dihydroisocoumarines, 
which have shown a variety of pharmacological activities including cytotoxic activity 
against human gastric cancer cell line and human nasopharyngeal carcinoma cell lines,
16
 
antifungal,
17
 antiallergic
18
 and differenciation-inducing
19
 activities. Delightfully, the 
Fe(OTf)2L1 complex afforded exclusively the desired dihydroisocoumarine products 52 and 
54 with moderate yields, excellent selectivity, and excellent mass balance and functional 
group tolerance (entries 7,8). Therefore, the Fe(OTf)2L1 catalysed aerobic cleavage of 
unstrained Csp
3
-Csp
3
 bonds can be potentially applied to the conversion of naturally 
occuring isochromans into biollogically important 3-aryl-3,4-dihydroisocoumarines. 
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Scheme 14. Selective aerobic cleavage of Csp
3
-Csp
3
 bonds in isochroman type substrates 
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5.3.2.2. Mechanistic investigations of the selective exocyclic Csp
3
-Csp
3
 cleavage  
5.3.2.2.1. Merging selective oxidation with selective alkyl coupling 
When investigating the substrate scope of the Fe(OTf)2L1 catalysed aerobic cleavage of 1-
alkylisochromans, we wondered whether the alkyl fragment was also being oxidised during 
the catalytic reaction. To our surprise, linear 1-alkylisochromans 46 and 48 were cleanly 
oxidised to isochromanone 47 and no other reaction products were isolated during the 
purification. Similarly, the oxidation of highly functionalised isochromans 51 and 53 
afforded the dihydroisocoumarine products exclusively. However, when 1-cyclohexyl 
substituted isochromanones 43 and 49 were subjected to the aerobic reaction, the alkyl 
coupling product 1,1’-bi(cyclohexane) was also isolated in 24% and 31% yields, 
respectively (Scheme 15). 
 
Scheme 15. Formation of the alkyl coupling product 55 from 1-cyclohexylisochromans 
These results indicate that the iron catalyst is capable of undergoing both the selective 
oxidation of the isochroman substrate and the selective alkyl coupling during the catalytic 
process. These results align with the oxidations of linear 1-alkylisochromans being so clean, 
as the corresponding alkyl coupling products which would generate from them are very 
volatile species. In line with these results, the Fe(OTf)3L1 complex has also been found 
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capable of generating volatile hydrocarbon products during the aerobic cleavage of olefinic 
substrates (chapter 6). Additional GC analyses for confirming the structure of the alkyl 
coupling products generated in those reactions are in current progress.  
In order to investigate whether the cleavage of the Csp
3
-Csp
3
 bonds occurs after or before 
the oxygenation step, the 1,1-dimethyl substituted isochroman 56 was subjected to the 
Fe(OTf)2L1 catalysed  aerobic cleavage (Scheme 16). As no reaction was observed on the 
1H NMR spectrum of the crude reaction, the oxidation of the CH bond in α-position to the 
ether functionality should take place prior the Csp
3
-Csp
3
 cleavage. 
 
Scheme 16. Reaction indicating that the oxidation of the CH bond is prior to the C-C 
cleavage 
5.3.2.2.2. Postulated catalytic cycle 
On the basis of these results, the mechanism for the Fe(OTf)2L1 catalysed aerobic oxidation 
of the 1-alkylisochromans could initially involve the coordination of two ethereal molecules 
to the iron centre (Chapter 10). Exposure to O2 atmosphere would again allow the formation 
of a Fe
III
 superoxo species from which a peroxide intermediate can be generated with 
concomitant formation of H2 gas (Scheme 17). Subsequent cleavage of the peroxide 
intermediate by oxidative addition of the peroxide O-O bond to the iron centre would result 
in the formation of a Fe
IV
 alkoxo compound (Chapter 10). Migration of the alkyl fragment to 
the iron centre either by a concerted radical process or by the less common β-alkyl 
elimination
20
 would result in the formation of the isochromanone product and a Fe
IV
 dialkyl 
species. Reductive elimination from the Fe
IV
 dialkyl intermediate would generate the 
observed 1,1’-bi(alkyl) byproducts.  
Chapter 5 
 
244 
 
 
 
Scheme 17. Proposed reaction pathway for the Fe(OTf)2L1 catalysed aerobic cleavage of 
Csp
3
-Csp
3
 bonds in 1-alkylisochromans 
Attempts to isolate and characterise the hypothesised peroxide intermediate are in current 
progress for gaining more experimental evidence to support the proposed mechanism. Such 
mechanistic studies are very relevant as the selective alkane-alkane coupling mediated by 
homogeneous catalysts is very rare.
21
 However, the development of catalyst capable of 
performing a selective alkyl coupling is highly desirable due to the importance of such 
reaction for producing higher hydrocarbons in an industrial scale.
22
 In addition, there are no 
reports in the literature of any iron catalysts capable of promoting the selective cleavage of 
unstrained Csp
3
-Csp
3
 bonds by combining a selective CH oxidation and a selective alkyl 
coupling under mild conditions. 
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5.3.2.2.3. Overriding alkyl coupling: oxidation of the alkyl fragment 
When 1-alkylisochromans incorporating a phenethyl group were subjected to the 
Fe(OTf)2L1 catalysed  aerobic cleavage, different oxygenated products were generated; 
aldehydes 58 and 59 were obtained in a 1.6 : 1.0 ratio from the cleavage of isochroman 57, 
whereas acetophenone 61 was exclusively formed during the aerobic cleavage of 
isochroman 60. These results indicate that modifications in the nature of the alkyl fragment 
can induce different reaction pathways and thus, the alkyl coupling can be overrode by 
introducing weaker CH bonds which are susceptible to be easily oxidised. In addition, the 
oxygenation of the alkyl fragments in the phenethyl derived isochromans suggest that an 
intramolecular Csp
3
-Csp
3
 cleavage may be taking place instead of an intermolecular reaction 
involving two ethereal molecules.  
 
Scheme 18. Different oxidation products are obtained depending on the nature of the alkyl 
group 
From a mechanistic perspective, the cleavage of isochroman 56 to afford the aldehyde 
byproduct 57 can be seen as the attack of the superoxo radical to the methylene in β-
position, from which a dioxetane species and a Fe
IV
- dihydride intermediate result (Scheme 
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19). The subsequent thermal or iron-mediated cleavage of the dioxetane (chapter 12) would 
furnish the detected isochromanone and aldehyde 58. 
 
 
Scheme 19. Proposed reaction pathway for the Fe(OTf)2L1 catalysed aerobic cleavage of 
Csp
3
-Csp
3
 bonds in 1-phenethylisochroman 57 to afford isochromanone 44 and aldehyde 58 
However, the mechanism behind the formation of carbonyl products 59 and 61 is unclear to 
us. By analogy to the aforementioned mechanism, the attack of the superoxo radical to the 
methylene in γ-position would initially allow the formation of a 1,2-dioxolane intermediate 
and a Fe
IV
-dihydride (Schemes 20). The cleavage of the proposed dioxolane into the 
oxygenated products is however unknown to us. We suspect that volatile hydrocarbons are 
also generated during such cleavage due to the strong gas smell emanating from the crude 
reactions. GC analyses to identify the formation of volatile products from these cleavages 
are in current progress. 
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Scheme 20. Proposed reaction pathway for the Fe(OTf)2L1 catalysed aerobic cleavage of 
Csp
3
-Csp
3
 bonds in 1-phenethylisochroman 56 and 60 
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5.3.2.2.4. Factors determining the selectivity of the Csp
3
-Csp
3
 vs Csp
3
-O bond cleavage 
The Fe(OTf)2L1 complex exhibited excellent selectivity in promoting the C-O cleavage of 
1-aryl isochromans and the exocyclic C-C cleavage of 1-alkyl substrates. However, when 1-
alkyl substituted 5,7-dihydro-4H-thieno[2,3c]pyranes were subjected to the Fe(OTf)2L1 
catalysed aerobic reaction both products derived from both C-O and C-C cleavage were 
obtained (Scheme 21). Independently of the alkyl substituent, both 4-H-thieno[2,3-c]pyran-
7(5H)-one 64 and the aliphatic ketone products were obtained in almost identical yields. 
Increasing the steric bulkiness of the alkyl fragment did not alter the product distribution; 
however, the reaction yields for both products were slightly reduced. 
 
Scheme 21. Fe(OTf)2L1 catalysed cleavage of alkyl substituted 5,7-dihydro-4H-
thieno[2,3c]pyranes 
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The selectivity showed by the Fe(OTf)2L1 complex in cleaving the Csp
3
-O bond of 1-
arylisochromans and the Csp
3
-Csp
3
 bond in 1-alkylisochromans can be interpreted in terms 
of the free energy changes associated to these reactions. In both types of cleavages, the 
formation of very stable conjugated carbonyl bonds can serve as a thermodynamic driving 
force to promote bond cleavage. In addition, as the bond cleavage makes the peroxide 
intermediates separate in two fragments, its cleavage is entropically favoured (Scheme 22). 
In 1-aryl isochromans, the cleavage of the C-O bond would be easier than the cleavage of 
the more stable and sterically encumbered Csp
3
-Csp
2
 bond (BDE of 70.5 vs 71.8 kcal/mol 
respectively). In 1-alkyl isochromans, the cleavage of the Csp
3
-Csp
3
 would be 
thermodynamically easier than cleaving the C-O bond (BDE of 69.2 (average) vs 70.5 
kcal/mol respectively). Thus, the selectivity observed in the reactions stems from the 
Fe(OTf)2L1 complex being prone to cleavage the weakest (and accessible) bond of the 1-
substituted isochroman. In addition, the higher yields observed in 1-cycloalkylisochromans 
are consistent with the progressive energy decrease of the Csp
3
-Csp
3
 bond.  
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Scheme 22. Enthalpic and entropic factors in the C-O and C-C cleavage of 1-substituted 
isochromans. Bond dissociation energies are provided in terms of formation enthalpies as 
reported in the literature. 
23
 
In the case of 1-alkyl substituted 5,7-dihydro-4H-thieno[2,3c]pyranes, the formation of 
products resulting from both Csp
3
-O and Csp
3
-Csp
3
 bond cleavages may stem from the 
energies of these two bonds being much more similar than in the case of 1-alkyl 
isochromans. However, contributions from other factors, such as the ring size or the reduced 
aromaticity in comparison with benzene type rings may also affect the selectivity of the 
cleavage. 
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5.3.3. Combined Fe(OTf)2L1 catalysed selective Csp
2
-Csp
3
 and Csp
3
-O cleavage 
The Fe(OTf)2L1 catalysed Csp
3
-Csp
3
 cleavage of 1-alkyl isochromans was also studied in 1-
methylisochromans substrates (Scheme 23) . Surprisingly, when isochroman 71 was 
subjected to the aerobic reaction, the phenethyl alcohol 72 was obtained in very good yield 
as the sole reaction product (entry 2). In fact, phenethyl alcohols were obtained exclusively 
from a variety of 1-methylisochromans with good to moderate yields. A sharp electronic 
bias was manifested, with reaction yields highly increasing in isochromans bearing electron 
withdrawing substituent (entries 1,2) and gradually decreasing in more electron rich 
substrates (entries 3-5). These data indicates that the Fe(OTf)2L1 complex is also capable of 
catalysing a sequential Csp
2
-Csp
3
 and Csp
3
-O cleavage under aerobic conditions.   
The reaction mechanism is unclear; however, the strong electronic bias is in agreement with 
the initial oxidation of the C2 bond of the 1-methylisochroman to form a peroxybisether 
species. Small amounts of acetaldehyde were also detected in 
1
H NMR spectra of the crude 
reactions; however, the yields were clearly lower than those found for the phenethyl 
alcohols, which may be an indication of the observed acetaldehyde being a byproduct 
originated from an unknown intermediate. 
From a synthetic perspective, the conversion of 1-methylisochromans to phenethyl alcohols 
can be seen as a greener alternative to oxidative ether deprotection reactions, which often 
require stoichiometric amounts of strong oxidants
24
 and/or exhibit limited selectivity and 
functional group tolerance
25
 (Scheme 23). 
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Scheme 23. Combined Fe(OTf)2L1 catalysed selective Csp
2
-Csp
3
 and Csp
3
-O cleavage in   
1-methylisochromans 
5.3.4. Combined Fe(OTf)2L1 catalysed selective Csp
3
-Csp
2
 and Csp
2
-X (X = O, N) 
cleavage via decarboxylation 
CloR enzymes participating in the biosynthesis of clorobiocin and aminocoumarine are 
known to undergo the decarboxyaltion of aliphatic C-C bonds of the mandelic acid fragment 
of 3DMA-4HPP affording the benzoic acid derivative 3DMA-4HB
26
 (Scheme 24 a). 
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Inspired by this biological system, the groups of Paine and Que Jr. reported a biomimetic 
Fe
II
 α-hydroxy acid complex capable of undergoing the aerobic decarboxylation of the α-
hydroxy acid moiety to generate benzoate, mimicking the activity of the natural system
27
 
(Scheme 24 b). 
 
Scheme 24. CloR oxidative decarboxylation of of 3DMA-4HPP and a related Fe
II
 α-hydroxy 
acid mimicking the natural activity 
Inspired by these natural decarboxylations, we envisioned that the selective Fe(OTf)2L1 
catalysed C-C cleavage could be combined with the decarboxylation of acid-derived 
functionalities. The CO2 release could be used as the thermodynamic driving force for 
cleaving the strong C-O or C-N bonds of esters and amides. In order to evaluate whether the 
Fe(OTf)2L1 complex could promote a tandem C-C and C-X cleavage via decarboxylation, 
tetrahydrofuran-2-carboxylic acid 79 was subjected to the Fe(OTf)2L1 catalysed aerobic 
reaction (Scheme 25). Delightfully, γ-butyrolactone 80 was obtained with a 10% yield in a 
clean reaction, with the starting material being easily recovered (entry 1). Indeed, the methyl 
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ester derivative 81 was also oxidatively decarboxylated with similar yields (entry 2). When 
the amide 82 was subjected to the reaction, γ-butyrolactone and ethyl piperidien-3-
carboxylate 83 were isolated as reaction products (entry 3). These data is in agreement with 
the proposed oxidative decarboxylation and highlight the excellent selectivity of the catalyst 
as no decarboxylation of the ester functionality was observed. The scope of this reaction and 
GC analysis to determine the possible CO2 release are under current investigation.  
 
Scheme 25.  Fe(OTf)2L1 catalysed oxidative decarboxylation of THFs substrates 
5.4. Conclusions 
The Fe(OTf)2-PyBisulidine complexes were found capable of catalysing a wide variety of 
selective aerobic C-C and C-O cleavages under mild reaction conditions. Some of these 
oxidative cleavages represent a good synthetic alternative for obtaining complex and/or 
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valuable oxygenated compounds, such as the conversion of 1-arylisochromans into aromatic 
ketones. Others, such as the conversion of natural isochromans into 3-aryl-3,4-
dihydrocoumarines, constitute an example of new and green synthetic transformations of 
potential commercial interest. The Fe(OTf)2-PyBisulidine was also found to promote tandem 
C-C and C-O cleavages, allowing the conversion of 1-methylisochromans into phenethyl 
alcohols, and active in the oxidative decarboxylation of THF’s. Therefore, many different 
cleavages can be accomplished on a selective manner using the same family of iron 
catalysts. 
 Even though the selective oxidation of organic compounds has been identified as the most 
important area to impact future industrial transformations, we anticipate that selective iron-
catalysed aerobic C-C and C-X cleavages would potentially become an equally important 
area of research in future organic syntheses. 
5.5. Experimental section 
5.5.1. General techniques 
Chemicals used in the synthesis of non-commercially available substrates were purchased 
from commercial suppliers and used without further purification.  
5.5.2. Substrate synthesis 
5.5.2.1. Synthesis of 1-arylisochromans 
1-Aryl isochromans were synthesised according to the acid-catalysed oxa-Pictet-Spengler 
reaction procedure described in Chapter 3.  
Analytical data 
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6,7-Dimethoxy-1-phenylisochroman
28 
White solid, 97% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) =  
7.35-7.27 (m, 5H), 6.64 (s, 1H), 6.22 (s, 1H), 5.67 (s, 1H), 4.14-4.09 (m, 
1H), 4.08-4.02 (m, 1H), 3.96 (s, 3H), 3.82 (s, 3H), 3.05-2.98 (m, 1H), 
2.74-2.68 (m, 1H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 147.9, 147.6, 
142.2, 129.2, 128.7, 128.5, 128.2, 126.1, 111.5, 109.7, 79.1, 63.5, 56.2, 
55.8, 28.3. IR (neat): υ = 2965, 2922, 2859, 2830, 1607, 1510, 1480, 
1455, 1383, 1359, 1342, 1331, 1275, 1254, 1243, 1219, 1204, 1175, 1110, 1088, 1036, 1027, 
1012, 948, 837, 822, 774, 691, 608, 566, 532 cm
-1
. HRMS (CI) m/z calc’d C17H19O3 [M + 
H]
+
: 271.1329, found: 271.1335. 
1-(4-Fluorophenyl)-6,7-dimethoxyisochroman
29 
 White solid, 98% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.27 (t, J = 5.9 Hz, 2H), 7.02 (t, J = 5.9 Hz, 2H), 6.65 (s, 1H), 6.18 (s, 
1H), 5.66 (s, 1H), 4.15-4.10 (m, 1H), 3.87 (s, 3H, overlapped), 3.85 (m, 
1H, overlapped), 3.65 (s, 3H), 3.07-2.99 (m, 1H), 2.74-2.70 (m, 1H).
13
C 
NMR (100 MHz, CDCl3): δ (ppm) =  163.7 (
1
JC-F  = 245.0 Hz), 147.9, 
147.3, 138.1 (
4
JC-F  = 3.1 Hz), 130.6 (
3
JC-F  = 8.2 Hz), 128.7, 126.1, 115.3 
(
2
JC-F  = 21.3 Hz), 111.2, 109.6, 78.4, 63.6, 55.8, 28.3. IR (neat): υ = 
2967, 2923, 2862, 2832, 1603, 1511, 1469, 1358, 1331, 1308, 1294, 1256, 1230, 1218, 1155, 
1111, 1085, 1064, 1035, 1013, 948, 910, 858, 833, 817, 796, 767, 562, 535 cm
-1
. HRMS 
(CI) m/z calc’d C17H18FO3 [M + H]
+
: 289.1234, found: 289.1238. 
1-(4-Methoxyphenyl)-6,7-dimethoxyisochroman
30 
White solid, 94% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.26 (d, J = 8.8 Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H), 6.64 (s, 1H), 6.23 (s, 
1H), 5.64 (s, 1H), 4.16-4.07 (m, 1H), 3.92-3.88 (m, 1H), 3.84 (s, 3H), 
3.80 (s, 3H), 3.66 (s, 3H), 3.08-2.96 (m, 1H), 2.77-2.67 (m, 1H).
 13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 159.4, 147.8, 147.2, 134.4, 130.1, 
129.2, 126.1, 113.7, 111.1, 109.8, 78.6, 63.4, 55.9, 55.8, 55.2, 28.3. IR 
(neat): υ = 2965, 2924, 2857, 2839, 1607, 1586, 1513, 1466, 1442, 1383, 
1357, 1329, 1305, 1252, 1206, 1186, 1170, 1112, 1088, 1064, 1031, 1014, 855, 827, 818, 
768, 578, 563, 541 cm
-1
. HRMS (CI) m/z calc’d C18H21O4 [M + H]
+
: 301.1434, found: 
301.1430. 
7-(4-Fluorophenyl)-5,7-dihydro-4H-thieno[2,3c]pyran 
Colourless oil, 97% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.38-
7.34 (m, 2H), 7.17 (d, J =  5.6 Hz, 1H), 7.06-7.02 (m, 2H), 6.86 (d, J = 5.0 Hz, 
1H), 5.77 (s, 1H), 4.26-4.21 (m ,1H), 3.94-3.87 (m, 1H), 3.02-2.94 (m, 1H), 
2.73-2.69 (m, 1H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 163.1 (
1
JC-F  = 
248.0 Hz), 137.4, 136.6, 133.8, 129.6 (
3
JC-F  = 8.2 Hz),, 126.8, 123.9, 115.5 (
2
JC-
F  = 21.4 Hz), 76.6, 64.3, 26.1. IR (neat): υ = 1674, 1601, 1507, 1270, 1221, 
1154, 1114, 1078, 1055, 1014, 979, 893, 856, 834, 780, 767, 706, 688, 670, 
611, 537 cm
-1
. HRMS (CI) m/z calc’d C13H12FOS [M + H]
+
: 235.0587, found: 235.0593.  
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7-(4-(Trifluoromethyl)phenyl)-5,7-dihydro-4H-thieno[2,3c]pyran 
Colourless oil, 97% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.63-
7.61 (m, 2H), 7.53-7.51 (m, 2H), 7.18 (d, J = 5.0 Hz, 1H), 6.87 (d, J = 5.2 Hz, 
1H), 5.84 (s, 1H), 4.27-4.22 (m, 1H), 3.95-3.89 (m, 1H), 3.04-2.95 (m, 1H), 
2.76-2.71 (m, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 145.4, 135.7, 
133.9, 130.7, 127.9, 126.9, 125.5 (
3
JC-F = 3.7 Hz), 125.4, 124.1, 122.7, 76.7, 
64.3, 26.1. IR (neat): υ = 1672, 1412, 1322, 1272, 1163, 1011, 1064, 1016, 907, 
893, 861, 838, 806, 794, 703, 688, 679, 611, 499 cm
-1
. HRMS (CI) m/z calc’d 
C14H11F3OS [M + H]
+
: 285.0555, found: 285.0558. 
1-(4-Fluorophenyl)-9-methyl-1,3,4,9,-tetrahydropyrano[3,4-c]indole 
 Dense yellow oil, 56% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
=7.61(d, J =8.1 Hz, 1H), 7.35-7.01 (m, 7H), 5.87 (s, 1H), 4.09-3.97 (m, 2H), 
3.32 (s, 3H), 2.98-2.87 (m, 2H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 
164.1 (
1
JC-F  = 246.0 Hz), 137.2, 135.5 (
4
JC-F  = 3.0 Hz), 133.7, 130.7 (
3
JC-F = 
8.2 Hz), 126.4, 121.6, 119.2, 118.4, 115.7 (
2
JC-F  = 21.3 Hz), 108.9, 108.6, 
73.7, 62.0, 30.1, 22.3. IR (neat): υ = 1639, 1597, 1506, 1469, 1412, 1378, 
1264, 1223, 1154, 1094, 1079, 1057, 1029, 1013, 959, 944, 835, 732, 702 
cm
-1
. 
 
5.5.2.2. Synthesis of 1-alkyl substituted isochromans 
5.5.2.2.1. Electron rich isochromans 
Electron rich 1-alkyl isochromans were synthesised according to the acid-catalysed oxa-
Pictet-Spengler reaction procedure described in Chapter 3.   
Analytical data 
7-Cyclopropyl-5,7-dihydro-4H-thieno[2,3-c]pyran 
Colourless oil, 87% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.15 (d, 
J = 5.0 Hz, 1H), 6.83 (d, J = 5.2 Hz, 1H), 4.27-4.22 (m, 1H), 3.88 (d, J = 8.2 Hz, 
1H), 3.77-3.70 (m, 1H), 2.94-2.86 (m, 1H), 2.60-2.56 (m, 1H), 1.24-1.11 (m 
,1H), 0.74-0.47 (m, 4H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 137.4, 133.1, 
126.8, 122.8, 80.5, 64.8, 26.2, 17.4, 3.7, 2.5. IR (neat): υ = 2920, 2853, 1675, 
1649, 1459, 1428, 1413, 1386, 1317, 1242, 1219, 1149, 1081, 1056, 1017, 990, 953, 924, 
893, 875, 790, 758, 706, 579 cm
-1
. HRMS (CI) m/z calc’d C10H13OS [M + H]
+
: 181.0682, 
found: 181.0685. 
 
 
 
 
 
Chapter 5 
 
258 
 
7-Pentyl-5,7-dihydro-4H-thieno[2,3-c]pyran
30 
Colourless oil, 89% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) =  
7.13 (d, J = 5.0 Hz, 1H), 6.81 (d, J = 5.1 Hz, 1H), 4.74 (s, 1H), 4.22-4.18 
(m, 1H), 3.77-3.71 (m, 1H), 2.90-2.82 (m, 1H), 2.60-2.56 (m, 1H), 1.82-
1.75 (m, 2H), 1.53-1.32 (m, 7H), 0.89 (t, J = 7.0 Hz, 3H).
 13
C NMR (100 
MHz, CDCl3): δ (ppm) = 137.8, 133.2, 127.1, 122.4, 75.2, 64.4, 37.4, 31.8, 26.3, 24.9, 22.6, 
14.0. HRMS (CI) m/z calc’d C12H19OS [M + H]
+
: 211.1151, found: 211.1154. 
7-(sec-Butyl)-5,7-dihydro-4H-thieno[2,3-c]pyran 
Colourless oil, 80% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) =  7.15 
(d, J = 5.0 Hz, 1H), 6.81 (d, J = 5.0 Hz, 1H), 4.75 (d, J = 16.7 Hz, 1H), 4.23-
4.19 (m, 1H), 3.71-3.65 (m, 1H), 1.87-1.84 (m, 1H), 1.45-1.20 (m, 2H), 0.95-
0.81 (m, 6H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 137.1, 134.4, 127.1, 
122.5, 80.0, 64.8, 39.6, 25.5, 20.7, 14.3, 13.4. HRMS (CI) m/z calc’d C11H17OS [M + H]
+
: 
197.0995, found: 197.0992. 
7-(tert-Butyl)-5,7-dihydro-4H-thieno[2,3-c]pyran 
Colourless oil, 80% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.13 (d, 
J = 5.1 Hz, 1H), 6.83 (d, J = 5.2 Hz, 1H), 4.40 (s, 1H), 4.22-4.18 (m, 1H), 3.64-
3.58 (m, 1H), 2.88-2.80 (m, 1H), 2.56 (m, 1H), 1.05 (s, 9H).
 13
C NMR (100 
MHz, CDCl3): δ (ppm) = 135.6, 134.5, 126.8, 122.6, 83.8, 64.8, 35.7, 26.9, 26.0. 
HRMS (CI) m/z calc’d C11H17OS [M + H]
+
: 197.0995, found: 197.0996. 
1-Cyclohexyl-6,7-dimethoxyisochroman
31 
Colourless wax, 79% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
6.58 (s, 1H), 6.57 (s, 1H), 4.57 (s, 1H), 4.16-4.12 (m, 1H), 3.85 (s, 6H), 
3.67-3.61 (m, 1H), 2.96-2.88 (m, 1H), 2.49-2.45 (m, 1H), 1.84-1.72 (m, 
5H), 1.32-1.11 (m, 5H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 147.4, 
147.2, 129.3, 127.1, 111.2, 107.8, 79.7, 64.1, 56.0, 55.8, 43.8, 30.2, 28.9, 
26.9, 26.5, 26.4, 25.3. IR (neat): υ = 2919, 2848, 1515, 1466, 1377, 1353, 
1251, 1234, 1218, 1203, 1106, 1093, 1034, 1007, 858, 819, 764 cm
-1
. HRMS (CI) m/z 
calc’d C17H25O3 [M + H]
+
: 277.1798, found: 277.1809. 
1-Isopropyl-6,7-dimethoxyisochroman
31 
White solid, 81% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 6.59 
(s, 1H), 6.56 (s, 1H), 4.60 (s, 1H), 4.18-4.14 (m, 1H), 3.86 (s, 3H), 3.84 (s, 
3H), 3.68-3.63 (m, 1H), 2.99-2.90 (m, 1H), 2.49-2.45 (m, 1H), 2.22-2.16 
(m, 1H), 1.16 (d, J = 6.8 Hz, 3H), 0.71 (d, J = 6.9 Hz, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 147.4, 147.1, 129.7, 127.0, 111.2, 107.6, 79.9, 64.2, 55.9, 55.8, 
33.4, 28.9, 19.8, 15.0. IR (neat): υ = 2966, 2928, 2860, 1607, 1509, 1470, 1458, 1449, 1377, 
1318, 1246, 1224, 1202, 1116, 1102, 1085, 1063, 1008, 950, 928, 895, 856, 810, 769 cm
-1
. 
HRMS (CI) m/z calc’d C14H21O3 [M + H]
+
: 237.1485, found: 237.1492.  
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6,7-Dimethoxy-1-phenethylisochroman 
Dense colourless oil, 84% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.39-7.12 (m, 5H), 6.62 (s, 1H), 6.54 (s, 1H), 4.73 (m, 1H), 
4.20-4.12 (m, 1H), 3.89 (s, 3H), 3.84 (s, 3H), 3.82 (m, 1H), 2.98-2.87 
(m, 1H), 2.78 (t, J= 6.8 Hz, 2H), 2.50-2.46 (m, 1H), 2.24-1.87 (m, 2H).
 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 147.5, 142.7, 130.0, 128.5, 
128.3, 128.1, 126.4, 125.7, 111.7, 107.8, 74.8, 63.2, 56.0, 55.8, 37.8, 
30.9, 28.7. IR (neat): υ = 2931, 2855, 2833, 1609, 1511, 1463, 1452, 
1408, 1331, 1314, 1253, 1226, 1204, 1107, 1029, 999, 858, 771, 749, 734, 699 cm
-1
. HRMS 
(CI) m/z calc’d C19H23O3 [M + H]
+
: 299.1642, found: 299.1644.  
6,7-Dimethoxy-1-(2-phenylpropyl)isochroman 
Dense colourless oil, 84% isol. yield. Data for the predominant 
diasteroisomer: 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.33-7.24 (m, 
5H), 6.47 (s, 1H), 6.36 (s, 1H), 4.81 (bs, 1H), 4.09 (m, 1H), 3.83 (s, 3H), 
3.81 (s, 3H0, 3.16-3.15 (m, 1H), 2.67-2.62 (m, 1H), 2.62 (t, J = 6.9 Hz, 
1H), 2.08-1.96 (m, 2H), 1.38 (d, J = 6.9 Hz, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 148.2, 147.4, 146.6, 130.7, 130.3, 128.4, 127.3, 
125.8, 111.5, 108.0, 73.3, 62.6, 56.0, 55.8, 45.1, 36.3, 28.6, 23.1. IR 
(neat): υ = 2955, 2930, 2832, 1610, 1509, 1494, 1374, 1330, 1253, 1227, 1204, 1130, 1098, 
1015, 1006, 853, 803, 781, 761, 699, 543 cm
-1
. HRMS (CI) m/z calc’d C20H25O3 [M + H]
+
: 
313.1798, found: 313.1808.  
6,7-Dimethoxy-1,1-dimethylisochroman
30 
Colourless oil, 96% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
6.56 (s, 2H), 3.93 (t, J = 5.6 Hz, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 2.74 (t, J 
= 5.8 Hz, 2H), 1.51 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
147.4, 147.3, 134.8, 125.1, 111.2, 108.5, 74.1, 59.6, 56.0, 55.8, 29.7, 29.1. 
IR (neat): υ = 2970, 2932, 1611, 1511, 1463, 1450, 1402, 1359, 1350, 1327, 1259, 1245, 
1210, 1182, 1155, 1091, 1072, 1057, 1028, 997, 954, 856, 786, 555, 504 cm
-1
. HRMS (CI) 
m/z calc’d C13H19O3 [M + H]
+
: 223.1329, found: 223.1327.  
1-Methylisochroman
28 
Colourless oil, 48% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.34-
7.22 (m, 4H), 4.71 (q, J = 5.6 Hz, 1H), 3.77-3.71 (m, 1H), 3.63-3.57 (m, 1H), 
2.87 (t, J = 7.0 Hz, 2H), 1.31 (d, J = 7.0 Hz, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 139.4, 129.3, 128.7, 126.5, 100.1, 66.4, 36.8, 20.0. HRMS 
(CI) m/z calc’d C10H13O [M + H]
+
: 149.0958, found: 149.0961. 
7-Methoxy-1-methylisochroman 
Colourless oil, 68% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.10 (d, J = 7.7 Hz, 2H), 6.82 (m, 1H), 4.66 (q, J = 5.3 Hz, 1H), 3.77 (s, 
3H), 3.68-3.62 (m, 1H), 3.55-3.49 (m, 1H), 2.76 (t, J = 7.2 Hz, 2H), 
1.28 (d, J = 5.3 Hz, 3H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 158.3, 
129.8, 114.0, 113.7, 99.6, 66.2, 55.3, 55.2, 38.2, 21.3. IR (neat): υ = 2936, 2909, 2867, 
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1612, 1583, 1511, 1464, 1442, 1319, 1300, 1242, 1177, 1128, 1096, 1060, 1030, 990, 921, 
823, 750, 557, 516 cm
-1
. HRMS (CI) m/z calc’d C11H15O2 [M + H]
+
: 179.1067, found: 
179.1070. 
7-Methyl-5,7-dihydro-4H-thieno[2,3-c]pyran 
Colourless oil, 96% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.14 (d, 
J = 5.0Hz, 1H), 6.82 (d, J = 5.1 Hz, 1H), 4.89 (q, J = 5.7 Hz, 1H), 4.23-4.18 (m, 
1H), 3.81-3.74 (m, 1H), 2.93-2.84 (m, 1H), 2.61-2.55 (m, 1H), 1.52 (d, J = 6.4 
Hz, 3H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 138.5, 132.8, 127.1, 122.4, 
71.3, 64.6, 26.2, 22.9. IR (neat): υ = 2973, 2924, 2849, 1443, 1372, 1316, 1264, 1166, 1119, 
1089, 1049, 1011, 997, 868, 843, 822, 723, 705, 659, 612, 578, 533 cm
-1
. HRMS (CI) m/z 
calc’d C8H11OS [M + H]
+
: 155.0525, found: 155.0529.   
6,7-Dimethoxy-1-methylisochroman 
Colourless oil, 97% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
6.52 (s, 1H), 6.48 (s, 1H), 4.72 (q, J = 6.3 Hz, 1H), 4.08-4.04 (m, 1H), 
3.78 (s, 6H), 3.73-3.66 (m, 1H), 2.91-2.83 (m, 1H), 2.54-2.50 (m, 1H), 
1.43 (d, J = 6.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 147.5, 
147.4, 131.4, 125.4, 111.4, 107.8, 72.0, 63.6, 56.0, 55.8, 28.6, 21.9. IR (neat): υ = 2932, 
2833, 1610, 1509, 1463, 1451, 1372, 1355, 1331, 1313, 1248, 1226, 1205, 1161, 1137, 1029, 
1010, 853, 796, 738, 708, 494 cm
-1
. HRMS (CI) m/z calc’d C12H17O3 [M + H]
+
: 209.1172, 
found: 209.1180.   
5.5.2.2.2. Neutral and electron deficient 1-alkyl isochromans 
The following multistep route was used to synthesise 1-alkyl isochromans which could not 
be obtained by oxa-Pictet-Spengler reactions: 
 
General procedure for the bromination of isochromans 
In a two-necked round bottom flask equipped with a magnetic bar, the corresponding 
isochroman (1.0 equiv, 3.0 mL) and NBS (1.1 equiv, 4.77 g) were added. The flask was 
degassed and placed under a N2 atmosphere. Freshly distilled CHCl3 (40 mL) was added by 
syringe and the reaction was heated gradually to 40 °C. The reaction was stirred at 40 °C for 
24 h and then allowed to cool at r.t. The solvent was eliminated under reduced pressure and 
Et2O (20 mL) were added to the residue. The solution was filtered to remove the white solid 
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and then the solvent was evaporated in vacuo to afford the desired 1-bromoisochroman 
(4.57g, 90% yield) as a dense oil. 
General procedure for the alkylation of 1-bromoisochromans 
In a two-necked round bottom flask equipped with a magnetic bar, the crude 1-
bromoisochroman (1.0 equiv., 4.57 g) was added. The flask was degassed and placed under 
a N2 atmosphere. Freshly distilled Et2O (40 mL) was added by syringe and the reaction was 
cooled down to 0 °C or -78°C. The corresponding alkylmagnesium bromide (1.4 equiv, 3.0 
M in hexanes sol.) was added dropwise to the reaction mixture. Once the addition was 
completed, the reaction mixture was stirred at 0 °C for an additional hour and at r.t. 
overnight. The reaction was slowly quenched with NH4Cl (aq.) and the two phases were 
separated. The organic phase was washed with water and brine, dried over MgSO4 and 
filtered. The solvent was removed in vacuo and the residue was purified by silica gel column 
chromatography (Hexane/EtOAc, 18/1) to afford the desired product as a clear oil.   
Analytical data 
1-Pentylisochroman 
Colourless oil, 74% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.16-7.08 (m, 4H), 4.75 (d, J = 7.8 Hz, 1H), 4.16-4.11 (m, 1H), 3.79-3.73 
(m, 1H), 3.02-2.94 (m, 1H), 2.71-2.67 (m, 1H), 1.92-1.77 (m, 2H), 1.45-
1.25 (m, 5H), 0.87 (t, J = 6.6 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 138.6, 133.9, 128.8, 127.4, 126.0, 124.7, 75.9, 63.1, 36.0, 31.8, 29.4, 25.2, 22.6, 
14.1. IR (neat): υ = 2955, 2926, 2856, 1491, 1454, 1425, 1376, 1311, 1286, 1158, 1104, 
1077, 1049, 934, 758, 642 cm
-1
. HRMS (CI) m/z calc’d C14H21O [M + H]
+
: 205.1587, 
found: 205.1590.   
1-Ethylisochroman
28 
Colourless oil, 65% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) =7.19-
7.06 (m, 4H), 4.71(d, J = 7.3 Hz, 1H), 4.16-4.11 (m, 1H), 3.80-3.74 (m, 1H), 
3.02-2.94 (m, 1H), 2.70-2.66 (m, 1H), 2.01-1.93 (m, 1H), 1.85-1.78 (m, 2H), 
0.98 (t, J = 7.3 Hz, 3H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 138.3, 134.1, 
128.8, 126.1, 126.0, 124.8, 76.2, 63.1, 29.2, 28.7, 9.5. HRMS (CI) m/z calc’d C11H15O [M + 
H]
+
: 163.1118, found: 163.1115.   
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1-Cyclohexylisochroman 
Colourless oil, 40% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.17-
7.02 (m, 4H), 4.74 (d, J = 7.0 Hz, 1H), 4.21-4.12 (m, 1H), 3.85-3.76 (m, 1H), 
3.14-2.97 (m, 1H), 2.68-2.59 (m, 1H), 1.74-1.42 (m, 4H), 134-1.10 (m, 6H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 137.5, 134.2, 128.6, 126.3, 126.0, 80.1, 
64.1, 43.4, 29.5, 27.0, 26.9, 26.5, 26.4. IR (neat): υ = 2922, 2850, 1490, 1450, 
1425, 1255, 1231, 1156, 1112, 1082, 1054, 1035, 1014, 1002, 890, 756, 743 cm
-1
. HRMS 
(CI) m/z calc’d C15H21O [M + H]
+
: 217.1587, found: 217.1586.   
1-Cyclopentylisochroman 
Colourless oil, 55% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.14-
7.09 (m, 4H), 4.74 (d, J =  6.9 Hz, 1H), 4.19-4.14 (m, 1H), 3.76-3.70 (m, 1H), 
3.04-2.96 (m, 1H), 2.66-2.60 (m, 1H), 2.53-2.47 (m, 1H), 1.79-1.26 (m, 10H).
 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 138.6, 134.3, 128.7, 125.9, 125.8, 
125.0, 77.8, 63.6, 44.8, 29.3, 29.1. IR (neat): υ = 2952, 1606, 1459, 1393, 
1293, 1242, 1192, 1158, 1060, 1028, 1001, 950, 744, 694, 639 cm
-1
. HRMS (CI) m/z calc’d 
C14H19O [M + H]
+
: 220.1696, found: 220.1699.   
7-Fluoro-1-methylisochroman 
Colourless oil, 57% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.09-7.03 (m, 1H), 6.93-6.75 (m, 3H), 4.84 (d, J = 7.0 Hz, 1H), 4.19-4.11 
(m, 1H), 3.81-3.73 (m, 1H), 3.03-2.91 (m, 1H), 2.68-2.61 (m, 1H), 1.50 (d, J 
= 6.9 Hz, 3H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 162.3 (
1
JC-F  = 242.1 
Hz), 141.3 (
3
JC-F  = 6.4 Hz), 130.2 (
3
JC-F  = 7.6 Hz), 113.4 (
2
JC-F = 21.3 Hz), 111.5 (
2
JC-F  = 21.6 
Hz), 72.2, 63.7, 28.3, 21.6. HRMS (CI) m/z calc’d C10H12FO [M + H]
+
: 167.0867, found: 
167.0870.   
5.5.2.3. Synthesis of natural isochromans 
Isochromans with a similar molecular skeleton to those found in softwood lignings were 
prepared according to the following synthetic route: 
 
 
 
 
Chapter 5 
 
263 
 
Procedure for the preparation of 2-(3,4-dimethoxy)propanoic acid
32 
In a two-necked round bottom flask equipped with a magnetic bar, diisopropylamine (5.64 g, 
7.81 mL) was added. The flask was degassed (3 times) and placed under a N2 atmosphere. 
Freshly distilled THF (40 mL) was added by syringe and the flask was cooled to -78 °C. n-
BuLi (22 mL, 2.5 M sol.) was added dropwise and once the addition was completed, the 
mixture was stirred for an additional 30 min. In a separated two-necked round bottom flask, 
3,4-dimethoxy phenylacetic acid (26.55 mmol, 5.2 g) was added, the flask was degassed ( 3 
times) and placed under a N2 atmosphere. Freshly distilled THF (10 mL) was added by 
syringe and the flask was cooled to -78 °C and the LDA solution was added dropwise. Once 
the addition was completed, the reaction was stirred for an additional hour. Then, the flask 
was warmed to 0 °C and MeI (7.54g, 3.31 mL) was added dropwise. The reaction was 
stirred overnight at r.t. Next morning, the reaction was slowly quenched with NH4Cl (aq). 
The organic phase was extracted with Et2O and separated. The aqueous phase was acidified 
with HCl (aq) to pH = 2.00 and extracted with Et2O. The latter organic phase was washed 
with water and brine and dried over MgSO4. The solution was filtered and the solvent 
removed in vacuo to afford the desired 2-(3,4-dimethoxy)propanoic acid as a dense yellow 
oil (5.12 g, 92% yield).  
Procedure for the preparation of 2-(3,4-dimethoxyphenyl)propanoyl chloride
32 
In a round bottom flask equipped with a magnetic bar, 2-(3,4-dimethoxy)propanoic acid 
(5.12 g) was added. The oil was dissolved in toluene (40 mL) and cooled to 0 °C. Thionyl 
chloride (2.3 equiv., 6.0 mL) was added dropwise and once the addition was completed, the 
reaction was stirred for an additional 15 min. The reaction mixture was gradually heated to 
80 °C and stirred for an additional 5 h. The flask was cooled down to r.t. and the solvent 
eliminated in vacuo to afford the 2-(3,4-dimethoxyphenyl)propanoyl chloride (5.15 g, 92% 
yield) as a dark oil. 
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Procedure for the Friedel Crafts reactions
32
 
In a two-necked round bottom flask equipped with a magnetic bar, AlCl3 (2.4 equiv., 7.2g) 
was added. The flask was degassed (3 times) and placed under a N2 atmosphere. Freshly 
distilled DCM (40 mL) was added and the flask was cooled to -20 °C. Anisole (1.1 equiv, 
2.7 mL) was added slowly and once the addition was completed, 2-(3,4-dimethoxyphenyl) 
propanoyl chloride (1.0 equiv, 5.15 g in 10 mL of DCM) was added over a period of 40 min. 
Once the addition was completed, the reaction mixture was stirred for an additional 3 h at -
20 °C. The reaction was warmed up to r.t. and slowly quenched with HCl (3.0M). The 
organic phase was extracted with DCM and washed with water and brine. The solution was 
dried over MgSO4, filtered and the solvent eliminated in vacuo. The crude was purified by 
silica gel column chromatography (Hexane/EtOAc, gradient: 7/2 to 3/2) to afford the desired 
product (2.03 g, 30% yield) as a pale yellow oil. 
Analytical data 
(±)-1-Ethyl-6,7-dimethoxy-3-(4-methoxyphenyl)-4-methylisochroman 
Dense colourless oil, 39% yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.41-7.38 (m, 2H), 6.97-6.78 (m, 4H), 4.95 (bs, 1H), 
4.18 (d, J = 9.4 Hz, 1H), 3.86 (s, 3H), 3.85 (s, 3H), 3.83 (s, 3H), 
3.50-3.42 (m, 1H), 1.62-1.54 (m, 2H), 1.15 (d, J = 6.9 Hz, 3H), 
0.98 (t, J= 7.0 Hz, 3H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 
157.4, 147.5, 147.3, 139.1, 130.9, 128.4, 128.3, 114.9, 109.7, 108.1, 83.4, 55.9, 55.8, 55.7, 
38.9, 29.4, 18.7, 8.9. IR (neat): υ = 2961, 2933, 2834, 1607, 1586, 1508, 1462, 1417, 1300, 
1245, 1171, 1141, 1108, 1027, 852, 825, 807, 764, 569, 543 cm
-1
. HRMS (CI) m/z calc’d 
C21H27O4 [M + H]
+
: 343.1904, found: 343.1913.   
(±)-3-(3,4-Dimethylphenyl)-1-ethyl-6,7-dimethoxy-4-methylisochroman 
Dense colourless oil, 39% yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.18 (s, 1H), 7.13 (s, 2H), 6.81 (s, 1H), 6.61 (s, 1H), 4.89 
(bs, 1H), 4.14 (d, J = 9.8 Hz, 1H), 3.87 (s, 6H), 3.09-2.99 (m, 1H), 
2.28 (s, 3H), 2.26 (s, 3H), 2.09-2.01 (m, 1H), 1.83-1.75 (m, 1H), 
1.07 (d, J = 6.8 Hz, 3H), 0.91 (t, J = 7.3 Hz, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 147.5, 147.2, 141.7, 139.1, 136.4, 136.1, 132.2, 129.9, 129.5, 
128.7, 128.3, 125.0, 109.5, 107.2, 83.2, 55.9, 55.6, 37.7, 28.8, 19.8, 19.4, 16.2, 8.6. HRMS 
(CI) m/z calc’d C22H28O3 [M + H]
+
: 341.2111, found: 341.2119.   
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5.5.3. General procedure for the Fe(OTf)2L1 catalysed aerobic cleavage of Csp
3
-O 
bonds 
Liquid samples: 
In a Radley’s tube equipped with a magnetic stir bar, ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The corresponding ether (2.0 mL) was 
added and the reaction tube was degassed, charged with dioxygen gas (1 atm, 3 times) and 
kept under oxygen (1 atm) by using a balloon. The reaction mixture was heated to 60 
°
C and 
left overnight. Next morning, a second addition of catalyst was made (5.67 x 10
-3
 mmol) and 
the reaction mixture was reacted at 60 
°
C overnight. If needed, a third addition of catalyst 
was made the following morning following the same procedure. The reaction was purified 
by silica gel column chromatography (Hexane/EtOAc, gradient: 10/1 to 4/1 or 2/1) to afford 
the unreacted starting material and the reaction products. 
 
Solid samples: 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 
times) and left under an inert atmosphere. C6H6 (0.5 mL) was added by syringe and the 
reaction mixture was stirred at 40 °C for 1 h. The corresponding ether (2.5 mmol) was added 
and the reaction tube was degassed, charged with dioxygen gas (1 atm, 3 times) and kept 
under oxygen (1 atm) by using a balloon. The reaction mixture was heated to 60 
°
C and left 
overnight. One or two more additions of catalyst were done according to the same 
procedure. The reaction was purified by silica gel column chromatography (Hexane/EtOAc, 
gradient: 6/1 to 3/2) to afford the unreacted starting material and the reaction products. 
 
 
 
Chapter 5 
 
266 
 
Analytical data 
(2-(2-Hydroxyethyl)-4,5-dimethoxyphenyl)(phenyl)methanone 
White solid, 15% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.82 (d, J = 7.2 Hz, 2H), 7.63 (t, J = 7.4 Hz, 1H), 7.49 (m, 2H), 6.88 (m, 
2H, overlapped), 3.96 (s, 3H), 3.92 (t, J = 6.8 Hz, 2H), 3.77 (s, 3H), 2.94 
(t, J = 6.4 Hz, 2H), 2.17 (bs, 1H) . 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 198.0, 151.4, 146.2, 138.0, 133.9, 133.6, 133.2, 130.6, 130.3, 
130.1, 129.3, 128.4, 128.2, 128.0, 126.8, 113.4, 64.1, 56.1, 55.8, 36.0. HRMS (EI) m/z 
calc’d C17H19O4 [M + H]
+
: 287.1278, found: 287.1274. 
(4-Fluorphenyl)(2-(2-hydroxyethyl)-4,5-dimethoxyphenyl)methanone 
Pale yellow oil, 68% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.85 (m, 2H), 7.15 (t, J = 8.6 Hz, 2H), 6.88 (s, 1H), 6.82 (s, 
2H), 3.96 (s, 3H), 3.89 (t, J = 6.3 Hz, 2H), 3.78 (s, 3H), 2.91 (t, J = 
6.0 Hz, 2H), 1.78 (bs, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
196.4, 151.5, 146.4, 134.4, 133.7, 133.2 (
3
JC-F  = 9.3 Hz), 130.1, 115.7 
(
2
JC-F  = 21.6 Hz), 113.5, 113.1, 64.0, 56.1, 56.0, 36.0. IR (neat): υ = 3365, 2934, 2847, 
1728, 1655, 1596, 1509, 1464, 1408, 1257, 1209, 1174, 1153, 1094, 1064, 948, 909, 855, 
792, 544, 506 cm
-1
. HRMS (EI) m/z calc’d C17H19O4F [M + H]
+
: 305.1184, found: 
305.1182. 
(2-(2-Hydroxyethyl)-4,5-dimethoxyphenyl)(4-methoxyphenyl)methanone 
Pale oil, 60% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.82 (d, J = 8.7 Hz, 2H), 6.94 (m, 4H), 3.95 (s, 3H), 3.87 (s, 3H), 
3.85 (m, 2H, overlapped), 3.79 (s, 3H), 2.89 (t, J = 5.96 Hz, 2H), 
2.05 (bs, 1H).  
13
C NMR (100 MHz, CDCl3): δ (ppm) = 196.7, 
163.7, 151.1, 146.2, 133.2, 133.0, 130.8, 130.6, 113.6, 113.3, 
112.8, 63.9, 56.1, 56.0, 55.5, 35.9. IR (neat): υ = 3378, 2971, 2931, 2841, 1729, 1639, 1595, 
1510, 1454, 1392, 1288, 1256, 1218, 1181, 1163, 1102, 1070, 1050, 1021, 999, 953, 845, 
820, 708 cm
-1
. HRMS (EI) m/z calc’d C18H21O5 [M + H]
+
: 317.1384, found: 317.1387. 
(4-Fluorophenethyl)(3-(2-hydroxyethyl)thiophen-2-yl)methanone 
Pale yellow oil, 60% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.92 (m, 2H), 7.59 (d, J = 4.9 Hz, 1H), 7.16 (m, 3H), 3.95 (t, J = 6.0 Hz, 
2H), 3.22 (t, J = 6.0 Hz, 2H), 2.05 (bs, 1H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 188.4, 166.7 (
1
JC-F = 252.9 Hz), 148.2, 135.6(
4
JC-F = 
3.0 Hz), 135.3, 132.3 (
3
JC-F = 9.2 Hz), 131.6, 131.4, 115.5 (
2
JC-F = 21.7 
Hz), 63.3, 33.1. IR (neat): υ = 3245, 3128, 1622, 1596, 1519, 1503, 
1410, 1381, 1343, 1293, 1281, 1265, 1234, 1154, 1067, 1048, 1034, 1012, 974, 961, 907, 
843, 833, 809, 771, 745, 655, 630, 592, 524 cm
-1
. HRMS (EI) m/z calc’d C13H12FO2S [M + 
H]
+
: 251.0537, found: 251.0539. 
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(3-(2-Hydroxyethyl)thiophen-2-yl)(4-(trifluoromethyl)phenyl)methanone 
Pale yellow oil, 59% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
=7.96 (d, J = 8.0 Hz, 2H), 7.76 (d, J = 8.1 Hz, 2H), 7.63 (d, J = 4.9 Hz, 
2H), 7.19 (s, 1H), 7.17 (s, 1H), 3.97 (t, J = 6.0 Hz, 2H), 3.28 (t, J = 6.1 
Hz, 2H), 2.11 (bs, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) =188.6, 
149.0, 142.6, 134.9, 133.9, 133.6, 132.4, 131.8, 129.8, 125.3 (
3
JC-F = 3.6 
Hz), 63.2, 33.3. IR (neat): υ = 3404, 2948, 2898, 1640, 1579, 1515, 1409, 1381, 1320, 1275, 
1243, 1164, 1122, 1108, 1063, 1037, 1015, 997, 980, 879, 851, 833, 773, 745, 713, 696, 677, 
669, 654, 630 cm
-1
. HRMS (EI) m/z calc’d C14H12F3O2S [M + H]
+
: 301.0505, found: 
301.0508. 
(4-Fluorophenyl)(3-(2-hydroxyethyl)-1-methyl-1H-indol-2-yl)methanone 
 Bright yellow liquid, 78% isol. yield.
 1
H NMR (250 MHz, CDCl3): 
δ (ppm) = 7.99-7.87 (m, 2H), 7.61 (d, J = 7.9 Hz, 1H), 7.31-7.19 (m, 
5H), 3.84 (t, J = 6.1 Hz, 2H), 3.72 (s, 3H), 3.02 (t, J = 6.0 Hz, 2H), 
2.36 (bs, 1H).
 13
C NMR (62.5 MHz, CDCl3): δ (ppm) = 188.6, 167.9 
(
1
JC-F = 349.0 Hz), 138.9, 135.2, 132.5 (
3
JC-F = 9.3 Hz), 126.8, 125.4, 120.7, 120.4., 119.6, 
116.1 (
2
JC-F = 21.8 Hz), 110.2, 63.0, 32.3, 28.3. IR (neat): υ = 3411, 3057, 2941, 2875, 1713, 
1634, 1595, 1528, 1503, 1463, 1428, 1410, 1360, 1341, 1295, 1225, 1197, 1093, 1045, 1012, 
980, 944, 841, 813, 779, 616, 543 cm
-1
. HRMS (EI) m/z calc’d C18H16FO2NNa [M + Na]
+
: 
320.1063, found: 320.1063. 
5.5.4. Reaction with a 1-cyclopropyl substituted substrate 
The reaction was performed according to the procedure in section 5.2. 
Analytical data 
Cyclopropyl(3-(2-hydroxyethyl)thiophen-2-yl)methanone 
Pale oil, 56% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) =7.50 (d, J = 
4.9 Hz, 2H), 7.07 (d, J = 4.9 Hz, 1H), 3.89 (t, J = 5.5 Hz, 2H), 3.24 (t, J= 6.0 
Hz, 2H), 2.74 (bs, 1H), 2.44 (m, 1H), 1.24 (m, 2H), 1.04 (m, 2H). 
13
C NMR 
(100 MHz, CDCl3): δ (ppm) = 194.7, 146.0, 137.2, 132.0, 130.2, 63.4, 33.3, 
30.9, 20.6, 11.9. IR (neat): υ = 3421, 2930, 2874, 1713, 1644, 1520, 1410, 
1387, 1325, 1216, 1180, 1099, 1030, 988, 955, 919, 865, 840, 759, 712, 677, 590 cm
-1
. 
HRMS (EI) m/z calc’d C10H13O2S [M + H]
+
: 197.0631, found: 197.0628. 
5.5.5. General procedure for the Fe(OTf)2L1 catalysed aerobic cleavage of Csp
3
-Csp
3
 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 
times) and left under an inert atmosphere. The corresponding ether (2.0 mL) was added and 
the reaction tube was degassed, charged with dioxygen gas (1 atm, 3 times) and kept under 
oxygen (1 atm) by using a balloon. The reaction mixture was heated to 60 
°
C and left 
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overnight. The reaction was purified by silica gel column chromatography (Hexane/EtOAc, 
gradient: 10/1 to 4/1 or 2/1) to afford the unreacted starting material and the reaction 
products. 
Analytical data 
6,7-Dimethoxyisochroman-1-one
33
  
 
White solid. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.54 (s, 1H), 6.69 (s, 
1H), 4.51 (t, J = 6.0 Hz, 2H), 3.94 (s, 3H), 3.87 (s, 3H), 2.99 (t, J = 6.0 Hz, 
2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 165.6, 154.0, 148.8, 134.3, 
117.8, 112.2, 109.5, 67.7, 56.5, 27.9. IR (neat): υ = 2952, 2911, 2836, 
1706, 1602, 1511, 1461, 1421, 1394, 1336, 1270, 1240, 1203, 1157, 1087, 1058, 1027, 962. 
HRMS (EI) m/z calc’d C11H13O4 [M + H]
+
:  209.0808, found, 209.0811.   
Isochroman-1-one
34
  
 Colourless liquid. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 8.12 (d, J = 7.7 Hz, 
1H), 7.57 (t,    J = 6.3 Hz, 1H), 7.41 (t, J = 7.6 Hz, 1H), 7.28 (d, J = 7.4 Hz, 1H), 
4.56 (t, J= 6.2 Hz, 2H), 3.08 (t, J = 6.0 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 165.1, 139.5, 133.6, 127.7, 125.3, 124.0, 67.3, 27.8. IR (neat): υ = 
1714, 1602, 1459, 1386, 1294, 1240, 1116, 1087, 1024, 954, 744, 693, 636 cm
-1
. HRMS 
(EI) m/z calc’d C9H9O2 [M + H]
+
: 149.0597, found, 149.0597.  
(±)-6,7-Dimethoxy-3-(4-methoxyphenyl)-4-methylisochroman-1-one 
White solid, 30% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.60 (s, 1H), 7.29 (m, 2H), 6.91 (d, J = 8.7 Hz, 2H), 
6.77 (s, 1H), 5.14 (d, J = 9.0 Hz, 1H), 3.96 (s, 3H), 3.93 (s, 3H), 
3.81 (s, 3H), 3.31 (m, 1H), 1.25 (d, J = 6.96 Hz, 3H). 
13
C NMR 
(100 MHz, CDCl3): δ (ppm) = 165.1, 159.8, 153.9, 148.2, 137.9, 
130.1, 128.5, 117.1, 113.9, 111.9, 107.5, 85.5, 56.2, 56.1, 55.3, 36.8, 15.9. IR (neat): υ = 
2968, 2932, 2836, 1709, 1604, 1511, 1457, 1411, 1379, 1282, 1248, 1213, 1178, 1165, 1134, 
1084, 1073, 1025, 876, 834, 559, 528 cm
-1
. HRMS (EI) m/z calc’d C19H21O5 [M + H]
+
: 
329.1384, found, 329.1390. Anal Calc’d for C19H20O5 : C, 60.50, H, 6.14, found: C, 60.14, 
H, 6.05. 
(±)-3-(3,4-Dimethylphenyl)-6,7-dimethoxy-4-methylisochroman-1-one 
White solid, 27% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.60 (s, 1H), 7.08 (m, 3H), 6.76 (s, 1H), 5.13 (d, J = 8.9 
Hz, 1H), 3.95 (s, 3H), 3.93 (s, 3H), 3.31 (m, 1H), 2.26 (s, 3H), 
2.25 (s, 3H), 1.26 (d, J = 7.0Hz, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 165.1, 153.9, 148.2, 137.9, 137.1, 136.8, 135.4, 
129.6, 128.3, 124.6, 117.1, 111.8, 107.5, 85.7, 56.2, 56.1, 36.7, 19.8, 19.5, 16.1. IR (neat): υ 
= 1698, 1604, 1507, 1454, 1413, 1356, 1290, 1252, 1213, 1196, 1169, 1157, 1087, 1072, 
1037, 950, 875, 875, 820, 802, 774, 752 cm
-1
. HRMS (EI) m/z calc’d C20H23O4 [M +        
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H]
+
: 327.1591, found, 327.1598. Anal Calc’d for C20H22O4 : C, 73.60, H, 6.79, found: C, 
73.28, H, 6.75.  
5.5.6. Factors determining the selectivity of the Csp
3
-Csp
3
 vs Csp
3
-O bond cleavage 
The reactions were performed according to the procedure described in section 5.4. 
Analytical data 
4H-Thieno[2,3-c]pyran-7(5H)-one
35
  
White solid, 18% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.59 (d, J 
= 4.8 Hz, 1H), 6.94 (d, J = 4.8 Hz, 1H), 4.52 (t, J = 6.0 Hz, 2H), 2.96 (t, J = 6.0 
Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 161.6, 147.8, 134.8, 127.1, 
126.9, 68.7, 25.5. IR (neat): υ = 1755, 1492, 1426, 1200, 1163, 1122, 1085 cm-1. 
HRMS (EI) m/z calc’d C7H7O2S [M + H]
+
: 155.0161, found, 155.0159.  
1-(3-(2-Hydroxyethyl)thiophene-2-yl)hexan-1-one 
Colourless oil, 20% isol. yield.
 1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 7.49 (d, J = 4.8 Hz, 1H), 7.05 (d, J = 4.7 Hz, 1H), 3.87 (t, J = 6.1 
Hz, 2H), 3.28 (t, J = 6.0 Hz, 2H), 2.87 (t, J = 7.0 Hz, 2H), 25.25 (bs, 
1H), 1.72 (m, 2H), 1.34 (m, 4H), 0.87 (m, 3H).
 13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 195.2, 146.7, 132.1, 129.8, 126.5, 63.3, 42.0, 33.3, 
31.4, 24.4, 22.4, 13.9. HRMS (CI) m/z calc’d C12H17OS [(M - H2O) + 
H]
+
: 209.0995, found, 209.1000. 
1-(3-(2-Hydroxyethyl)thiophene-2-yl)-2-methylbutan-1-one 
 Colourless oil, 13% isol. yield.
 1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.49 
(d, J = 4.8 Hz, 1H), 7.05 (d, J = 4.8 Hz, 1H), 3.90 (t, J = 5.9 Hz, 2H), 3.27 (t, 
J = 6.0 Hz, 2H), 2.30 (bs, 1H), 1.80 (m, 1H), 1.44 (m, 2H), 1.20 (d, J = 7.0 
Hz, 3H), 0.90 (t, J = 7.0 Hz, 3H) .
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 
195.6, 146.5, 133.0, 128.9, 122.5, 68.1, 41.1, 35.9, 25.1, 22.7, 13.9. HRMS 
(CI) m/z calc’d C11H17O2S [M + H]
+
:  213.0944, found, 213.0949. 
1-(3-(2-Hydroxyethyl)thiophene-2-yl)-2,2-diemthylpropan-1-one 
Colourless oil, 12% isol. yield.
 1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.43 (d, 
J= 4.9 Hz, 1H), 7.02 (d, J= 4.9 Hz, 1H), 3.89 (t, J = 5.8 Hz, 2H), 3.08 (t, J= 6.0 
Hz, 2H), 1.60 (bs, 1H), 1.37 (s, 9H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
202.5, 147.4, 133.2, 130.4, 128.3, 63.3, 44.6, 33.4, 27.7. HRMS (CI) m/z 
calc’d C11H17O2S [M + H]
+
:  213.0944, found, 213.0950. 
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5.5.7. General procedure for the Fe(OTf)2L1 catalysed aerobic cleavage of Csp
2
-Csp
3
 
and Csp
3
-O bonds 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 
times) and left under an inert atmosphere. The corresponding ether (2.0 mL) was added and 
the reaction tube was degassed, charged with dioxygen gas (1 atm, 3 times) and kept under 
oxygen (1 atm) by using a balloon. The reaction mixture was heated to 60 
°
C and left 
overnight. The reaction was purified by silica gel column chromatography (Hexane/EtOAc, 
gradient: 10/1 to 2/1) to afford the unreacted starting material and the phenethyl alcohol. 
Analytical data 
2-(4-Fluorophenyl)ethanol 
36 
Colourless oil, 91% isol. yield.
 1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.18 (m, 2H), 7.00 (m, 2H), 3.84 (t, J = 6.0 Hz, 2H), 2.84 (t, J = 6.4 Hz, 
2H), 1.42 (bs, 1H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 162.8 (
1
JC-F  
= 242.7 Hz), 134.1 (
4
JC-F  = 3.1 Hz), 130.4 (
3
JC-F  = 7.7 Hz), 115.4 (
2
JC-F  = 20.8 Hz), 63.6, 
38.3. IR (neat): υ = 3322, 2939, 2877, 1601, 1508, 1219, 1158, 1097, 1043, 1016, 934, 851, 
820, 767, 722, 544, 502 cm
-1
. HRMS (CI) m/z calc’d C8H13FON [M + NH4]
+
:  158.0976, 
found, 158.0976.  
2-Phenylethanol 
37 
Colourless oil, 87 % isol. yield.
 1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.36 
(m, 2H), 7.28 (m, 3H), 3.88 (t, J = 6.3 Hz, 2H), 2.89 (t, J = 6.4 Hz, 2H), 1.58 
(bs, 1H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 138.7, 129.3, 128.8, 126.7, 
63.9, 39.5, 31.2. HRMS (CI) m/z calc’d C8H14NO [M + NH4]
+
:  140.1070, found, 140.1071. 
2-(4-Methoxyphenyl)ethanol 
37 
Dense colourless oil, 47 % isol. yield.
 1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.15 (m, 2H), 6.86 (m, 2H), 3.81 (t, J = 6.0 Hz, 2H), 3.79 (s, 
3H, overlapped), 2.81 (t, J = 6.5 Hz, 2H), 1.53 (bs, 1H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 158.2, 130.4, 129.9, 114.0, 63.8, 55.2, 38.2. IR (neat): υ = 3342, 
2935, 2835, 1611, 1510, 1464, 1441, 1300, 1241, 1177, 1110, 1033, 819, 809, 560, 518 cm
-1
. 
HRMS (CI) m/z calc’d C9H12O2 [M + H]
+
:  153.091, found, 153.0909.  
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2-(Thiophen-3-yl)ethanol 
38
 
Colourless oil, 34 % isol. yield.
 1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.34 
(d, J = 4.91 Hz, 1H), 7.14 (s, 1H), 7.04 (d, J = 4.8 Hz, 1H), 3.98 (t, J = 5.9 Hz, 
2H), 2.97 (t, J = 6.0 Hz, 2H), 1.6 (bs, 1H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 138.7, 128.3, 125.9, 121.7, 62.9, 33.6. IR (neat): υ = 3321, 2933, 2876, 1409, 1389, 
1331, 1153, 1044, 1018, 860, 834, 768, 689, 662, 630, 582 cm
-1
. HRMS (CI) m/z calc’d 
C6H6S [M + H]
+
: 111.0263, found, 111.0261.  
2-(3,4-Dimethoxyphenyl)ethanol
 39 
White solid, 10 % isol. yield.
 1
H NMR (400 MHz, CDCl3): δ (ppm) = 
6.82 (m, 3H), 3.88 (s, 3H), 3.85 (s, 3H, overlapped), 3.83 (t, 2H, 
overlapped), 2.82 (t, J = 6.0 Hz, 2H), 1.50 (bs, 1H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 149.0, 147.7, 130.9, 120.9, 112.1, 111.3, 63.7, 55.9, 55.8, 38.7. IR 
(neat): υ = 3234, 2981, 2884, 2837, 1588, 1514, 1470, 1481, 1444, 1417, 1332, 1255, 1235, 
1189, 1154, 1136, 1073, 1042, 1024, 859, 849, 807, 763, 631 cm
-1
. HRMS (CI) m/z calc’d 
C10H14O3 [M + H]
+
:  183.1016, found, 183.1020.  
5.5.8. General procedure for the Fe(OTf)2L1 catalysed aerobic cleavage of Csp
3
-Csp
3
 
with decarboxylative cleavage of Csp
2
-O or Csp
2
-N bonds 
In a Radley’s tube equipped with a magnetic stir bar ligand L1 (5.67 x 10-3 mmol, 5.2 mg) 
and Fe(OTf)2 (5.65 x 10
-3
 mmol, 2.0 mg) were added. The tube was sealed, degassed (3 
times) and left under an inert atmosphere. The corresponding ether (2.0 mL) was added and 
the reaction tube was degassed, charged with dioxygen gas (1 atm, 3 times) and kept under 
oxygen (1 atm) by using a balloon. The reaction mixture was heated to 60 
°
C and left 
overnight. The reaction was purified by silica gel column chromatography (Hexane/EtOAc, 
gradient: 4/1 to 1/1) to afford the unreacted starting material and the products. 
Analytical data 
γ-Butyrolactone40 
Colourless oil. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 4.37 (t, J = 7.0 Hz, 2H), 
2.53 (t, J = 7.0 Hz, 2H), 2.30 (q, J = 7.0 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 178.1, 68.9, 28.2, 22.6. IR ν (neat) = 1764, 1375, 1162, 1034, 990 cm-1. 
HRMS (ESI) m/z calc’d C4H10O2N [M+NH4]
+
: 104.0706, found, 104.0707.  
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Ethyl piperidine-3-carboxylate
41 
Colourless oil, 16% isol. yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 4.12 
(q, J = 6.8 Hz, 2H), 3.20 (d, J = 12.3, 3.8 Hz, 1H), 2.99-2.94 (m, 1H), 2.85 (dt, 
J = 12.3, 9.3 Hz, 1H), 2.65 (dt, J = 12.4, 10.3 Hz, 1H), 2.45-2.41 (m, 2H), 
2.09-1.97 (m, 1H), 1.67 (bs, 1H), 1.66 (m, 1H, overlapped), 1.48 (m, 1H), 1.28 (t, J = 6.8 
Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 174.4, 60.2, 48.5, 46.3, 42.5, 27.3, 25.5, 
14.2. HRMS (CI) m/z calc’d C8H16O2N [M+H]
+
: 158.1176, found, 158.1176.  
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6.1. Introduction 
6.1.1. Oxidative cleavage of olefins 
6.1.1.1. Ozonolysis 
In synthetic chemistry, the oxidative cleavage of alkenes is a widely employed methodology 
as it allows the introduction of oxygen functionalities in molecules, functional group 
deprotection or degradation of large molecules.
1
 Additionally, it is a frequent transformation 
in the synthesis of pharmaceutical and biologically active compounds or in total synthesis of 
complex molecules.
2
 For instance, the oxidative cleavage of the olefin functionality in 
precursor 1 allows a facile preparation of intermediate 2 which is used in the synthesis of 
cephalosporin antibiotics cefaclor and ceftibuten
3
 (Scheme 1). In addition, the oxidative 
olefin cleavage in species 5 is a crucial final step in Avery’s ten step total synthesis of the 
antimalarial drug (+)-artemisinin
4
 (Scheme 1). 
Since its discovery by C. Friedrich Schönbein in 1840, ozonolysis has initially been 
employed as an important method for structural elucidation of unknown molecules and with 
the development of modern spectroscopic techniques, it has evolved to a widely applied 
methodology in synthetic chemistry for the selective oxidation of organic compounds.
5
  
Harries ozonolysis, i.e. the oxidative cleavage of olefins to carbonyl groups mediated by 
ozone, has gained particular attention as a useful synthetic method for obtaining carbonyl 
compounds from olefins with good efficiency and cleanness.
6
 
The accepted reaction mechanism was proposed by Criegee in 1953 and involves the 1,3-
cycloaddition of ozone to the olefin affording a molozonide intermediate that rapidly 
decomposes into the Criegee zwitterion via 1,3-retrocycloaddition. A subsequent 1,3-
cycloaddition of the zwitterion generates a more stable trioxolane intermediate
7
 (Scheme 2). 
Experimental evidence in agreement with this mechanism has been provided by Berger et al. 
using 
17
O-NMR techniques and other isotopic labeling experiments.
8
 Further exposure of the 
resulting trioxolane to reducing or oxidizing conditions as well as the addition of different 
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additives allow strict control of the degree of oxidation in the final reaction product 
expanding the versatility of this method
9
 (Scheme 3).  
 
 
Scheme 1. Examples of oxidative cleavage of olefins in the synthesis of pharmaceutical 
compounds 
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Scheme 2. Generally accepted mechanism of the ozonolysis of olefins 
 
 
Scheme 3. Control of the product distribution by reductive or oxidant conditions and 
additives 
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In spite of the versatility and cleanness of the Harries ozonolysis, safety issues related to the 
use of ozone and the in situ formation of explosive peroxide intermediates tend to make 
difficult its large scale applications.
10
 Additionally, the stoichiometric amounts of reducing 
or oxidizing agents needed during the work up and low reaction temperatures required (-78 
°
C) do not fit in the context of sustainable chemistry. 
6.1.1.2. Alternatives to ozonolysis 
In an attempt to overcome the operational issues related to the ozonolysis reaction, Dussault 
et al. demonstrated a safer reductive ozonolysis in the presence of amine N-Oxides.
11
 
Aldehydes were selectively obtained upon reaction of monosubstituted olefins with an 
excess of NMMO under ozone at significantly higher temperatures (circa 0 
°
C) than a 
conventional ozonolysis. From a mechanistic perspective, an initial molozonide formation 
followed by its decomposition into the zwitterion species is proposed. However, the 
resulting carbonyl oxide fragment is attacked by the nucleophilic amine N-oxide generating 
an unstable zwitterion that rapidly decomposes releasing oxygen, amine and the aldehyde 
product (Scheme 4).  
 
Scheme 4. Ozonolysis in the presence of amine N-oxides 
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Other operationally safer methodologies based on the use of metal oxidants have been 
widely explored.  However, they normally exhibit lower efficiencies and poorer selectivity 
and involve the use of toxic metals. Toxic and strong oxidizing agents such as CrO3 and 
neutral or acidic solutions of KMnO4 can undergo the oxidation of olefins to carbonyl 
compounds on its highest oxidation state.
12
 The reaction mechanism involves the oxidation 
of the olefin substrate to a diol intermediate and its subsequent cleavage to carbonyl 
compounds.  Under the aqueous reaction conditions, the aldehyde products can undergo 
facile overoxidation to carboxylic acids. In the case of KMnO4, the selectivity towards the 
formation of the carbonyl product can be improved by using a benzene solution with crown 
ether to trap the K
+ 
cations (Scheme 5a)). 
 
Scheme 5. Additional methods for olefin oxidation to carbonyls using toxic metals have 
limitations such as overoxidation or multistep syntheses 
 
The overoxidation problem can be overcome with the Johnson-Lemieux oxidation
13
 that 
uses a combination of OsO4 and NaIO4 in an organic solvent to prevent the overoxidation of 
aldehydes to carboxylic acids (Scheme 5 b)), or by using OsO4 as oxidizing agent to afford a 
cis-diol intermediate that can be further cleaved to carbonyl groups by subsequent treatment 
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with periodic acid or Pb(OAc)4 (Upjohn dihydroxylation/ diol cleavage)
14
 (Scheme 5 c)). In 
order to avoid the use of toxic OsO4, combinations of RuCl3 with oxidants such as Oxone or 
HIO4 under buffered conditions have been applied to the selective oxidation of olefins to 
aldehydes.
15
 Even though the scope of this method covered an ample variety of olefins, high 
catalyst loadings and more than stoichiometric amounts of oxidants were required to afford 
the carbonyl products in good yields. Additionally, undesired diol formation was also 
observed when monosubstituted olefins were used as substrates (Scheme 6). 
 
Scheme 6. Ru catalysed oxidative cleavage of olefins 
 
Similarly, combinations of OsO4 with Oxone as the oxidizing reagent have been reported by 
Borhan et al. as an alternative to ozonolysis.
16
 Aromatic and aliphatic olefins were converted 
to carboxylic acids with good yields by this method without the formation of an intermediate 
diol species (Scheme 7 a)). However, a large excess of oxidant was required and the use of 
toxic OsO4 even in catalytic amounts question the environmental friendliness of this method. 
On the contrary, the combination of OsO4 with 2,6-lutidine and PhI(OAc)2 as oxidant was 
successfully applied to the selective cleavage of olefins to aldehydes with moderate to good 
yields.
17
 Although good selectivity towards the formation of the aldehyde was achieved, 
some undesired α-ketoalcohol formation was also observed in specific substrates and a large 
amount of waste was generated due to the large amounts of additives needed (Scheme 7 b)). 
Chapter 6 
 
282 
 
 
Scheme 7. Oxidative cleavage of olefins to carboxylic acids catalysed by OsO4 
 
More recently, greener approaches to the oxidative cleavage of olefins have merged. 
Aromatic olefins can be selectively cleaved to aldehydes and ketones with moderate yields 
upon exposure to catalytic amounts of AuCl-neocuprine.
18
 The reaction is proposed to 
proceed via initial epoxidation of the olefin followed by its oxidation to the carbonyl 
functionalities. Even though the reaction proceeds in water and gold salts are less toxic than 
osmium ones, high catalyst loadings and a large excess of a peroxide oxidant are required to 
accomplish the reaction (Scheme 8). 
 
 
Scheme 8. Au-catalysed oxidative cleavage of olefins 
 
Additionally, an organocatalytic oxidative cleavage of styrenes to carbonyls has been 
reported recently.
19
 This method provides access to ketones with moderate yields under 
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aerobic exposure and the reaction is believed to occur via the formation of a dioxetane 
intermediate. Nonetheless, a high catalyst loading is needed and low efficiency is achieved 
in the case of monosubstituted styrenes (Scheme 9 a)). Wang and Jiao have also reported the 
use of TEMPO as an organocatalyst for the oxidative nitrogenation of olefins by C-C 
cleavage allowing the formation of synthetically useful and versatile oxo nitrile scaffolds
20
 
(Scheme 9 b)). 
 
 
Scheme 9. Organocatalytic cleavage of olefins 
 
Due to the potential usefulness of iron in oxidation chemistry and due to its environmental 
friendliness, Beller and co-workers reported the use of Fe2O3 nanoparticles as heterogeneous 
catalysts for the selective oxidation of styrenes to aldehydes using H2O2 as oxidant.
21
 
Although excellent selectivity was achieved, this method still suffers from limited efficiency 
and poor scope which hampers its applicability in conventional organic synthesis (Scheme 
10). 
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Scheme 10. Oxidative cleavage of styrenes catalysed by Fe2O3 nanoparticles 
 
Finally, the direct oxidative cleavage of olefins to carbonyl compounds has also been 
attempted in the absence of catalytic species by using singlet oxygen (
1
O2) that can be 
generated from the chemical reaction of H2O2 and NaOCl or by irradiating O2 with light.  
For instance, the photooxidation of monosubstituted olefins has been achieved in biphasic 
media under UV light irradiation using molecular oxygen as the sole oxidant.
22
 However, in 
the absence of a molecular catalyst selectivity becomes problematic with an ample 
distribution of products being obtained and a very limited substrate scope being achieved. 
6.1.2. Additional strategies for transforming olefins into carbonyls 
6.1.2.1. Hydroformylation 
Aldehydes can be obtained from alkenes under high pressures of CO/H2 (10-100 atm) and 
high temperatures (40 to 200 
°
C) in the presence of catalytic amounts of a Rh complex 
(Scheme 11). The process is known as hydroformylation, oxo synthesis or oxo process and 
since its introduction in 1938 it has become probably one of the most relevant industrial 
processes of the 20
th
 century, reaching a production of 6,6 x 10
6
 tons in 1995.
23 
Otto Roelen 
demonstrated the use of HCo(CO)3 as the first catalyst for hydroformylation; however, Co 
based catalysts have been replaced since 1970 with more selective and highly active 
rhodium-based catalysts.
24
 Many improvements have been successfully introduced to the 
initial reaction including asymmetric versions
25
 and water soluble catalysts that simplify 
product separation from the catalyst.
26
 The HCo(CO)4 catalysed conversion of ethene into 
propanal (Scheme 11) involves the coordination of ethene to the Co catalyst and its insertion 
into the Co-H bond, followed by a fast migratory insertion of a carbonyl into the resulting 
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Co-C bond. Oxidative addition of H2 followed by reductive elimination affords the aldehyde 
product and regenerates the initial catalytic species HCo(CO)4. Due to the incorporation of 
the carbonyl moiety during the catalytic cycle, the hydroformylation reaction promotes the 
aldehyde chain extension with one additional carbon. 
 
 
Scheme 11. General scheme of the hydroformylation reaction and the catalytic cycle 
proposed for the conversion of ethene to propanal 
 
6.1.2.2. Wacker oxidation 
The Wacker-Tsuji oxidation is a widely applied methodology for the production of ketone 
type compounds from olefinic substrates under aerobic conditions on a laboratory scale.
27
 
This transformation originally stems from the Wacker process that allows the conversion of 
ethene into acetaldehyde on an industrial scale.
28  
Wacker processes rely on the use of PdCl2 
as catalyst, water as the oxygen source and CuCl as additive to regenerate the active catalytic 
species (Scheme 12). Important industrial applications have originated from Wacker 
chemistry. Thus it is considered one of the most relevant processes of the century. 
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Scheme 12. Proposed catalytic cycle for the Wacker oxidation of ethane to acetaldehyde 
6.1.3. Additional alternatives for synthesizing carbonyl compounds 
Apart from oxidation reactions and hydroformylation, other relevant methodologies for the 
preparation of carbonyl compounds from precursors different from olefins include hydration 
of alkynes, oxidation of alcohols and Friedel Crafts acylation of aromatics. 
 
6.2. Aims of this chapter 
Research conducted in the area of iron-catalysed oxidation of olefins is mainly focused on 
undergoing epoxidation reactions or cis-diol synthesis.
29
 Olefins have indeed proven 
challenging substrates for biomimetic iron catalsyts as they are prone to decompose π-rich 
substrates under oxidative reaction conditions.
30
  However, iron-based metalloenzymes are 
capable of selectively cleaving olefinic substrates under aerobic atmosphere with excellent 
efficiency.
31
 Beller and co-workers have shown that iron nanoparticles can undergo olefin 
cleavage in the presence of H2O2 (vide supra); but to the best of our knowledge, there are no 
reports in the literature of an iron catalyst that specifically attempts the oxidative cleavage of 
olefins with O2. The synthetic relevance of this transformation in conjunction with the 
environmental and safety issues of the currently available methodologies suggests that a 
mild, selective and environmentally friendly iron-catalysed oxidative cleavage of olefinic 
substrates under aerobic conditions would be highly desirable for synthetic chemists. In this 
chapter, two main targets are attempted: 
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1. To expand the scope of the catalytic applications of Fe(OTf)2L1 in oxidation 
chemistry, evolving  from the selective aerobic oxidations and C-C cleavages of 
ethereal substrates to alkene type substrates which represent a current challenge for 
oxidation chemistry. 
2. To develop an efficient and highly selective iron-catalysed methodology for the 
aerobic cleavage of olefins to carbonyl compounds that can overcome the limitations 
of the already available methods. 
 
6.3. Results and discussion 
6.3.1. Optimisation of the Fe-catalysed aerobic cleavage of olefins 
6.3.1.1. Model reaction for optimization studies 
To start our investigations, the non-sterically encumbered and slightly electron rich 4-
methylstyrene 7 was chosen as model substrate.   Due to their superior performance in the 
selective oxidation and cleavage of ethereal substrates, iron triflates were initially chosen as 
preferred metals salts. Almost no oxidative cleavage was observed when 7 was exposed to 
catalytic amounts of Fe(OTf)2-L1 under aerobic atmosphere, however, replacement of the 
iron salt with the stronger Lewis acid Fe(OTf)3
32
 cleanly furnished the aldehyde product 8 in 
low yields (Scheme 13). Among the PyBisulidine ligands, L1 was selected as the starting 
ligand as it showed the highest efficiency in the aerobic oxidation of ethers. Due to our 
interest in developing oxidation reactions under aerobic atmosphere, oxygen was targeted as 
the desired oxidant for accomplishing this transformation. 
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Scheme 13. Reaction conditions for screening 
 
6.3.1.2. Effect of temperature and concentration 
Under the conditions in Scheme 13, the oxidative cleavage of 7 to afford aldehyde 8 was 
observed and further investigated in a range of temperatures and concentrations. Formation 
of 8 was found to increase gradually with temperature until full conversion was achieved at 
70 
°
C (Scheme 14, entry 7). Additionally, more concentrated solutions of 7 resulted in higher 
conversions under identical reaction conditions in agreement with the significant 
concentration effect observed during the oxidation of ethereal substrates. Formation of 
formaldehyde 9 was also observed by 
1
H NMR. 
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Scheme 14. Effect of temperature and concentration in the oxidative cleavage of 7 
 
6.3.1.3. Solvent effect 
The Fe(OTf)3-L1 catalysed aerobic oxidation of 7 showed strong dependency on the reaction 
solvent (Scheme 15). Chlorinated solvents afforded the oxidised product 8 with moderate to 
very good yields, whereas poor activity was found in aryl solvents. This trend is opposite to 
the solvent effect observed during the oxidation of ethers where chlorinated solvents were 
found detrimental for the reactivity of the complex. The catalytic activity of the Fe(OTf)3L1 
complex was also inhibited in coordinating solvents such as alcohols or MeCN. 
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Scheme 15. Solvent studies 
 
6.3.1.4. Ligand effect 
Among all the reaction parameters investigated, the ligand selection was found crucial for 
achieving good catalytic activity in the oxidation of 7 (Scheme 16). Iron-PyBisulidine 
complexes afforded the best conversions, with L1 showing the highest efficiency. 
Combinations of Fe(OTf)3 with the slightly electron rich PyBisulidines L2 and L3 also 
afforded 8 in good conversions whereas moderate conversions were obtained with the more 
sterically demanding L4 and the more electron deficient L5. However, replacement of 
PyBisulidine skeletons with asymmetric or bidentate derivatives was found very detrimental 
for the aerobic cleavage of 7. Saturated tridentated and bidentate Box type ligands also 
showed poor efficiency. In the absence of ligand, catalytic amounts of Fe(OTf)3 caused total 
decomposition of the initial substrate, highlighting again the importance of the ligand in 
tuning the metal properties and achieving good selectivity. 
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Scheme 16. Ligand effect in the aerobic cleavage of 7 
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6.3.2. Substrate scope 
6.3.2.1. Aerobic cleavage of monosubstituted styrenes 
Under optimised conditions an ample variety of styrenes were subjected to the Fe(OTf)3L1 
catalysed aerobic cleavage (Scheme 17). Good to excellent yields were obtained for styrene 
substrates with very low catalyst loadings (0.7 mol%). The catalyst tolerated the presence of 
electron-withdrawing groups in both meta- and para-positions and similar efficiency was 
observed with more electron rich substrates. Nonetheless, medium conversions were 
achieved with more sterically demanding substrates probably because their interaction with 
the iron centre is hampered by the steric hindrance of the bulky L1 ligand. In fact, ortho-
methylstyrene was oxidatively cleaved in lower yield (circa 12%), probably because of such 
steric effects. Interestingly, the reactions proceeded cleanly and selectively to afford the 
aldehyde product without any further oxidation to their carboxylic acid form as no aqueous 
media is needed to accomplish the reaction. Diol byproduct formation was not observed 
either under these reaction conditions with the formaldehyde resulting from the olefin 
cleavage being the only additional species detected by 
1
H NMR spectroscopy. In addition, 
the use of a previously formed Fe(OTf)3L1 complex did not improve the reaction 
conversion; thus a facile methodology involving an in situ prepared complex can be used.  
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Scheme 17. Aerobic cleavage of monosubstituted styrenes 
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6.3.2.2. Aerobic cleavage of 1,1,-substituted styrenes 
Generating ketone products from 1,1-disubstituted styrenes via aerobic cleavage was next 
targeted. The conjugated alkene α-methylstyrene was selected as model substrate and under 
optimised conditions it was successfully converted to acetophenone 11 with moderate yield.  
A slight increase in the reaction temperature and a decrease in the S/C ratio contributed to an 
increase in the conversion (Scheme 18). Nonetheless, replacement of PyBisulidine ligand L1 
with the bulkier L4 provided very good conversion too. 
 
Scheme 18. Optimisation of the aerobic cleavage of 32 
With the optimal conditions in hands, the scope of the Fe(OTf)3L4 catalysed aerobic 
cleavage of α-methylstyrenes was next investigated (Scheme 19). α-Methylstyrenes bearing 
electron withdrawing functionalities were efficiently oxidised to ketones in very good yields 
with low catalyst loadings (1 mol%). To our delight, the very challenging 4-(prop-1-en-2-
yl)pyridine (entry 5) was also partially oxidized to its ketone form in moderate yields. 
Remarkably, the catalytic aerobic cleavage proceeded with very good yields even after 
replacement of the α-methyl group with bulkier pi-, pseudo-pi, or alkyl cycles (entries 6-9). 
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Scheme 19. Aerobic cleavage of 1,1-disubstituted styrenes 
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6.3.3. Mechanistic investigations 
6.3.3.1. Involvement of radical species 
In order to elucidate whether radical species are generated in the oxidative cleavage of 
olefins, styrene 22 was subjected to the Fe(OTf)3L1 catalysed aerobic cleavage under 
optimal conditions in the presence of a radical trapping reagent (Table 1). Whereas 2,6-di-t-
butyl-4-methylphenol caused complete inhibition of the reaction even in equimolecular 
amounts of catalyst (entries 1-3), other C-selective radical traps hardly affected the oxidative 
cleavage (BrCCl3) or caused significant inhibition when added in large excess (p-
benzoquinone). O-selective trapping reagents (Ph2NH) also caused total inhibition of the 
reaction in small amounts. 
These results suggest that radical species may be generated during the aerobic cleavage. 
However, it cannot be discarded that the reduced reactivity observed may stem from the 
catalysts being deactivated by interacting with some of the trapping reagents rather than 
from proper radical formation. 
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Table 1. Fe(OTf)3L1 catalysed aerobic cleavage of 22 in the presence of C- and O-selective 
radical trapping reagents. 
 
To shed some light into the possible radical formation, the aerobic cleavage of styrene 22 
was next conducted in the presence of the radical initiator benzoyl peroxide at 45 °C 
(Scheme 24). The presence of the radical initiator did not affect the aerobic cleavage of 22 
(13% vs 12%), nor did it result in other products formation.  These results suggest that a 
freely diffusing carbon-based radical species are not involved in the iron-catalysed aerobic 
cleavage. 
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Scheme 24. Fe(OTf)3L1 catalsyed aerobic cleavage of 22 in the presence of a radical 
initiator 
Interestingly, catalytic oxidative cleavages of styrene type substrates normally involve the 
formation of benzyl radical intermediates
33
 from which polymerization or dimer byproducts 
are also generated (Scheme 25). In contrast, formation of radical-derived byproducts was not 
detected during the Fe(OTf)3-L1 catalysed oxidative cleavages. Moreover, catalysts 
following radical pathways are inactive towards the oxidation of electron deficient styrenes 
probably because of the lower stability of the radical intermediates. In contrast, the 
Fe(OTf)3-L1 catalyst can oxidise electron deficient styrenes with good yields (Scheme 17 
and 19). 
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Scheme 25. Catalytic aerobic cleavage of styrene type substrates involving benzyl radical 
intermediates 
Further evidence of the absence of free radical species formation was manifested during the 
chemoselective aerobic cleavage of 44 to 45 and formaldehyde (Scheme 19, entries 7,8). 
Formation of radical species during the oxidation of this pseudo-pi compound would 
generate cyclopropylbenzyl radical clocks which are known to undergo fast ring-opening 
rearrangements
34
 (k = 3.9 x 10
5
 s
-1
) and thus, the formation of different oxidised products 
would be expected (Scheme 26). Indeed, ring opening products have been characterised 
during the photooxidation of some cyclopropyl substituted-alkenes
35
 (Scheme 27).
 
However, 
singlet oxygen mediated cleavages of cyclopropyl substituted olefins are highly substrate 
dependent. For instance, allylic hydroperoxides have been observed as major products 
during the cleavage of electron rich cyclopropyl olefins probably via a mechanism involving 
H-abstraction from zwitterionic intermediates
36
 (Scheme 27).
 
On the other hand, the 
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photooxidation of 44 is known to furnish a distribution of products with the carbonyl 
product 45 being generated as a minor byporduct
37
 (Scheme 27). 
 
Scheme 26. Iron-catalysed aerobic cleavage of 44 to afford 45 does not involve the 
formation of byproducts resulting from ring opening processes. 
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Scheme 27. Photooxidation of cycloproppyl substituted olefins. 
Even though the formation of radical intermediates cannot be discarded, from these 
observations it can be concluded that freely diffusing C-based radicals are not being 
generated during the iron catalysed aerobic cleavage. In addition, the oxidative cleavage of 
radical-sensitive substrate to selectively afford ketone products seems to suggest that 
formation of singlet oxygen is not involved during the iron-catalysed oxidation reaction. 
6.3.3.2. Coordination of the olefin to the catalyst 
As the reactions between olefins and singlet oxygen are well known and oxidative cleavages 
to carbonyls have been widely observed from 
1
O2 reactions,
38
 we next investigated the 
differences between the 
1
O2 promoted and the Fe(OTf)3-L4 catalyzed aerobic cleavages of 
olefins. The 1,3-addition of singlet oxygen to olefins possessing at least one allylic hydrogen 
is known to  afford mainly allylic hydroperoxides.
39 However, when α-alkyl styrenes 50 and 
53 possessing allylic hydrogens were subjected to the Fe(OTf)3-L4 catalytic reaction, the 
carbonyl compounds 51 and 54 were obtained as oxidised products respectively, with no 
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formation of allylic hydroperoxides being observed (Scheme 28). Interestingly, the 
competing isomerization of the Z- olefin to its E-isomer was observed under the reaction 
conditions (products 52 and 55 respectively). Moreover, under inert atmosphere the iron 
catalyst furnished such isomerization products exclusively
40
 (Scheme 28), whereas under O2 
atmosphere oxidation products generated from the E-isomer were also observed albeit in low 
yields (product 33). Similarly, previously reported iron-catalysed isomerizations of olefins 
involve the initial coordination of the olefin to the iron centre.
41
 Thus, the observed 
isomerization points towards an initial coordination of the olefinic substrate to the iron 
catalyst during the aerobic cleavage. 
 
Scheme 28. Fe(OTf)3L4 catalysed aerobic cleavage of styrenes possessing allylic hydrogens 
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6.3.3.3. Competitive direct dehydrogenation of dienes 
Next we focus our attention in the oxidative cleavage of diene substrates. The 1,4-addition 
of singlet oxygen to these substrates is prone to yield endoperoxides, although depending on 
the substrate and/or reaction conditions subsequent rearrangements to afford different 
products have been reported.
42
 Delightfully, the trans-diene 56 was oxidatively cleaved into 
cinnamaldehyde and benzaldehyde when exposed to the catalytic reaction (Scheme 29). In 
stark contrast, cis-dienes 58 and 60 were dehydrogenated to arene products either under inert 
or aerobic atmosphere (Scheme 29). As discussed before the Fe(OTf)2L1 catalyst can 
undergo oxygenative dehydrogenation of ethereal substrates under aerobic conditions 
(chapter 4), however, the Fe(OTf)3L1 complex is capable of promoting the direct 
dehydrogenation of partially oxidised substrates under inert conditions. Similarly, exposure 
of dihydronaphthalenes 62 and 64 to the iron catalyst under inert atmosphere afforded 
naphthalene in low yields (Scheme 29).  Interestingly, traces of 62 were detected during the 
dehydrogenation of 64 suggesting a reaction mechanism that involves the initial 
isomerization of the substrate followed by the direct dehydrogenation
43
 of the relatively 
weak allylic CH bond in 62 (~85 kcal/mol).
44
 In contrast, the reaction of 62 with singlet 
oxygen initially affords the allylic hydroperoxide, which easily looses H2O2 yielding 
naphthalene
45
 (Scheme 30). In addition, exposure of 64 to singlet oxygen yields a 
distribution of products including naphthalene and a hydroperoxide
46
 (Scheme 30).
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Scheme 29. Competitive dehydrogenation of cis-dienes was observed in the presence of the 
iron catalyst under inert conditions 
 
Scheme 30. Reaction of 62 and 64 with singlet oxygen 
The photooxygenation of 1-phenyl-1-cycloalkenes 65 and 67 is known to afford 
hydroperoxides,
47
 however, exposure of these phenyl-1-cycloalkenes to the Fe(OTf)3-L4 
catalyzed oxidation reaction furnished, much to our surprise, naphthalene as major product 
(Scheme 31). The acyclic dialdehydes 66 and 68 were also obtained albeit in lower yields. 
Interestingly, ethene and small amounts of ethane were also identified as reaction byproducts 
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by GC, highlighting again the potential of the iron catalyst to promote C-C bond cleavages 
under aerobic conditions. Although the mechanism by which naphthalene is generated from 
65 and 67 is unclear, it might involve the iron-promoted rearrangement of the olefinic 
substrate under aerobic conditions, as no reaction takes place in the absence of O2 or the iron 
catalyst or in the presence of the radical initiator benzoyl peroxide. In fact, rearrangements 
of olefinic substrates in the presence of singlet oxygen have been widely reported and often 
led to unexpected products.
48
  
These results indicate that the iron catalyst can promote the aerobic cleavage of trans-dienes, 
however, cis-dienes are either selectively dehydrogenated or cleaved to afford unexpected 
products.   
 
Scheme 31. Fe(OTf)3-L4 catalysed aerobic cleavage of phenyl-1-cycloalkanes 
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6.3.3.4. Dioxetane intermediate formation 
Products resulting from the 1,3-addition of O2 to substrates possessing allylic hydrogens 
(Scheme 28) or from the 1,4-addition of O2 to dienes (Scheme 29) were not observed when 
investigating the substrate scope of the iron catalyzed aerobic oxidation. Nonetheless, the 
1,2-addition of 
1
O2 to very electron rich olefins is known to furnish dioxetane species that 
can easily cleave, affording carbonyl compounds.
49
 In contrast, the Fe(OTf)3-L1 catalyst was 
found capable of promoting the aerobic cleavage of electron deficient styrenes with high 
yields (Schemes 17 and 19). The iron-mediated 1,2-addition of O2 to the olefinic substrates 
to form a dioxetane species followed by its subsequent thermal or iron-mediated cleavage 
appears to be a plausible mechanism to explain the experimental observations. Indeed, 
formaldehyde and acetaldehyde were detected by NMR during the aerobic cleavages of 
monosubstituted styrenes and the 1,2-disubstituted styrene 12 respectively (Scheme 32). 
Significantly, the oxidation of 12 took place with lower yields than the cleavage of styrenes. 
 
Scheme 32. Postulated 1,2-addition of oxygen to olefins catalysed by Fe(OTf)3-L1 
Attempts to isolate any possible intermediate from the aerobic cleavage of 22 were 
unsuccessful probably because dioxetanes are thermally sensitive and can be cleaved even in 
the presence of metal traces
50
 and silica.
51
 Nonetheless, dioxetanes resulting from the 1,2-
additon of 
1
O2 to electron rich olefins can further react with diphenyl sulfide furnishing 
ketone type products. This is due to the diphenyl sulfide being capable of rapidly react with 
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dioxetanes whilst being inert towards endoperoxides, hydroperoxides and singlet oxygen.
52
 
Bearing this in mind and considering that the iron catalysts can oxidize electron deficient 
olefins, we envisioned that exposure of vinyl bromide 70 to the iron-catalyzed aerobic 
oxidation reaction would afford a dioxetane inetermediate, which could be further cleaved 
with the assistance of diphenyl sulfide affording phenacyl bromide 71 via halogen migration 
(Scheme 33). To our delight, 71 was obtained in 61% yield as the sole reaction product after 
exposure to the iron catalyst under aerobic atmosphere. Moreover, addition of diphenyl 
sulfide to the catalytic reaction furnished 71 in 96% yield, suggesting that dioxetane 
intermediates are involved in the oxidation reaction and that diphenyl sulfide can assist the 
iron catalyst in promoting their subsequent cleavage (Scheme 33). 
Some substrate scope in the oxygenation of vinyl halides with halogen migration has also 
been performed. 
 
Scheme 33. Iron catalysed conversion of vinyl bromide into phenacyl bromide is consistent 
with dioxetane intermediates 
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6.3.3.5. Postulated catalytic cycle 
The results above point to the Fe(OTf)3-L1 catalyzed oxygenation of olefins to afford a 
labile dioxetane intermediate followed by its iron or thermal-mediated cleavage to furnish 
carbonyl compounds. The formation of the peroxide intermediate is unclear mechanistically, 
however, its formation via 1,2-addition of singlet oxygen is not in agreement with 
experimental observations. Formation of the dioxetane via a radical pathway also seems 
unlikely as no byproducts derived from benzyl radicals were observed and no ring-opening 
of pseudo-pi substituted styrenes was observed.  
Having in mind the observed isomerization of olefins displaying allylic hydrogens, a 
mechanism involving the coordination of the substrate and the oxygen to the iron centre with 
concomitant formation of the dioxetane intermediate seems to be in operation. Such 
mechanism resembles the aerobic cleavages performed by some natural dioxygenases, such 
as tryptophan pyrrolase,
53
 which is known to cleave the C=C bond of the pyrrole ring in 
tryptophan probably via the formation of a ternary complex in which both molecular oxygen 
and substrate coordinate to the metalloenzyme.
54
 Due to the lack of free radicals formation, 
we suspect that the Fe(OTf)3-L1 mediated formation of the dioxetane species is likely to 
occur in a concerted fashion, with the both C-O bonds being formed almost simultaneously 
(Scheme 34). 
 
Scheme 34. Proposed catalytic cycle for the Fe(OTf)3-L1 catalyzed oxidative cleavage of 
olefins to carbonyls 
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6.4. Conclusions 
In conclusion, an operationally simple and environmentally friendly method for the 
oxidative cleavage of olefins is presented. An ample variety of olefins can be transformed to 
aldehydes or ketones with excellent chemoselectivity, good yields and high functional group 
tolerance. A catalytic cycle involving the formation of dioxetane intermediates is postulated 
on the basis of mechanistic studies. 
6.5. Experimental section 
6.5.1. General techniques 
Olefins were purchased from commercial suppliers and used without further purification 
unless otherwise specified. DCE was refluxed over CaH2 and distilled under N2 atmosphere. 
6.5.2. Synthesis of 1-substituted styrenes 
1-Substituted styrenes were synthesized via methylenation of the corresponding ketones as 
reported in the literature.
55
 A representative synthetic procedure is described below: 
Synthesis of 4-bromo-α-methylstyrene  
In a round bottom flask equipped with a magnetic bar, methyltriphenylphosphonium 
bromide (1.4 equiv., 7.0 mmol, 2.5 g), potassium tert-butoxide (1.4 equiv., 7.0 mmol, 785 
mg) and 4-bromoacetophenone (1.0 equiv., 5.00 mmol, 1.0 g) were added and dissolved in 
THF (20 mL). The reaction was stirred for 24h at r.t. and monitored by t.l.c. Upon 
completion, the solvent was eliminated in vacuo and the residue was purified by flash 
column chromatography (Hex/AcOEt 40/1) to afford the desired product as a colorless liquid 
(98% yield, 965 mg). 
Substrate characterization 
4-Bromo-α-methylstyrene56 (38) 
Colourless liquid, 95% isol.  yield. Purification by flash chromatography 
(Hexane/ AcOEt, 40/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.46-7.42 
(m, 2H), 7.34-7.31 (m, 2H), 5.35 (d, J = 0.4 Hz, 1H), 5.10 (q, J = 1.2 Hz, 
1H), 2.12 (d, J = 0.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
142.6, 140.5, 131.6, 127.5, 121.7, 113.4, 22.1. HRMS (EI) m/z calc’d C9H9Br [M + H]
+
: 
196.9961, found: 196.9957. 
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(Pyridin-4-yl)-α-methylstyrene57 (40) 
Yellowish liquid, 87% isol. yield. Purification by flash chromatography 
(AcOEt/ Hexane, 3/2). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 8.55 (dd, J = 
1.6, 4.8 Hz, 2H), 7.33 (dd, J = 1.6, 4.8 Hz, 2H), 5.57 (s, 1H), 5.26 (q, J = 1.6 
Hz, 1H), 2.14 (d, J = 1.6 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
150.2, 133.4, 132.5, 132.4, 128.8, 120.5, 116.3, 21.2. HRMS (EI) m/z calc’d C8H10N[M + 
H]
+
: 120.0808, found: 120.0810. 
Ethene, 11-diyldibenzene
58
 (42) 
Colourless liquid, 96% isol. yield. Purification by flash chromatography 
(Hexane/ AcOEt, 40/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.34-7.24 
(m, 10H), 5.46 (s, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 150.0, 
141.6, 128.2, 128.1, 127.7, 114.3. HRMS (EI) m/z calc’d C14H13 [M + H]
+
: 
181.1012, found: 181.1013. 
(1-Cyclopropylvinyl)benzene
59
 (44) 
Colourless liquid, 97% isol. yield. Purification by flash chromatography 
(Hexane/ AcOEt, 40/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.36-7.24 
(m, 5H), 5.14 (d, J = 0.2 Hz, 1H), 5.03 (t, J = 1.6 Hz, 1H), 1.71 (m, 1H), 
1.10 (m, 4H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) =156.1, 143.2, 128.5, 
127.4, 127.0, 110.3, 19.8, 11.0. HRMS (EI) m/z calc’d C14H13 [M + H]
+
: 145.1012, found: 
145.1012. 
(1-Cyclobutylvinyl)benzene
60
 (46) 
Colourless liquid, 87% isol. Yield. Purification by flash chromatography 
(Hexane/AcOEt, 30/1).
 1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.46-7.13 
(m, 5H), 5.38 (s, 1H), 5.02 (s, 1H), 3.56-3.34 (m, 1H), 2.31-2.15 (m, 2H), 
2.08-1.92 (m, 3H), 1.87-1.74 (m, 1H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) =152.0, 140.7, 128.1, 127.2, 126.1, 109.7, 39.5, 28.4, 17.7. HRMS (EI) m/z calc’d 
C12H15 [M + H]
+
: 159.1168, found: 159.1169. 
But-1-en-2-ylbenzene
56
 (50)
 
Colourless liquid, 97% isol. yield. Purification by flash chromatography 
(Hexane/ AcOEt, 40/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.42-7.39 
(m, 2H), 7.34-7.30 (m, 2H), 7.28-7.23 (m, 1H), 5.27 (s, 1H), 5.06 (q, J = 1.6 
Hz, 1H), 2.54-2.49 (m, 2H), 1.11 (t, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 150.4, 141.9, 128.6, 127.6, 126.4, 111.3, 28.4, 13.3. HRMS (EI) m/z 
calc’d C10H13 [M + H]
+
: 133.1012, found: 133.1011. 
(3-Methylbut-1-en-2-yl)benzene
61
 (53) 
Colourless liquid, 96% isol. yield. Purification by flash chromatography 
(Hexane/ AcOEt 40/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.61-7.58 
(m, 2H), 7.36-7.25 (m, 3H), 5.27 (d, J = 0.8 Hz, 1H), 4.93 (t, J = 1.2 Hz, 1H), 
1.68-1.65 (m, 1H), 0.87-0.81 (m, 3H), 0.60-0.57 (m, 3H). 
13
C NMR (100 
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MHz, CDCl3): δ (ppm) = 149.7, 142.0, 128.5, 127.8, 126.5, 109.4, 16.0, 7.0. HRMS (EI) 
m/z calc’d C11H14 [M +H]
+
: 147.1168, found: 147.11741. 
Analytical data for compounds 44-53 is in agreement with the commercially available 
materials. 
6.5.3. General procedure for the Fe(OTf)3L1 catalysed aerobic cleavage of styrenes 
In a Radley’s tube equipped with a magnetic stirring bar, Fe(OTf)3 (5.65 x 10
-3
 mmol, 2.9 
mg) and L1 (5.67 x 10
-3
 mmol, 5.2 mg) were added. The tube was sealed, degassed and left 
under inert atmosphere (3 times). Freshly distilled DCE (0.5 mL) was injected by syringe 
and the reaction mixture was allowed stirring for 1 hour at 40
°
C. 4-Methylstyrene (0.75 
mmol, 90 μL) was added by syringe and the reaction tube was degassed with dioxygen gas 
(1 atm, 3 times) and keep under oxygen (1 atm) by using a balloon. The tube was gradually 
heated to 70 
°
C and allowed to react for 5 hours. The reaction was purified by silica gel 
column chromatography (Hexane/EtOAc, 20/1) to afford the unreacted starting material and 
the aldehyde product. 
Product characterisation 
4-Methylbenzaldehyde
62
 (8) 
Colourless liquid (92% isol. yield, 0.69 mmol, 82.8 mg). Purification by 
flash chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 9.96 (s, 1H), 7.80 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 
2.44 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 192.0, 145.5, 134.2, 129.8, 129.7, 
21.9. IR (neat) ν = 3084, 2917, 1705, 1670, 1608, 1514, 1281, 1179, 1117, 807, 806, 751, 
540, 467 cm
-1
. HRMS (EI) m/z calc’d C8H9O [M + H]
+
: 121.0648, found: 121.0645. 
4-(Trifluoromethyl)benzaldehyde
62
 (11) 
Colourless liquid (90% isol. yield, 0.67 mmol, 116.4 mg). Purification by 
flash chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, 
DMSO-d6): δ (ppm) = 10.12 (s, 1H), 8.12 (d, J = 8.0 Hz, 2H), 7.88 (d, J = 
8.4 Hz, 2H). 
13
C NMR (100 MHz, DMSO-d6): δ (ppm) = 193.0, 166.5, 134.9, 130.5, 126.4, 
122.8. IR (neat) ν = 2670, 2549, 1691, 1583, 1515, 1425, 1315, 1286, 1162, 1135, 1106, 
1058, 1016, 937, 858, 775, 754, 700. HRMS (EI) m/z calc’d C8H6F3O [M + H]
+
: 175.0366, 
found: 175.0364. 
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4-Fluorobenzaldehyde
63
 (13) 
Colourless oil (78% isol. yield, 0.58 mmol, 71.8 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 9.97 (s, 1H), 7.99-7.90 (m, 2H), 7.32-7.21 (m, 3H).
 13
C NMR (100 
MHz, CDCl3): δ (ppm) = 190.4, 167.8 (
1
JC-F  = 255 Hz), 133.0 (
4
JC-F  = 3 Hz), 132.2 (
3
JC-F  = 
10 Hz), 116.4 (
2
JC-F  = 22 Hz). IR (neat) ν = 3098, 1701, 1601, 1508, 1424, 1312, 1291, 
1225, 1156, 1129, 853, 845, 767, 609, 495 cm
-1
. HRMS (EI) m/z calc’d C7H6OF [M + H]
+
: 
121.0397, found: 125.0398. 
4-Chlorobenzaldehyde
64
 (15) 
White solid (87% isol. yield, 0.65 mmol, 91.1 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 9.98 (s, 1H), 7.84 (d, J = 8.6 Hz, 2H), 7.59 (d, J = 8.4 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 190.8, 140.9, 134.7, 130.9, 129.4. IR (neat) ν = 
2840, 2654, 2588, 1702, 1590, 1573, 1486, 1400, 1286, 1257, 1207, 1166, 1087, 1012, 966, 
937, 823, 761. HRMS (EI) m/z calc’d C7H6ClO [M + H]
+
: 141.0102, found: 141.0100. 
4-Bromobenzaldehyde
62
 (17) 
White solid (79% isol. yield, 0.59 mmol, 146.0 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 9.98, 7.76 (dd, J = 8.4, 2.0 Hz, 2H), 7.68 (dd, J = 8.3, 2.0 Hz, 
2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 191.4, 137.2, 132.8, 131.3, 130.2. IR (neat) ν 
= 2857, 2761, 1683, 1583, 1569, 1475, 1386, 1290, 1199, 1149, 1062, 1006, 829, 808, 678.  
HRMS (EI) m/z calc’d C7H6BrO [M + H]
+
: 184.9597, found: 184.9595. 
3-Fluorobenzaldehyde
65
 (19) 
Colourless liquid (93% isol. yield, 0.70 mmol, 86.9 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 9.99 (s, 1H), 7.81 (d, J = 2.1 Hz, 1H), 7.68-7.54 (m, 2H), 7.34-7.24 (m, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) =190.9, 164.3 (
1
JC-F  = 248 Hz), 138.4 
(
3
JC-F = 6 Hz), 130.8 (
3
JC-F  = 8 Hz), 126.0 (
3
JC-F  = 3 Hz), 121.7 (
2
JC-F  = 22 Hz), 115.4 (
2
JC-F  = 
22 Hz). IR (neat) ν = 3067, 3021, 1712, 1698, 1608, 1413, 1287, 1154, 769, 748, 640, 485 
cm
-1
. HRMS (EI) m/z calc’d C7H6FO [M + H]
+
: 125.0398, found: 125.0395. 
3-Chlorobenzaldehyde
65
 (21) 
Colourless liquid (75% isol. yield, 0.56 mmol, 78.5 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 9.98 (s, 1H), 7.95 (s, 1H), 7.84 (d, J = 7.5 Hz, 1H), 7.62 (d, J = 7.8 Hz, 1H), 
7.58-7.74 (m, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 190.8, 137.8, 
135.4, 134.4, 130.4, 127.9, 126.5. IR (neat) ν = 2937, 2836, 1714, 1678, 1588, 1573, 1488, 
1420, 1400, 1253, 1169, 1127, 1013, 712, 681 cm
-1
. HRMS (EI) m/z calc’d C7H6ClO [M + 
H]
+
: 141.0102, found: 141.0106.  
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Benzaldehyde
62
 (23) 
Colourless liquid (77% isol. yield, 0.58 mmol, 61.4 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 10.02 (s, 1H), 8.13-8.10 (m, 2H), 7.89-7.87 (m, 1H), 7.65-7.62 (m, 2H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 192.8, 136.8, 134.8, 129.9, 129.4. IR (neat) ν = 3062, 
2819, 2736, 1698, 1652, 1598, 1583, 1454, 1390, 1311, 1207, 1162, 1070, 1020, 1002, 825, 
744, 682, 642. HRMS (EI) m/z calc’d C7H6O [M + H]
+
: 107.0492, found: 107.0488.  
3-Methylbenzaldehyde
63
 (25) 
Colourless liquid (95% isol. yield, 0.71 mmol, 85.2 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 10.00 (s, 1H), 7.69-7.67 (m, 2H), 7.46-7.40 (m, 2H), 2.44 (s, 3H). 
13
C NMR 
(100 MHz, CDCl3): δ (ppm) =192.6, 138.9, 136.4, 135.3, 130.0, 128.8, 127.2, 
21.2. IR (neat) ν = 3078, 2921, 1701, 1606, 1588, 1488, 1433, 1278, 1246, 1158, 1142, 778, 
745, 684, 653 cm
-1
. HRMS (EI) m/z calc’d C8H8O [M + H]
+
: 121.0648, found: 121.0646. 
3-Methoxybenzaldehyde
66
 (27) 
Colourless liquid (78% isol. yield, 0.58 mmol, 78.8 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 9.98 (s, 1H), 7.47-7.42 (m, 2H), 7.40 (d, J = 2.0 Hz, 1H), 7.26-7.16 (m, 1H), 
3.87 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 192.5, 160.5, 138.2, 
130.4, 123.9, 121.9, 112.4, 55.8. IR (neat) ν = 2840, 2732, 1698, 1587, 1482, 1457, 1436, 
1382, 1321, 1286, 1261, 1203, 1145, 1066, 1037, 1006, 927, 869, 833, 815, 786, 744, 678, 
628. HRMS (EI) m/z calc’d C8H9O2 [M + H]
+
: 137.0597, found: 137.0596. 
2-Naphthaldehyde
63
 (29) 
White solid (30% isol. yield, 0.22 mmol, 34.4 mg). Purification by flash 
chromatography (Hexane/AcOEt, 30/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 10.17 (s, 1H), 8.35 (s, 1H), 8.02-7.85 (m, 4H), 7.64-7.57 (m, 
2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 192.6, 136.8, 134.9, 134.5, 133.0, 129.9, 
129.5, 128.5, 127.5, 123.1. IR (neat) ν = 3062, 2846, 2829, 1689, 1661, 1598, 1402, 1365, 
1165, 1142, 909, 800, 746, 699, 501 cm
-1
. HRMS (EI) m/z calc’d C11H9O [M + H]
+
: 
157.0648, found: 157.0646. 
Biphenyl-4-carboxaldehyde
64
 (31) 
White solid (57% isol. yield, 0.43 mmol, 78.2 mg). Purification by flash 
chromatography (Hexane/ AcOEt 20/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 10.06 (s, 1H), 7.95 (dd, J = 1.6, 8.4 Hz, 2H), 7.75 (dd, J = 1.5, 
8.4 Hz, 2H), 7.64 (dd, J = 1.8, 8.4 Hz, 2H), 7.62-7.50 (m, 3H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 192.3, 140.1, 135.6, 130.6, 129.4, 128.8, 128.1, 127.7. 
IR (neat) ν = 3058, 3033, 2829, 2736, 1695, 1602, 1562, 1482, 1450, 1411, 1386, 1307, 
1213, 1166, 1078, 1008, 833, 761, 725, 694. HRMS (EI) m/z calc’d C13H10O [M + H]
+
: 
183.0805, found: 183.0805. 
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The aldehyde products are commercially available and the analytical data obtained is in 
agreement with the data reported by the manufacturers. 
6.5.4. General procedure for the Fe(OTf)3L4 catalysed aerobic cleavage of styrenes 
In a Radley’s tube equipped with a magnetic stirring bar, Fe(OTf)3 (5.65 x 10
-3
 mmol, 2.9 
mg) and L4 (5.67 x 10
-3
 mmol, 7.1 mg) were added. The tube was sealed, degassed and left 
under inert atmosphere (3 times). Freshly distilled DCE (0.5 mL) was injected by syringe 
and the reaction mixture was allowed stirring for 1 hour at 40
°C. α-Methylstyrene (0.50 
mmol, 40 μL) was added by syringe and the reaction tube was degassed, charged with 
dioxygen gas (1 atm, 3 times) and keep under oxygen (1 atm) by using a balloon. The tube 
was gradually heated to 75 
°
C and allowed to react for 5 hours. The reaction was purified by 
silica gel column chromatography (Hexane/EtOAc: 20:1) to afford the unreacted starting 
material and the ketone product. 
Product characterisation 
Acetophenone
63
 (33) 
Colourless liquid (87% isol. yield, 0.43 mmol, 51.6 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 7.97-7.95 (m, 2H), 7.59-7.54 (m, 1H), 7.48-7.45 (m, 2H), 2.61 (s, 3H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 198.5, 137.5, 133.5, 129.1, 128.9, 128.7, 
27.0. IR (neat) ν = 1681, 1598, 1583, 1448, 1357, 1303, 1265, 1178, 1078, 1024, 952, 761, 
686. HRMS (EI) m/z calc’d C8H9O [M + H]
+
: 121.0648, found: 121.0647. 
4-Fluoroacetophenone
63
 (35) 
Colourless liquid (40% isol. yield, 0.20 mmol, 27.5 mmol). Purification by 
flash chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 8.00-7.97 (m, 2H), 7.16-7.11 (m, 2H), 2.59 (s, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 196.8, 167.4 ( d, 
1
JC-F  = 253.1 Hz) , 134.0, 133.9 (d, 
4
JC-F  = 3 Hz) , 131.3 (d, 
3
JC-F  = 9.3 Hz), 116.1 (d, 
2
JC-F  = 21.8 Hz), 26.9. IR (neat) ν = 1681, 
1594, 1500, 1407, 1361, 1261, 1224, 1153, 1103, 1012, 958, 833. HRMS (EI) m/z calc’d 
C8H8FO [M + H]
+
: 139.0554, found: 139.0551. 
4-Chloroacetophenone
67
 (37) 
Colourless liquid (83% isol. yield, 0.41 mmol, 63.4 mg). Purification by 
flash chromatography (Hexane/ AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 7.91-7.88 (m, 2H), 7.45-7.42 (m, 2H), 2.59 (s, 3H). 13C NMR 
(100 MHz, CDCl3): δ (ppm) = 197.2, 139.9, 135.8, 130.1, 129.2, 26.9. IR 
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(neat) ν = 1683, 1587, 1486, 1428, 1394, 1357, 1261, 1174, 1087, 1016, 954, 823, 757, 620. 
HRMS (EI) m/z calc’d C8H8ClO [M + H]
+
: 155.0259, found: 155.0264. 
4-Bromoacetophenone
67
 (39) 
White solid (85% isol. yield, 0.42 mmol, 83.7 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.84-7.80 (m, 2H), 7.62-7.59 (m, 2H), 2.59 (s, 3H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 197.4, 136.2, 132.3, 130.2, 128.7, 26.9. IR (neat) 
ν = 1670, 1583, 1482, 1425, 1396, 1353, 1267, 1178, 1074, 1008, 954, 819, 750, 711. 
HRMS (EI) m/z calc’d C8H8BrO [M + H]
+
: 198.9754, found: 198.9750. 
4-Acetylpyridine
67
 (41) 
Yellow liquid (20% isol. yield, 0.10 mmol, 12.2 mg). Purification by flash 
chromatography (Hexane/AcOEt, 2/3). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 8.82 (dd, J = 1.6, 4.4 Hz, 2H), 7.74 (dd, J = 1.6, 5.6 Hz, 2H), 2.64 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 197.7, 151.3, 143.1, 121.6, 27.0. IR 
(neat) ν = 1691, 1598, 1554, 1407, 1361, 1265, 1216, 1062, 995, 962, 815. HRMS (EI) m/z 
calc’d C7H8NO [M + H]
+
: 122.0601, found: 122.0606. 
Benzophenone
64
 (43) 
White solid (98% isol. yield, 0.49 mmol, 89.3 mg). Purification by flash 
chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.81-7.79 (m, 4H), 7.60-7.56 (m, 2H), 7.49-7.45 (m, 4H).
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 197.1, 138.0, 132.5, 130.4, 128.6. 
IR (neat) ν = 1650, 1593, 1575, 1447, 1320, 1275, 1175, 1160, 1150, 1075, 998, 944, 935, 
918, 813, 764, 702, 692, 636 cm
-1
.HRMS (EI) m/z calc’d C13H11O [M + H]
+
: 183.0804, 
found: 183.0808. 
Cyclopropyl phenyl ketone
68
 (45) 
Colourless liquid (87% isol. yield, 0.43 mmol, 62.9 mg). Purification by 
flash chromatography (Hexane/AcOEt, 25/1). 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 8.03-8.01 (m, 2H), 7.59-7.54 (m, 1H), 7.49-7.45 (m, 2H), 2.71-
2.65 (m, 1H), 1.26-1.19 (m, 2H), 1.08-1.03 (m, 2H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 201.0, 138.4, 133.1, 128.9, 128.4, 17.5, 12.0. IR (neat) ν = 3062, 3008, 
1666, 1598, 1577, 1448, 1382, 1224, 1178, 1033, 987, 869, 815, 782, 703, 646. HRMS (EI) 
m/z calc’d C10H11O [M + H]
+
: 147.0805, found: 147.0804. 
Cyclobutyl phenyl ketone
69
 (47) 
Colourless liquid (54% isol. yield, 0.27 mmol, 43.2 mg). Purification by 
flash chromatography (Hexane/AcOEt, 30/1). 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 7.98-7.87 (m, 2H), 7.71-7.62 (m, 1H), 7.58-7.50 (m, 2H), 4.05 
(q, J= 6.7 Hz, 1H), 2.54-2.38 (m, 3H), 2.21-2.02 (m, 2H), 1.97-1.84 (m, 
1H). IR (neat) ν = 2983, 2942, 1674, 1597, 1579, 1448, 1346, 1248, 1221, 1177, 966, 771, 
737, 692, 659 cm
-1
.
13
C NMR (100 MHz, CDCl3): δ (ppm) = 201.0, 135.6, 132.8, 128.5, 
128.3, 42.2, 25.1, 18.1. HRMS (EI) m/z calc’d C11H13O [M + H]
+
: 161.0961, found: 
161.0960. 
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Cyclohexyl phenyl ketone
65
 (49) 
Colourless liquid (73% isol. yield, 0.36 mmol, 67.8 mg). Purification by 
flash chromatography (Hexane/AcOEt, 30/1). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.98 (d, J = 7.8 Hz, 2H), 7.74-7.68 (m, 1H), 7.64-7.58 
(m, 2H), 3.37 (q, J = 7.0 Hz, 1H), 1.97-1.35 (m, 10H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 203.9, 136.3, 132.7, 128.5, 128.2, 45.6, 29.4, 26.2, 25.8. IR (neat) 
ν = 2928, 2853, 1679, 1597, 1580, 1447, 1288, 1250, 1206, 1172, 973, 763, 696, 660 cm-1. 
HRMS (EI) m/z calc’d C13H17O [M + H]
+
: 189.1274, found: 189.1267. 
The carbonyl products are commercially available and the analytical data obtained is in 
agreement with the data reported by the manufacturers. 
6.5.5. Coordination of the olefin to the catalyst 
Reactions were performed as described in section 6.5.4. 
Product characterisation 
Propiophenone
64
 (51) 
Colourless liquid (7% isol. yield, 0.04 mmol, 5.4 mg). Purification by flash 
chromatography (Hexane/AcOEt, 40/1 to 20/1). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.98-7.95 (m, 2H), 7.57-7.53 (m, 1H), 7.49-7.44 (m, 2H), 
3.02 (q, J = 6.8 Hz, 2H), 1.24 (t, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 201.2, 137.3, 133.2, 128.9, 128.3, 32.1, 8.6. IR (neat) ν = 2977, 2940, 
2904, 1683, 1598, 1450, 1411, 1349, 1213, 1178, 1081, 1012, 954, 744, 690, 642. HRMS 
(EI) m/z calc’d C9H11O [M + H]
+
: 135.0805, found: 135.0811. 
 (Z)- 2-Buten-2-ylbenzene
70
 (52) 
Colourless liquid (53% isol. yield, 0.26 mmol, 34.3 mg). Purification by flash 
chromatography (Hexane/AcOEt, 40/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 7.40-7.15 (m, 5H), 5.89-5.83 (m, 1H), 2.03 (s, 3H), 1.80 (dd, J = 1.2, 5.6 Hz, 
3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 144.4, 135.9, 128.5, 126.7, 
125.9, 122.8, 15.8, 14.7. HRMS (EI) m/z calc’d C10H13 [M + H]
+
: 133.1012, found: 
133.1008. 
Isobutyrophenone
72
 (54) 
Colourless liquid (36% isol. yield, 0.18 mmol, 26.7 mg). Purification by 
flash chromatography (Hexane/AcOEt, 40/1 to 20/1). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.97-7.94 (m, 2H), 7.57-7.53 (m, 1H), 7.48-7.44 (m, 2H), 
3.56 (quintet, J = 7.2 Hz, 1H), 1.22 (d, J = 7.2 Hz, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 204.9, 136.6, 133.1, 129.0, 128.7, 35.7, 19.5. IR (neat) ν = 2973, 2933, 
2875, 1681, 1598, 1577, 1469, 1448, 1382, 1353, 1216, 1162, 1087, 979, 794, 696, 646. 
HRMS (EI) m/z calc’d C10H13O [M + H]
+
: 149.0961, found: 149.0960. 
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 (3-Methylbut-2-en-2-yl)benzene
71
(55) 
Colourless liquid (34% isol. yield, 0.17 mmol, 24.8 mg). Purification by 
flash chromatography (Hexane/AcOEt, 40/1). 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 7.36-7.12 (m, 5H), 2.01 (s, 3H), 1.87 (s, 3H), 1.68 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ (ppm) = 144.3, 139.6, 130.2, 128.7, 127.8, 
126.9, 21.4, 21.1, 13.1. HRMS (EI) m/z calc’d C11H15 [M + H]
+
: 147.1169, found: 
147.1162. 
These products are commercially available and the analytical data obtained is in agreement 
with the data reported by the manufacturers. 
6.5.6. Competitive direct dehydrogenation 
Reactions were performed as described in section 6.5.4. 
Product characterisation 
Cinnamaldehyde
64
 (57) 
Colourless liquid (35% isol yield, 0.17 mmol, 23.1 mg). Purification by 
flash chromatography (Hexane/AcOEt, 20/1). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 9.91 (d, J = 7.2H, 1H), 7.81-7.42 (m, 6H), 6.72 (dd, J = 
15.8, 7.2 Hz, 1H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 193.8, 152.9, 134.0, 131.3, 
129.1, 128.5. IR (neat) ν = 3066, 3027, 2827, 1672, 1626, 1495, 1449, 1418, 1282, 1225, 
1176, 1159, 1134, 976, 943, 911, 766, 697, 682, 589, 541, 480 cm
-1
. HRMS (CI) m/z calc’d 
C9H9O [M + H]
+
: 133.0648, found: 133.0649. 
Anisole
73
 (61) 
Colourless liquid (60% isol. yield, 0.30 mmol, 32.4 mg). Purification by flash 
chromatography (Hexane/AcOEt, 30/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 7.42-7.36 (m, 2H), 6.99-6.87 (m, 3H), 3.87 (s, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 159.5, 129.7, 120.6, 113.8, 55.1. IR (neat) ν = 2957, 2836, 1599, 1587, 
1495, 1467, 1454, 1302, 1243, 1172, 1153, 1077, 1153, 1077, 1038, 1020, 883, 783, 700, 
689, 552, 509 cm
-1
. 
Naphthtalene
74
 (63) 
White solid. Purification by flash chromatography (Hexane/AcOEt, 50/1).   
1
H 
NMR (400 MHz, CDCl3): δ (ppm) = 7.84-7.78 (m, 4H), 7.47-7.44 (m, 4H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 133.8, 128.3, 126.2. IR (neat) ν = 2923, 
2854, 1702, 1590, 1504, 1457, 1386, 1267, 1207, 1120, 1006, 958, 775. HRMS (EI) m/z 
calc’d C10H9 [M + H]
+
: 129.0699, found: 129.0696. 
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6-Oxo-6-phenylhexanal
75
 (66) 
Yellowish liquid (27% isol. yield, 0.13 mmol, 25.7 mg). 
Purification by flash chromatography (Hexane/AcOEt, 50/1 to 
20/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 9.45 (s, 1H), 
8.09-7.98 (m, 2H), 7.74-7.34 (m, 3H), 3.02 (t, J = 7.0Hz, 2H), 
2.51 (t, J = 7.0 Hz, 2H), 1.98-1.76 (m, 4H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 202.3, 
199.8, 136.7, 132.7, 128.0, 128.4, 43.2, 37.8, 23.5, 21.4. HRMS (CI) m/z calc’d C12H15O2 
[M + H]
+
: 191.1067, found: 191.1062. 
5-Oxo-5-phenylpentanal
75
 (68) 
Yellowish liquid (20% isol. yield, 0.10 mmol, 17.6 mg). 
Purification by flash chromatography (Hexane/AcOEt, 50/1 to 
20/1). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 9.80 (s, 1H), 7.96 
(d, J = 7.8 Hz, 2H), 7.52-7.45 (m, 3H), 3.05 (t, J = 7.0 Hz, 2H), 2.57 
(t, J= 6.9 Hz, 2H), 2.09-2.03 (m, 2H).
 13
C NMR (100 MHz, CDCl3): δ (ppm) = 202.0, 199.9, 
137.1, 134.0, 128.7, 127.9, 43.3, 37.5, 16.8. HRMS (CI) m/z calc’d C11H13O2 [M + H]
+
: 
177.0911, found: 177.0.919. 
Analytical data of the isolated products is in agreement with that of the commercially 
available compounds. 
6.5.6. Detection of volatile hydrocarbon byproducts 
In a Radley’s tube equipped with a magnetic stirring bar, Fe(OTf)3 (5.65 x 10
-3
 mmol, 2.9 
mg) and L4 (5.67 x 10
-3
 mmol, 7.1 mg) were added. The tube was sealed, degassed and left 
under inert atmosphere (3 times). Freshly distilled DCE (0.5 mL) was injected by syringe 
and the reaction mixture was allowed stirring for 1 hour at 40
°
C. 1-Phenyl-1-cyclohexene 
(0.50 mmol) was added by syringe and the reaction tube was degassed, charged with 
dioxygen gas (1 atm, 3 times) and keep under oxygen (1 atm) by using a balloon. The tube 
was gradually heated to 75 
°
C and allowed to react for 4 hours. For the GC analyis, a sample 
of gas phase (100 μL) contained on the sealed Radley’s tube was taken and injected on a 
Varian star GC spectrometer for hydrocarbon detection. The retention times obtained were 
4.637 (CH3CH3) and 4.756 (CH2=CH2). 
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Sample 1: Chromatogram data 
 
Sample 2 (duplicate): Chromatogram data 
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6.5.5. Radical trapping experiments: General procedure 
 
In a Radley’s tube equipped with a magnetic stirring bar, Fe(OTf)3 (5.65 x 10
-3
 mmol, 2.9 
mg) and L1 (6.67 x 10
-3
 mmol, 5.2 mg) were added. The tube was sealed, degassed and left 
under an inert atmosphere (3 times). Freshly distilled DCE (0.5 mL) was injected by syringe 
and the reaction mixture was allowed stirring for 1 hour at 40
°
C. Next, styrene (0.75 mmol, 
90 μL) and a certain amount of radical trapping reagent were added. The reaction tube was 
degassed with dioxygen gas (1 atm, 3 times) and kept under oxygen (1 atm) by using a 
balloon. The tube was gradually heated to 70 
°
C and allowed to react for 5 hours. The 
reaction was purified by silica gel flash column chromatography (Hexane/EtOAc, 20/1) to 
afford the unreacted starting material and the aldehyde product. 
6.5.6. Effect of a radical initiator: General procedure 
In a Radley’s tube equipped with a magnetic stirring bar, Fe(OTf)3 (5.65 x 10
-3
 mmol, 2.9 
mg) and L1 (5.67 x 10
-3
 mmol, 5.2 mg) were added. The tube was sealed, degassed and left 
under an inert atmosphere (3 times). Freshly distilled DCE (0.5 mL) was injected by syringe 
and the reaction mixture was allowed stirring for 1 hour at 40 
°
C. Next, styrene (0.75 mmol, 
90 μL) and the radical initiator benzoyl peroxide (0.02 mmol) were added. The reaction tube 
was degassed with dioxygen gas (1 atm, 3 times) and kept under oxygen (1 atm) by using a 
balloon. The tube was gradually heated to 45 
°
C and allowed to react overnight. The reaction 
was purified by silica gel flash column chromatography (Hexane/EtOAc, 20/1) to afford the 
unreacted starting material and the aldehyde product. The same procedure was repeated in 
the absence of the radical initiator. 
6.5.7. Oxidation of vinyl halides 
In a Radley’s tube equipped with a magnetic stirring bar, Fe(OTf)3 (5.65 x 10
-3
 mmol, 2.9 
mg) and L1 (5.67 x 10
-3
 mmol, 5.7 mg) were added. The tube was sealed, degassed and left 
under an inert atmosphere (3 times). Freshly distilled DCE (0.5 mL) was injected by syringe 
and the reaction mixture was allowed stirring for 1 hour at 40
°C. Next, α-bromostyrene (0.50 
mmol, 60 μL) and diphenyl sulphide (0.25 mmol, 40μL) were added by syringe. The 
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reaction tube was degassed with dioxygen gas (1 atm, 3 times) and kept under oxygen (1 
atm) by using a balloon. The tube was gradually heated to 75 
°
C and allowed to react 
overnight. The reaction was purified by silica gel flash column chromatography 
(Hexane/EtOAc, 30/1) to afford the unreacted starting material and the ketone product. The 
same procedure was repeated in the absence of diphenyl sulfide. 
Product characterisation 
Phenacyl bromide
76
 (71) 
White solid (61% isol. yield, 0.30 mmol, 59.8 mg). Purification by flash 
chromatography (Hexane/AcOEt, 30/1). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 8.00 (d, J = 7.8 Hz, 2H), 7.64-7.60 (m, 1H), 7.58-7.50 (m, 2H), 
4.52 (s, 2H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 193.2, 133.9, 133.7, 
128.9, 128.8, 30.9. IR (neat) ν = 1702, 1677, 1595, 1580, 1448, 1427, 1320, 1307, 1277, 
1193, 1012, 989, 749, 709, 685, 622, 608, 590, 527 cm
-1
. HRMS (EI) m/z calc’d C8H7BrO 
[M + H]
+
 : 198.9753, found: 198.9753. 
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7.1. Introduction 
7.1.1. Dimerisation of styrenes: importance and challenges 
The dimerisation of olefins is a C-C bond forming reaction that has attracted industrial 
interest because it allows the synthesis of useful intermediates
1
 with excellent atom 
economy.
2
 For instance, styrene dimers can be used as intermediates in lubricants or fluids, 
co-monomers in polymers and plastics, and chain transfer reagents for acrylics.
3
 
Despite its industrial relevance, olefin dimerisation processes often provide a distribution of 
products that varies depending on the reaction conditions and/or catalysts employed
2
 
(Scheme 1). Thus, the development of chemo- and regioselective methods for olefin 
dimerisation is still in demand. Traditionally, catalysts based on Ni or Pd have been 
investigated for olefin dimerisation processes; however, a mixture of oligomers and 
polymers is normally obtained due to low catalyst selectivity.
4
 In addition to uncontrolled 
polymerisation, competing side reactivity
5
 (i.e. Friedel Crafts reactions) is often observed, 
limiting the reaction efficiency. 
 
Scheme 1. Reaction pathways for the dimerisation of olefins 
7.1.2. Catalytic methods for the dimerisation of α-methylstyrenes 
7.1.2.1. Acid catalysts 
In 1958, Petropoulos and Fischer demonstrated that strong mineral acids such as H2SO4, HCl 
or p-toluenesulfonic acid catalysed the dimerisation of α-methylstyrene to afford a mixture 
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of dimers and indene products.
6
 The proposed reaction mechanism involved the protonation 
of the olefin to give a benzylic carbocation intermediate 2. Attack by another olefin 
molecule results in the formation of the intermediate 3 from which polymerisation (via 
attack of a second monomer) or dimerisation (via deprotonation of 3) could occur (Scheme 
2). The scope of the reaction was expanded to another three p-substituted α-methylstyrenes; 
however, indene products were obtained predominantly and exhaustive control of the 
temperature and acid concentration was essential to reproduce the reactions and reduce the 
yield of polymerisation products. 
 
Scheme 2. Acid-catalysed dimerisation of α-methylstyrenes 
Wolovsky and co-workers reported the use of ethylaluminium chloride (EADC) as catalyst 
for the conversion of α-methylstyrene to indene-type dimers and trimers in benzene solution7 
(Scheme 3). The product distribution varied with the temperature, with the percentage of the 
dimer product increasing with temperature and reaching a maximum 73% yield at 80 °C. 
However, the substrate scope of the reaction was not further explored. 
 
Scheme 3. EADC-catalysed dimerisation of α-methylstyrene  
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Aminium salts such as tris-(2,4-dibromophenyl) aminium hexachloroantimonate and tris-(4-
dibromophenyl) aminium hexachloroantimonante were also investigated as potential 
catalysts for the dimerisation of α-methylstyrene.8 In MeCN solution, a mixture of the linear 
dimers was detected whereas in CH2Cl2 the indene dimer and small amount of indene 
trimers were obtained. Similarly, the indene dimer was formed predominantly when 
trifluoroacetic acid was used as catalyst (Scheme 4). 
 
Scheme 4. Aminium salts-catalysed dimerisation of α-methylstyrene 
7.1.2.2. Transition metal-based catalysts 
The group of Nishibayashi demonstrated that the dicationic diruthenium complex [Cp*Ru(μ-
SMe)2RuCp*(OH2)](OTf)2 could be used as catalysts for the dimerisation of α-
methylstyrene. 
9
 Interestingly, the Ru
III
-Ru
III
 complex afforded the acyclic dimers 12 and 13 
in a 3:1 ratio whereas the mixed valence complex Ru
III
-Ru
IV
 generated the indene dimer in 
the presence of cinnamyl alcohol as additive (Scheme 5). The scope was extended to four 
substrates with the indene products obtained with good yields. However, more moderate 
yields were achieved for the linear dimers. 
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Scheme 5. Dimerisation of α-methylstyrene catalysed by dinuclear Ru complexes. 
The group of Valerga reported a family of Ni-based complexes bearing N-carbene ligands of 
the formula [(L)Ni(NHC)][BAr
F
4] and its catalytic application for the dimerisation of α-
methylstyrene and 4-methylstyrene
10
 (Scheme 6). Most of the catalysts showed high activity 
under mild conditions without any need for a co-catalyst. However, no additional substrate 
scope was reported. 
 
Scheme 6. Nickel-catalysed dimerisation of α-methylstyrene 
Pd(OAc)2 has also been explored as catalyst for α-methylstyrene  and styrene dimerisation 
by Shirakawa and co-workers.
11
 In combination with In(OTf)3 as an activator of the alkene, 
a mixture of the linear dimers 12 and 13 was obtained in 78% yield under mild conditions 
(Scheme 7). However, the substrate scope was not further expanded to substituted 
analogues. 
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Scheme 7. Pd(OAc)2/In(OTf)3 catalysed dimerisation of α-methylstyrene 
Inspired by this study, the group of Peppe reported the use of InBr3 as a Lewis acid catalyst 
for the dimerisation of substituted α-methylstyrenes12 (Scheme 8). The reaction proceeded 
under mild conditions but high catalysts loading (10 mol%) were needed to afford the linear 
dimer 13. However, in many cases the indene product 14 was formed exclusively, limiting 
the scope to only 4 linear dimers.  
 
Scheme 8. Indium-catalysed dimerisation of α-methylstyrenes 
The use of iron-based catalysts for the dimerisation of styrenes was explored by the group of 
Corma, who demonstrated that the in situ prepared Fe(NTf2)3 was an effective catalyst for 
the regioselective head-to-tail dimerisation of styrenes and α-methylstyrene.2 Indeed, the 
linear dimer 12 was obtained exclusively with 51% yield and no side products formation 
(Scheme 9). However, the scope is limited to a few styrene substrates and normally high 
loadings of the expensive AgNTf2 were required to achieve good yields. 
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Scheme 9. Iron-catalysed dimerisation of α-methylstyrene 
7.2. Aims of this chapter 
Even though many different catalysts have been tested for the dimerisation of α-
methylstyrene, the development of new catalyst capable of selectively convert α-
methylstyrene to its linear dimers is still challenging. This chapter presents our efforts in the 
development of a greener iron-catalysed methodology for the selective dimerisation of α-
methylstyrenes to its linear dimers without generating a complex mixture of oligomers. 
Considering the limitations of the current methods, a wider substrate scope and a catalyst 
design that allows controlling the regioselectivity of the double bond of the dimer are the 
main targets. 
7.3. Results and discussion 
7.3.1. Discovery and optimisation of the iron-catalysed olefin dimerisation 
Fe(OTf)3-PyBisulidine complexes were found to catalyse the aerobic cleavage of olefins to 
its corresponding carbonyl form under aerobic atmosphere. Surprisingly, under conditions of 
limiting oxidant unexpected head-to-tail dimerisation of the starting α-methylstyrene was 
observed in low yields (Scheme 10). The industrial relevance of olefin dimerisation 
prompted us to investigate whether this family of iron-PyBisulidine complexes could be 
used as potential catalysts for the selective dimerisation of α-methylstyrenes under inert 
atmosphere. 
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Scheme 10. Formation of the styrene dimer 3 under conditions of limiting oxidant 
On the basis of this preliminary data, α-methylstyrene 1 was selected as a model substrate 
for investigating the Fe(OTf)3-PyBisulidine catalysed olefin dimerisation.  
7.3.1.1. Solvent effect 
Chlorinated solvents were found ideal for the regioselective formation of the terminal dimer 
4 with DCM showing the best efficiency (Scheme 11). Interestingly, arene and coordinating 
solvents were all found detrimental for the dimerisation reaction (entries 4-9), probably due 
to either poor catalyst solubility or competing coordination of solvent molecules to the iron 
centre. 
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Scheme 11. Effect of solvent in the Fe(OTf)3-PyBisulidine catalysed dimerization of 1 
7.3.1.2. Effect of the iron salt 
The iron salt was also found to play a crucial role in the dimerisation reaction (Scheme 12). 
Significantly, Fe(OTf)3 was found to be the only efficient iron salt due to its better solubility 
in DCM and its superior Lewis acidity than its Fe(OTf)2 analogue. Other iron salts, covering 
oxidations states ranging from 0 to 3 were found completely inactive (entries 3-7), revealing 
that both high Lewis acidity and good leaving groups as counterions are required for 
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achieving good catalytic activity in the dimerisation of 1. In the absence of ligand L2, both 
Fe(OTf)3 and Fe(OTf)2 were found inactive for dimerisation. 
 
Scheme 12. Effect of the iron salt in the Fe(OTf)3-PyBisulidine catalysed dimerization of 1 
7.3.1.3. Ligand effect 
The effect of the ligand in the iron-catalysed dimerisation of 1 was next investigated 
(Scheme 13). Tridentate PyBisulidine ligands in combination with equimolecular amounts of 
Fe(OTf)3 showed certain efficiency in catalysing the dimerisation of 1 to the terminal dimer 
4, with L2 showing the best results (entries 1-4). On the contrary, conjugated tridentate 
ligands such as PyBox or terpy were found inactive for the dimerisation of 1 (entries 5-6). 
Nonetheless, conjugated bidentate ligands showed certain efficiency for this transformation 
with phenantroline affording a mixture of both regioisomers 3 and 4. The superior efficiency 
of conjugated bidentate ligands in comparison with the conjugated tridentate ones prompted 
us to investigate whether the bidentate Bisulidines or the asymmetric PyBisulidines could 
indeed show superior performance to their analogue tridentate PyBisulidines.  
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Scheme 13. Ligand effect in the Fe(OTf)3-PyBisulidine catalysed dimerization of 1 
Indeed, the combination of Fe(OTf)3 with equimolecular amounts of the bidentate Bisulidine 
L9 afforded a mixture of dimers 3 and 4 with 70% 
1
H NMR conversion at 24 
°
C (Scheme 
14), showing improved activity in comparison with the tridentate L2 under identical reaction 
conditions.  In addition, small modifications in the reaction temperature significantly 
affected the product distribution with the terminal olefin being formed predominantly at 
lower temperatures and the proportion of the internal isomer increasing progressively at 
higher temperatures. Therefore, at ambient temperature (circa 19 
°
C) the Fe(OTf)3L9 
complex can be used to generate the kinetic product 4 predominantly (ratio > 3:1). 
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Scheme 14. Fe(OTf)3L9 catalysed regioselective formation of the terminal dimer 4  
Similarly, complexation of Fe(OTf)3 with the asymmetric ligand L10 contributed to increase 
the efficiency in the catalytic dimerisation of 1 (Scheme 15). However, the internal dimer 
was obtained preferably even at ambient temperatures and its proportion increased smoothly 
with temperature until reaching a maximal 65% 
1
H NMR conversion (89% total conversion) 
at 40 
°
C (entry 5). Thus, the Fe(OTf)3L10 complex can be applied for the predominant 
formation of the thermodynamic product 3 (ratio > 3:1). This opposite selectivity towards 
the internal olefin 3 can be attributed to the minimised steric bulkiness of L10 in comparison 
with the Bisulidine L9. Therefore and for the first time, the regioselectivity of the double 
bond in the head-to-tail dimerisation of 1 can be controlled by simple replacement of the 
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ligand in the Fe(OTF)3 complex and by controlling the reaction temperature with no 
oligomerisation derived byproducts formation.  
 
Scheme 15. Fe(OTf)3L10 catalysed regioselective formation of the terminal dimer 3 under 
thermodynamic conditions 
7.3.2. Substrate scope  
7.3.2.1. Electron rich substrates 
With the optimised conditions in hand, the substrate scope of the regioselective head-to-tail 
dimerisation of electron rich α-methylstyrenes was next investigated (Scheme 16). These 
Chapter 7 
 
340 
 
substrates are particularly challenging due to the frequent uncontrolled byproduct and 
oligomer formation. 
The Fe(OTf)3L9 catalysts afforded a mixture of the kinetic and thermodynamic dimers with 
good overall yields (circa 80%) and no undesired byproduct formation. Nonetheless, lower 
temperatures (0 
°
C) and shorter reaction times (maximum 4 hours) were required to achieve 
good catalytic performance without uncontrolled oligomer formation. Unfortunately, even 
under such reaction conditions the internal olefin was obtained as the major product 
preventing the control of the C=C bond regioselectivy in the dimer products (entries 1,2). 
Regiocontrolled dimerisation in favour of the terminal olefin was finally achieved with the 
less electron rich substrate 22 under identical low temperatures and shorter reaction times 
(entry 3). On the other hand, when L10 was used, the selectivity was reversed to favour 24. 
Aditionally, olefins bearing several electron donating functionalities such as 25 can be 
facilely dimerised with the Fe(OTf)3L9 catalyst, however; the resulting dimer product 
undergoes a rapid Friedel-Crafts cyclisation and thus, the indane product 27 is obtained 
exclusively (Scheme 17). 
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Scheme 16. Dimerisation of electron rich styrenes catalysed by Fe(OTf)3-L9 and/or 
Fe(OTf)3L10 
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Scheme 17. Friedel-Crafts side reaction with electron rich olefins 
Next, the effect of fused aryl and heterocyclic substitution in the regioselective dimerisation 
of α-methylstyrenes was studied (Scheme 18). Regioselective dimerisation of bulky 
substrates such as 28 and 31 was achieved with very good yields under smooth conditions by 
simple ligand replacement (entries 1, 2). To our surprise, the resulting dimmers 29-33 
exhibited luminescence properties (glow in darkness) and thus, these products could be 
applied as potential monomers in luminiscent materials syntheses. Sulphur-based 
heterocycles were well tolerated by both catalysts affording regioselectively the kinetic and 
thermodynamic products with good yields (entry 3). Dimers 35 and 36 showed a strong 
citric aroma and thus, they could potentially be used in fragrance industries as replacements 
or complements of the commonly used dimmers 3 and 4. 
However, some limitations were observed in this type of substrates. For instance, the 
Friedel-Crafts byproduct 43 was obtained predominantly with the more electron rich 
substrate 37 even at lower reaction temperatures and shorter reaction times. In addition, very 
sterically demanding substrates such as 40 can only be subjected to dimerisation with the 
less sterically hindered Fe(OTf)3L10 catalyst which affords the internal olefin 
predominantly. 
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Scheme 18. Dimerisation of aryl and heterocyclic-substituted styrenes catalysed by 
Fe(OTf)3L9 and/or Fe(OTf)3L10 
7.3.2.2. Electron deficient substrates 
Electron deficient α-methylstyrenes were next targeted as substrates (Scheme 19). 
Unfortunately, the Fe(OTf)3L10 complex showed limited efficiency in the dimerisation of 
electron deficient substrates whereas the Fe(OTf)3L9 complex was found completely 
inactive. Surprised by this lack of activity, the bidentate ligand L7 and the conjugated 
bidentate L8, which showed some efficiency in the dimerisation of 1, were also tested for 
this reaction. Indeed, the phenenatroline skeleton L8 afforded the dimmer products with 
moderate to good yields and no oligomerisation (Scheme 19). Some regiocontrol was also 
achieved with this catalytic system particularly in the selective formation of the internal 
olefin. However, application of this Fe(OTf)3L8 complex in the dimerisation of more 
electron rich substrates afforded predominantly undesired oligomerisation products. 
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Scheme 19. Dimerisation of electron deficient α-methylstyrenes catalysed by Fe(OTf)3L8. 
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7.3.3. Mechanistic considerations 
7.3.3.1. Coordination of the substrate to the catalyst 
Throughout the substrate scope of the iron-catalysed olefin dimerisation, the head-to-tail 
dimers were obtained exclusively. In addition, no oligomerisation products or uncontrolled 
polymerisation were observed under the reaction conditions, suggesting that free radical 
species are not involved in the dimerisation reaction.  
As discussed in chapter 6, coordination of the substrate to the iron catalyst can be initially 
postulated due to the higher efficiency exhibited by the Fe
III
 complexes in comparison with 
the weaker Lewis acidic Fe
II
 complexes (Scheme 12). 
7.3.3.2. Carbocation intermediate formation 
Although the Fe(OTf)3-L1 catalyst was capable of undergoing the aerobic cleavage of 
electron rich and electron deficient styrenes with comparable high efficiency, the iron 
catalysed dimerisation of styrenes proceeded easily for electron rich styrenes but much 
harsher conditions were needed for accomplishing the dimerisation of electron deficient 
substrates (scheme 19).  This different reactivity may result from the involvement of cationic 
species during the dimerisation reaction. 
7.3.3.2. Comparison with protic and Lewis acidic catalysts 
In order to further understand the role of the iron complex in controlling the selectivity of 
the dimerisation reaction, the dimerisation of 1 was investigated using 
trifluoromethanesulfonic acid and Bi(OTf)3 as catalysts (Scheme 20). Interestingly, the use 
of trifluoromethanesulfonic acid as a protic acid catalyst resulted in the selective formation 
of the indane product. Moreover, temperature modifications did not alter the reaction 
selectivity and conversion, nor yielded the desired linear dimers. In contrast, when Bi(OTf)3 
was used as a Lewis acid catalyst at 25 °C, a complex distribution of products was observed 
including linear and cyclic dimers (3.3 : 2.6 : 1.0 approximated ratio for 53 : 3 : 4) and other 
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uncharacterised products. Again, the reaction temperature did not modify the reaction 
conversion or the product distribution. 
These results clearly indicate that the iron complex is acting as the catalyst of the 
regioselective dimerisation reaction and that the observed selectivity is controlled by the 
ligand and reaction temperature. 
 
Scheme 20. The use of protic and Lewis acids as catalysts for the dimerisation of 1 afforded 
a different product distribution highlighting the essential role of the iron catalyst in defining 
the reaction selectivity. 
7.3.3.4. Postulated catalytic cycle 
To explain the reaction selectivity, we propose that the highly Lewis acidic Fe
III
 catalyst can 
activate α-methylstyrenes, forming the intermediate species 54 where the benzylic cation is 
stabilised by both the methyl group and the phenyl ring (Scheme 20) . This electrophilic 
species 54 can be attacked by a weak nucleophile such as another α-methylstyrene molecule, 
generating the key intermediate 55. From intermediate 55, elimination of the Hext proton can 
occur in the presence of the bulkier Fe(OTf)3L9 catalyst at low temperatures, affording the 
terminal olefin as product. The formation of the internal olefin can be achieved via Hint 
elimination with the less sterically hindered Fe(OTf)3L10 complex at higher reaction 
temperatures. The unexpected formation of indane byproducts when using some electron 
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rich α-methylstyrenes can be attributed to a rapid intramolecular Friedel Crafts reaction from 
intermediate 55. However, this Friedel-Crafts reactivity is substrate dependent and thus, it 
was not observed with more electron deficient substrates. 
 
Scheme 20. Proposed reaction mechanism for the iron catalysed olefin dimerisation. 
7.4. Conclusions 
A facile and regioselective method for the linear dimerisation of α-methylstyrenes is 
presented. For the first time, a variety of substrates were covered with the dimers being 
generated with good to excellent yields. Moreover, by modifying the bulkiness of the N-
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donor ligand, good to moderate regiocontrol of the double bond position of the resulting 
dimers was also achieved. 
7.5. Experimental section 
7.5.1 General techniques 
Unless otherwise specified, alkene substrates and the chemicals used in the synthesis of non 
commercially available substrates were purchased from commercial suppliers and used 
without further purification. Solvents used in these experiments were reagent grade or better. 
MeCN, DCM, DCE and CHCl3 were refluxed over CaH2 and THF and Et2O were refluxed 
over Na/benzophenone and distilled under purified N2 atmosphere. Anhydrous benzene 
99.9% was purchased from Aldrich and stored over CaH2 under N2 atmosphere. Experiments 
involving air or moisture sensitive reagents were performed under an atmosphere of purified 
N2 using standard Schlenck techniques.   
7.5.2. Substrate syntheses 
Non commercially available styrenes were synthesised via ketone methylenation according 
to the experimental procedure described in Chapter 6.  
Analytical data  
1-Methoxy-4-(prop-1-en-2-yl)benzene
13
  
 
Colourless liquid. Yield: 77%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.43 
(d, J= 7.6 Hz, 2H), 6.87 (d, J= 7.6 Hz, 2H), 5.28 (t, J= 0.8 Hz, 1H), 4.99 (q, J= 
1.2 Hz, 1H), 3.81 (s, 3H), 2.12 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) 
= 159.8, 142.6, 133.7, 126.9, 113.9, 111.0, 55.6, 22.3. 
1-Methyl-4-(prop-1-en-2-yl)benzene
13
  
Colourless liquid. Yield: 97%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.38-
7.35 (m, 2H), 7.14-7.12 (m, 2H), 5.33 (t, J= 0.8 Hz, 1H), 5.03 (q, J= 1.0 Hz, 1H), 
2.34 (s, 3H), 2.13 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 143.5, 138.7, 
137.5, 129.3, 125.7, 111.9, 22.2, 21.4. 
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1-Methyl-3-(prop-1-en-2-yl)benzene
14
  
Colourless liquid. Yield: 89%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.28-
7.20 (m, 3H), 7.09-7.07 (m, 1H), 5.34 (q, J= 0.8 Hz, 1H), 5.06 (q, J= 1.2 Hz, 
1H), 2.36 (s, 3H), 2.14 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 143.8, 
141.6, 138.1, 128.6, 128.5, 126.6, 123.0, 112.6, 23.0, 22.2. 
1,2-Dimethoxy-4-(prop-1-en-2-yl)benzene
15
  
Colourless liquid. Yield: 98%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.26-
7.01 (m, 2H), 6.83 (t, J= 4.4 Hz, 1H), 5.29 (d, J= 0.4 Hz, 1H), 5.01 (t, J= 1.2 
Hz, 1H), 3.91 (s, 3H), 3.89 (s, 3H), 2.14 (s, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 157.9, 158.7, 142.5, 133.8, 126.8, 113.7, 110.9, 55.8, 
55.6, 22.3. 
4-(Prop-1-en-2-yl)-1,1'-biphenyl
16
  
White solid. Yield: 92%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.62-7.46 
(m, 6H), 7.46-7.41 (m, 2H), 7.36-7.32 (m, 1H), 5.43 (q, J= 0.8 Hz, 1H), 5.11 
(q, J= 1.6 Hz, 1H), 2.19 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
143.1, 140.8, 140.2, 129.1, 127.6, 127.4, 127.3, 126.3, 112.8, 22.2. 
3-(Prop-1-en-2-yl)thiophene
17
  
Colourless liquid. Yield: 97%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.17 (dd, 
J= 5.2, 1.2 Hz, 1H), 7.03 (dd, J= 3.6, 1.2 Hz, 1H), 6.97 (dd, J= 5.2, 3.6 Hz, 1H), 
5.37 (s, 1H), 4.95 (t, J= 1.2 Hz, 1H), 2.15 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 145.8, 137.2, 127.3, 124.2, 123.5, 111.2, 21.8. 
2-Methoxy-6-(prop-1-en-2-yl)naphthalene
18
  
White solid. Yield: 96%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.79 (s, 
1H), 7.74-7.63 (m, 3H), 7.26-7.12 (m, 2H), 5.49 (s, 1H), 5.14 (d, J= 1.2 
Hz, 1H), 3.92 (s, 3H), 2.25 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 157.0, 142.6, 139.4, 138.9, 130.1, 129.1, 126.9, 124.7, 124.5, 119.2, 112.5, 106.0, 
55.7, 22.2. 
2-(Prop-1-en-2-yl)-9H-fluorene
19
  
White solid. Yield: 76%. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.78-
7.72 (m, 2H), 7.66 (s, 1H), 7.55-7.49 (m, 2H), 7.39-7.31 (m, 1H), 7.29-
7.26 (m, 1H), 5.43 (d, J= 0.8 Hz, 1H), 5.10 (t, J= 1.6 Hz, 1H), 3.91 (s, 2H), 
2.22 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 143.1, 143.0, 142.7, 
141.0, 140.6, 140.2, 127.1, 127.0, 126.3, 125.4, 122.5, 120.2, 119.9, 112.5, 37.3, 22.5. 
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7.5.3. Representative procedure for the iron-catalysed regioselective dimerisation of α-
methylstyrenes 
In a Radley’s tube equipped with a stirring bar, ligand L9 (9.1 mg, 0.01 mmol) and Fe(OTf)3 
(5.0mg, 0.01 mmol) were added. The tube was sealed, degassed and left under N2 
atmosphere (3 times). Freshly distilled DCM (2.0 mL) was added by syringe and the catalyst 
was allowed to form in situ upon stirring at 40 
°
C for 1 h. Then, the tube was cooled to r.t. 
and α-methylstyrene (40 μl, 0.3 mmol) was added by syringe. The tube was stirred overnight 
at r.t. and conversion was calculated form 
1
H NMR analysis. The reaction products were 
purified by silica gel column chromatography (Hexane/EtOAc, gradient: 20/1) to afford the 
unreacted starting material and the desired products. 
Analytical data 
(4-Methylpent-1-ene-2,4-diyl)dibenzene
20
  
Colourless oil, 55% yield (L9). 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.42-7.09 (m, 10H), 5.13 (d, J= 2.0 Hz, 1H), 4.78 (d, J= 2.0 Hz, 1H), 2.83 
(s, 2H), 1.21 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) =150.5, 
149.2, 145.4, 127.2, 127.1, 127.0, 125.8, 125.7, 125.5, 125.1, 124.9, 124.8, 124.4, 115.9, 
56.1, 40.0, 29.5, 28.7. MS (ESI) m/z calc’d C18H21 [M + H]
+
: 237.3, found: 237.3. 
(4-Methylpent-2-ene-2,4-diyl)benzene
21
  
Colourless oil, 65% yield (L10).
 1
H NMR (400 MHz, CDCl3): δ (ppm) = 
7.51-7.21 (m, 10H), 6.12 (s, 1H), 2.78 (s, 3H), 1.68 (s, 6H).
13
C NMR 
(100 MHz, CDCl3): δ (ppm) = 150.7, 144.8, 138.7, 128.0, 127.7, 126.2, 
125.9, 125.0, 49.6, 31.6, 31.4, 17.2. MS (ESI) m/z calc’d C18H21 [M + H]
+
: 237.3, found: 
237.3. 
4,4’-(4-Methylpent-1-ene-2,4-diyl)bis(methoxibenzene)22  
Colourless oil, 22% yield (L9). 
1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 7.2-7.16 (m, 4H), 6.77-6.75 (m, 4H), 5.08 (d, J= 2.0 
Hz, 1H), 4.70 (d, J= 2.0 Hz, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 
2.16 (s, 2H), 1.55 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 157.6, 142.1, 135.8, 
127.9, 127.1, 115.8, 113.5, 55.7, 50.2, 38.4, 32.1. MS (ESI) m/z calc’d C20H25O2 [M + H]
+
: 
297.1, found: 297.1. 
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4,4’-(4-Methylpent-2-ene-2,4-diyl)bis(methoxybenzene)  
Colourless oil, 65% yield (L9).
 1
H NMR (400 MHz, CDCl3): 
δ (ppm) = 7.33-7.29 (m, 4H), 6.86-6.75 (m, 4H), 6.03 (d, J= 
2.0 Hz, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 1.47 (s, 6H), 1.19 (s, 
3H).
13
C NMR (100 MHz, CDCl3): δ (ppm) = 159.0, 143.2, 137.8, 127.5, 127.3, 113.9, 
113.8, 55.6, 39.7, 32.0, 17.5. MS (ESI) m/z calc’d C20H25O2 [M + H]
+
: 297.2, found: 297.2. 
4,4’-(4-Methylpent-1-ene-2,4-diyl)bis(methylbenzene)23  
Colourless liquid, 21% yield (L9). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.24-7.16 (m, 4H), 7.06-7.04 (m, 4H), 5.12 (d, J= 2.0 Hz, 
1H), 4.80 (d, J= 2.0 Hz, 1H), 2.78 (s, 2H), 2.33 (s, 3H), 2.32 (s, 
3H), 1.53 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 145.6, 139.8, 137.2, 135.4, 
130.1, 129.2, 129.1, 126.7, 126.1, 40.0, 29.1, 21.4, 21.3, 17.6. MS (ESI) m/z calc’d C20H25 
[M + H]
+
: 265.2, found: 265.2. 
4,4’-(4-Methylpent-2-ene-2,4-diyl)bis(methylbenzene)  
Colourless liquid, 61% yield (L9). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.30-7.27 (m, 4H), 7.12-7.08 (m, 4H), 6.08 (d, J= 2.0 Hz, 
1H), 2.30 (s, 3H), 2.29 (s, 3H), 1.55 (s, 3H), 1.48 (s, 6H).
13
C NMR 
(100 MHz, CDCl3): δ (ppm) = 147.9, 142.4, 138.4, 136.6, 136.3, 135.0, 129.2, 126.4, 126.0, 
40.0, 29.1, 23.0, 14.5. MS (ESI) m/z calc’d C20H25 [M + H]
+
: 265.2, found: 265.2. 
3,3’-(4-Methylpent-1-ene-2,4-diyl)bis(methylbenzene)  
White solid, 50% yield (L9).
 1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 7.20-6.86 (m, 8H), 5.13 (d, J= 2.0 Hz, 1H), 4.80 (d, J= 2.0 Hz, 
1H), 2.80 (s, 2H), 2.32 (s, 6H), 1.21 (s, 6H).
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 147.6, 137.7, 137.4, 128.4, 128.1, 127.9, 127.7, 127.6, 127.2, 126.9, 
126.5, 124.0, 123.3, 116.9, 50.0, 38.8, 29.1, 22.1. MS (ESI) m/z calc’d C20H25 [M + H]
+
: 
265.2, found: 265.2. 
3,3’-(4-Methylpent-2-ene-2,4-diyl)bis(methylbenzene)  
White solid, 26% yield (L9). 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 7.25-6.87 (m, 8H), 6.09 (s, 1H), 2.34 (s, 3H), 2.32 (s, 3H), 1.56 
(s, 3H), 1.53 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
149.1, 138.6, 137.8, 129.88, 128.0, 127.8, 126.8, 126.3, 123.6, 123.3, 40.0, 28.7, 21.4, 21.2, 
17.2. MS (ESI) m/z calc’d C20H25 [M + H]
+
: 265.2, found: 265.2. 
3-(3,4-Dimethoxyphenyl)-4,5-dimethoxy-1,1,3-trimethyl-2,3-dihydro-1H-indene  
Colourless oil, 99% yield (L9). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 6.76-6.6 (m, 5H), 3.9 (s, 3H), 3.85 (s, 3H), 3.83 (s, 3H), 
3.76 (s, 3H), 2.34 (d, J= 12.8 Hz, 1H), 2.17 (d, J= 12.7 Hz, 1H), 1.66 
(s, 3H), 1.32 (s, 3H), 1.05 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 149.2, 148.8, 148.7, 147.2, 144.4, 144.3, 140.6, 119.0, 
110.9, 107.8, 105.6, 60.2, 56.5, 56.3, 56.2, 50.7, 43.1, 31.2, 30.9. MS 
(ESI) m/z calc’d C22H29O4 [M + H]
+
: 357.2, found: 357.2. 
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2,2’-(4-Methylpent-1-ene-2,4-diyl)dinaphthalene  
White solid, 70% yield (L9). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.84-7.63 (m,7H), 7.53-7.37 (m, 7H), 5.24 (d, J= 2.0 
Hz, 1H), 4.88 (d, J= 2.0 Hz, 1H), 3.03 (s, 2H), 1.54 (s, 6H). 
13
C 
NMR (100 MHz, CDCl3): δ (ppm) = 149.3, 148.7, 142.3, 134.6, 132.4, 128.3, 128.2, 127.9, 
127.8, 127.7, 127.6, 126.3, 126.0, 125.9, 125.5, 125.4, 124.4, 117.8, 49.7, 39.4, 29.2. MS 
(ESI) m/z calc’d C26H25 [M + H]
+
: 337.5, found: 337.5. 
2,2’-(4-Methylpent-2-ene-2,4-diyl)dinaphthalene  
White solid, 86% yield (L10).
 1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.87-7.62 (m, 7H), 7.59-7.07 (m, 7H), 6.35 (d, J= 2.0 
Hz, 1H), 2.07 (s, 3H), 1.65 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 149.0, 143.1, 133.4, 132.6, 130.1, 129.2, 129.1, 128.5, 128.4, 127.8, 
126.7, 126.2, 125.9, 125.7, 125.4, 124.9, 123.9, 121.7, 41.7, 31.8, 21.3. MS (ESI) m/z calc’d 
C26H25 [M + H]
+
: 337.5, found: 337.5. 
4,4’’-(4-Methylpent-1-ene-2,4-diyl)di-1,1’-biphenyl24  
White solid, 60% yield (L10, r.t.). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.65-7.12 (m, 18H), 5.21 (s, 1H), 4.89 
(s, 1H), 2.89 (s, 2H), 1.31 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 150.0, 148.6, 141.3, 141.2, 139.1, 138.6, 
129.1, 129.0, 127.5, 127.4, 127.3, 127.2, 126.9, 126.8, 126.5, 117.2, 50.3, 40.3, 29.1. MS 
(ESI) m/z calc’d C30H29 [M + H]
+
: 389.2, found: 389.2. 
4,4’’-(4-Methylpent-2-ene-2,4-diyl)di-1,1’-biphenyl24  
White solid, 52% yield (L10, 35 °C). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.63-7.23 (m, 18H), 6.23 (d, J= 2.0 Hz, 
1H), 1.65 (s, 3H), 1.32 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 148.6, 146.8, 142.5, 141.3, 139.8, 139.1, 
129.1, 129.0, 127.5, 127.4, 127.3, 127.2, 126.9, 126.8, 126.5, 38.7, 32.0, 17.6. MS (ESI) m/z 
calc’d C30H29 [M + H]
+
: 389.2, found: 389.2. 
2,2’-(4-Methylpent-1-ene-2,4-diyl)dithiophene  
Pale yellow liquid, 87% yield (L9). 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.14-7.10 (m, 2H), 6.90-6.84 (m, 2H), 6.80 (d, J= 3.6 Hz, 2H), 
5.41 (s, 1H), 4.70 (s, 1H), 2.80 (s, 2H), 1.33 (s, 6H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) = 156.5, 148.8, 136.6, 127.6, 126.6, 124.3, 124.0, 123.6, 123.4, 
122.9, 115.7, 51.0, 38.7, 30.3. MS (ESI) m/z calc’d C14H17S2 [M + H]
+
: 249.1, found: 249.1. 
2,2’-(4-Methylpent-2-ene-2,4-diyl)dithiophene  
Pale yellow liquid, 61% yield (L10, 35 °C). 
1
H NMR (400 MHz, 
CDCl3): δ (ppm) = 7.21-7.12 (m, 2H), 6.97-6.93 (m, 2H), 6.79-6.78 (m, 
2H), 6.29 (s, 1H), 1.77 (s, 3H), 1.58 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 147.2, 136.6, 131.2, 126.7, 126.6, 124.0, 123.4, 123.0, 122.9, 122.7, 39.0, 
33.2, 17.2. MS (ESI) m/z calc’d C14H17S2 [M + H]
+
: 249.1, found: 249.1. 
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4,4’-(4-Methylpent-1-ene-2,4-diyl)bis(fluorobenzene)  
Colourless liquid, 45% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 7.19-7.09 (m, 4H), 6.90-6.83 (m, 4H), 5.08 (s, 1H), 4.77 (s, 1H), 
2.77 (s, 2H), 1.22 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 
160.0, 149.7, 143.8, 138.8, 128.4 (
3
JC-F = 7.8 Hz), 127.6 (
3
JC-F = 7.8 Hz), 115.2 (
2
JC-F = 11.4 
Hz), 115.0, 114.8 (
2
JC-F = 21.0 Hz), 51.4, 38.6, 32.0. MS (ESI) m/z calc’d C18H19F2 [M + 
H]
+
: 273.1, found: 273.1. 
4,4’-(4-Methylpent-2-ene-2,4-diyl)bis(fluorobenzene) 
Colourless liquid, 65% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 
= 7.37-7.30 (m, 4H), 7.01-6.99 (m, 2H), 6.98-6.83 (m, 2H), 6.04 (s, 
1H), 1.58 (s, 3H), 1.53 (s, 6H).
 13
C NMR (100 MHz, CDCl3): δ 
(ppm) = 161.0 (
1
JC-F = 253.0 Hz), 143.0, 138.8, 136.0, 127.9 (
3
JC-F = 7.6 Hz), 127.6 (
3
JC-F = 
8.2 Hz), 115.3 (
2
JC-F = 21.0 Hz), 40.0, 29.4, 17.7. MS (ESI) m/z calc’d C18H19F2 [M + H]
+
: 
273.1, found: 273.1. 
 
4,4’-(4-Methylpent-1-ene-2,4-diyl)bis(chlorobenzene)12 
Colourless liquid, 48% yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.18-7.07 (m, 8H), 5.11 (d, J= 2.0 Hz, 1H), 4.79 (d, J= 
2.0 Hz, 1H), 2.76 (s, 2H), 1.20 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) = 147.7, 145.8, 141.9, 133.0, 131.7, 128.5, 128.2, 128.2, 128.1, 127.8, 
117.9, 50.1, 38.8, 29.1. MS (ESI) m/z calc’d C18H19Cl2 [M + H]
+
: 305.1, found: 305.1. 
4,4’-(4-Methylpent-2-ene-2,4-diyl)bis(chlorobenzene) 
Colourless liquid, 63% yield. 
1
H NMR (400 MHz, CDCl3): δ 
(ppm) = 7.33-7.24 (m, 8H), 6.07 (s, 1H), 1.48 (s, 6H), 1.20 (s, 
3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 149.2, 143.3, 
139.0, 136.0, 132.9, 131.6, 129.5, 128.5, 128.1, 127.4, 40.2, 31.7, 17.6. MS (ESI) m/z calc’d 
C18H19Cl2 [M + H]
+
: 305.1, found: 305.1. 
4,4’-(4-Methylpent-1-ene-2,4-diyl)bis(bromobenzene)12 
Colourless liquid, 49% yield. 
1
H NMR (100 MHz, CDCl3): δ 
(ppm) = 7.33-7.27 (m, 4H), 7.10-06 (m, 2H), 7.04-7.00 (m, 2H), 
5.11 (d, J= 2.0 Hz, 1H), 4.80 (d, J= 2.0 Hz, 1H), 2.75 (s, 2H), 2.17 
(s, 6H).
 13
C NMR (62.5 MHz, CDCl3): δ (ppm) = 149.4, 145.8, 140.8, 132.5, 131.2, 128.7, 
128.5, 128.0, 127.3, 116.5, 50.1, 38.5, 28.9. MS (ESI) m/z calc’d C18H19Br2 [M + H]
+
: 
395.0, found: 395.0. 
4,4’-(4-Methylpent-2-ene-2,4-diyl)bis(bromobenzene) 
Colourless liquid, 68% yield. 
1
H NMR (100 MHz, CDCl3): δ 
(ppm) = 7.43-7.39 (m, 4H), 7.28-7.21 (m, 4H), 6.07 (d, J= 2.0 Hz, 
1H), 1.53 (s, 6H), 1.20 (s, 3H). 
13
C NMR (62.5 MHz, CDCl3): δ 
(ppm) = 148.9, 142.2, 132.5, 132.1, 130.7, 128.5, 127.4, 123.8, 122.8, 121.2, 40.2, 31.5, 
17.4. MS (ESI) m/z calc’d C18H19Br2 [M + H]
+
: 395.0, found: 395.0. 
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7.5.4. Procedure for the protic and Lewis acid catalysed dimerisation of α-
methylstyrene 
In a vial equipped with a stirring bar, freshly distilled DCM (2.0 mL) and α-methylstyrene 
(0.3 mmol, 40 μL) were added. Bi(OTf)3 (3 mol%, 6.8 mg) was added and the reaction was 
stirred at r.t. for 24h. The same procedure was repeated using triflic acid (3 mol%, 2μL) as 
catalyst and running both reactions at 40 °C. The reaction products were characterised by 
1
H 
NMR. 
1,1,3-Trimethyl-3-phenyl-2,3-dihydro-1H-indene
25 
Colourless liquid, 100% yield. 
1
H NMR (400 MHz, CDCl3): δ (ppm) = 7.41-
7.12 (m, 9H), 2.45 (d, J = 13.0 Hz, 1H), 2.24 (d, J = 13.0 Hz, 1H), 1.76 (s, 3H), 
1.42 (s, 3H), 1.12 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) = 152.2, 
151.0, 148.7, 127.9, 127.1, 126.8, 126.6, 125.4, 125.0, 122.5, 59.2, 50.8, 42.8, 
30.8, 30.6, 30.3. HRMS (EI) m/z calc’d C18H21 [M + H]
+
: 237.1638, found: 
237.1630. 
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8.1. General perspective of the Thesis 
Selective oxidation has been highlighted as one of the most important areas of research in 
catalysis for future industrial applications in the “Technology Vision 2020: The Chemical 
Industry” report. Some of the most important goals of the report include methods for the 
selective oxidation and dehydrogenative oxidation of alkanes, methods for the selective 
oxidation of olefins and aromatics and for activating molecular oxygen.  
This thesis covers our efforts in tackling some of the major issues affecting current oxidation 
methods in the field of iron catalysis. Most of the iron catalysts rely on the use of 
tetradentate N-donor ligands and require strong hydrogen peroxide as the oxidising agent in 
order to generate an iron-oxo species that ultimately acts as the real oxidant in the reaction. 
Thus, selectivity issues, poor functional group tolerance to electron rich functionalities 
(mainly ethers, aromatics, olefins, alcohols and amines) and poor mass balances are major 
limitations.  
In this thesis, we have demonstrated that novel tridentate N-donor ligands incorporating 
electron-withdrawing sulfonamide groups can coordinate to commercial iron salts and 
facilely tune its electrophilic properties, enhancing the ability of the iron centre for O2 
activation. An ample ligand library was created by selectively modifying the initial ligand 
skeleton, allowing control of the steric hindrance around the metal centre (Scheme 1). 
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Scheme 1. Library of PyBisulidine type ligands presented in this thesis 
 
Complexes of iron triflates bearing Pybisulidine ligands were found active for the selective 
α-aerobic oxidation of ethereal substrates under very mild conditions. In particular, the 
oxidation of isochromans and phthalans was achieved with high efficiency, allowing the 
construction of synthetically useful isochromanones and phthalides (Scheme 2). To the best 
of our knowledge these iron complexes represent the first type of iron catalysts capable of 
highly selectively oxidising CH bonds in the presence of electron rich functionalities and 
one of the most efficient types of catalysts in activating dioxygen for oxidation reactions. 
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From a mechanistic perspective, evidence of an unprecedented two step mechanism 
involving the dehydrogenative oxygenation of two ethereal molecules to form a 
peroxybisether intermediate, followed by its dehydrogenative cleavage to afford two ester 
molecules was presented (Scheme 3). These mechanistic studies may have important 
implications in understanding biological oxygenases and in inspiring new biomimetic iron 
complex designs. 
 
Scheme 2. Selective oxidation of isochromans and phthalans 
 
 
Scheme 3. Selective dehydrogenative oxygenation of ethers 
 
Natural oxygenases capable of selectively oxidise organic substrates are also capable of 
selectively cleaving C-C bonds under mild aerobic conditions. However, biomimetic iron 
complexes have been mainly used for selective oxidation reactions. In this thesis we have 
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demonstrated that the same family of iron-Pybisulidine complexes can selectively cleavage 
aliphatic C-O and C-C bonds of ethereal substrates under aerobic conditions (Scheme 4). 
Moreover, some of these reactions allow the formation of complex and/or valuable 
oxygenated compounds, highlighting the potential applicability of selective aerobic 
cleavages in organic synthesis.  
The cleavage of olefinic C-C bonds to afford carbonyl compounds was also demonstrated, 
providing a greener and safer alternative to traditional ozonolysis (Scheme 5). To the best of 
our knowledge, this is the first iron catalysts capable of efficiently promoting the aerobic 
cleavage of olefinic bonds. 
 
 
 
Scheme 4. Selective aerobic cleavage of aliphatic bonds 
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Scheme 5. Selective aerobic cleavage of olefinic bonds 
 
8.2. Future work 
An ample variety of iron-Pybisulidine aerobic transformations have been presented in this 
thesis. However, other challenging reactions, such as oxidation of unactivated CH bonds to 
alcohols and oxidation of aromatic rings to phenols are attractive transformations to 
investigate by other members of this group. Additionally, the modification of the ligand 
structure to improve its efficiency can be further explored for instance, by introducing 
tetradentate or asymmetric multidentate designs.  
Additional investigations and computational studies on the reaction mechanisms of the 
oxidations presented in this thesis can be further continued in order to shed more light into 
the catalytic performance of iron-PyBisulidine complexes. 
The discovery of the iron-Pybisulidine catalysed head-to-tail dimerisation of α-
methylstyrenes under inert atmosphere also indicates that this family of complexes may be 
capable of promoting other catalytic reactions in fields different from selective oxidation. 
Further investigations in the fields of enantioselective C-C bond forming reactions or 
reduction chemistry are other alternatives to explore in the future. 
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A1 
 
1. Additional X-ray diffraction data 
1.1. Complex (S,S)-[Fe(BF4)(NNN)(MeCN)2](BF4) (20) 
Table 2. Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for (S,S)-20. Ueq is defined as 1/3 of of the 
trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
Fe1 3616.8(3) 5510.0(3) 8955.3(1) 15.6(1) 
S1 2876.1(6) 9095.1(5) 8458.3(2) 22.8(2) 
S2 4858.4(6) 2825.7(5) 7919.4(2) 17.9(2) 
F1 1587.8(14) 5756.8(11) 8928.3(4) 27.5(5) 
F2 33.8(17) 6846.1(13) 8941.6(5) 41.5(7) 
F3 134.8(17) 5809.9(13) 9389.9(5) 35.2(6) 
F4 1654.7(15) 6897.5(11) 9340.5(4) 25.5(5) 
O1 3644.9(19) 9805.4(13) 8314.4(6) 26.2(6) 
O2 1731.4(18) 8811.6(14) 8283.9(6) 33.2(7) 
O3 4188.9(18) 2092.2(14) 7755.9(5) 25.0(6) 
O4 5502.9(17) 3489.7(14) 7705.8(5) 22.7(6) 
N1 3656.8(19) 5776.2(14) 8397.3(6) 15.4(6) 
N2 3853.5(18) 7014.5(14) 8899.8(6) 15.5(7) 
N3 3803.6(19) 8190.5(14) 8470.1(6) 16.4(6) 
N4 3662(2) 4129.1(15) 8704.9(6) 15.9(6) 
N5 3769(2) 3400.2(15) 8146.7(6) 16.4(7) 
N6 5596(2) 5294.6(15) 9016.3(6) 20.8(8) 
N7 3288(2) 5095.0(18) 9481.0(7) 27.1(8) 
C1 3413(2) 6610.4(17) 8277.4(7) 15.4(8) 
C2 3209(2) 7311.9(18) 8570.3(7) 17.6(8) 
C3 5177(2) 7375.1(18) 8865.2(7) 15.6(8) 
C4 5036(2) 8289.3(18) 8664.9(7) 16.4(8) 
C5 2536(3) 9383(2) 8908.2(9) 31.9(10) 
C6 1575(3) 8934(2) 9087.1(10) 41.2(11) 
C7 1412(4) 9104(3) 9451.3(11) 52.7(14) 
C8 2218(4) 9691(3) 9631.7(11) 52.0(14) 
C9 3163(4) 10139(3) 9447.1(11) 45.7(12) 
C10 3323(3) 9986(2) 9086.9(9) 35.4(11) 
C11 2055(6) 9848(3) 10030.3(12) 74.3(19) 
C12 6170(2) 8507.6(17) 8432.1(7) 17.3(8) 
C13 6203(3) 8313.3(19) 8073.0(7) 21.1(8) 
C14 7282(3) 8501(2) 7872.8(8) 25.2(9) 
C15 8339(3) 8887(2) 8030.3(8) 27.6(9) 
C16 8325(3) 9073(2) 8391.6(9) 27.2(9) 
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C17 7242(3) 8880.6(19) 8593.2(8) 23.5(9) 
C18 5856(2) 7492.1(18) 9217.2(7) 17.5(8) 
C19 7127(3) 7264(2) 9244.3(8) 22.3(9) 
C20 7811(3) 7439(2) 9553.3(8) 28.3(10) 
C21 7216(3) 7846(2) 9838.2(8) 32.1(10) 
C22 5933(3) 8095(2) 9814.7(9) 32.9(10) 
C23 5261(3) 7914(2) 9504.5(8) 25.6(9) 
C24 3303(2) 6798.6(19) 7919.9(7) 19.5(8) 
C25 3446(2) 6085.6(18) 7681.6(7) 19.3(8) 
C26 3703(2) 5220.3(19) 7805.4(7) 19.1(8) 
C27 3811(2) 5084.1(18) 8169.3(7) 14.5(8) 
C28 4219(2) 4210.7(18) 8346.2(7) 15.7(8) 
C29 2462(2) 3608.2(18) 8644.7(7) 15.5(8) 
C30 2869(2) 2881.2(18) 8375.1(7) 17.0(8) 
C31 5976(2) 2377.5(19) 8219.3(7) 19.4(8) 
C32 5729(3) 1550(2) 8381.0(8) 25.3(9) 
C33 6606(3) 1213(2) 8622.7(8) 30.9(10) 
C34 7728(3) 1667(2) 8696.2(8) 28(1) 
C35 7969(3) 2479(2) 8523.7(8) 25.1(9) 
C36 7101(2) 2845(2) 8288.4(8) 22.0(9) 
C37 8678(3) 1298(2) 8961.5(9) 40.5(11) 
C38 1762(2) 2460.1(19) 8177.3(7) 18.6(8) 
C39 1463(3) 1558(2) 8239.1(8) 27.2(9) 
C40 428(3) 1162(2) 8065.9(9) 35.6(11) 
C41 -296(3) 1665(3) 7835.6(9) 39.7(11) 
C42 -16(3) 2564(2) 7774.2(8) 32.6(10) 
C43 1018(3) 2972(2) 7948.0(8) 25.0(9) 
C44 1890(2) 3261.6(18) 8984.3(7) 17.7(8) 
C45 2485(3) 2629(2) 9196.8(8) 28.0(9) 
C46 1937(3) 2362(2) 9517.6(9) 35.0(11) 
C47 781(3) 2705(2) 9620.4(9) 34.7(11) 
C48 182(3) 3340(3) 9409.4(9) 40.8(13) 
C49 721(3) 3622(2) 9094.0(8) 28.6(10) 
C50 6618(3) 5044.4(19) 9000.3(8) 22.0(9) 
C51 7912(3) 4713(2) 8972.1(9) 30.5(10) 
C52 3124(3) 4747(2) 9745.5(9) 36.4(11) 
C53 2926(5) 4312(3) 10087(1) 61.3(16) 
B1 833(3) 6333(2) 9156.3(9) 22.8(10) 
N8 10401(4) 5206(3) 8167.3(13) 75.7(16) 
C54 10017(3) 5927(3) 8152.5(10) 39.4(11) 
C55 9538(3) 6832(2) 8134.4(9) 35.9(11) 
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N9 6816(3) 5588(3) 8187.6(9) 55.9(13) 
C56 6974(3) 5440(3) 7894.7(10) 36.8(11) 
C57 7177(3) 5259(2) 7520.9(9) 40.3(11) 
F5 5622.6(16) 3072.5(12) 9057.0(5) 31.8(6) 
F6 7107.3(18) 2890.0(16) 9490.9(6) 50.4(8) 
F7 5108(2) 3339.5(14) 9632.9(5) 44.4(7) 
F8 5478(2) 1895.4(13) 9448.0(6) 46.0(7) 
B2 5841(3) 2796(3) 9409.6(10) 30.2(11) 
  
Table 3 Anisotropic Displacement Parameters (Å
2
×10
3
) for (S,S)-20. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
Fe1 17.7(2) 14.8(2) 14.1(2) 1.3(2) 0.5(2) 0.4(1) 
S1 19.5(3) 17.0(4) 31.9(4) 5.7(3) 0.6(3) 4.4(3) 
S2 17.9(3) 18.9(4) 16.9(3) -2.9(3) 4.0(2) 1.3(2) 
F1 20.9(8) 35(1) 26.5(9) -5.6(8) 3.3(7) 0.2(7) 
F2 35.1(10) 57.0(13) 32.5(11) -2.5(10) -5.5(9) 21.8(9) 
F3 33.2(10) 43.0(12) 29.4(10) -6.6(9) 13.8(8) -14.5(8) 
F4 24.2(9) 26.6(9) 25.8(9) -7.9(7) 4.9(7) -4.0(7) 
O1 27(1) 18.8(11) 32.9(12) 7.0(9) 0.2(9) 4.0(8) 
O2 21.5(10) 25.8(12) 52.4(15) 9.3(11) -6.0(9) 3.7(8) 
O3 23.8(10) 24.0(11) 27.3(12) -10.2(9) 1.1(8) 1.4(8) 
O4 22.6(10) 29.5(12) 16.1(10) 2.1(9) 4.7(8) 1.1(8) 
N1 12.5(10) 17.6(12) 16.2(11) 1.9(9) -0.1(9) 0.3(8) 
N2 12.1(10) 17.4(12) 16.9(12) 0.5(9) 1.6(8) 0.8(8) 
N3 15.1(10) 12.9(11) 21.3(12) 1.1(9) 0.6(9) 1.5(8) 
N4 16.2(10) 18.1(11) 13.4(11) 3.7(9) 1.3(9) -0.3(9) 
N5 16.9(11) 15.0(12) 17.2(12) -1.6(9) 3.4(9) -1.0(9) 
N6 19.7(12) 18.7(13) 24.0(14) 0.5(10) -3.6(9) -0.6(9) 
N7 32.1(14) 29.4(14) 19.8(14) 4.9(12) 3.4(10) 2.3(11) 
C1 12.4(12) 14.9(14) 19.0(14) 2.8(11) 0.1(10) -2(1) 
C2 17.6(13) 14.6(14) 20.7(14) 5.9(11) 0.7(10) 2.1(10) 
C3 14.2(12) 15.9(14) 16.6(14) 0.9(11) 2.9(10) 1.7(10) 
C4 17.0(12) 14.1(14) 18.2(14) -0.6(11) -0.6(10) 2.2(10) 
C5 31.3(15) 27.6(18) 36.7(19) 7.6(15) 9.3(14) 13.1(13) 
C6 47(2) 25.6(19) 51(2) -2.0(16) 18.5(17) 10.3(15) 
C7 68(3) 39(2) 51(2) 5.2(19) 31(2) 7(2) 
C8 83(3) 27(2) 46(2) -11.7(18) 13(2) 14.3(19) 
C9 63(2) 29(2) 45(2) -5.4(17) 2.6(19) 9.4(17) 
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C10 44.4(19) 23.7(18) 38(2) -2.5(15) 5.7(15) 9.9(14) 
C11 123(4) 48(3) 52(3) -2(2) 29(3) 17(3) 
C12 18.5(13) 11.1(13) 22.2(15) 3.1(11) 1.0(11) 1.4(9) 
C13 18.2(13) 24.2(16) 20.9(15) 1.5(12) -2.9(11) -1.2(11) 
C14 26.5(15) 28.6(17) 20.4(16) 5.1(13) 3.6(12) 1.7(12) 
C15 22.8(14) 26.4(17) 33.5(18) 4.8(13) 8.1(12) -2.6(12) 
C16 22.2(14) 24.2(16) 35.1(18) -1.1(14) 0.1(12) -7.8(12) 
C17 24.9(14) 20.9(16) 24.8(16) 1.0(12) 1.4(11) -2.2(11) 
C18 19.9(13) 14.9(15) 17.7(14) 3.7(11) 0.5(10) 0.2(10) 
C19 22.1(14) 21.1(16) 23.6(16) -3.6(12) 2.5(11) -1.0(11) 
C20 19.8(14) 36.9(19) 28.3(17) 0.2(14) -4.6(12) 2.9(12) 
C21 32.3(16) 44(2) 20.1(16) -0.9(15) -7.0(12) 1.0(14) 
C22 31.0(17) 48(2) 19.8(16) -2.8(15) 1.0(12) 0.8(14) 
C23 19.3(14) 35.2(18) 22.2(16) -0.9(13) -0.3(11) 3.9(12) 
C24 18.6(13) 16.3(14) 23.6(15) 5.9(12) -1.4(11) -1.4(10) 
C25 19.1(13) 25.0(16) 13.7(13) 2.0(11) 0.2(10) -3.6(11) 
C26 17.1(12) 25.5(15) 14.6(13) -2.3(11) 1.6(10) -2.9(11) 
C27 9.8(11) 16.2(14) 17.6(14) -0.4(11) 1.2(10) -3.0(9) 
C28 16.6(12) 16.8(14) 13.8(14) -1.2(11) 2.9(10) -2.1(10) 
C29 15.6(12) 13.5(14) 17.5(14) 0.2(11) 0.6(10) 1.1(9) 
C30 18.2(12) 16.5(14) 16.4(14) -0.3(11) 2.2(10) -0.2(10) 
C31 20.0(13) 22.1(16) 16.0(14) -2.2(12) 3.9(10) 7.1(10) 
C32 27.1(15) 18.2(16) 30.7(17) -2.8(13) 4.4(13) 3.9(12) 
C33 38.2(18) 21.1(17) 33.5(18) 5.8(14) 8.9(14) 10.2(13) 
C34 31.6(16) 29.6(18) 22.9(16) -3.0(14) 1.7(13) 12.9(13) 
C35 23.3(14) 30.6(17) 21.3(16) -6.4(13) 2.9(11) 2.5(12) 
C36 22.1(14) 21.7(16) 22.2(15) -2.8(12) 5.2(11) 3.7(11) 
C37 42.1(18) 44(2) 35.4(19) 6.4(17) -5.6(17) 14.0(16) 
C38 16.1(12) 21.0(15) 18.8(14) -5.9(12) 5.8(10) -3.8(10) 
C39 24.8(14) 26.7(17) 30.1(17) -5.1(13) 8.1(13) -2.2(13) 
C40 30.1(16) 30.6(19) 46(2) -16.2(16) 12.8(15) -14.4(14) 
C41 24.2(16) 57(2) 38(2) -23.2(18) 7.9(14) -15.7(15) 
C42 20.3(14) 55(2) 22.6(16) -8.1(15) 0.4(12) -1.1(14) 
C43 22.6(14) 32.3(18) 20.2(16) -4.7(13) 4.7(11) -1.7(12) 
C44 19.0(12) 16.6(14) 17.5(14) -0.3(12) 0.6(10) -3.8(10) 
C45 31.5(15) 26.3(17) 26.1(17) 5.1(13) 7.7(12) 7.6(13) 
C46 52(2) 27.4(19) 25.6(18) 9.4(14) 1.6(14) 4.0(15) 
C47 38.6(17) 41(2) 24.4(18) 10.0(16) 9.0(14) -8.4(15) 
C48 25.0(16) 65(3) 32.4(19) 12.1(18) 8.1(14) 2.3(16) 
C49 20.2(14) 42(2) 23.7(16) 9.0(14) 2.5(12) 5.0(13) 
C50 24.6(15) 18.1(15) 23.2(16) -1.0(12) -5.7(12) 0.0(11) 
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C51 20.9(14) 33.8(18) 36.9(18) -2.1(15) -3.8(13) 4.8(12) 
C52 45.4(19) 33(2) 30.7(19) 0.3(15) 3.2(15) 6.1(14) 
C53 95(3) 60(3) 29(2) 8(2) 13(2) 5(2) 
B1 20.5(15) 29(2) 19.0(18) -1.5(15) 2.5(12) 2.1(13) 
N8 60(2) 46(2) 121(4) 15(2) -20(2) 15.5(18) 
C54 31.1(17) 43(2) 44(2) 6.3(18) -10.7(15) -3.6(16) 
C55 46(2) 29.7(19) 31.9(19) 4.0(15) -1.6(15) -3.3(14) 
N9 35.8(16) 97(3) 34.9(19) 10(2) -2.0(13) -24.1(17) 
C56 21.5(14) 49(2) 40(2) 17.4(18) -3.3(14) -12.4(14) 
C57 42.9(19) 42(2) 36(2) 8.4(16) 10.8(16) -0.6(16) 
F5 35.8(9) 35.9(11) 23.8(10) 9.0(8) 5.2(7) 13.6(8) 
F6 32.1(11) 73.5(16) 45.6(13) 10.3(12) -4.6(9) -1.1(10) 
F7 55.0(12) 51.7(13) 26.5(11) 2.8(10) 6.2(9) 19.6(10) 
F8 57.9(13) 31.9(12) 48.2(13) 15.7(10) -1.8(10) -0.4(9) 
B2 28.6(18) 36(2) 26(2) 9.7(17) 3.2(14) 8.0(15) 
  
Table 4 Bond Lengths for (S,S)-20. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
Fe1 F1 2.1632(15) 
 
C14 C15 1.381(4) 
Fe1 N1 2.136(2) 
 
C15 C16 1.387(5) 
Fe1 N2 2.242(2) 
 
C16 C17 1.396(4) 
Fe1 N4 2.244(2) 
 
C18 C19 1.380(4) 
Fe1 N6 2.114(2) 
 
C18 C23 1.395(4) 
Fe1 N7 2.099(3) 
 
C19 C20 1.390(4) 
S1 O1 1.429(2) 
 
C20 C21 1.378(4) 
S1 O2 1.432(2) 
 
C21 C22 1.399(4) 
S1 N3 1.652(2) 
 
C22 C23 1.389(4) 
S1 C5 1.781(3) 
 
C24 C25 1.390(4) 
S2 O3 1.429(2) 
 
C25 C26 1.385(4) 
S2 O4 1.436(2) 
 
C26 C27 1.388(4) 
S2 N5 1.660(2) 
 
C27 C28 1.512(4) 
S2 C31 1.757(3) 
 
C29 C30 1.536(4) 
F1 B1 1.444(4) 
 
C29 C44 1.501(4) 
F2 B1 1.389(4) 
 
C30 C38 1.513(3) 
F3 B1 1.380(4) 
 
C31 C32 1.388(4) 
F4 B1 1.385(4) 
 
C31 C36 1.392(3) 
N1 C1 1.335(3) 
 
C32 C33 1.386(4) 
N1 C27 1.343(3) 
 
C33 C34 1.383(4) 
N2 C2 1.479(3) 
 
C34 C35 1.385(4) 
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N2 C3 1.493(3) 
 
C34 C37 1.512(4) 
N3 C2 1.487(3) 
 
C35 C36 1.380(4) 
N3 C4 1.494(3) 
 
C38 C39 1.386(4) 
N4 C28 1.476(3) 
 
C38 C43 1.387(4) 
N4 C29 1.493(3) 
 
C39 C40 1.395(4) 
N5 C28 1.488(3) 
 
C40 C41 1.371(5) 
N5 C30 1.489(3) 
 
C41 C42 1.377(5) 
N6 C50 1.136(4) 
 
C42 C43 1.403(4) 
N7 C52 1.133(4) 
 
C44 C45 1.378(4) 
C1 C2 1.526(4) 
 
C44 C49 1.400(4) 
C1 C24 1.378(4) 
 
C45 C46 1.394(4) 
C3 C4 1.552(4) 
 
C46 C47 1.370(4) 
C3 C18 1.514(4) 
 
C47 C48 1.379(5) 
C4 C12 1.513(3) 
 
C48 C49 1.379(5) 
C5 C6 1.382(5) 
 
C50 C51 1.448(4) 
C5 C10 1.388(4) 
 
C52 C53 1.451(5) 
C6 C7 1.403(6) 
 
N8 C54 1.138(6) 
C7 C8 1.388(6) 
 
C54 C55 1.428(5) 
C8 C9 1.379(6) 
 
N9 C56 1.135(5) 
C8 C11 1.527(6) 
 
C56 C57 1.447(5) 
C9 C10 1.384(5) 
 
F5 B2 1.407(4) 
C12 C13 1.381(4) 
 
F6 B2 1.371(4) 
C12 C17 1.392(4) 
 
F7 B2 1.393(4) 
C13 C14 1.388(4) 
 
F8 B2 1.389(5) 
  
Table 5. Bond Angles for (S,S-20). 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
F1 Fe1 N1 86.69(7) 
 
C12 C13 C14 120.6(3) 
F1 Fe1 N2 86.46(7) 
 
C13 C14 C15 120.3(3) 
F1 Fe1 N4 98.85(7) 
 
C14 C15 C16 119.6(3) 
F1 Fe1 N6 176.32(8) 
 
C15 C16 C17 120.1(3) 
F1 Fe1 N7 86.06(7) 
 
C12 C17 C16 120.2(3) 
N1 Fe1 N2 74.01(8) 
 
C3 C18 C19 119.5(2) 
N1 Fe1 N4 75.75(8) 
 
C3 C18 C23 121.2(2) 
N1 Fe1 N6 96.60(8) 
 
C19 C18 C23 119.0(3) 
N1 Fe1 N7 169.39(9) 
 
C18 C19 C20 121.1(3) 
N2 Fe1 N4 148.92(8) 
 
C19 C20 C21 119.8(3) 
N2 Fe1 N6 92.86(8) 
 
C20 C21 C22 120.1(3) 
N2 Fe1 N7 113.23(9) 
 
C21 C22 C23 119.4(3) 
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N4 Fe1 N6 83.60(8) 
 
C18 C23 C22 120.6(3) 
N4 Fe1 N7 97.72(9) 
 
C1 C24 C25 117.9(2) 
N6 Fe1 N7 90.89(9) 
 
C24 C25 C26 120.1(2) 
O1 S1 O2 120.97(13) 
 
C25 C26 C27 118.7(2) 
O1 S1 N3 105.62(11) 
 
N1 C27 C26 120.7(2) 
O1 S1 C5 107.37(14) 
 
N1 C27 C28 113.6(2) 
O2 S1 N3 105.74(12) 
 
C26 C27 C28 125.5(2) 
O2 S1 C5 109.69(14) 
 
N4 C28 N5 105.66(19) 
N3 S1 C5 106.56(13) 
 
N4 C28 C27 111.1(2) 
O3 S2 O4 120.46(12) 
 
N5 C28 C27 111.9(2) 
O3 S2 N5 105.61(11) 
 
N4 C29 C30 102.98(18) 
O3 S2 C31 108.67(13) 
 
N4 C29 C44 112.6(2) 
O4 S2 N5 105.35(12) 
 
C30 C29 C44 115.8(2) 
O4 S2 C31 107.53(11) 
 
N5 C30 C29 101.5(2) 
N5 S2 C31 108.74(12) 
 
N5 C30 C38 114.5(2) 
Fe1 F1 B1 127.69(16) 
 
C29 C30 C38 113.42(18) 
Fe1 N1 C1 119.84(17) 
 
S2 C31 C32 119.2(2) 
Fe1 N1 C27 119.36(17) 
 
S2 C31 C36 120.0(2) 
C1 N1 C27 120.5(2) 
 
C32 C31 C36 120.8(2) 
Fe1 N2 C2 108.71(15) 
 
C31 C32 C33 118.6(3) 
Fe1 N2 C3 117.62(15) 
 
C32 C33 C34 121.6(3) 
C2 N2 C3 104.30(19) 
 
C33 C34 C35 118.7(3) 
S1 N3 C2 117.58(15) 
 
C33 C34 C37 121.3(3) 
S1 N3 C4 116.41(17) 
 
C35 C34 C37 120.0(3) 
C2 N3 C4 108.92(19) 
 
C34 C35 C36 121.2(3) 
Fe1 N4 C28 108.56(16) 
 
C31 C36 C35 119.1(3) 
Fe1 N4 C29 120.85(15) 
 
C30 C38 C39 119.0(2) 
C28 N4 C29 103.75(19) 
 
C30 C38 C43 121.0(2) 
S2 N5 C28 116.80(16) 
 
C39 C38 C43 119.9(2) 
S2 N5 C30 118.16(17) 
 
C38 C39 C40 120.0(3) 
C28 N5 C30 108.9(2) 
 
C39 C40 C41 120.0(3) 
Fe1 N6 C50 166.2(2) 
 
C40 C41 C42 120.6(3) 
Fe1 N7 C52 170.0(3) 
 
C41 C42 C43 120.0(3) 
N1 C1 C2 114.1(2) 
 
C38 C43 C42 119.5(3) 
N1 C1 C24 122.1(2) 
 
C29 C44 C45 122.9(2) 
C2 C1 C24 123.8(2) 
 
C29 C44 C49 118.2(2) 
N2 C2 N3 106.20(19) 
 
C45 C44 C49 118.9(3) 
N2 C2 C1 109.9(2) 
 
C44 C45 C46 120.4(3) 
N3 C2 C1 110.4(2) 
 
C45 C46 C47 120.4(3) 
N2 C3 C4 105.25(18) 
 
C46 C47 C48 119.5(3) 
N2 C3 C18 113.7(2) 
 
C47 C48 C49 120.9(3) 
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C4 C3 C18 111.8(2) 
 
C44 C49 C48 119.9(3) 
N3 C4 C3 103.66(19) 
 
N6 C50 C51 178.6(3) 
N3 C4 C12 114.7(2) 
 
N7 C52 C53 179.1(3) 
C3 C4 C12 113.02(19) 
 
F1 B1 F2 107.9(2) 
S1 C5 C6 119.7(2) 
 
F1 B1 F3 109.9(2) 
S1 C5 C10 119.6(2) 
 
F1 B1 F4 108.0(2) 
C6 C5 C10 120.4(3) 
 
F2 B1 F3 110.7(2) 
C5 C6 C7 118.6(3) 
 
F2 B1 F4 109.9(2) 
C6 C7 C8 121.0(4) 
 
F3 B1 F4 110.4(3) 
C7 C8 C9 119.4(4) 
 
N8 C54 C55 179.9(6) 
C7 C8 C11 120.4(4) 
 
N9 C56 C57 179.5(5) 
C9 C8 C11 120.2(4) 
 
F5 B2 F6 109.8(3) 
C8 C9 C10 120.1(4) 
 
F5 B2 F7 108.2(3) 
C5 C10 C9 120.4(3) 
 
F5 B2 F8 109.3(3) 
C4 C12 C13 122.8(2) 
 
F6 B2 F7 110.1(3) 
C4 C12 C17 117.9(2) 
 
F6 B2 F8 109.8(3) 
C13 C12 C17 119.2(2) 
 
F7 B2 F8 109.6(3) 
  
Table 6. Hydrogen Bonds for (S,S-20). 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
N2 H2 F4 0.9800 2.1500 2.847(3) 127.00 
N4 H4 F5 0.9300 2.0100 2.901(3) 159.00 
C10 H10 O1 0.9500 2.5600 2.938(4) 104.00 
C13 H13 N3 0.9500 2.6100 2.934(4) 101.00 
C21 H21 F4
1
 0.9500 2.5400 3.168(3) 124.00 
C26 H26 O4 0.9500 2.5600 3.197(3) 124.00 
C32 H32 O1
2
 0.9500 2.5100 3.386(4) 153.00 
C36 H36 O4 0.9500 2.5600 2.919(3) 102.00 
C47 H47 F7
3
 0.9500 2.3800 3.281(4) 159.00 
C51 H51A F3
4
 0.9800 2.3000 3.245(4) 162.00 
C57 H57B O3
5
 0.9800 2.5000 3.232(4) 132.00 
C57 H57C O4 0.9800 2.5900 3.222(4) 122.00 
1
1/2+X,3/2-Y,2-Z; 
2
+X,-1+Y,+Z; 
3
-1/2+X,1/2-Y,2-Z; 
4
1+X,+Y,+Z; 
5
1-X,1/2+Y,3/2-
Z 
  
 
 
Appendix 
 
A9 
 
Table 7. Torsion Angles for (S,S-20). 
A B C D Angle/˚   A B C D Angle/˚ 
Fe1 F1 B1 F2 134.33(18) 
 
N7 Fe1 N4 C29 75.38(19) 
Fe1 F1 B1 F3 -104.9(2) 
 
C1 N1 C27 C26 -0.9(3) 
Fe1 F1 B1 F4 15.6(3) 
 
C1 N1 C27 C28 173.80(19) 
Fe1 N1 C1 C2 3.8(2) 
 
C1 C24 C25 C26 -0.6(3) 
Fe1 N1 C1 C24 -173.48(16) 
 
C2 N2 C3 C4 34.2(2) 
Fe1 N1 C27 C26 172.96(16) 
 
C2 N2 C3 C18 156.8(2) 
Fe1 N1 C27 C28 -12.4(2) 
 
C2 N3 C4 C3 4.1(2) 
Fe1 N2 C2 N3 -157.94(14) 
 
C2 N3 C4 C12 127.8(2) 
Fe1 N2 C2 C1 -38.5(2) 
 
C2 C1 C24 C25 -176.6(2) 
Fe1 N2 C3 C4 154.64(16) 
 
C3 N2 C2 N3 -31.7(2) 
Fe1 N2 C3 C18 -82.7(2) 
 
C3 N2 C2 C1 87.7(2) 
Fe1 N4 C28 N5 -158.24(14) 
 
C3 C4 C12 C13 96.0(3) 
Fe1 N4 C28 C27 -36.7(2) 
 
C3 C4 C12 C17 -80.9(3) 
Fe1 N4 C29 C30 163.22(16) 
 
C3 C18 C19 C20 174.1(3) 
Fe1 N4 C29 C44 -71.4(2) 
 
C3 C18 C23 C22 -173.8(3) 
S1 N3 C2 N2 -118.22(18) 
 
C4 N3 C2 N2 17.0(2) 
S1 N3 C2 C1 122.72(18) 
 
C4 N3 C2 C1 -102.1(2) 
S1 N3 C4 C3 139.91(17) 
 
C4 C3 C18 C19 -101.2(3) 
S1 N3 C4 C12 -96.4(2) 
 
C4 C3 C18 C23 72.0(3) 
S1 C5 C6 C7 173.4(3) 
 
C4 C12 C13 C14 -178.0(3) 
S1 C5 C10 C9 -172.6(3) 
 
C4 C12 C17 C16 178.4(2) 
S2 N5 C28 N4 -132.50(17) 
 
C5 S1 N3 C2 72.9(2) 
S2 N5 C28 C27 106.5(2) 
 
C5 S1 N3 C4 -59.0(2) 
S2 N5 C30 C29 156.73(16) 
 
C5 C6 C7 C8 -1.8(6) 
S2 N5 C30 C38 -80.7(2) 
 
C6 C5 C10 C9 0.6(5) 
S2 C31 C32 C33 -178.7(2) 
 
C6 C7 C8 C9 2.4(6) 
S2 C31 C36 C35 -179.7(2) 
 
C6 C7 C8 C11 -178.2(4) 
F1 Fe1 N1 C1 67.53(17) 
 
C7 C8 C9 C10 -1.6(6) 
F1 Fe1 N1 C27 -106.35(17) 
 
C8 C9 C10 C5 0.1(6) 
F1 Fe1 N2 C2 -56.63(14) 
 
C10 C5 C6 C7 0.2(5) 
F1 Fe1 N2 C3 -174.77(18) 
 
C11 C8 C9 C10 179.0(4) 
F1 Fe1 N4 C28 107.69(14) 
 
C12 C13 C14 C15 -0.1(4) 
F1 Fe1 N4 C29 -11.82(19) 
 
C13 C12 C17 C16 1.4(4) 
O1 S1 N3 C2 -173.08(19) 
 
C13 C14 C15 C16 1.1(4) 
O1 S1 N3 C4 55.0(2) 
 
C14 C15 C16 C17 -0.8(4) 
O1 S1 C5 C6 164.9(2) 
 
C15 C16 C17 C12 -0.5(4) 
O1 S1 C5 C10 -21.9(3) 
 
C17 C12 C13 C14 -1.1(4) 
O2 S1 N3 C2 -43.7(2) 
 
C18 C3 C4 N3 -147.42(19) 
O2 S1 N3 C4 -175.64(18) 
 
C18 C3 C4 C12 87.8(2) 
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O2 S1 C5 C6 31.7(3) 
 
C18 C19 C20 C21 0.1(4) 
O2 S1 C5 C10 -155.1(2) 
 
C19 C18 C23 C22 -0.6(4) 
O3 S2 N5 C28 179.87(18) 
 
C19 C20 C21 C22 -1.0(4) 
O3 S2 N5 C30 46.9(2) 
 
C20 C21 C22 C23 1.1(4) 
O3 S2 C31 C32 -28.8(3) 
 
C21 C22 C23 C18 -0.3(4) 
O3 S2 C31 C36 150.3(2) 
 
C23 C18 C19 C20 0.7(4) 
O4 S2 N5 C28 -51.6(2) 
 
C24 C1 C2 N2 -158.5(2) 
O4 S2 N5 C30 175.44(18) 
 
C24 C1 C2 N3 -41.7(3) 
O4 S2 C31 C32 -160.7(2) 
 
C24 C25 C26 C27 0.1(3) 
O4 S2 C31 C36 18.4(3) 
 
C25 C26 C27 N1 0.7(3) 
N1 Fe1 F1 B1 -131.3(2) 
 
C25 C26 C27 C28 -173.4(2) 
N1 Fe1 N2 C2 30.94(14) 
 
C26 C27 C28 N4 -152.3(2) 
N1 Fe1 N2 C3 -87.20(18) 
 
C26 C27 C28 N5 -34.5(3) 
N1 Fe1 N4 C28 23.41(14) 
 
C27 N1 C1 C2 177.60(19) 
N1 Fe1 N4 C29 -96.09(19) 
 
C27 N1 C1 C24 0.3(3) 
N1 C1 C2 N2 24.3(3) 
 
C28 N4 C29 C30 41.4(2) 
N1 C1 C2 N3 141.1(2) 
 
C28 N4 C29 C44 166.8(2) 
N1 C1 C24 C25 0.4(3) 
 
C28 N5 C30 C29 20.4(2) 
N1 C27 C28 N4 33.4(3) 
 
C28 N5 C30 C38 143.0(2) 
N1 C27 C28 N5 151.2(2) 
 
C29 N4 C28 N5 -28.5(2) 
N2 Fe1 F1 B1 -57.2(2) 
 
C29 N4 C28 C27 93.0(2) 
N2 Fe1 N1 C1 -19.73(16) 
 
C29 C30 C38 C39 -112.2(3) 
N2 Fe1 N1 C27 166.39(18) 
 
C29 C30 C38 C43 65.2(3) 
N2 Fe1 N4 C28 9.8(2) 
 
C29 C44 C45 C46 177.1(3) 
N2 Fe1 N4 C29 -109.7(2) 
 
C29 C44 C49 C48 -178.2(3) 
N2 C3 C4 N3 -23.5(2) 
 
C30 N5 C28 N4 4.5(2) 
N2 C3 C4 C12 -148.3(2) 
 
C30 N5 C28 C27 -116.5(2) 
N2 C3 C18 C19 139.8(2) 
 
C30 C29 C44 C45 53.3(3) 
N2 C3 C18 C23 -47.0(3) 
 
C30 C29 C44 C49 -128.9(2) 
N3 S1 C5 C6 -82.4(3) 
 
C30 C38 C39 C40 178.5(3) 
N3 S1 C5 C10 90.9(3) 
 
C30 C38 C43 C42 -178.8(3) 
N3 C4 C12 C13 -22.6(4) 
 
C31 S2 N5 C28 63.4(2) 
N3 C4 C12 C17 160.5(2) 
 
C31 S2 N5 C30 -69.5(2) 
N4 Fe1 F1 B1 153.7(2) 
 
C31 C32 C33 C34 -2.1(5) 
N4 Fe1 N1 C1 167.53(19) 
 
C32 C31 C36 C35 -0.6(4) 
N4 Fe1 N1 C27 -6.35(16) 
 
C32 C33 C34 C35 0.3(5) 
N4 Fe1 N2 C2 44.7(2) 
 
C32 C33 C34 C37 179.7(3) 
N4 Fe1 N2 C3 -73.5(2) 
 
C33 C34 C35 C36 1.4(5) 
N4 C29 C30 N5 -37.6(2) 
 
C34 C35 C36 C31 -1.2(4) 
N4 C29 C30 C38 -160.8(2) 
 
C36 C31 C32 C33 2.3(4) 
N4 C29 C44 C45 -64.8(3) 
 
C37 C34 C35 C36 -178.0(3) 
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N4 C29 C44 C49 113.0(3) 
 
C38 C39 C40 C41 -0.2(5) 
N5 S2 C31 C32 85.7(2) 
 
C39 C38 C43 C42 -1.4(4) 
N5 S2 C31 C36 -95.2(2) 
 
C39 C40 C41 C42 -0.4(5) 
N5 C30 C38 C39 132.0(3) 
 
C40 C41 C42 C43 0.0(5) 
N5 C30 C38 C43 -50.6(3) 
 
C41 C42 C43 C38 0.9(5) 
N6 Fe1 N1 C1 -110.82(18) 
 
C43 C38 C39 C40 1.1(4) 
N6 Fe1 N1 C27 75.30(18) 
 
C44 C29 C30 N5 -160.84(19) 
N6 Fe1 N2 C2 126.99(15) 
 
C44 C29 C30 C38 75.9(3) 
N6 Fe1 N2 C3 8.86(18) 
 
C44 C45 C46 C47 2.0(5) 
N6 Fe1 N4 C28 -75.09(15) 
 
C45 C44 C49 C48 -0.3(4) 
N6 Fe1 N4 C29 165.41(19) 
 
C45 C46 C47 C48 -2.1(5) 
N7 Fe1 F1 B1 56.5(2) 
 
C46 C47 C48 C49 1.1(5) 
N7 Fe1 N2 C2 -140.81(14) 
 
C47 C48 C49 C44 0.1(5) 
N7 Fe1 N2 C3 101.05(18) 
 
C49 C44 C45 C46 -0.8(4) 
N7 Fe1 N4 C28 -165.12(15) 
      
 
Table 8. Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement 
Parameters (Å
2
×10
3
) for (S,S-20). 
Atom x y z U(eq) 
H2 3412 7315 9097 41.6(14) 
H2A 2272 7377 8641 41.3(15) 
H3 5581 6957 8722 41.5(14) 
H4 4122 3728 8847 41.6(14) 
H4A 4942 8782 8841 41.5(14) 
H6 1036 8519 8966 41.6(16) 
H7 739 8814 9576 42.0(16) 
H9 3705 10553 9568 42.1(16) 
H10 3976 10296 8961 41.9(15) 
H11A 1862 10488 10074 42.6(17) 
H11B 2845 9685 10154 42.3(16) 
H11C 1355 9471 10119 42.4(17) 
H13 5480 8049 7962 41.5(14) 
H14 7293 8364 7626 41.5(15) 
H15 9072 9023 7892 41.5(16) 
H16 9053 9333 8502 41.7(15) 
H17 7237 9004 8841 41.5(15) 
H19 7541 6982 9049 41.5(14) 
H20 8686 7279 9568 41.6(15) 
H21 7678 7957 10051 41.6(16) 
H22 5524 8386 10009 41.8(15) 
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H23 4389 8079 9488 41.8(15) 
H24 3136 7397 7839 41.4(15) 
H25 3367 6192 7433 41.3(15) 
H26 3803 4729 7644 41.3(15) 
H28 5112 4257 8368 41.4(14) 
H29 1838 3990 8536 41.3(14) 
H30 3331 2390 8488 41.3(15) 
H32 4974 1222 8327 41.4(15) 
H33 6432 656 8741 41.5(15) 
H35 8746 2790 8568 41.6(15) 
H36 7269 3408 8175 41.7(14) 
H37A 8558 1599 9191 41.8(16) 
H37B 9545 1411 8875 41.9(16) 
H37C 8547 643 8990 41.8(17) 
H39 1963 1210 8399 41.3(15) 
H40 225 543 8108 41.4(17) 
H41 -997 1392 7717 41.3(18) 
H42 -523 2908 7614 41.2(17) 
H43 1208 3594 7909 41.3(15) 
H45 3274 2373 9124 41.5(15) 
H46 2367 1940 9666 41.6(15) 
H47 396 2506 9835 41.6(16) 
H48 -613 3587 9482 41.9(16) 
H49 300 4060 8951 41.6(15) 
H51A 8453 5034 9143 41.6(15) 
H51B 8230 4820 8731 41.7(15) 
H51C 7929 4062 9023 41.7(15) 
H53A 3366 4657 10273 42.2(16) 
H53B 3267 3693 10079 42.3(17) 
H53C 2013 4290 10140 42.5(17) 
H55A 8888 6918 8318 41.8(14) 
H55B 9161 6937 7900 41.8(15) 
H55C 10237 7261 8173 41.8(15) 
H57A 7931 4875 7492 41.8(15) 
H57B 7307 5833 7394 41.8(15) 
H57C 6430 4948 7423 41.9(15) 
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Experimental  
Single crystals of C57H57B2F8FeN9O4S2  were grown in MeCN/Et2O. A suitable 
crystal was selected and placed on a diffractometer. The crystal was kept at 110(2) K 
during data collection. Using Olex2 [1], the structure was solved with the [2] 
structure solution program using and refined with the [3] refinement package using 
minimisation. 
1. Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, 
H. (2009), J. Appl. Cryst. 42, 339-341. 
 
1.2. Complex (R,R)-[Fe(BF4)(NNN)(MeCN)2](BF4) (20) 
Table 2 Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for (R,R)-20. Ueq is defined as 1/3 of of the 
trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
Fe1 6386.1(2) 4480.0(2) 1043.5(1) 13.3(1) 
S1 7122.8(4) 887.0(3) 1538.4(1) 19.2(1) 
S2 5142.2(4) 7164.7(3) 2080.4(1) 16.0(1) 
F1 8417.3(11) 4230.1(7) 1071.6(3) 23.6(3) 
F2 9970.9(12) 3138.2(9) 1058.4(3) 36.8(4) 
F3 9873.6(12) 4179.7(8) 610.6(3) 30.2(4) 
F4 8349.0(11) 3091.2(7) 658.7(3) 22.8(3) 
O1 6351.9(14) 176.8(8) 1683.5(3) 23.2(4) 
O2 8273.4(13) 1168.5(9) 1711.7(4) 28.0(4) 
O3 5810.1(13) 7899.5(9) 2244.4(3) 22.4(4) 
O4 4500.5(13) 6498.5(9) 2294.6(3) 20.2(4) 
N1 6351.1(14) 4214.1(9) 1600.4(3) 13.4(4) 
N2 6152.4(13) 2970.5(9) 1098.3(4) 14.2(4) 
N3 6195.5(14) 1796.6(9) 1528.9(4) 14.6(4) 
N4 6341.1(14) 5856.8(9) 1294.7(3) 13.5(4) 
N5 6231.8(14) 6593.2(9) 1852.7(4) 14.1(4) 
N6 4408.3(15) 4695.6(10) 981.4(4) 18.4(4) 
N7 6721.0(17) 4896.7(11) 517.3(4) 23.7(5) 
C1 6595.4(17) 3374.9(11) 1719.8(4) 13.9(5) 
C2 6792.9(17) 2673.3(11) 1427.9(4) 14.8(5) 
C3 4827.1(17) 2618.8(11) 1133.4(4) 13.7(4) 
C4 4965.6(17) 1694.4(11) 1333.8(4) 14.5(5) 
C5 7460(2) 603.0(13) 1089.7(5) 25.4(6) 
C6 8424(2) 1053.0(14) 909.4(6) 32.6(7) 
C7 8582(3) 890.3(16) 545.7(6) 43.1(8) 
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C8 7772(3) 304.0(15) 361.9(6) 41.8(8) 
C9 6832(3) -147.5(15) 548.7(6) 39.1(7) 
C10 6669(2) -2.8(14) 910.3(5) 30.0(6) 
C11 7937(4) 149(2) -34.3(7) 62.1(12) 
C12 3826.2(17) 1479.5(11) 1566.1(5) 15.5(5) 
C13 3800.6(19) 1675.4(12) 1928.1(5) 19.3(5) 
C14 2716(2) 1486.7(13) 2127.8(5) 23.1(6) 
C15 1654(2) 1105.2(13) 1970.0(5) 24.1(6) 
C16 1663.5(19) 922.7(13) 1606.7(5) 24.1(6) 
C17 2750.7(19) 1110.2(12) 1407.0(5) 20.8(5) 
C18 4141.8(18) 2498.7(12) 782.7(4) 16.2(5) 
C19 2866.1(18) 2733.5(12) 755.2(5) 18.9(5) 
C20 2186(2) 2551.6(14) 445.4(5) 25.0(6) 
C21 2784(2) 2135.0(15) 160.9(5) 28.1(6) 
C22 4060(2) 1891.0(15) 184.4(5) 27.4(6) 
C23 4738.4(19) 2070.1(14) 494.5(5) 22.2(5) 
C24 6701.9(17) 3187.5(12) 2080.5(4) 17.0(5) 
C25 6559.6(17) 3899.3(12) 2318.4(4) 17.5(5) 
C26 6303.6(18) 4769.3(12) 2194.4(4) 16.5(5) 
C27 6195.0(16) 4901.2(11) 1829.7(4) 13.7(5) 
C28 5779.2(17) 5781.8(11) 1654.0(4) 13.8(5) 
C29 7539.8(17) 6380.6(11) 1356.0(4) 13.9(5) 
C30 7135.2(17) 7116.2(11) 1623.5(4) 14.5(5) 
C31 4018.4(17) 7610.5(12) 1781.2(4) 17.1(5) 
C32 4265(2) 8442.8(12) 1617.6(5) 21.8(5) 
C33 3379(2) 8774.8(13) 1377.4(5) 26.7(6) 
C34 2257(2) 8320.2(14) 1303.1(5) 26.0(6) 
C35 2018(2) 7499.7(14) 1477.6(5) 23.1(6) 
C36 2898.9(18) 7137.9(13) 1713.1(5) 19.2(5) 
C37 1302(2) 8688.6(16) 1039.1(6) 36.2(7) 
C38 8239.9(17) 7533.5(12) 1822.3(4) 16.9(5) 
C39 8542(2) 8440.0(13) 1759.7(5) 23.5(5) 
C40 9578(2) 8837.6(15) 1932.9(6) 32.4(7) 
C41 10296(2) 8334.5(17) 2166.0(6) 34.5(7) 
C42 10013(2) 7431.5(16) 2227.9(5) 29.5(6) 
C43 8983.4(18) 7026.9(14) 2053.9(5) 21.8(5) 
C44 8124.5(17) 6727.3(11) 1014.0(4) 15.5(5) 
C45 7523(2) 7368.7(13) 803.9(5) 23.8(5) 
C46 8073(2) 7635.8(14) 481.8(5) 29.4(6) 
C47 9223(2) 7273.8(15) 375.5(5) 29.9(6) 
C48 9821(2) 6628.7(17) 583.7(5) 32.6(7) 
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C49 9274.3(19) 6357.5(14) 903.1(5) 24.1(6) 
C50 3387.3(19) 4952.9(12) 1000.4(4) 19.0(5) 
C51 2089.2(19) 5285.5(13) 1029.6(6) 26.2(6) 
C52 6876(2) 5246.7(14) 252.3(5) 30.0(6) 
C53 7071(3) 5698(2) -90.4(6) 52.9(10) 
B1 9179(2) 3655.0(15) 843.8(5) 20.2(6) 
N8 -390(3) 4796.1(17) 1835.9(8) 67(1) 
C54 -15(2) 4073.9(17) 1848.4(6) 35.1(7) 
C55 459(2) 3159.5(15) 1864.6(6) 32.0(7) 
N9 3200(2) 4386.4(18) 1812.5(5) 48.5(8) 
C56 3035(2) 4537.8(17) 2103.9(6) 33.1(7) 
C57 2816(2) 4730.1(15) 2478.9(5) 36.7(7) 
F5 4384.5(12) 6924.8(8) 945.7(3) 27.8(3) 
F6 2890.8(13) 7107.2(10) 511.7(3) 41.2(4) 
F7 4898.9(14) 6661.7(9) 368.1(3) 37.5(4) 
F8 4525.8(14) 8108.9(8) 555.3(3) 38.1(4) 
B2 4170(2) 7204.7(16) 592.4(6) 25.1(6) 
  
Table 3 Anisotropic Displacement Parameters (Å
2
×10
3
) for (R,R)-20. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+...+2hka×b×U12] 
Atom U11 U22 U33 U23 U13 U12 
Fe1 15.4(1) 12.8(1) 11.6(1) 0.9(1) 0.5(1) 0.2(1) 
S1 17.5(2) 14.3(2) 25.7(2) 4.3(2) -0.4(2) 3.6(2) 
S2 16.4(2) 16.7(2) 14.8(2) -3.0(2) 3.1(2) 0.9(2) 
F1 19.9(6) 28.7(6) 22.3(5) -5.0(4) 2.1(5) -0.4(5) 
F2 31.2(7) 49.2(8) 30.1(6) -1.9(6) -4.9(6) 20.1(6) 
F3 28.6(7) 35.8(7) 26.2(5) -6.2(5) 10.8(5) -11.7(6) 
F4 22.4(6) 23.2(5) 22.7(5) -6.0(4) 4.7(4) -4.0(5) 
O1 25.3(7) 16.5(6) 27.9(6) 5.7(5) -0.3(6) 0.8(6) 
O2 20.0(8) 23.0(7) 41.0(8) 6.4(6) -5.6(6) 3.0(6) 
O3 22.0(7) 22.6(7) 22.7(6) -8.0(5) 1.3(5) 0.7(6) 
O4 19.8(7) 25.3(7) 15.4(6) 0.5(5) 4.4(5) 1.0(6) 
N1 10.6(7) 13.9(6) 15.7(6) 0.4(5) 0.3(6) -2.4(6) 
N2 11.4(7) 16.0(7) 15.2(7) -0.1(5) 1.3(5) 0.8(6) 
N3 12.7(8) 11.8(6) 19.4(7) 0.5(5) -0.1(6) 2.0(6) 
N4 13.8(7) 14.8(6) 11.8(6) 1.5(5) 1.9(6) 0.3(6) 
N5 15.0(8) 12.6(7) 14.8(6) -1.5(5) 4.2(6) -0.5(6) 
N6 18.6(8) 16.8(7) 19.7(7) 0.0(6) -3.2(6) -0.2(6) 
N7 27.0(9) 25.2(8) 18.9(7) 1.3(6) 2.5(6) 4.8(7) 
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C1 10.8(9) 13.4(8) 17.6(8) 0.6(6) 0.4(6) -0.7(7) 
C2 14.3(9) 13.3(8) 16.7(7) 3.4(6) 0.7(6) 0.7(7) 
C3 13.0(8) 13.1(8) 14.9(7) -0.1(6) 1.0(6) 0.6(7) 
C4 15.8(9) 12.6(8) 15.1(7) -0.7(6) 0.2(7) 1.0(7) 
C5 28.6(11) 19.3(9) 28.2(9) 3.0(8) 6.3(8) 9.6(8) 
C6 36.6(13) 20.2(10) 41.1(11) -3.4(8) 12.1(10) 4.8(9) 
C7 57.4(17) 29.8(11) 42.1(12) 2.6(10) 24.1(13) 6.3(12) 
C8 64.9(18) 27.5(12) 33.1(11) -5.0(9) 10.8(12) 14.2(12) 
C9 55.8(16) 24.5(11) 36.9(11) -8.4(9) 0.1(11) 9.6(11) 
C10 36.8(13) 20.4(10) 32.8(10) -3.7(8) 3.5(9) 8.4(9) 
C11 105(3) 45.9(16) 35.4(13) -5.2(12) 20.9(17) 12.4(18) 
C12 16.5(9) 10.5(7) 19.6(8) 3.3(6) 0.8(7) 1.5(6) 
C13 18.4(10) 20.1(9) 19.5(8) 1.9(7) 0.1(7) -0.1(8) 
C14 25.1(11) 25.2(10) 18.9(8) 2.0(7) 3.9(8) 1.9(8) 
C15 21.5(11) 21.9(9) 28.9(9) 3.6(7) 8.6(8) -2.4(8) 
C16 19.8(10) 21.8(9) 30.8(10) 0.3(8) 0.0(8) -4.4(8) 
C17 23(1) 17.0(9) 22.3(8) 0.0(7) 1.1(7) -2.4(8) 
C18 18.0(9) 14.5(8) 16.1(8) 2.4(6) -0.1(7) -0.7(7) 
C19 17.8(10) 18.2(9) 20.6(8) -3.1(7) 0.1(7) 1.4(8) 
C20 17(1) 31(1) 27.0(9) -1.4(8) -4.9(8) 1.8(8) 
C21 27.3(11) 38.1(12) 19.0(9) -1.3(8) -6.5(8) -0.5(10) 
C22 27.6(11) 37.8(12) 16.8(8) -4.7(8) 1.0(8) 0.7(9) 
C23 17.4(10) 30.1(10) 19.0(8) -0.2(7) 0.8(7) 4.1(8) 
C24 16.0(9) 16.2(8) 18.7(8) 4.4(7) -1.5(7) -0.9(7) 
C25 15.9(9) 23.4(9) 13.1(7) 2.5(6) -0.1(7) -3.5(8) 
C26 16.2(9) 19.1(8) 14.1(7) -1.3(6) 0.4(7) -2.6(7) 
C27 7.7(8) 15.3(8) 18.1(8) -0.2(6) 2.1(6) -2.4(7) 
C28 14.0(9) 14.0(8) 13.5(7) -1.9(6) 2.3(6) -1.3(7) 
C29 14.7(9) 11.9(8) 15.2(7) 0.0(6) 0.9(6) 1.0(6) 
C30 16.8(9) 12.3(8) 14.5(7) 0.8(6) 3.3(6) 0.4(7) 
C31 18.0(9) 16.9(8) 16.4(8) -2.6(6) 2.7(7) 4.2(7) 
C32 22.6(10) 16.2(9) 26.6(9) -1.4(7) 3.3(8) 0.5(8) 
C33 32.4(12) 18.3(9) 29.3(10) 4.4(8) 6.9(8) 7.0(9) 
C34 30.7(12) 27.8(10) 19.6(8) -1.1(8) 2.4(8) 11.8(9) 
C35 20.1(10) 27.8(10) 21.3(9) -4.4(7) 1.7(7) 2.0(8) 
C36 18.9(10) 18.5(9) 20.2(8) -1.8(7) 4.5(7) 0.5(8) 
C37 40.7(14) 39.9(12) 28.1(10) 4.3(9) -5.1(10) 13.3(11) 
C38 15.3(9) 18.7(8) 16.8(8) -5.0(7) 6.6(6) -3.5(7) 
C39 21.5(10) 19.7(9) 29.2(9) -4.7(7) 7.2(8) -2.1(8) 
C40 28.5(12) 27.8(11) 40.8(12) -16.1(9) 11.0(9) -13.2(9) 
C41 21.5(11) 49.1(13) 33.0(11) -21(1) 6.2(9) -14.6(10) 
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C42 18.2(10) 49.9(13) 20.4(9) -6.2(9) 0.8(8) 0.6(10) 
C43 18.9(10) 27.9(10) 18.6(8) -2.7(7) 3.6(7) -1.4(8) 
C44 18.1(9) 14.7(8) 13.8(7) -0.8(6) 0.6(7) -4.1(7) 
C45 28.1(11) 21.5(9) 21.7(8) 4.4(7) 6.4(8) 4.8(8) 
C46 44.3(14) 22.6(10) 21.3(9) 7.5(8) 3.8(9) 3.3(9) 
C47 31.1(12) 36.7(12) 21.9(9) 7.6(9) 7.8(8) -6.5(10) 
C48 20.5(11) 49.9(14) 27.3(10) 6.9(9) 7.8(8) 3.1(10) 
C49 17.1(10) 34.0(11) 21.3(9) 6.7(8) 2.1(7) 1.3(8) 
C50 23.3(10) 15.4(8) 18.2(8) -0.9(7) -2.4(7) -0.8(7) 
C51 18.7(10) 28.1(10) 31.9(10) -2.7(8) -1.9(8) 4.1(8) 
C52 39.6(13) 28.5(11) 21.9(9) -0.2(8) 4.5(9) 4.9(9) 
C53 83(2) 53.5(18) 22.2(11) 9.5(11) 10.6(12) 2.3(16) 
B1 17.9(11) 25.3(11) 17.4(9) -2.1(8) 1.3(8) 1.4(9) 
N8 56.2(17) 44.8(14) 100(2) 8.5(14) -19.9(15) 17.1(12) 
C54 25.7(12) 40.0(13) 39.6(11) 1.1(10) -11.2(9) -0.8(10) 
C55 40.3(14) 28.1(11) 27.7(10) 2.0(8) -1.4(9) -1(1) 
N9 31.1(11) 82.5(17) 32(1) 8.6(11) -3.2(8) -21.8(12) 
C56 19.8(11) 45.0(13) 34.6(11) 15.6(10) -1.8(9) -10.3(10) 
C57 42.9(15) 33.2(12) 34.1(11) 8.6(9) 11.2(10) 0.5(11) 
F5 32.6(7) 30.2(6) 20.6(5) 6.7(5) 3.2(5) 10.1(5) 
F6 28.1(7) 56.8(9) 38.7(7) 5.8(7) -4.6(6) -0.7(7) 
F7 47.1(8) 41.3(7) 24.2(6) 2.5(5) 6.2(6) 16.2(7) 
F8 48.7(9) 26.9(6) 38.8(7) 11.1(5) -1.9(6) -1.2(6) 
B2 27.0(12) 26.0(11) 22.4(10) 9.0(9) 1.6(9) 5.1(10) 
  
Table 4 Bond Lengths for (R,R)-20. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
Fe1 F1 2.1646(12) 
 
C14 C15 1.382(3) 
Fe1 N1 2.1303(12) 
 
C15 C16 1.392(3) 
Fe1 N2 2.2461(14) 
 
C16 C17 1.393(3) 
Fe1 N4 2.2374(13) 
 
C18 C19 1.386(3) 
Fe1 N6 2.1116(16) 
 
C18 C23 1.401(3) 
Fe1 N7 2.1009(15) 
 
C19 C20 1.392(3) 
S1 O1 1.4303(13) 
 
C20 C21 1.383(3) 
S1 O2 1.4328(15) 
 
C21 C22 1.389(3) 
S1 N3 1.6559(14) 
 
C22 C23 1.391(3) 
S1 C5 1.7735(19) 
 
C24 C25 1.386(2) 
S2 O3 1.4291(14) 
 
C25 C26 1.390(2) 
S2 O4 1.4368(13) 
 
C26 C27 1.390(2) 
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S2 N5 1.6574(15) 
 
C27 C28 1.519(2) 
S2 C31 1.7565(17) 
 
C29 C30 1.538(2) 
F1 B1 1.445(2) 
 
C29 C44 1.513(2) 
F2 B1 1.386(2) 
 
C30 C38 1.510(2) 
F3 B1 1.377(2) 
 
C31 C32 1.396(2) 
F4 B1 1.390(2) 
 
C31 C36 1.389(3) 
N1 C1 1.340(2) 
 
C32 C33 1.385(3) 
N1 C27 1.339(2) 
 
C33 C34 1.383(3) 
N2 C2 1.476(2) 
 
C34 C35 1.398(3) 
N2 C3 1.489(2) 
 
C34 C37 1.511(3) 
N3 C2 1.485(2) 
 
C35 C36 1.386(3) 
N3 C4 1.492(2) 
 
C38 C39 1.392(3) 
N4 C28 1.478(2) 
 
C38 C43 1.387(3) 
N4 C29 1.493(2) 
 
C39 C40 1.396(3) 
N5 C28 1.487(2) 
 
C40 C41 1.373(3) 
N5 C30 1.495(2) 
 
C41 C42 1.382(3) 
N6 C50 1.138(3) 
 
C42 C43 1.396(3) 
N7 C52 1.133(2) 
 
C44 C45 1.384(3) 
C1 C2 1.522(2) 
 
C44 C49 1.387(3) 
C1 C24 1.388(2) 
 
C45 C46 1.398(3) 
C3 C4 1.563(2) 
 
C46 C47 1.378(3) 
C3 C18 1.512(2) 
 
C47 C48 1.382(3) 
C4 C12 1.514(2) 
 
C48 C49 1.389(3) 
C5 C6 1.386(3) 
 
C50 C51 1.451(3) 
C5 C10 1.393(3) 
 
C52 C53 1.464(3) 
C6 C7 1.398(3) 
 
N8 C54 1.135(4) 
C7 C8 1.395(4) 
 
C54 C55 1.437(3) 
C8 C9 1.381(4) 
 
N9 C56 1.131(3) 
C8 C11 1.517(4) 
 
C56 C57 1.456(3) 
C9 C10 1.387(3) 
 
F5 B2 1.409(3) 
C12 C13 1.391(3) 
 
F6 B2 1.383(3) 
C12 C17 1.388(3) 
 
F7 B2 1.391(3) 
C13 C14 1.391(3) 
 
F8 B2 1.390(3) 
  
Table 5. Bond Angles for (R,R)-20 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
F1 Fe1 N1 86.43(5) 
 
C12 C13 C14 120.15(18) 
F1 Fe1 N2 86.26(5) 
 
C13 C14 C15 120.59(18) 
F1 Fe1 N4 98.87(5) 
 
C14 C15 C16 119.61(18) 
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F1 Fe1 N6 176.28(5) 
 
C15 C16 C17 119.76(18) 
F1 Fe1 N7 86.05(6) 
 
C12 C17 C16 120.72(17) 
N1 Fe1 N2 74.10(5) 
 
C3 C18 C19 119.66(15) 
N1 Fe1 N4 75.61(5) 
 
C3 C18 C23 120.97(16) 
N1 Fe1 N6 96.86(6) 
 
C19 C18 C23 119.07(16) 
N1 Fe1 N7 169.12(6) 
 
C18 C19 C20 120.61(17) 
N2 Fe1 N4 148.88(5) 
 
C19 C20 C21 120.00(19) 
N2 Fe1 N6 92.97(5) 
 
C20 C21 C22 120.17(18) 
N2 Fe1 N7 113.19(6) 
 
C21 C22 C23 119.82(18) 
N4 Fe1 N6 83.66(6) 
 
C18 C23 C22 120.33(18) 
N4 Fe1 N7 97.83(5) 
 
C1 C24 C25 118.11(16) 
N6 Fe1 N7 90.93(6) 
 
C24 C25 C26 120.11(14) 
O1 S1 O2 120.95(8) 
 
C25 C26 C27 118.41(15) 
O1 S1 N3 105.53(8) 
 
N1 C27 C26 121.30(15) 
O1 S1 C5 107.65(8) 
 
N1 C27 C28 113.59(13) 
O2 S1 N3 105.69(8) 
 
C26 C27 C28 124.88(14) 
O2 S1 C5 109.44(9) 
 
N4 C28 N5 105.77(13) 
N3 S1 C5 106.71(9) 
 
N4 C28 C27 110.28(13) 
O3 S2 O4 120.32(7) 
 
N5 C28 C27 112.08(13) 
O3 S2 N5 105.63(8) 
 
N4 C29 C30 103.45(13) 
O3 S2 C31 108.80(8) 
 
N4 C29 C44 112.61(13) 
O4 S2 N5 105.41(8) 
 
C30 C29 C44 115.45(13) 
O4 S2 C31 107.45(8) 
 
N5 C30 C29 100.89(13) 
N5 S2 C31 108.78(8) 
 
N5 C30 C38 114.27(13) 
Fe1 F1 B1 127.93(11) 
 
C29 C30 C38 113.50(14) 
Fe1 N1 C1 119.71(10) 
 
S2 C31 C32 119.09(14) 
Fe1 N1 C27 119.72(10) 
 
S2 C31 C36 119.87(14) 
C1 N1 C27 120.32(13) 
 
C32 C31 C36 121.04(17) 
Fe1 N2 C2 108.72(10) 
 
C31 C32 C33 118.23(18) 
Fe1 N2 C3 117.02(10) 
 
C32 C33 C34 122.14(18) 
C2 N2 C3 104.32(13) 
 
C33 C34 C35 118.46(18) 
S1 N3 C2 117.47(12) 
 
C33 C34 C37 121.55(18) 
S1 N3 C4 115.91(11) 
 
C35 C34 C37 119.99(19) 
C2 N3 C4 109.09(13) 
 
C34 C35 C36 120.84(19) 
Fe1 N4 C28 109.05(9) 
 
C31 C36 C35 119.25(17) 
Fe1 N4 C29 121.04(10) 
 
C30 C38 C39 118.78(15) 
C28 N4 C29 103.50(11) 
 
C30 C38 C43 121.56(16) 
S2 N5 C28 116.58(11) 
 
C39 C38 C43 119.61(17) 
S2 N5 C30 118.24(11) 
 
C38 C39 C40 120.05(18) 
C28 N5 C30 109.08(13) 
 
C39 C40 C41 119.9(2) 
Fe1 N6 C50 165.34(14) 
 
C40 C41 C42 120.6(2) 
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Fe1 N7 C52 169.91(16) 
 
C41 C42 C43 119.86(19) 
N1 C1 C2 114.26(13) 
 
C38 C43 C42 119.97(19) 
N1 C1 C24 121.74(14) 
 
C29 C44 C45 122.05(16) 
C2 C1 C24 123.95(15) 
 
C29 C44 C49 118.37(15) 
N2 C2 N3 106.29(13) 
 
C45 C44 C49 119.53(16) 
N2 C2 C1 110.01(13) 
 
C44 C45 C46 119.90(18) 
N3 C2 C1 110.41(13) 
 
C45 C46 C47 120.24(19) 
N2 C3 C4 105.01(13) 
 
C46 C47 C48 119.94(18) 
N2 C3 C18 114.03(13) 
 
C47 C48 C49 120.00(19) 
C4 C3 C18 111.26(13) 
 
C44 C49 C48 120.37(18) 
N3 C4 C3 103.27(13) 
 
N6 C50 C51 179.20(18) 
N3 C4 C12 114.85(13) 
 
N7 C52 C53 179.8(3) 
C3 C4 C12 112.76(14) 
 
F1 B1 F2 107.95(14) 
S1 C5 C6 119.86(15) 
 
F1 B1 F3 109.93(16) 
S1 C5 C10 119.53(15) 
 
F1 B1 F4 107.49(15) 
C6 C5 C10 120.27(18) 
 
F2 B1 F3 111.21(16) 
C5 C6 C7 118.9(2) 
 
F2 B1 F4 109.80(16) 
C6 C7 C8 121.2(2) 
 
F3 B1 F4 110.36(14) 
C7 C8 C9 118.8(2) 
 
N8 C54 C55 179.9(4) 
C7 C8 C11 120.7(3) 
 
N9 C56 C57 179.7(3) 
C9 C8 C11 120.6(2) 
 
F5 B2 F6 109.35(16) 
C8 C9 C10 120.8(2) 
 
F5 B2 F7 108.39(17) 
C5 C10 C9 120.0(2) 
 
F5 B2 F8 109.39(17) 
C4 C12 C13 122.43(16) 
 
F6 B2 F7 109.91(17) 
C4 C12 C17 118.36(16) 
 
F6 B2 F8 109.75(17) 
C13 C12 C17 119.15(17) 
 
F7 B2 F8 110.02(17) 
  
Table 6. Hydrogen Bonds for (R,R)-20 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
N2 H2 F4 0.9600 2.1600 2.8410(18) 127.00 
N4 H4 F5 0.9400 1.9900 2.8996(18) 160.00 
C10 H10 O1 0.9500 2.5600 2.938(2) 104.00 
C13 H13 N3 0.9500 2.6100 2.932(2) 101.00 
C21 H21 F4
1
 0.9500 2.5300 3.155(2) 123.00 
C26 H26 O4 0.9500 2.5600 3.195(2) 124.00 
C32 H32 O1
2
 0.9500 2.5000 3.373(2) 153.00 
C36 H36 O4 0.9500 2.5500 2.913(2) 103.00 
C47 H47 F7
3
 0.9500 2.3800 3.283(2) 158.00 
C51 H51A F3
4
 0.9800 2.3000 3.246(2) 162.00 
Appendix 
 
A21 
 
C57 H57B O4 0.9800 2.5800 3.223(3) 123.00 
C57 H57C O3
5
 0.9800 2.5000 3.229(3) 131.00 
1
-1/2+X,1/2-Y,-Z; 
2
+X,1+Y,+Z; 
3
1/2+X,3/2-Y,-Z; 
4
-1+X,+Y,+Z; 
5
1-X,-1/2+Y,1/2-Z 
  
Table 7 Torsion Angles for (R,R)-20 
A B C D Angle/˚ 
 
A B C D Angle/˚ 
Fe1 F1 B1 F2 -134.11(12) 
 
N7 Fe1 N4 C29 -75.21(11) 
Fe1 F1 B1 F3 104.43(15) 
 
C1 N1 C27 C26 1.2(3) 
Fe1 F1 B1 F4 -15.7(2) 
 
C1 N1 C27 C28 -173.52(15) 
Fe1 N1 C1 C2 -3.9(2) 
 
C1 C24 C25 C26 0.7(3) 
Fe1 N1 C1 C24 173.83(13) 
 
C2 N2 C3 C4 -34.70(15) 
Fe1 N1 C27 C26 -173.01(13) 
 
C2 N2 C3 C18 -156.74(14) 
Fe1 N1 C27 C28 12.29(19) 
 
C2 N3 C4 C3 -4.59(16) 
Fe1 N2 C2 N3 157.58(10) 
 
C2 N3 C4 C12 -127.77(14) 
Fe1 N2 C2 C1 38.03(15) 
 
C2 C1 C24 C25 176.88(16) 
Fe1 N2 C3 C4 -154.82(10) 
 
C3 N2 C2 N3 32.03(16) 
Fe1 N2 C3 C18 83.14(15) 
 
C3 N2 C2 C1 -87.52(15) 
Fe1 N4 C28 N5 158.25(10) 
 
C3 C4 C12 C13 -96.02(19) 
Fe1 N4 C28 C27 36.86(15) 
 
C3 C4 C12 C17 81.09(19) 
Fe1 N4 C29 C30 -163.84(9) 
 
C3 C18 C19 C20 -174.06(17) 
Fe1 N4 C29 C44 70.84(15) 
 
C3 C18 C23 C22 174.19(18) 
S1 N3 C2 N2 117.70(13) 
 
C4 N3 C2 N2 -16.80(17) 
S1 N3 C2 C1 -123.01(13) 
 
C4 N3 C2 C1 102.48(15) 
S1 N3 C4 C3 -139.88(11) 
 
C4 C3 C18 C19 101.66(19) 
S1 N3 C4 C12 96.94(15) 
 
C4 C3 C18 C23 -71.9(2) 
S1 C5 C6 C7 -173.06(18) 
 
C4 C12 C13 C14 178.23(16) 
S1 C5 C10 C9 172.37(18) 
 
C4 C12 C17 C16 -178.24(16) 
S2 N5 C28 N4 133.04(12) 
 
C5 S1 N3 C2 -72.54(14) 
S2 N5 C28 C27 -106.74(14) 
 
C5 S1 N3 C4 58.93(14) 
S2 N5 C30 C29 -156.99(11) 
 
C5 C6 C7 C8 1.5(4) 
S2 N5 C30 C38 80.86(17) 
 
C6 C5 C10 C9 -1.0(3) 
S2 C31 C32 C33 178.78(14) 
 
C6 C7 C8 C9 -2.6(4) 
S2 C31 C36 C35 179.72(14) 
 
C6 C7 C8 C11 178.7(3) 
F1 Fe1 N1 C1 -67.58(13) 
 
C7 C8 C9 C10 1.9(4) 
F1 Fe1 N1 C27 106.64(13) 
 
C8 C9 C10 C5 -0.1(4) 
F1 Fe1 N2 C2 56.73(10) 
 
C10 C5 C6 C7 0.3(3) 
F1 Fe1 N2 C3 174.50(11) 
 
C11 C8 C9 C10 -179.4(3) 
F1 Fe1 N4 C28 -107.76(10) 
 
C12 C13 C14 C15 -0.1(3) 
F1 Fe1 N4 C29 11.98(11) 
 
C13 C12 C17 C16 -1.0(3) 
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O1 S1 N3 C2 173.13(11) 
 
C13 C14 C15 C16 -1.1(3) 
O1 S1 N3 C4 -55.40(13) 
 
C14 C15 C16 C17 1.2(3) 
O1 S1 C5 C6 -164.86(16) 
 
C15 C16 C17 C12 -0.1(3) 
O1 S1 C5 C10 21.77(19) 
 
C17 C12 C13 C14 1.2(3) 
O2 S1 N3 C2 43.90(14) 
 
C18 C3 C4 N3 147.91(14) 
O2 S1 N3 C4 175.37(12) 
 
C18 C3 C4 C12 -87.53(17) 
O2 S1 C5 C6 -31.66(19) 
 
C18 C19 C20 C21 -0.2(3) 
O2 S1 C5 C10 154.97(16) 
 
C19 C18 C23 C22 0.6(3) 
O3 S2 N5 C28 179.97(13) 
 
C19 C20 C21 C22 0.5(3) 
O3 S2 N5 C30 -46.90(14) 
 
C20 C21 C22 C23 -0.3(3) 
O3 S2 C31 C32 29.16(16) 
 
C21 C22 C23 C18 -0.3(3) 
O3 S2 C31 C36 -150.30(14) 
 
C23 C18 C19 C20 -0.3(3) 
O4 S2 N5 C28 51.60(13) 
 
C24 C1 C2 N2 158.36(16) 
O4 S2 N5 C30 -175.27(12) 
 
C24 C1 C2 N3 41.4(2) 
O4 S2 C31 C32 160.92(14) 
 
C24 C25 C26 C27 0.1(3) 
O4 S2 C31 C36 -18.55(16) 
 
C25 C26 C27 N1 -1.0(3) 
N1 Fe1 F1 B1 131.58(14) 
 
C25 C26 C27 C28 173.05(16) 
N1 Fe1 N2 C2 -30.62(10) 
 
C26 C27 C28 N4 152.32(16) 
N1 Fe1 N2 C3 87.15(11) 
 
C26 C27 C28 N5 34.8(2) 
N1 Fe1 N4 C28 -23.79(10) 
 
C27 N1 C1 C2 -178.05(15) 
N1 Fe1 N4 C29 95.95(11) 
 
C27 N1 C1 C24 -0.4(3) 
N1 C1 C2 N2 -24.0(2) 
 
C28 N4 C29 C30 -41.41(15) 
N1 C1 C2 N3 -141.01(15) 
 
C28 N4 C29 C44 -166.73(13) 
N1 C1 C24 C25 -0.6(3) 
 
C28 N5 C30 C29 -20.68(16) 
N1 C27 C28 N4 -33.2(2) 
 
C28 N5 C30 C38 -142.83(14) 
N1 C27 C28 N5 -150.76(14) 
 
C29 N4 C28 N5 28.16(16) 
N2 Fe1 F1 B1 57.30(13) 
 
C29 N4 C28 C27 -93.23(15) 
N2 Fe1 N1 C1 19.54(13) 
 
C29 C30 C38 C39 112.70(18) 
N2 Fe1 N1 C27 -166.24(14) 
 
C29 C30 C38 C43 -64.8(2) 
N2 Fe1 N4 C28 -10.25(17) 
 
C29 C44 C45 C46 -176.96(17) 
N2 Fe1 N4 C29 109.49(13) 
 
C29 C44 C49 C48 177.42(18) 
N2 C3 C4 N3 24.09(15) 
 
C30 N5 C28 N4 -4.09(17) 
N2 C3 C4 C12 148.65(14) 
 
C30 N5 C28 C27 116.13(15) 
N2 C3 C18 C19 -139.81(16) 
 
C30 C29 C44 C45 -52.9(2) 
N2 C3 C18 C23 46.6(2) 
 
C30 C29 C44 C49 129.81(17) 
N3 S1 C5 C6 82.25(18) 
 
C30 C38 C39 C40 -178.39(17) 
N3 S1 C5 C10 -91.12(17) 
 
C30 C38 C43 C42 178.75(17) 
N3 C4 C12 C13 21.9(2) 
 
C31 S2 N5 C28 -63.37(13) 
N3 C4 C12 C17 -160.97(15) 
 
C31 S2 N5 C30 69.75(14) 
N4 Fe1 F1 B1 -153.60(13) 
 
C31 C32 C33 C34 1.6(3) 
N4 Fe1 N1 C1 -167.69(14) 
 
C32 C31 C36 C35 0.3(3) 
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N4 Fe1 N1 C27 6.53(12) 
 
C32 C33 C34 C35 0.0(3) 
N4 Fe1 N2 C2 -44.26(16) 
 
C32 C33 C34 C37 -179.71(19) 
N4 Fe1 N2 C3 73.51(15) 
 
C33 C34 C35 C36 -1.6(3) 
N4 C29 C30 N5 37.75(14) 
 
C34 C35 C36 C31 1.4(3) 
N4 C29 C30 C38 160.44(13) 
 
C36 C31 C32 C33 -1.8(3) 
N4 C29 C44 C45 65.6(2) 
 
C37 C34 C35 C36 178.16(19) 
N4 C29 C44 C49 -111.68(18) 
 
C38 C39 C40 C41 -0.2(3) 
N5 S2 C31 C32 -85.44(15) 
 
C39 C38 C43 C42 1.2(3) 
N5 S2 C31 C36 95.10(15) 
 
C39 C40 C41 C42 0.8(3) 
N5 C30 C38 C39 -132.34(16) 
 
C40 C41 C42 C43 -0.4(3) 
N5 C30 C38 C43 50.1(2) 
 
C41 C42 C43 C38 -0.6(3) 
N6 Fe1 N1 C1 110.68(13) 
 
C43 C38 C39 C40 -0.8(3) 
N6 Fe1 N1 C27 -75.10(13) 
 
C44 C29 C30 N5 161.23(14) 
N6 Fe1 N2 C2 -126.91(11) 
 
C44 C29 C30 C38 -76.09(18) 
N6 Fe1 N2 C3 -9.14(12) 
 
C44 C45 C46 C47 -1.1(3) 
N6 Fe1 N4 C28 74.98(11) 
 
C45 C44 C49 C48 0.1(3) 
N6 Fe1 N4 C29 -165.28(11) 
 
C45 C46 C47 C48 1.5(3) 
N7 Fe1 F1 B1 -56.28(14) 
 
C46 C47 C48 C49 -1.2(3) 
N7 Fe1 N2 C2 140.81(11) 
 
C47 C48 C49 C44 0.4(3) 
N7 Fe1 N2 C3 -101.43(12) 
 
C49 C44 C45 C46 0.3(3) 
N7 Fe1 N4 C28 165.05(11)             
  
Table 8 Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement 
Parameters (Å
2
×10
3
) for (R,R)-20 
Atom x y z U(eq) 
H2 6583 2677 903 17(5) 
H2A 7723 2615 1359 16(5) 
H3 4416 3034 1278 12(5) 
H4 5868 6264 1153 21(5) 
H4A 5055 1209 1159 5(4) 
H6 8969 1465 1031 20(5) 
H7 9254 1185 421 35(6) 
H9 6290 -562 428 62(9) 
H10 6019 -317 1036 53(8) 
H11A 8188 -483 -77 109(14) 
H11B 8599 556 -126 84(12) 
H11C 7130 273 -156 140(20) 
H13 4526 1938 2039 28(6) 
H14 2705 1621 2375 34(6) 
H15 921 968 2109 37(6) 
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H16 931 671 1495 37(7) 
H17 2756 984 1159 15(5) 
H19 2452 3021 950 18(5) 
H20 1311 2714 429 31(6) 
H21 2320 2016 -51 27(6) 
H22 4468 1602 -11 27(6) 
H23 5610 1901 511 18(5) 
H24 6867 2588 2162 27(6) 
H25 6637 3792 2567 23(5) 
H26 6205 5262 2355 22(5) 
H28 4878 5735 1632 4(4) 
H29 8153 6002 1464 9(5) 
H30 6659 7602 1511 11(5) 
H32 5021 8773 1670 24(6) 
H33 3548 9333 1260 38(7) 
H35 1242 7186 1434 34(6) 
H36 2739 6573 1827 34(6) 
H37A 1442 8405 806 51(8) 
H37B 1407 9348 1018 48(7) 
H37C 436 8552 1121 89(12) 
H39 8042 8788 1599 21(5) 
H40 9786 9456 1890 53(8) 
H41 10994 8609 2286 42(7) 
H42 10518 7087 2388 27(6) 
H43 8792 6405 2094 17(5) 
H45 6737 7627 878 34(6) 
H46 7653 8068 336 34(6) 
H47 9605 7468 159 24(6) 
H48 10606 6371 508 48(8) 
H49 9690 5916 1046 34(6) 
H51A 1547 4968 858 35(6) 
H51B 2073 5939 980 40(7) 
H51C 1771 5175 1271 44(7) 
H53A 6625 5360 -277 109(14) 
H53B 7985 5718 -145 98(13) 
H53C 6735 6318 -79 117(15) 
H55A 1084 3065 1674 69(10) 
H55B -250 2733 1835 60(9) 
H55C 868 3057 2096 69(10) 
H57A 2057 5113 2504 77(11) 
H57B 3558 5048 2577 90(12) 
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H57C 2687 4159 2608 71(9) 
 
     
 
1.3. Fe(OTf)2L1(THF) complex (CCDC 945601) 
 
Table 2 Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for CCDC 945601. Ueq is defined as 1/3 of of 
the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
Fe1 5853.2(3) 5853.2(3) 0 17.29(12) 
S1 8120.9(6) 7358.5(8) -928.20(14) 27.77(18) 
S2 3671.0(7) 7920.1(7) 213.50(13) 25.30(16) 
O3 4538.7(18) 4538.7(18) 0 28.5(7) 
N4 7216(2) 7216(2) 0 21.6(7) 
O5 4442.0(19) 7202.9(18) 43.7(4) 24.8(4) 
O6 8178(2) 8468(2) -1070.2(4) 36.3(6) 
O7 2405(2) 7912(2) 147.4(4) 36.1(5) 
F8 3594(3) 10283(2) 281.5(4) 59.2(7) 
F9 3959(2) 9735.3(18) -105.2(4) 44.2(5) 
C10 3979(3) 5799(3) -776.8(6) 26.6(6) 
O11 9208(2) 6828(2) -823.0(4) 37.7(6) 
C12 1816(3) 5651(3) -725.1(6) 32.7(7) 
C13 4172(4) 9470(3) 136.6(6) 36.6(8) 
N14 6090(2) 6337(2) -414.2(4) 18.5(5) 
F15 5362(2) 9595.2(19) 180.2(5) 52.3(6) 
C16 1851(3) 6576(3) -550.0(6) 31.2(7) 
C17 2951(3) 7109(3) -482.5(5) 24.0(6) 
C18 5933(2) 7919(3) -738.6(5) 19.9(6) 
O19 3971(2) 7758(2) 477.8(4) 36.9(5) 
N20 7229(2) 7630(2) -681.4(4) 22.1(5) 
C21 7556(3) 7727(3) 220.1(5) 28.5(6) 
C22 7356(3) 6269(3) -1119.8(5) 26.4(6) 
C23 6608(3) 4252(3) -1186.9(6) 34.1(7) 
C24 5235(2) 7278(2) -517.1(5) 17.7(5) 
C25 4032(3) 6717(2) -595.3(5) 18.9(5) 
C26 5651(3) 9266(3) -753.9(5) 25.7(6) 
C27 6846(3) 7310(3) 453.6(5) 22.9(6) 
C28 6024(3) 4605(3) -1414.3(6) 32.6(7) 
C29 2877(3) 5259(3) -841.4(6) 31.5(7) 
C30 7273(3) 5060(3) -1041.9(5) 29.6(7) 
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C31 2928(3) 3285(3) 135.7(8) 43.8(9) 
C32 6788(3) 6661(3) -1340.3(5) 29.8(7) 
C33 6141(3) 5820(3) -1486.4(6) 32.7(7) 
C34 4993(4) 11711(3) -776.8(8) 51.5(10) 
C35 5930(4) 11343(3) -626.3(7) 44.2(8) 
C37 5263(4) 3671(3) -1568.4(7) 46.9(10) 
C39 4083(5) 3413(4) -1423.8(8) 58.7(12) 
C40 8431(4) 8634(4) 228.7(6) 43.2(9) 
C42 4920(5) 4183(4) -1830.1(7) 55.5(11) 
C44 4726(4) 9644(4) -909.7(10) 65.3(11) 
C48 3443(3) 4565(3) 153.0(8) 42.5(9) 
C51 4391(5) 10860(4) -914.5(11) 76.5(12) 
C52 6252(3) 10129(3) -613.0(7) 38.8(8) 
C1 8976(3) 8976(3) 0 53.2(14) 
C2 5998(6) 2499(4) -1606(1) 83.8(19) 
  
Table 3 Anisotropic Displacement Parameters (Å
2
×10
3
) for CCDC 945601. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+...+2hka×b×U12] 
Atom U11 U22 U33 U23 U13 U12 
Fe1 18.77(16) 18.77(16) 14.3(2) 0.49(15) -0.49(15) -3.9(2) 
S1 17.8(3) 48.1(5) 17.4(3) 6.7(3) 1.1(3) -4.4(3) 
S2 31.2(4) 27.0(4) 17.7(3) 0.8(3) 2.1(3) 1.8(3) 
O3 24.6(9) 24.6(9) 36.4(17) -4.9(10) 4.9(10) -8.0(11) 
N4 24.8(10) 24.8(10) 15.3(15) 5.1(10) -5.1(10) -5.6(14) 
O5 31.2(11) 20.5(10) 22.6(10) -0.7(8) -1.3(8) 4.3(8) 
O6 27.5(12) 54.9(16) 26.4(11) 11.1(10) 1.6(9) -13.7(11) 
O7 32.6(12) 45.0(14) 30.9(11) 3.5(10) 2.5(10) 5.9(11) 
F8 97(2) 32.4(12) 47.8(13) -14(1) 11.9(13) 16.3(12) 
F9 73.2(16) 29.3(10) 30.2(10) 6.8(8) 3(1) 3.3(10) 
C10 20.9(14) 30.4(15) 28.4(15) -3.1(13) -2.6(12) -0.7(12) 
O11 18.9(11) 67.7(17) 26.4(11) 6.1(11) 0.1(9) -1.8(11) 
C12 21.0(15) 34.6(18) 42.6(18) 8.5(15) -9.6(14) -10.3(13) 
C13 54(2) 23.5(16) 32.2(17) -3.0(13) 0.5(16) 5.2(15) 
N14 17.4(12) 22.8(11) 15.4(10) 0.5(9) -1.8(8) -3.0(9) 
F15 59.5(15) 31.0(11) 66.5(15) 2.4(11) -11.3(12) -13.3(10) 
C16 18.4(15) 45(2) 30.3(16) 5.8(14) 2.7(12) -1.7(13) 
C17 21.9(14) 30.6(16) 19.6(13) 0.7(12) -2.0(11) -1.2(11) 
C18 16.5(13) 30.5(15) 12.9(11) 2.3(10) -4.3(10) -6.2(11) 
O19 40.6(14) 50.4(15) 19.6(10) 3.8(10) 0.5(9) -0.5(11) 
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N20 16.9(11) 34.8(13) 14.6(10) 4.8(10) -3.2(9) -7(1) 
C21 36.3(16) 26.4(15) 22.8(14) 7.7(11) -9.6(12) -11.7(12) 
C22 21.8(14) 44.7(18) 12.6(12) -0.3(12) 2.3(11) 2.8(13) 
C23 46(2) 33.8(18) 22.0(14) 1.2(14) 0.2(14) 14.2(15) 
C24 18.2(13) 19.2(13) 15.8(12) -1(1) -1(1) -3.0(11) 
C25 17.3(13) 20.6(13) 18.8(13) 1.7(10) -1.9(10) -3.3(10) 
C26 28.5(14) 28.0(14) 20.8(13) 8.3(12) -6.3(11) -8.7(12) 
C27 31.1(15) 20.3(14) 17.3(13) 1.5(11) -6.2(11) -3.2(12) 
C28 42.3(19) 37.1(17) 18.4(14) -5.5(12) -5.7(13) 13.2(14) 
C29 32.4(17) 26.7(16) 35.4(17) -4.6(13) -9.4(14) -5.5(13) 
C30 33.0(17) 44.0(18) 11.9(13) 3.6(12) 1.0(12) 11.6(14) 
C31 28.5(18) 36.2(19) 67(2) 11.7(17) 2.1(17) -8.5(15) 
C32 30.5(17) 39.3(18) 19.6(14) 4.8(13) 0.0(12) 6.5(13) 
C33 38.3(18) 38.6(18) 21.2(14) 1.9(13) -6.0(12) 13.4(15) 
C34 71(2) 25.1(16) 59(2) 10.4(16) -24.8(19) -6.6(16) 
C35 50(2) 35.0(16) 47.7(18) -15.2(15) -11.0(16) -4.4(16) 
C37 81(3) 27.4(17) 32.3(18) -5.0(15) -19.5(19) 15.3(18) 
C39 81(3) 49(2) 47(2) 4.6(19) -20(2) -17(2) 
C40 62(2) 43.9(18) 24.3(15) 12.3(14) -19.3(15) -33.3(16) 
C42 91(3) 42(2) 33(2) -7.0(17) -28(2) 7(2) 
C44 76(2) 34.6(18) 85(3) 9.9(19) -59(2) -10.6(18) 
C48 35.3(19) 36.6(19) 56(2) -4.8(17) 12.7(17) -5.8(15) 
C51 94(3) 36.1(19) 99(3) 15(2) -65(2) -5(2) 
C52 38.7(17) 38.7(17) 39.0(17) -11.0(14) -17.4(15) 4.7(14) 
C1 64(2) 64(2) 31(2) 17.3(19) -17.3(19) -49(3) 
C2 138(5) 45(3) 68(3) -25(2) -48(3) 45(3) 
  
Table 4 Bond Lengths for CCDC 945601 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
Fe1 O3 2.042(3) 
 
C18 N20 1.489(3) 
Fe1 N4 2.117(3) 
 
C18 C24 1.560(4) 
Fe1 O5
1
 2.157(2) 
 
C18 C26 1.514(4) 
Fe1 O5 2.157(2) 
 
N20 C27
1
 1.476(3) 
Fe1 N14
1
 2.252(2) 
 
C21 C27 1.523(4) 
Fe1 N14 2.252(2) 
 
C21 C40 1.385(4) 
S1 O6 1.430(2) 
 
C22 C30 1.393(5) 
S1 O11 1.438(2) 
 
C22 C32 1.383(4) 
S1 N20 1.650(2) 
 
C23 C28 1.409(4) 
S1 C22 1.774(3) 
 
C23 C30 1.378(5) 
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S2 O5 1.460(2) 
 
C24 C25 1.514(4) 
S2 O7 1.433(2) 
 
C26 C44 1.368(5) 
S2 C13 1.834(3) 
 
C26 C52 1.372(4) 
S2 O19 1.436(2) 
 
C27 N14
1
 1.468(3) 
O3 C48 1.447(4) 
 
C27 N20
1
 1.476(3) 
O3 C48
1
 1.447(4) 
 
C28 C33 1.392(5) 
N4 C21
1
 1.337(3) 
 
C28 C37 1.551(5) 
N4 C21 1.337(3) 
 
C31 C31
1
 1.528(8) 
F8 C13 1.333(4) 
 
C31 C48 1.519(5) 
F9 C13 1.323(4) 
 
C32 C33 1.395(5) 
C10 C25 1.388(4) 
 
C34 C35 1.358(6) 
C10 C29 1.390(4) 
 
C34 C51 1.354(6) 
C12 C16 1.370(5) 
 
C35 C52 1.381(5) 
C12 C29 1.384(5) 
 
C37 C39 1.528(6) 
C13 F15 1.334(5) 
 
C37 C42 1.531(5) 
N14 C24 1.497(3) 
 
C37 C2 1.532(5) 
N14 C27
1
 1.468(3) 
 
C40 C1 1.393(4) 
C16 C17 1.388(4) 
 
C44 C51 1.386(6) 
C17 C25 1.395(4) 
 
C1 C40
1
 1.393(4) 
1
+Y,+X,-Z 
  
Table 5 Bond Angles for CCDC 945601 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
O3 Fe1 N4 180.00(3) 
 
N20 C18 C24 103.0(2) 
O3 Fe1 O5
1
 88.73(6) 
 
N20 C18 C26 114.5(2) 
O3 Fe1 O5 88.73(6) 
 
C26 C18 C24 112.3(2) 
O3 Fe1 N14 104.38(6) 
 
C18 N20 S1 116.60(17) 
O3 Fe1 N14
1
 104.38(6) 
 
C27
1
 N20 S1 119.6(2) 
N4 Fe1 O5
1
 91.27(6) 
 
C27
1
 N20 C18 110.2(2) 
N4 Fe1 O5 91.27(6) 
 
N4 C21 C27 115.2(3) 
N4 Fe1 N14
1
 75.62(6) 
 
N4 C21 C40 121.6(3) 
N4 Fe1 N14 75.62(6) 
 
C40 C21 C27 123.0(3) 
O5 Fe1 O5
1
 177.47(12) 
 
C30 C22 S1 120.5(2) 
O5 Fe1 N14
1
 89.31(8) 
 
C32 C22 S1 118.5(3) 
O5
1
 Fe1 N14
1
 91.32(8) 
 
C32 C22 C30 120.8(3) 
O5 Fe1 N14 91.32(8) 
 
C30 C23 C28 122.1(3) 
O5
1
 Fe1 N14 89.30(8) 
 
N14 C24 C18 105.7(2) 
N14 Fe1 N14
1
 151.24(12) 
 
N14 C24 C25 111.3(2) 
O6 S1 O11 120.58(14) 
 
C25 C24 C18 114.2(2) 
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O6 S1 N20 106.29(14) 
 
C10 C25 C17 118.7(3) 
O6 S1 C22 107.48(14) 
 
C10 C25 C24 121.2(3) 
O11 S1 N20 105.35(12) 
 
C17 C25 C24 120.1(2) 
O11 S1 C22 109.70(15) 
 
C44 C26 C18 118.7(3) 
N20 S1 C22 106.60(13) 
 
C44 C26 C52 118.0(3) 
O5 S2 C13 101.10(15) 
 
C52 C26 C18 123.2(3) 
O7 S2 O5 114.30(13) 
 
N14
1
 C27 N20
1
 106.3(2) 
O7 S2 C13 104.12(16) 
 
N14
1
 C27 C21 110.9(2) 
O7 S2 O19 117.08(14) 
 
N20
1
 C27 C21 111.7(2) 
O19 S2 O5 112.93(13) 
 
C23 C28 C37 120.3(3) 
O19 S2 C13 104.98(16) 
 
C33 C28 C23 116.9(3) 
C48 O3 Fe1 125.03(17) 
 
C33 C28 C37 122.8(3) 
C48
1
 O3 Fe1 125.03(17) 
 
C12 C29 C10 119.6(3) 
C48
1
 O3 C48 109.9(3) 
 
C23 C30 C22 119.1(3) 
C21
1
 N4 Fe1 119.62(17) 
 
C48 C31 C31
1
 101.4(2) 
C21 N4 Fe1 119.62(17) 
 
C22 C32 C33 118.9(3) 
C21 N4 C21
1
 120.8(3) 
 
C28 C33 C32 122.2(3) 
S2 O5 Fe1 148.48(13) 
 
C51 C34 C35 118.4(4) 
C25 C10 C29 120.9(3) 
 
C34 C35 C52 120.7(3) 
C16 C12 C29 120.1(3) 
 
C39 C37 C28 108.7(3) 
F8 C13 S2 110.7(3) 
 
C39 C37 C42 107.7(4) 
F8 C13 F15 107.4(3) 
 
C39 C37 C2 110.8(4) 
F9 C13 S2 111.2(2) 
 
C42 C37 C28 110.9(3) 
F9 C13 F8 108.4(3) 
 
C42 C37 C2 108.9(3) 
F9 C13 F15 108.4(3) 
 
C2 C37 C28 109.8(4) 
F15 C13 S2 110.6(2) 
 
C21 C40 C1 117.6(3) 
C24 N14 Fe1 116.00(16) 
 
C26 C44 C51 120.0(4) 
C27
1
 N14 Fe1 109.33(16) 
 
O3 C48 C31 104.9(3) 
C27
1
 N14 C24 105.0(2) 
 
C34 C51 C44 121.7(4) 
C12 C16 C17 120.6(3) 
 
C26 C52 C35 121.1(3) 
C16 C17 C25 120.2(3) 
 
C40 C1 C40
1
 120.7(4) 
1
+Y,+X,-Z 
  
Table 6 Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement 
Parameters (Å
2
×10
3
) for CCDC 945601 
Atom x y z U(eq) 
H10 4691 5541 -856 32 
H12 1077 5286 -766 39 
H14 6016 5648 -509 22 
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H16 1133 6849 -476 37 
H17 2967 7729 -362 29 
H18 5707 7533 -900 24 
H20 7519 8354 -623 27 
H23 6543 3448 -1133 41 
H24 5079 7880 -383 21 
H27 6182 7885 487 28 
H29 2853 4639 -962 38 
H30 7661 4801 -894 36 
H31A 2052 3280 158 53 
H31B 3299 2748 261 53 
H32 6836 7472 -1390 36 
H33 5777 6078 -1637 39 
H34 4771 12527 -785 62 
H35 6359 11915 -531 53 
H39A 4273 3144 -1254 88 
H39B 3632 2791 -1511 88 
H39C 3604 4143 -1415 88 
H40 8646 9002 382 52 
H42A 4445 4910 -1809 83 
H42B 4452 3590 -1922 83 
H42C 5646 4371 -1924 83 
H44 4322 9084 -1012 78 
H48A 2868 5155 86 51 
H48B 3630 4774 328 51 
H51 3735 11098 -1015 92 
H52 6887 9893 -507 47 
H1 9574 9574 0 64 
H2A 6772 2692 -1681 126 
H2B 5560 1958 -1717 126 
H2C 6123 2112 -1444 126 
 
1.4. Cis 1,1’-peroxydiisochroman (CCDC 945602) 
Table 2 Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for CCDC 945602. Ueq is defined as 1/3 of of 
the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O2 -66.2(6) 1766.1(7) 350.5(13) 20.1(3) 
C3 1471.6(9) 2354.7(10) -1489.1(17) 18.9(3) 
C4 883.0(8) 3140.2(10) -920.4(17) 16.7(3) 
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C5 987.7(9) 4190.1(10) -1469.7(17) 18.3(3) 
C6 116.0(9) 2855.6(10) 274.5(17) 17.3(3) 
C7 1348.5(10) 1220.2(11) -897(2) 24.4(3) 
C8 1668.5(9) 4463.2(11) -2599.8(18) 20.1(3) 
C9 2254.7(9) 3681.2(11) -3185.5(18) 21.9(3) 
C10 736.5(9) 1154.9(10) 666(2) 21.4(3) 
C11 2156.1(9) 2641.9(11) -2626.5(18) 22.2(3) 
O1 400.3(6) 3282.7(7) 1928.6(12) 18.2(2) 
  
 
Table 3 Anisotropic Displacement Parameters (Å
2
×10
3
) for CCDC 945602. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+...+2hka×b×U12] 
Atom U11 U22 U33 U23 U13 U12 
O2 19.0(5) 17.7(5) 23.4(5) -0.2(4) -2.6(4) -1.8(3) 
C3 20.1(6) 20.8(7) 15.8(7) -3.7(5) -3.6(5) 1.1(5) 
C4 17.2(6) 19.3(6) 13.6(6) -2.7(5) -2.3(5) 0.1(5) 
C5 18.8(6) 19.6(6) 16.3(7) -2.2(5) -1.6(5) 0.9(5) 
C6 18.3(6) 16.3(6) 17.3(7) -0.3(5) -2.1(5) 0.5(5) 
C7 29.0(8) 18.4(7) 25.6(8) -4.8(6) 0.0(6) 3.9(6) 
C8 20.4(7) 22.2(7) 17.5(7) 0.9(5) -3.0(5) -2.4(5) 
C9 18.4(7) 30.8(7) 16.4(7) -1.9(6) 0.5(5) -2.0(5) 
C10 23.1(7) 16.4(6) 24.6(8) 1.0(5) -2.7(6) 1.2(5) 
C11 20.0(7) 27.5(7) 19.1(7) -5.0(5) -0.4(6) 3.9(5) 
O1 16.6(5) 22.6(5) 15.4(5) -2.3(3) 4.5(4) -2.5(3) 
 
Table 4 Bond Lengths for CCDC 945602. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
O2 C6 1.3999(15) 
 
C5 C8 1.3842(18) 
O2 C10 1.4416(16) 
 
C6 O1 1.4307(16) 
C3 C4 1.3957(18) 
 
C7 C10 1.513(2) 
C3 C7 1.5101(19) 
 
C8 C9 1.3946(19) 
C3 C11 1.3964(19) 
 
C9 C11 1.385(2) 
C4 C5 1.3962(18) 
 
O1 O1
1
 1.4879(16) 
C4 C6 1.5152(17) 
    
1
-X,+Y,1/2-Z 
Appendix 
 
A32 
 
  
Table 5 Bond Angles for CCDC 945602. 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
C6 O2 C10 111.63(10) 
 
O2 C6 O1 112.79(10) 
C4 C3 C7 119.87(12) 
 
O1 C6 C4 102.92(10) 
C4 C3 C11 118.55(12) 
 
C3 C7 C10 111.34(11) 
C11 C3 C7 121.57(12) 
 
C5 C8 C9 119.51(13) 
C3 C4 C5 120.29(12) 
 
C11 C9 C8 119.94(13) 
C3 C4 C6 120.18(12) 
 
O2 C10 C7 110.37(11) 
C5 C4 C6 119.52(11) 
 
C9 C11 C3 121.17(12) 
C8 C5 C4 120.53(12) 
 
C6 O1 O1
1
 106.57(10) 
O2 C6 C4 113.91(10) 
     
1
-X,+Y,1/2-Z 
  
Table 6 Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement 
Parameters (Å
2
×10
3
) for CCDC 945602.  
Atom x y z U(eq) 
H10A 555(10) 411(12) 910(20) 19(4) 
H5 573(10) 4738(12) -1050(20) 18(4) 
H6 -459(10) 3189(11) -106(19) 12(3) 
H9 2741(11) 3882(13) -3990(20) 26(4) 
H8 1720(10) 5208(12) -2990(20) 19(4) 
H7A 1928(11) 899(13) -560(20) 28(4) 
H7B 1094(11) 804(13) -1870(20) 28(4) 
H11 2564(12) 2097(14) -3020(20) 35(5) 
H10B 1040(10) 1430(11) 1740(20) 18(4) 
 
 
1.5. Trans 1,1’-peroxydiisochroman (CCDC 945603) 
Table 2 Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for CCDC 945603. Ueq is defined as 1/3 of of 
the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O1 10484.6(13) 6206.8(14) 2097.2(4) 18.3(3) 
O2 4550.5(13) 4711.4(14) 2888.8(4) 17.1(2) 
O3 7548.5(14) 5756.3(14) 2774.7(4) 19.2(3) 
C4 8194.8(19) 5965.5(19) 1425.8(5) 14.9(3) 
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O5 7501.0(14) 5164.2(14) 2239.7(4) 19.2(3) 
C6 6737.1(19) 4978.0(19) 3586.3(5) 14.9(3) 
C7 5376(2) 5790.6(19) 3872.8(5) 16.7(3) 
C8 6502(2) 6451(2) 1224.5(6) 19.8(3) 
C9 8618.5(19) 6362.3(19) 1974.4(5) 15.1(3) 
C10 8398(2) 4499(2) 3808.2(6) 22.3(3) 
C11 5720(2) 6107(2) 4382.6(6) 21.9(3) 
C12 6394.8(19) 4568.3(19) 3034.1(5) 15.1(3) 
C13 9044(2) 4785(2) 621.5(6) 21.1(3) 
C14 11332(2) 4624(2) 1344.8(6) 22.2(4) 
C15 3570(2) 6284(2) 3630.8(6) 22.0(4) 
C16 6089(2) 6136(2) 722.5(6) 24.1(4) 
C17 9498(2) 5124.4(19) 1124.5(5) 16.6(3) 
C18 11259(2) 4594(2) 1916.6(6) 22.0(3) 
C19 7370(2) 5292(2) 421.1(6) 23.6(4) 
C20 3738(2) 6318(2) 3061.4(6) 21.5(3) 
C21 8716(2) 4816(2) 4315.1(6) 29.1(4) 
C22 7365(2) 5625(2) 4602.5(6) 26.9(4) 
  
Table 3 Anisotropic Displacement Parameters (Å
2
×10
3
) for CCDC 945603. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+...+2hka×b×U12] 
Atom U11 U22 U33 U23 U13 U12 
O1 15.9(5) 19.7(6) 19.4(5) -1.7(4) -3.4(4) -0.3(4) 
O2 15.7(5) 17.8(5) 17.9(5) -1.0(4) -2.8(4) 0.6(4) 
O3 24.7(6) 21.6(6) 11.3(5) -3.6(4) 2.3(4) -8.5(5) 
C4 16.2(7) 12.4(7) 16.2(7) 0.6(6) 0.6(5) -2.7(6) 
O5 25.5(6) 21.1(6) 11.0(5) -3.9(4) 2.3(4) -8.5(4) 
C6 16.0(7) 13.3(7) 15.3(7) 2.1(6) 0.5(5) -1.6(6) 
C7 16.6(7) 15.1(7) 18.5(7) 1.1(6) 0.1(6) -1.2(6) 
C8 17.8(7) 20.5(8) 21.0(8) -0.4(6) 0.5(6) 1.8(6) 
C9 15.4(7) 13.6(7) 16.2(7) 1.1(6) 0.8(5) -2.3(6) 
C10 18.9(8) 25.3(9) 22.8(8) -2.5(7) -1.3(6) 3.3(6) 
C11 23.0(8) 24.0(8) 18.6(8) -2.3(6) 4.4(6) -0.8(7) 
C12 14.8(7) 14.1(7) 16.5(7) 0.8(6) -0.2(5) -0.5(6) 
C13 22.0(8) 22.4(8) 18.9(8) -0.5(6) 5.5(6) -2.2(6) 
C14 17.6(7) 24.3(8) 24.6(8) -2.5(7) 1.6(6) 4.1(6) 
C15 17.9(8) 23.6(8) 24.4(8) -3.7(7) -0.8(6) 5.5(6) 
C16 19.5(8) 28.8(9) 24.0(8) 2.0(7) -5.2(6) -0.1(7) 
C17 16.8(7) 14.8(7) 18.3(7) 2.6(6) 1.9(5) -2.8(6) 
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C18 19.1(8) 21.7(8) 25.1(8) 0.8(7) -3.4(6) 5.8(6) 
C19 28.4(8) 28.4(9) 13.9(7) 1.5(7) -1.8(6) -6.2(7) 
C20 19.5(8) 20.0(8) 24.9(8) -0.2(6) -5.7(6) 4.9(6) 
C21 24.3(8) 37.2(10) 25.6(9) -0.7(8) -8.9(7) 5.9(8) 
C22 30.2(9) 34.9(10) 15.5(8) -1.5(7) -4.7(6) -1.8(8) 
  
Table 4 Bond Lengths for CCDC 945603. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
O1 C9 1.4014(17) 
 
C7 C11 1.395(2) 
O1 C18 1.4455(18) 
 
C7 C15 1.509(2) 
O2 C12 1.4002(17) 
 
C8 C16 1.385(2) 
O2 C20 1.4457(18) 
 
C10 C21 1.384(2) 
O3 O5 1.4903(14) 
 
C11 C22 1.381(2) 
O3 C12 1.4210(17) 
 
C13 C17 1.397(2) 
C4 C8 1.393(2) 
 
C13 C19 1.385(2) 
C4 C9 1.517(2) 
 
C14 C17 1.506(2) 
C4 C17 1.402(2) 
 
C14 C18 1.518(2) 
O5 C9 1.4184(17) 
 
C15 C20 1.516(2) 
C6 C7 1.399(2) 
 
C16 C19 1.392(2) 
C6 C10 1.392(2) 
 
C21 C22 1.394(2) 
C6 C12 1.517(2) 
    
  
Table 5 Bond Angles for CCDC 945603. 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
C9 O1 C18 112.09(11) 
 
C21 C10 C6 120.34(15) 
C12 O2 C20 111.95(11) 
 
C22 C11 C7 120.95(14) 
C12 O3 O5 104.65(9) 
 
O2 C12 O3 112.65(11) 
C8 C4 C9 119.32(13) 
 
O2 C12 C6 113.73(12) 
C8 C4 C17 120.40(13) 
 
O3 C12 C6 103.79(11) 
C17 C4 C9 120.28(13) 
 
C19 C13 C17 121.20(14) 
C9 O5 O3 105.23(9) 
 
C17 C14 C18 110.89(12) 
C7 C6 C12 120.20(13) 
 
C7 C15 C20 110.73(12) 
C10 C6 C7 120.33(14) 
 
C8 C16 C19 119.36(15) 
C10 C6 C12 119.45(13) 
 
C4 C17 C14 119.92(13) 
C6 C7 C15 119.98(13) 
 
C13 C17 C4 118.20(14) 
C11 C7 C6 118.63(14) 
 
C13 C17 C14 121.89(13) 
C11 C7 C15 121.38(13) 
 
O1 C18 C14 109.48(12) 
C16 C8 C4 120.65(14) 
 
C13 C19 C16 120.17(14) 
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O1 C9 C4 113.49(12) 
 
O2 C20 C15 109.60(12) 
O1 C9 O5 112.80(12) 
 
C10 C21 C22 119.60(15) 
O5 C9 C4 103.31(11) 
 
C11 C22 C21 120.16(15) 
  
Table 6 Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement 
Parameters (Å
2
×10
3
) for CCDC 945603.  
Atom x y z U(eq) 
H8 5640 6991 1429 24 
H9 8210 7547 2051 18 
H10 9298 3964 3615 27 
H11 4830 6652 4577 26 
H12 6816 3382 2965 18 
H13 9883 4209 418 25 
H14A 12256 5450 1237 27 
H14B 11681 3484 1222 27 
H15A 3195 7421 3750 26 
H15B 2635 5452 3727 26 
H16 4967 6486 588 29 
H18A 10512 3625 2028 26 
H18B 12487 4445 2053 26 
H19 7099 5068 84 28 
H20A 2533 6463 2910 26 
H20B 4497 7292 2960 26 
H21 9824 4492 4463 35 
H22 7571 5840 4943 32 
 
 
1.6. 1,1’-Oxydiisochroman (CCDC 945604) 
Table 2 Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for CCDC 945604. Ueq is defined as 1/3 of of 
the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O1 2423.5(5) 11836.7(19) 935.1(4) 21.5(2) 
O2 2500 9005(3) 0 19.5(3) 
C3 3729.9(7) 8893(3) 881.8(5) 18.5(3) 
C4 2971.3(7) 10852(3) 530.0(5) 19.1(3) 
C5 2227.6(7) 9337(3) 1336.3(6) 22.4(3) 
C6 3774.4(7) 7754(3) 1508.6(5) 19.6(3) 
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C7 3042.4(8) 8432(3) 1839.7(6) 22.9(3) 
C8 4492.4(7) 5971(3) 1815.2(6) 22.4(3) 
C9 5156.8(7) 5347(3) 1502.3(6) 24.7(3) 
C10 4394.1(7) 8235(3) 565.2(6) 21.6(3) 
C11 5107.6(7) 6479(3) 873.9(6) 24.4(3) 
  
 
 
Table 3 Anisotropic Displacement Parameters (Å
2
×10
3
) for CCDC 945604. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+...+2hka×b×U12] 
Atom U11 U22 U33 U23 U13 U12 
O1 19.5(4) 22.3(4) 23.7(4) -0.6(3) 6.8(3) 2.3(3) 
O2 17.2(5) 20.2(6) 18.9(5) 0 -0.1(4) 0 
C3 14.1(5) 19.8(6) 20.9(5) -2.9(4) 2.9(4) -3.6(4) 
C4 17.5(5) 21.0(6) 19.0(6) -1.8(4) 4.8(4) -2.4(4) 
C5 17.9(6) 26.0(6) 24.9(6) 0.3(5) 8.4(5) 0.7(5) 
C6 16.4(5) 21.8(6) 20.3(5) -3.3(4) 3.6(4) -3.0(4) 
C7 21.9(6) 28.0(6) 20.2(6) 0.5(5) 7.4(5) 1.9(5) 
C8 20.0(5) 25.4(6) 20.4(6) -1.4(5) 1.7(4) -1.1(5) 
C9 16.3(6) 26.8(6) 28.1(6) -3.2(5) -0.8(5) 1.7(5) 
C10 17.7(5) 25.9(6) 21.7(6) -1.8(5) 5.2(4) -4.0(5) 
C11 15.2(5) 29.8(7) 29.1(6) -4.8(5) 7.1(5) -1.5(5) 
  
Table 4 Bond Lengths for CCDC 945604. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
O1 C4 1.4141(13) 
 
C5 C7 1.5195(16) 
O1 C5 1.4400(14) 
 
C6 C7 1.5129(15) 
O2 C4
1
 1.4288(13) 
 
C6 C8 1.3981(17) 
O2 C4 1.4288(13) 
 
C8 C9 1.3907(16) 
C3 C4 1.5117(16) 
 
C9 C11 1.3934(18) 
C3 C6 1.3926(16) 
 
C10 C11 1.3879(17) 
C3 C10 1.3983(15) 
    
1
1/2-X,+Y,-Z 
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Table 5 Bond Angles for CCDC 945604 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
C4 O1 C5 112.19(9) 
 
C3 C6 C7 119.50(10) 
C4 O2 C4
1
 112.88(12) 
 
C3 C6 C8 119.07(10) 
C6 C3 C4 121.23(10) 
 
C8 C6 C7 121.42(10) 
C6 C3 C10 120.11(10) 
 
C6 C7 C5 110.29(9) 
C10 C3 C4 118.66(10) 
 
C9 C8 C6 120.74(11) 
O1 C4 O2 110.61(8) 
 
C8 C9 C11 119.99(11) 
O1 C4 C3 113.55(9) 
 
C11 C10 C3 120.51(11) 
O2 C4 C3 106.83(9) 
 
C10 C11 C9 119.58(11) 
O1 C5 C7 109.53(9) 
     
1
1/2-X,+Y,-Z 
 
Table 6 Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement 
Parameters (Å
2
×10
3
) for CCDC 945604.  
Atom x y z U(eq) 
H5A 1995(9) 7540(30) 1060(6) 21(3) 
H7A 3212(9) 10180(40) 2160(7) 28(4) 
H7B 2921(9) 6560(30) 2093(7) 26(4) 
H4 3171(8) 12760(30) 367(6) 18(3) 
H9 5652(10) 4050(40) 1709(7) 28(4) 
H5B 1776(9) 10210(30) 1538(6) 23(3) 
H11 5567(10) 6040(40) 653(7) 35(4) 
H10 4349(9) 9040(30) 120(7) 25(3) 
H8 4522(9) 5090(30) 2255(7) 27(3) 
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2. Chapter 2: additional information 
2.1. 
1
H and 
13
C NMR of novel PyBisulidine ligands 
2-((2R,4R,5R)-1-((4-(tert-Butyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)-6-
((2S,4R,5R)-1-((4-(tert-butyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)pyridine  
 
N
N
NH HN
N
O2S SO2
 
 
 
N
N
NH HN
N
O2S SO2
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2-((2R,4R,5R)-1-((4-Methoxyphenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)-6-
((2S,4R,5R)-1-((4-methoxyphenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)pyridine  
 
 
N
N
NH HN
N
O2S SO2
OMeOMe
 
 
 
N
N
NH HN
N
O2S SO2
OMeOMe
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2-((2R,4R,5R)-4,5-Diphenyl-1-tosylimidazolidin-2-yl)-6-((2S,4R,5R)-4,5-diphenyl-1-
tosylimidazolidin-2-yl)pyridine  
 
 
N
N
NH HN
N
O2S SO2
 
 
N
N
NH HN
N
O2S SO2
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2-((2R,4R,5R)-4,5-Diphenyl-1-((4-trifluoromethyl)phenyl)sulfonyl)imidazolidin-2-yl)-6-
((2S, 4R,5R)-4,5-diphenyl-1-((4-(trifluoromethyl)phenyl)sulfonyl)imidazolidin-2-
yl)pyridine  
 
 
N
N
NH HN
N
O2S SO2
CF3CF3
 
 
N
N
NH HN
N
O2S SO2
CF3CF3
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2-((2R,4R,5R)-4,5-Diphenyl-1-((2,4,6-triisopropylphenyl)sulfonyl)imidazolidin-2-yl)-6-
((2S,4R,5R)-4,5-diphenyl-1-((2,4,6-triisopropylphenyl)sulfonyl)imidazolidin-2-
yl)pyridine  
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2-((2R,4R,5R)-1-Benzyl-4,5-diphenyl-3-tosylimidazolidin-2-yl)-6-((2S,4R,5R)-1-benzyl-
4,5-diphenyl-3-tosylimidazolidin-2-yl)pyridine  
 
 
N
N
N N
N
O2S SO2
 
 
 
N
N
N N
N
O2S SO2
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2-((2R,4S,5S)-1-Benzyl-4,5-diphenyl-3-(methoxyphenyl)imidazolidin-2-yl)-6-
((2S,4S,5S)-1-benzyl-4,5-diphenyl-3-(methoxyphenyl)imidazolidin-2-yl)pyridine 
 
N
N
N N
N
S OO S O
O
MeO
OMe
 
 
 
 
N
N
N N
N
S OO S O
O
MeO
OMe
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2-((2R,4S,5S)-1-Benzyl-4,5-diphenyl-3-(methoxyphenyl)imidazolidin-2-yl)-6-
((2S,4S,5S)-1-benzyl-4,5-diphenyl-3-(methoxyphenyl)imidazolidin-2-yl)pyridine  
 
 
N
N
N N
N
O2S SO2
OMe OMe
 
 
N
N
N N
N
O2S SO2
OMe OMe
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2-((2R,4R,5R)-4,5-Diphenyl-1-tosylimidazolidin-2-yl)-6-((2S,4R,5R)-4,5-diphenyl-3-
tosylpyrrolidin -2yl)-4-methoxypyridine 
 
N
N
NH HN
N
SS OO
O
O
OMe
 
 
N
N
NH HN
N
SS OO
O
O
OMe
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1-((2R,4R,5R)-1-((4-(tert-Butyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)-2-
((2S,4R,5R)-1-((4-(tert-butyl)phenyl)sulfonyl)-4,5-diphenylimidazolidin-2-yl)benzene 
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2-((2S,4R,5R)-4,5-Diphenyl-1-((2,4,6-triisopropylphenyl)sulfonyl)imidazolidin-2-yl)-6-
(1H-pyrazol-1-yl)pyridine 
 
 
N
HN
N
SO2
N
N
 
 
N
HN
N
SO2
N
N
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3. Chapter 3: additional information 
3.1. 
1
H and 
13
C NMR of novel compounds  
1,1’-Oxydiisochroman  
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1,1’-Oxybis(3-methylisochroman)  
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7-(Trifuoromethyl)isochroman-1-one  
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1,1’-Oxybis(7-(trifluoromethyl)isochroman)  
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7-Fluoroisochroman-1-one  
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1,1’-Oxybis(7-fluoroisochroman) 
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1,1’-Oxybis(7-chloroisochroman)  
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1-Oxoisochroman-7-yl acetate  
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1,1’-Oxybis(isochroman-7,1-diyl) acetate  
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1,1’-Oxybis(7-methylisochroman)  
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4,4’-(Oxybis(methoxymethylene))bis(bromobenzene)  
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3.2. Assignment of the regioselectivity in phthalides: 
Example of 5-chloroisobenzofuran-1(3H)-one: 
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4. Chapter 4: additional data 
4.1. NMR data of the mechanistic investigations of the Fe(OTF)2-L1 catalysed 
aerobic oxidation of ethers. 
4.1.1. 1,1’-oxybis(3-methyl-3,4-dihydro-1H-isochromene-5,8-dione) (14) 
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4.1.2. Effect of a radical initiator: enlarged NMR spectra  
Scheme 4, entry 1: catalyst only 
 
Scheme 4, entry 2: catalyst in the presence of Luperox 
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Scheme 4, entry 3: Fe(OTf)2 and Luperox 
 
Scheme 4, entry 4: Luperox only 
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4.1.3. Isochroman hydroperoxide 
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4.1.4. Oxidation of the radical clock: NMR of the isolated products 
 
 
B 
B B B 
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4.1.5. Isolation of the 1,1’-peroxydiisochroman intermediate: enlarged spectra 
Scheme 6, entry 1: 1.0 ml isochroman in 2.0 ml C6H6, overnight reaction 
 
Scheme 6, entry 2: 2.0 ml isochroman in 1.0 ml C6H6, overnight reaction 
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Scheme 6, entry 3: 0.5 ml isochroman in 2.0 ml C6H6, 1h reaction 
 
Scheme 6, entry 4: 1.0 ml isochroman in 1.5 ml C6H6, 1h reaction 
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Scheme 6, entry 5: 2.0 ml isochroman in 0.5 ml C6H6, 1h reaction 
 
Scheme 6, entry 6: 2.0 ml isochroman in 0.5 ml C6H6, overnight reaction 
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4.1.6. Conversion of 1,1’- peroxyisochroman to chromanone: enlarged spectra 
Scheme 8, entry 1: starting mixture of 1,1’- peroxyisochroman and 1,1’-
oxydiisochroman 
 
Scheme 8, entry 2: reaction under oxygen atmosphere 
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Scheme 8, entry 3: reaction under N2 atmosphere 
 
Scheme 9, entry 2: reaction run in the presence of radical initiator Luperox 
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Scheme 9, entry 3: reaction run in the presence of radical inhibitor p-benzoquinone 
 
Scheme 10, entry 2: starting mixture of isochroman, 1,1’-peroxidiisochroman and 1,1’-
oxydiisochroman 
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Scheme 10, entry 3: reaction under N2 atmosphere 
 
4.1.7.Effect of the sulfonamide: Comparison between Fe(OTf)2PyBisulidine and 
Fe(OTf)2PyBidine in isochroman oxidation: NMR spectra 
Scheme 11, entry 1: Fe-PyBidine catalyst 
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Scheme 11, entry 2: Fe-PyBisulidine catalyst 
 
4.1.8. Oxidation of THF to γ-butyrolactone: NMR spectra 
NMR spectrum of the crude reaction 
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2,2’-peroxybis(tetrahydrofuran) 
 
 
 
 
 
Appendix 
 
A75 
 
3-(1,3-dioxan-2-yl)propyl formate 
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4.1.9. Isotope labelling experiments: NMR of the peroxide species 
4.1.9.1. 1,1-Peroxydiisochroman under 
16
O2 atmosphere 
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4.1.9.2. 1,1-peroxydiisochroman under 
18
O2 atmosphere 
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4.1.10. H/D exchange experiments: crude NMR spectra 
Reaction under N2 atmosphere 
 
Reaction under O2 atmosphere 
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Mixture of peroxide and oxidation dimer 
 
4.1.11. Experiments with 
2
H-labelled peroxides 
4.1.11.1. 
13
C NMR characterisation of 1,1’-Peroxybis(1,3-dihydroisobenzofuran)-d6: 
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4.1.11.2. Crude 
1
H NMR of the reaction with phthalan-d3. Oxidation of phthalan-d3 in 
the Young’s tube afforded phthalide-d2 in small amounts. Resonances corresponding to the 
aromatic protons of the phthalide-d2 are highlighted with a black arrow. 
 
 
Solution of phthalan-d3 in C6H6 
Crude 1H NMR of the mixture 
after the oxidation reaction 
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4.1.13. Comparison of mass vs gas pressure in samples 10, 9 and 8 
 
sample10.csv 
 
sample9.csv 
 
sample8.csv 
Start 1 
 
Start 1 
 
Start 1 
 End 50 
 
End 10 
 
End 10 
 Dwell 20 
 
Dwell 20 
 
Dwell 20 
 MultVolt 0 
 
MultVolt 0 
 
MultVolt 0 
 MultGain 1 
 
MultGain 1 
 
MultGain 1 
 MultProt 1 
 
MultProt 1 
 
MultProt 1 
 1 2.08E-09 
 
1 6.20E-09 
 
1 6.11E-09 
 1.1 2.46E-09 
 
1.1 5.73E-09 
 
1.1 5.85E-09 
 1.2 2.44E-09 
 
1.2 4.71E-09 
 
1.2 4.77E-09 
 1.3 2.40E-09 
 
1.3 3.64E-09 
 
1.3 3.75E-09 
 1.4 2.95E-09 
 
1.4 4.31E-09 
 
1.4 4.48E-09 
 1.6 4.48E-09 
 
1.5 5.47E-09 
 
1.5 5.62E-09 
 1.7 5.38E-09 
 
1.6 6.61E-09 
 
1.6 6.52E-09 
 1.8 5.94E-09 
 
1.7 7.68E-09 
 
1.7 7.68E-09 
 1.9 5.65E-09 
 
1.8 8.73E-09 
 
1.8 8.79E-09 
 2.1 4.80E-09 
 
1.9 8.44E-09 
 
1.9 8.44E-09 
 2.2 3.73E-09 
 
2 7.97E-09 
 
2 7.97E-09 
 2.3 4.09E-10 
 
2.1 7.10E-09 
 
2.1 7.13E-09 
 2.4 5.41E-11 
 
2.2 5.33E-09 
 
2.2 5.36E-09 
 2.5 4.55E-11 
 
2.3 6.98E-10 
 
2.3 5.20E-10 
 2.7 1.32E-10 
 
2.4 6.82E-11 
 
2.4 1.08E-12 
 2.8 4.55E-11 
 
2.5 1.61E-11 
 
2.5 4.43E-11 
 2.9 6.28E-11 
 
2.6 1.61E-11 
 
2.6 8.78E-11 
 3 4.55E-11 
 
2.7 6.82E-11 
 
2.7 1.31E-10 
 3.2 3.68E-11 
 
2.8 1.03E-10 
 
2.8 1.48E-10 
 3.3 2.44E-10 
 
2.9 5.96E-11 
 
2.9 7.87E-11 
 3.4 1.51E-09 
 
3 1.55E-10 
 
3 7.87E-11 
 3.5 4.39E-09 
 
3.1 1.11E-10 
 
3.1 1.05E-10 
 3.6 7.97E-09 
 
3.2 4.21E-11 
 
3.2 1.48E-10 
 3.8 1.30E-08 
 
3.3 2.16E-10 
 
3.3 2.51E-10 
 3.9 1.20E-08 
 
3.4 1.19E-09 
 
3.4 1.18E-09 
 4 1.21E-08 
 
3.5 3.13E-09 
 
3.5 3.13E-09 
 4.1 1.11E-08 
 
3.6 5.70E-09 
 
3.6 5.62E-09 
 4.3 2.52E-09 
 
3.7 7.63E-09 
 
3.7 7.45E-09 
 4.4 8.87E-11 
 
3.8 9.02E-09 
 
3.8 8.96E-09 
 4.5 9.73E-11 
 
3.9 8.50E-09 
 
3.9 8.32E-09 
 4.6 4.55E-11 
 
4 8.09E-09 
 
4 8.15E-09 
 4.7 1.08E-11 
 
4.1 7.51E-09 
 
4.1 7.51E-09 
 4.9 1.00E-14 
 
4.2 5.91E-09 
 
4.2 5.88E-09 
 5 1.00E-14 
 
4.3 1.71E-09 
 
4.3 1.59E-09 
 5.1 3.68E-11 
 
4.4 1.00E-14 
 
4.4 1.00E-14 
 5.2 1.00E-14 
 
4.5 5.96E-11 
 
4.5 3.57E-11 
 5.4 1.00E-14 
 
4.6 1.00E-14 
 
4.6 1.00E-14 
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5.5 2.16E-12 
 
4.7 4.21E-11 
 
4.7 9.64E-11 
 5.6 2.16E-12 
 
4.8 1.00E-14 
 
4.8 1.00E-14 
 5.7 1.00E-14 
 
4.9 1.00E-14 
 
4.9 1.00E-14 
 5.9 1.00E-14 
 
5 1.00E-14 
 
5 4.43E-11 
 6 1.00E-14 
 
5.1 1.61E-11 
 
5.1 1.00E-14 
 6.1 1.00E-14 
 
5.2 2.49E-11 
 
5.2 9.72E-12 
 6.2 1.00E-14 
 
5.3 1.61E-11 
 
5.3 9.72E-12 
 6.3 1.00E-14 
 
5.4 1.61E-11 
 
5.4 5.30E-11 
 6.5 3.68E-11 
 
5.5 1.00E-14 
 
5.5 1.08E-12 
 6.6 4.55E-11 
 
5.6 5.09E-11 
 
5.6 2.71E-11 
 6.7 4.55E-11 
 
5.7 2.49E-11 
 
5.7 1.00E-14 
 6.8 2.81E-11 
 
5.8 7.56E-12 
 
5.8 1.84E-11 
 7 7.14E-11 
 
5.9 1.00E-14 
 
5.9 1.08E-12 
 
   
6 4.21E-11 
 
6 1.00E-14 
 
   
6.1 2.49E-11 
 
6.1 3.57E-11 
 
   
6.2 1.61E-11 
 
6.2 1.08E-12 
 
   
6.3 1.00E-14 
 
6.3 1.00E-14 
 
   
6.4 2.49E-11 
 
6.4 1.08E-12 
 
   
6.5 1.00E-14 
 
6.5 1.08E-12 
 
   
6.6 1.00E-14 
 
6.6 5.30E-11 
 
   
6.7 2.49E-11 
 
6.7 8.78E-11 
 
   
6.8 2.49E-11 
 
6.8 6.14E-11 
 
   
6.9 1.00E-14 
 
6.9 9.72E-12 
 
   
7 1.00E-14 
 
7 8.78E-11 
  
 
4.1.14. Comparison of mass vs gas pressure in samples 7, 6 and 4. 
 
sample7.csv 
 
sample6.csv 
 
sample4.csv 
Start 1 
 
Start 1 
 
Start 1 
 End 50 
 
End 10 
 
End 10 
 Dwell 20 
 
Dwell 20 
 
Dwell 20 
 MultVolt 0 
 
MultVolt 0 
 
MultVolt 0 
 MultGain 1 
 
MultGain 1 
 
MultGain 1 
 MultProt 1 
 
MultProt 1 
 
MultProt 1 
 1 6.26E-09 
 
1 8.15E-09 
 
1 1.03E-08 
 1.1 5.53E-09 
 
1.1 8.03E-09 
 
1.1 1.69E-05 
 1.2 4.57E-09 
 
1.2 6.52E-09 
 
1.2 6.81E-09 
 1.3 3.75E-09 
 
1.3 3.68E-09 
 
1.3 3.20E-09 
 1.4 4.54E-09 
 
1.4 4.16E-09 
 
1.4 3.75E-09 
 1.6 6.78E-09 
 
1.5 5.21E-09 
 
1.5 5.68E-09 
 1.7 7.97E-09 
 
1.6 6.58E-09 
 
1.6 7.92E-09 
 1.8 8.91E-09 
 
1.7 8.27E-09 
 
1.7 1.01E-08 
 1.9 8.56E-09 
 
1.8 9.55E-09 
 
1.8 1.29E-08 
 2.1 6.96E-09 
 
1.9 9.26E-09 
 
1.9 1.44E-08 
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2.2 5.18E-09 
 
2 9.02E-09 
 
2 1.36E-08 
 2.3 4.95E-10 
 
2.1 8.09E-09 
 
2.1 1.16E-08 
 2.4 3.24E-12 
 
2.2 6.20E-09 
 
2.2 7.92E-09 
 2.5 6.37E-11 
 
2.3 1.21E-09 
 
2.3 1.43E-09 
 2.7 9.82E-11 
 
2.4 1.00E-14 
 
2.4 1.96E-10 
 2.8 1.16E-10 
 
2.5 4.43E-11 
 
2.5 6.91E-10 
 2.9 7.23E-11 
 
2.6 8.78E-11 
 
2.6 1.57E-09 
 3 1.85E-10 
 
2.7 1.84E-11 
 
2.7 2.24E-09 
 3.2 2.91E-11 
 
2.8 8.78E-11 
 
2.8 2.87E-09 
 3.3 1.33E-10 
 
2.9 3.57E-11 
 
2.9 3.04E-09 
 3.4 8.84E-10 
 
3 2.71E-11 
 
3 2.79E-09 
 3.5 2.60E-09 
 
3.1 9.64E-11 
 
3.1 2.39E-09 
 3.6 4.74E-09 
 
3.2 6.14E-11 
 
3.2 1.88E-09 
 3.8 7.07E-09 
 
3.3 8.78E-11 
 
3.3 4.04E-10 
 3.9 6.64E-09 
 
3.4 4.43E-11 
 
3.4 1.11E-10 
 4 6.58E-09 
 
3.5 9.72E-12 
 
3.5 1.45E-10 
 4.1 5.68E-09 
 
3.6 1.84E-11 
 
3.6 4.66E-10 
 4.3 1.10E-09 
 
3.7 4.43E-11 
 
3.7 7.42E-10 
 4.4 1.07E-10 
 
3.8 9.72E-12 
 
3.8 9.31E-10 
 4.5 1.19E-11 
 
3.9 1.00E-14 
 
3.9 1.06E-09 
 4.6 1.00E-14 
 
4 9.72E-12 
 
4 9.53E-10 
 4.7 9.82E-11 
 
4.1 1.00E-14 
 
4.1 8.29E-10 
 4.9 3.77E-11 
 
4.2 1.00E-14 
 
4.2 7.17E-10 
 5 7.23E-11 
 
4.3 1.00E-14 
 
4.3 2.23E-10 
 5.1 8.96E-11 
 
4.4 1.00E-14 
 
4.4 1.00E-14 
 5.2 1.00E-14 
 
4.5 1.84E-11 
 
4.5 1.00E-14 
 5.4 1.00E-14 
 
4.6 1.84E-11 
 
4.6 1.00E-14 
 5.5 1.00E-14 
 
4.7 1.00E-14 
 
4.7 1.00E-14 
 5.6 1.00E-14 
 
4.8 1.00E-14 
 
4.8 1.00E-14 
 5.7 2.91E-11 
 
4.9 1.08E-12 
 
4.9 1.00E-14 
 5.9 2.06E-11 
 
5 9.72E-12 
 
5 1.00E-14 
 6 1.00E-14 
 
5.1 4.43E-11 
 
5.1 1.00E-14 
 6.1 1.00E-14 
 
5.2 1.00E-14 
 
5.2 1.00E-14 
 6.2 1.00E-14 
 
5.3 2.71E-11 
 
5.3 1.00E-14 
 6.3 1.00E-14 
 
5.4 1.00E-14 
 
5.4 1.00E-14 
 6.5 2.91E-11 
 
5.5 5.30E-11 
 
5.5 1.51E-11 
 6.6 1.19E-11 
 
5.6 1.08E-12 
 
5.6 1.00E-14 
 6.7 3.77E-11 
 
5.7 9.72E-12 
 
5.7 1.00E-14 
 6.8 8.96E-11 
 
5.8 1.00E-14 
 
5.8 6.48E-12 
 7 1.25E-10 
 
5.9 1.08E-12 
 
5.9 1.00E-14 
 
   
6 1.08E-12 
 
6 1.51E-11 
 
   
6.1 1.00E-14 
 
6.1 1.00E-14 
 
   
6.2 1.00E-14 
 
6.2 1.00E-14 
 
   
6.3 1.00E-14 
 
6.3 1.00E-14 
 
   
6.4 1.00E-14 
 
6.4 6.48E-12 
 
   
6.5 1.00E-14 
 
6.5 1.00E-14 
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6.6 5.30E-11 
 
6.6 5.82E-11 
 
   
6.7 2.71E-11 
 
6.7 1.79E-10 
 
   
6.8 5.30E-11 
 
6.8 2.75E-10 
 
   
6.9 6.14E-11 
 
6.9 2.91E-10 
 
   
7 1.84E-11 
 
7 2.49E-10 
  
5. Chapter 5: additional data 
5.1. NMR of products 
5.1.1. 2-(Hydroxyethyl)benzophenone products from the Csp
3
-O cleavage of 1-
arylisochromans 
(4-Fluorophenyl)(2-(2-hydroxyethyl)-4,5-dimethoxyphenyl)methanone 
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(2-(2-Hydroxyethyl)-4,5-dimethoxyphenyl)(4-methoxyphenyl)methanone 
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(2-(2-Hydroxyethyl)-4,5-dimethoxyphenyl)(phenyl)methanone 
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(4-Fluorophenyl)(3-(2-hydroxyethyl)thiophen-2-yl)methanone 
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(3-(2-Hydroxyethyl)thiophen-2-yl)(4-(trifluoromethyl)phenyl)methanone 
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(4-Fluorophenyl)(3-(2-hydroxyethyl)-1-methyl-1H-indol-2-yl)methanone 
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Cyclopropyl(3-(2-hydroxyethyl)thiophen-2-yl)methanone 
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5.1.2. Products from the selective Csp
3
-Csp
3
 cleavage of 1-alkyl isochromans 
1,1’-Bi(cyclohexane) 
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6,7-Dimethoxy-3-(4-methoxyphenyl)-4-methylisochroman-1-one 
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3-(3,4-Dimethylphenyl)-6,7-dimethoxy-4-methylisochroman-1-one 
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5.1.3. Products from the cleavage of 1-alkyl 5,7-dihydro-4H-thieno[2,3c]pyranes 
1-(3-(2-Hydroethyl)thiophen-2-yl)-2,2-dimethylpropan-1-one 
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5.1.4. Products from the Csp
2
-Csp
3
 and Csp
3
-O cleavage of 1-methylisochromans 
2-(4-Fluorophenyl)ethanol 
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2-(Thiophen-3-yl)ethanol 
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2-(4-Methoxyphenyl)ethanol 
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2-(3,4-Dimethoxyphenyl)ethanol 
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5.1.5. Combined Csp
3
-Csp
2
 and Csp
2
-N cleavage: example of the decarboxylation of 
ethyl 1-(tetrahydrofuran-2-carbonyl)piperidine-3-carboxylate 
Crude 
1
H NMR 
 
Isolated amine 
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6. Chapter 6: additional data 
6.1. Aerobic cleavage of styrene in the presence of a radical initiator. Crude 
1
H NMR 
spectra of the aerobic cleavage of styrene in the presence and in the absence of the radical 
initiator benzoyl peroxide. 
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Without initiator, enlarged spectra 
 
 
 
 
Appendix 
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With radical inititator, enlarged spectra 
 
 
6.2. Iron catalysed oxidation of vinyl bromide to phenacyl bromide. Crude 1H NMR 
spectra of the catalytic oxidation of vinyl bromide in the presence and in the absence of 
diphenyl sulphide. 
Crude 
1
H NMR of the Fe(OTf)3-L1 catalysed oxygenation of 1-bromostyrene (no Ph2S) 
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Crude 
1
H NMR of the Fe(OTf)3-L1 catalysed oxygenation of 1-bromostyrene (with 0.5 
equiv. Ph2S) 
 
 
Chapter 7: additional data 
α-Methylstyrene dimers under thermodynamic conditions 
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1,1,3-Trimethyl-3-phenyl-2,3-dihydro-1H-indene obtained using triflic acid as catalyst 
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Product distribution obtained using Bi(OTf)3 as catalyst 
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Example of a very electron rich substrate: 1-methoxy-4-(prop-1-en-2-yl)benzene 
dimers (integrated signals correspond to the internal olefin product) 
 
 
 
 
 
